WO2015049370A1 - Detergent composition and use of detergent composition - Google Patents
Detergent composition and use of detergent composition Download PDFInfo
- Publication number
- WO2015049370A1 WO2015049370A1 PCT/EP2014/071231 EP2014071231W WO2015049370A1 WO 2015049370 A1 WO2015049370 A1 WO 2015049370A1 EP 2014071231 W EP2014071231 W EP 2014071231W WO 2015049370 A1 WO2015049370 A1 WO 2015049370A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lipase
- seq
- points
- cellulase
- enzyme
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 264
- 239000003599 detergent Substances 0.000 title claims abstract description 144
- 108090001060 Lipase Proteins 0.000 claims abstract description 167
- 102000004882 Lipase Human genes 0.000 claims abstract description 167
- 239000004367 Lipase Substances 0.000 claims abstract description 166
- 235000019421 lipase Nutrition 0.000 claims abstract description 166
- 108010059892 Cellulase Proteins 0.000 claims abstract description 124
- 238000000034 method Methods 0.000 claims abstract description 98
- 229940106157 cellulase Drugs 0.000 claims abstract description 90
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 150
- 229920001184 polypeptide Polymers 0.000 claims description 139
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 139
- 102000004190 Enzymes Human genes 0.000 claims description 131
- 108090000790 Enzymes Proteins 0.000 claims description 131
- 229940088598 enzyme Drugs 0.000 claims description 130
- 150000003839 salts Chemical class 0.000 claims description 78
- 230000000694 effects Effects 0.000 claims description 75
- 238000006467 substitution reaction Methods 0.000 claims description 69
- 150000001413 amino acids Chemical class 0.000 claims description 65
- 239000004753 textile Substances 0.000 claims description 55
- 238000000576 coating method Methods 0.000 claims description 52
- 239000008187 granular material Substances 0.000 claims description 51
- 239000011248 coating agent Substances 0.000 claims description 50
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 49
- 150000002632 lipids Chemical class 0.000 claims description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 40
- 230000007935 neutral effect Effects 0.000 claims description 33
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 28
- 210000004027 cell Anatomy 0.000 claims description 22
- 239000004094 surface-active agent Substances 0.000 claims description 22
- 239000012634 fragment Substances 0.000 claims description 21
- 230000002378 acidificating effect Effects 0.000 claims description 18
- 239000000872 buffer Substances 0.000 claims description 17
- 239000003054 catalyst Substances 0.000 claims description 17
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 16
- 150000001768 cations Chemical class 0.000 claims description 16
- 150000002978 peroxides Chemical class 0.000 claims description 16
- 101710111935 Endo-beta-1,4-glucanase Proteins 0.000 claims description 14
- 235000019626 lipase activity Nutrition 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 239000003638 chemical reducing agent Substances 0.000 claims description 11
- 239000003963 antioxidant agent Substances 0.000 claims description 9
- 230000003078 antioxidant effect Effects 0.000 claims description 8
- 210000004899 c-terminal region Anatomy 0.000 claims description 7
- 239000005711 Benzoic acid Substances 0.000 claims description 5
- 230000001747 exhibiting effect Effects 0.000 claims description 5
- 108010091371 endoglucanase 1 Proteins 0.000 claims description 4
- 108010091384 endoglucanase 2 Proteins 0.000 claims description 4
- 108010092450 endoglucanase Z Proteins 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 3
- 239000011253 protective coating Substances 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 description 71
- -1 optical brighteners Substances 0.000 description 71
- 229940024606 amino acid Drugs 0.000 description 65
- 239000002585 base Substances 0.000 description 46
- 102000040430 polynucleotide Human genes 0.000 description 46
- 108091033319 polynucleotide Proteins 0.000 description 46
- 239000002157 polynucleotide Substances 0.000 description 46
- 102220052839 rs73113102 Human genes 0.000 description 40
- 108020004414 DNA Proteins 0.000 description 39
- 239000003795 chemical substances by application Substances 0.000 description 39
- 239000004744 fabric Substances 0.000 description 38
- 238000004140 cleaning Methods 0.000 description 37
- 239000000975 dye Substances 0.000 description 34
- 229910052799 carbon Inorganic materials 0.000 description 33
- 108090000623 proteins and genes Proteins 0.000 description 33
- 238000005406 washing Methods 0.000 description 33
- 239000002689 soil Substances 0.000 description 32
- 102220598657 5-hydroxytryptamine receptor 1E_D27R_mutation Human genes 0.000 description 30
- 239000007788 liquid Substances 0.000 description 30
- 239000000049 pigment Substances 0.000 description 30
- 229920000642 polymer Polymers 0.000 description 30
- 102000013142 Amylases Human genes 0.000 description 29
- 108010065511 Amylases Proteins 0.000 description 29
- 235000019418 amylase Nutrition 0.000 description 29
- 102220104607 rs879253987 Human genes 0.000 description 29
- 239000002773 nucleotide Substances 0.000 description 28
- 125000003729 nucleotide group Chemical group 0.000 description 28
- 229920002678 cellulose Polymers 0.000 description 24
- 239000001913 cellulose Substances 0.000 description 24
- 239000000843 powder Substances 0.000 description 24
- 239000000344 soap Substances 0.000 description 24
- 102220479102 CD59 glycoprotein_N33Q_mutation Human genes 0.000 description 23
- 108091026890 Coding region Proteins 0.000 description 22
- 239000003925 fat Substances 0.000 description 22
- 235000019197 fats Nutrition 0.000 description 22
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 21
- 229940025131 amylases Drugs 0.000 description 21
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- 102220104423 rs63749907 Human genes 0.000 description 21
- 238000012217 deletion Methods 0.000 description 20
- 230000037430 deletion Effects 0.000 description 20
- 102000004169 proteins and genes Human genes 0.000 description 20
- 239000000523 sample Substances 0.000 description 20
- 238000004061 bleaching Methods 0.000 description 19
- 239000000463 material Substances 0.000 description 19
- 235000018102 proteins Nutrition 0.000 description 19
- 102000035195 Peptidases Human genes 0.000 description 18
- 108091005804 Peptidases Proteins 0.000 description 18
- 108010084185 Cellulases Proteins 0.000 description 17
- 102000005575 Cellulases Human genes 0.000 description 17
- 229920000742 Cotton Polymers 0.000 description 17
- 241000219146 Gossypium Species 0.000 description 17
- 235000015112 vegetable and seed oil Nutrition 0.000 description 17
- 239000008158 vegetable oil Substances 0.000 description 17
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 16
- 239000004365 Protease Substances 0.000 description 16
- 238000007792 addition Methods 0.000 description 16
- 239000002853 nucleic acid probe Substances 0.000 description 16
- 239000002253 acid Substances 0.000 description 15
- 239000000654 additive Substances 0.000 description 15
- 239000000835 fiber Substances 0.000 description 15
- 239000003752 hydrotrope Substances 0.000 description 15
- 239000011734 sodium Substances 0.000 description 15
- 230000001580 bacterial effect Effects 0.000 description 14
- 230000008901 benefit Effects 0.000 description 14
- 239000007844 bleaching agent Substances 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- 229920001577 copolymer Polymers 0.000 description 13
- 230000002538 fungal effect Effects 0.000 description 13
- 229920000728 polyester Polymers 0.000 description 13
- 238000012546 transfer Methods 0.000 description 13
- 235000019737 Animal fat Nutrition 0.000 description 12
- 241000193830 Bacillus <bacterium> Species 0.000 description 12
- 238000003780 insertion Methods 0.000 description 12
- 230000037431 insertion Effects 0.000 description 12
- 102220059797 rs786203763 Human genes 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 239000004372 Polyvinyl alcohol Substances 0.000 description 11
- 235000014121 butter Nutrition 0.000 description 11
- 230000000295 complement effect Effects 0.000 description 11
- 108010005400 cutinase Proteins 0.000 description 11
- 238000004851 dishwashing Methods 0.000 description 11
- 150000004665 fatty acids Chemical class 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- 235000015243 ice cream Nutrition 0.000 description 11
- 229920002451 polyvinyl alcohol Polymers 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 10
- 241001494489 Thielavia Species 0.000 description 10
- 229940001468 citrate Drugs 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 10
- 102220056652 rs397514616 Human genes 0.000 description 10
- 102220087418 rs864622444 Human genes 0.000 description 10
- 210000002374 sebum Anatomy 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 229920002125 Sokalan® Polymers 0.000 description 9
- 230000000996 additive effect Effects 0.000 description 9
- 108090000637 alpha-Amylases Proteins 0.000 description 9
- 102000004139 alpha-Amylases Human genes 0.000 description 9
- 235000019219 chocolate Nutrition 0.000 description 9
- 239000006081 fluorescent whitening agent Substances 0.000 description 9
- 230000004927 fusion Effects 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 238000009396 hybridization Methods 0.000 description 9
- 239000002480 mineral oil Substances 0.000 description 9
- 235000010446 mineral oil Nutrition 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 229920001223 polyethylene glycol Polymers 0.000 description 9
- 238000003752 polymerase chain reaction Methods 0.000 description 9
- 235000019419 proteases Nutrition 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 241000894007 species Species 0.000 description 9
- 229910000368 zinc sulfate Inorganic materials 0.000 description 9
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 8
- 239000004382 Amylase Substances 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 239000002202 Polyethylene glycol Substances 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 229940024171 alpha-amylase Drugs 0.000 description 8
- 125000000539 amino acid group Chemical group 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 239000000945 filler Substances 0.000 description 8
- 230000002209 hydrophobic effect Effects 0.000 description 8
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 230000035772 mutation Effects 0.000 description 8
- 239000002304 perfume Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 238000002741 site-directed mutagenesis Methods 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 235000015424 sodium Nutrition 0.000 description 8
- 239000003381 stabilizer Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 241000223218 Fusarium Species 0.000 description 7
- 241000223198 Humicola Species 0.000 description 7
- 241001480714 Humicola insolens Species 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 239000012190 activator Substances 0.000 description 7
- 239000003945 anionic surfactant Substances 0.000 description 7
- 239000001768 carboxy methyl cellulose Substances 0.000 description 7
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 7
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 7
- 229940105329 carboxymethylcellulose Drugs 0.000 description 7
- 229960004106 citric acid Drugs 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 239000004519 grease Substances 0.000 description 7
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 7
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 7
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 238000002703 mutagenesis Methods 0.000 description 7
- 231100000350 mutagenesis Toxicity 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 7
- 239000001509 sodium citrate Substances 0.000 description 7
- 235000011083 sodium citrates Nutrition 0.000 description 7
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 6
- 239000004471 Glycine Substances 0.000 description 6
- 102000003992 Peroxidases Human genes 0.000 description 6
- 241000589516 Pseudomonas Species 0.000 description 6
- 229920000297 Rayon Polymers 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 108090000787 Subtilisin Proteins 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- 238000010276 construction Methods 0.000 description 6
- 229910000397 disodium phosphate Inorganic materials 0.000 description 6
- 239000002270 dispersing agent Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000002979 fabric softener Substances 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 239000006260 foam Substances 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 238000004900 laundering Methods 0.000 description 6
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 6
- 150000004965 peroxy acids Chemical class 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 5
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 5
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 5
- 102100032487 Beta-mannosidase Human genes 0.000 description 5
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 5
- 102000005741 Metalloproteases Human genes 0.000 description 5
- 108010006035 Metalloproteases Proteins 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 108700020962 Peroxidase Proteins 0.000 description 5
- 108010056079 Subtilisins Proteins 0.000 description 5
- 102000005158 Subtilisins Human genes 0.000 description 5
- 241000223258 Thermomyces lanuginosus Species 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
- 230000004075 alteration Effects 0.000 description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 5
- 108010055059 beta-Mannosidase Proteins 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 5
- 239000002738 chelating agent Substances 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 235000015223 cooked beef Nutrition 0.000 description 5
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 5
- 150000002191 fatty alcohols Chemical class 0.000 description 5
- 239000004220 glutamic acid Substances 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 229930182817 methionine Natural products 0.000 description 5
- 235000006109 methionine Nutrition 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 239000002736 nonionic surfactant Substances 0.000 description 5
- 235000008390 olive oil Nutrition 0.000 description 5
- 239000004006 olive oil Substances 0.000 description 5
- 150000002891 organic anions Chemical class 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical class [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 239000010452 phosphate Chemical class 0.000 description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 5
- 229910052939 potassium sulfate Inorganic materials 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 5
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical group CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 5
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 5
- 229910052727 yttrium Inorganic materials 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- PQHYOGIRXOKOEJ-UHFFFAOYSA-N 2-(1,2-dicarboxyethylamino)butanedioic acid Chemical compound OC(=O)CC(C(O)=O)NC(C(O)=O)CC(O)=O PQHYOGIRXOKOEJ-UHFFFAOYSA-N 0.000 description 4
- NSMMFSKPGXCMOE-UHFFFAOYSA-N 2-[2-(2-sulfophenyl)ethenyl]benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1C=CC1=CC=CC=C1S(O)(=O)=O NSMMFSKPGXCMOE-UHFFFAOYSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- 241000194108 Bacillus licheniformis Species 0.000 description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 241000223221 Fusarium oxysporum Species 0.000 description 4
- 101000598987 Homo sapiens Medium-wave-sensitive opsin 1 Proteins 0.000 description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- 229910017677 NH4H2 Inorganic materials 0.000 description 4
- 102000004316 Oxidoreductases Human genes 0.000 description 4
- 108090000854 Oxidoreductases Proteins 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 108010059820 Polygalacturonase Proteins 0.000 description 4
- 102000012479 Serine Proteases Human genes 0.000 description 4
- 108010022999 Serine Proteases Proteins 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 238000002105 Southern blotting Methods 0.000 description 4
- 101710135785 Subtilisin-like protease Proteins 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 241001284352 Terminalia buceras Species 0.000 description 4
- 241001313536 Thermothelomyces thermophila Species 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 235000004279 alanine Nutrition 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 239000003899 bactericide agent Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000012876 carrier material Substances 0.000 description 4
- 239000000919 ceramic Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000000224 chemical solution deposition Methods 0.000 description 4
- 235000021438 curry Nutrition 0.000 description 4
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 108010093305 exopolygalacturonase Proteins 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000013922 glutamic acid Nutrition 0.000 description 4
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 125000005647 linker group Chemical group 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 4
- 239000006072 paste Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000004014 plasticizer Substances 0.000 description 4
- 239000004584 polyacrylic acid Substances 0.000 description 4
- 229920005646 polycarboxylate Polymers 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Inorganic materials [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 4
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Inorganic materials [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000000375 suspending agent Substances 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 4
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 4
- 229960001763 zinc sulfate Drugs 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- 102000057234 Acyl transferases Human genes 0.000 description 3
- 108700016155 Acyl transferases Proteins 0.000 description 3
- 101710152845 Arabinogalactan endo-beta-1,4-galactanase Proteins 0.000 description 3
- 241000193422 Bacillus lentus Species 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical class [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- 239000003298 DNA probe Substances 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 101710147028 Endo-beta-1,4-galactanase Proteins 0.000 description 3
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 3
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 3
- 102220468791 Inositol 1,4,5-trisphosphate receptor type 2_Y167A_mutation Human genes 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 3
- 229910003202 NH4 Inorganic materials 0.000 description 3
- 229910002651 NO3 Inorganic materials 0.000 description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 241000194109 Paenibacillus lautus Species 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- 102220626757 Probable E3 ubiquitin-protein ligase HERC3_W10D_mutation Human genes 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 241000187747 Streptomyces Species 0.000 description 3
- 241000187392 Streptomyces griseus Species 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical class OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 3
- 108700005078 Synthetic Genes Proteins 0.000 description 3
- 241000203780 Thermobifida fusca Species 0.000 description 3
- 241001495429 Thielavia terrestris Species 0.000 description 3
- 241000499912 Trichoderma reesei Species 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 229920006397 acrylic thermoplastic Polymers 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 108010089934 carbohydrase Proteins 0.000 description 3
- 238000005352 clarification Methods 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000005260 corrosion Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229920000578 graft copolymer Polymers 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 108010020132 microbial serine proteinases Proteins 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229920000847 nonoxynol Polymers 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002964 rayon Substances 0.000 description 3
- 238000005215 recombination Methods 0.000 description 3
- 230000006798 recombination Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 102220052102 rs35524245 Human genes 0.000 description 3
- 102220087235 rs864622622 Human genes 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 235000019832 sodium triphosphate Nutrition 0.000 description 3
- 229920002994 synthetic fiber Polymers 0.000 description 3
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 3
- 229910052723 transition metal Inorganic materials 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 229910052720 vanadium Inorganic materials 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 238000004383 yellowing Methods 0.000 description 3
- 239000010457 zeolite Substances 0.000 description 3
- LIPJWTMIUOLEJU-UHFFFAOYSA-N 2-(1,2-diamino-2-phenylethenyl)benzenesulfonic acid Chemical class NC(=C(C=1C(=CC=CC1)S(=O)(=O)O)N)C1=CC=CC=C1 LIPJWTMIUOLEJU-UHFFFAOYSA-N 0.000 description 2
- CIEZZGWIJBXOTE-UHFFFAOYSA-N 2-[bis(carboxymethyl)amino]propanoic acid Chemical compound OC(=O)C(C)N(CC(O)=O)CC(O)=O CIEZZGWIJBXOTE-UHFFFAOYSA-N 0.000 description 2
- 102220466243 Acyl-coenzyme A thioesterase MBLAC2_R170A_mutation Human genes 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 241000194103 Bacillus pumilus Species 0.000 description 2
- 108091005658 Basic proteases Proteins 0.000 description 2
- 240000008564 Boehmeria nivea Species 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000589513 Burkholderia cepacia Species 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- 241000123346 Chrysosporium Species 0.000 description 2
- 240000000491 Corchorus aestuans Species 0.000 description 2
- 235000011777 Corchorus aestuans Nutrition 0.000 description 2
- 235000010862 Corchorus capsularis Nutrition 0.000 description 2
- 241000583946 Crinipellis scabella Species 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 2
- 241000567163 Fusarium cerealis Species 0.000 description 2
- 241000146406 Fusarium heterosporum Species 0.000 description 2
- 241000221779 Fusarium sambucinum Species 0.000 description 2
- 102220604065 Homeobox protein SIX3_N39A_mutation Human genes 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 241001016263 Lectera colletotrichoides Species 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 229920000433 Lyocell Polymers 0.000 description 2
- 241001495426 Macrophomina phaseolina Species 0.000 description 2
- 241001344131 Magnaporthe grisea Species 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000187480 Mycobacterium smegmatis Species 0.000 description 2
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
- 229920002319 Poly(methyl acrylate) Polymers 0.000 description 2
- 229920002873 Polyethylenimine Polymers 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
- 241000168225 Pseudomonas alcaligenes Species 0.000 description 2
- 241000589755 Pseudomonas mendocina Species 0.000 description 2
- 241000589630 Pseudomonas pseudoalcaligenes Species 0.000 description 2
- 241000577556 Pseudomonas wisconsinensis Species 0.000 description 2
- 108020004518 RNA Probes Proteins 0.000 description 2
- 239000003391 RNA probe Substances 0.000 description 2
- 239000004115 Sodium Silicate Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004280 Sodium formate Substances 0.000 description 2
- 241001123667 Sordaria fimicola Species 0.000 description 2
- 229920002334 Spandex Polymers 0.000 description 2
- 241001085826 Sporotrichum Species 0.000 description 2
- 241001518258 Streptomyces pristinaespiralis Species 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- BGRWYDHXPHLNKA-UHFFFAOYSA-N Tetraacetylethylenediamine Chemical compound CC(=O)N(C(C)=O)CCN(C(C)=O)C(C)=O BGRWYDHXPHLNKA-UHFFFAOYSA-N 0.000 description 2
- 241000223257 Thermomyces Species 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 101100049199 Xenopus laevis vegt-a gene Proteins 0.000 description 2
- 101100049200 Xenopus laevis vegt-b gene Proteins 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- YDONNITUKPKTIG-UHFFFAOYSA-N [Nitrilotris(methylene)]trisphosphonic acid Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CP(O)(O)=O YDONNITUKPKTIG-UHFFFAOYSA-N 0.000 description 2
- 108700014220 acyltransferase activity proteins Proteins 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000020244 animal milk Nutrition 0.000 description 2
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229940077388 benzenesulfonate Drugs 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 239000002361 compost Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- PMPJQLCPEQFEJW-GNTLFSRWSA-L disodium;2-[(z)-2-[4-[4-[(z)-2-(2-sulfonatophenyl)ethenyl]phenyl]phenyl]ethenyl]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC=CC=C1\C=C/C1=CC=C(C=2C=CC(\C=C/C=3C(=CC=CC=3)S([O-])(=O)=O)=CC=2)C=C1 PMPJQLCPEQFEJW-GNTLFSRWSA-L 0.000 description 2
- VUJGKADZTYCLIL-YHPRVSEPSA-L disodium;5-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-[(e)-2-[4-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-sulfonatophenyl]ethenyl]benzenesulfonate Chemical compound [Na+].[Na+].C=1C=C(\C=C\C=2C(=CC(NC=3N=C(N=C(NC=4C=CC=CC=4)N=3)N3CCOCC3)=CC=2)S([O-])(=O)=O)C(S(=O)(=O)[O-])=CC=1NC(N=C(N=1)N2CCOCC2)=NC=1NC1=CC=CC=C1 VUJGKADZTYCLIL-YHPRVSEPSA-L 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 description 2
- 238000010410 dusting Methods 0.000 description 2
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 2
- 238000004453 electron probe microanalysis Methods 0.000 description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- UFZOPKFMKMAWLU-UHFFFAOYSA-N ethoxy(methyl)phosphinic acid Chemical compound CCOP(C)(O)=O UFZOPKFMKMAWLU-UHFFFAOYSA-N 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000001087 glyceryl triacetate Substances 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 235000015220 hamburgers Nutrition 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 150000003949 imides Chemical class 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000004337 magnesium citrate Substances 0.000 description 2
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Inorganic materials [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 description 2
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 2
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 2
- MFUVDXOKPBAHMC-UHFFFAOYSA-N magnesium;dinitrate;hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O MFUVDXOKPBAHMC-UHFFFAOYSA-N 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- FFQQCJGNKKIRMD-UHFFFAOYSA-N methyl n-(3-hydroxyphenyl)carbamate Chemical compound COC(=O)NC1=CC=CC(O)=C1 FFQQCJGNKKIRMD-UHFFFAOYSA-N 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 108010087558 pectate lyase Proteins 0.000 description 2
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 2
- 229960003330 pentetic acid Drugs 0.000 description 2
- 238000002823 phage display Methods 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical class [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 239000013615 primer Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000002708 random mutagenesis Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 102220285717 rs1555461680 Human genes 0.000 description 2
- 102220026086 rs397518426 Human genes 0.000 description 2
- 102220080275 rs797045512 Human genes 0.000 description 2
- 102220020885 rs80356880 Human genes 0.000 description 2
- 102220095089 rs876659883 Human genes 0.000 description 2
- 238000005201 scrubbing Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 150000004760 silicates Chemical class 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 229940079842 sodium cumenesulfonate Drugs 0.000 description 2
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 2
- 235000019254 sodium formate Nutrition 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 2
- 229910052911 sodium silicate Inorganic materials 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 229940048842 sodium xylenesulfonate Drugs 0.000 description 2
- KVCGISUBCHHTDD-UHFFFAOYSA-M sodium;4-methylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1 KVCGISUBCHHTDD-UHFFFAOYSA-M 0.000 description 2
- QEKATQBVVAZOAY-UHFFFAOYSA-M sodium;4-propan-2-ylbenzenesulfonate Chemical compound [Na+].CC(C)C1=CC=C(S([O-])(=O)=O)C=C1 QEKATQBVVAZOAY-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 150000003871 sulfonates Chemical class 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- 229960002622 triacetin Drugs 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 101150068675 vegt gene Proteins 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- JQFLYFRHDIHZFZ-RXMQYKEDSA-N (2s)-3,3-dimethylpyrrolidine-2-carboxylic acid Chemical compound CC1(C)CCN[C@@H]1C(O)=O JQFLYFRHDIHZFZ-RXMQYKEDSA-N 0.000 description 1
- CNPSFBUUYIVHAP-AKGZTFGVSA-N (2s)-3-methylpyrrolidine-2-carboxylic acid Chemical compound CC1CCN[C@@H]1C(O)=O CNPSFBUUYIVHAP-AKGZTFGVSA-N 0.000 description 1
- VXWBQOJISHAKKM-UHFFFAOYSA-N (4-formylphenyl)boronic acid Chemical compound OB(O)C1=CC=C(C=O)C=C1 VXWBQOJISHAKKM-UHFFFAOYSA-N 0.000 description 1
- HHBOUFYYHJJTNU-UHFFFAOYSA-N 1,3,6-thiadiazepane-2,7-dithione Chemical compound S=C1NCCNC(=S)S1 HHBOUFYYHJJTNU-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- OMGHIGVFLOPEHJ-UHFFFAOYSA-N 2,5-dihydro-1h-pyrrol-1-ium-2-carboxylate Chemical compound OC(=O)C1NCC=C1 OMGHIGVFLOPEHJ-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-L 2-(carboxymethyl)-2-hydroxysuccinate Chemical compound [O-]C(=O)CC(O)(C(=O)O)CC([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-L 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 1
- PFBBCIYIKJWDIN-BUHFOSPRSA-N 2-[(e)-tetradec-1-enyl]butanedioic acid Chemical compound CCCCCCCCCCCC\C=C\C(C(O)=O)CC(O)=O PFBBCIYIKJWDIN-BUHFOSPRSA-N 0.000 description 1
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 1
- MHOFGBJTSNWTDT-UHFFFAOYSA-M 2-[n-ethyl-4-[(6-methoxy-3-methyl-1,3-benzothiazol-3-ium-2-yl)diazenyl]anilino]ethanol;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC(N(CCO)CC)=CC=C1N=NC1=[N+](C)C2=CC=C(OC)C=C2S1 MHOFGBJTSNWTDT-UHFFFAOYSA-M 0.000 description 1
- PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 description 1
- CDUUKBXTEOFITR-UHFFFAOYSA-N 2-methylserine zwitterion Chemical compound OCC([NH3+])(C)C([O-])=O CDUUKBXTEOFITR-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
- GDTSJMKGXGJFGQ-UHFFFAOYSA-N 3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound O1B([O-])OB2OB([O-])OB1O2 GDTSJMKGXGJFGQ-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- MHKLKWCYGIBEQF-UHFFFAOYSA-N 4-(1,3-benzothiazol-2-ylsulfanyl)morpholine Chemical compound C1COCCN1SC1=NC2=CC=CC=C2S1 MHKLKWCYGIBEQF-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- GAUWGYGVFJBRRR-UHFFFAOYSA-N 4-decanoyloxybenzenesulfonic acid Chemical compound CCCCCCCCCC(=O)OC1=CC=C(S(O)(=O)=O)C=C1 GAUWGYGVFJBRRR-UHFFFAOYSA-N 0.000 description 1
- QTMHHQFADWIZCP-UHFFFAOYSA-N 4-decanoyloxybenzoic acid Chemical compound CCCCCCCCCC(=O)OC1=CC=C(C(O)=O)C=C1 QTMHHQFADWIZCP-UHFFFAOYSA-N 0.000 description 1
- CAERUOHSFJZTJD-UHFFFAOYSA-N 4-dodecanoyloxybenzenesulfonic acid Chemical compound CCCCCCCCCCCC(=O)OC1=CC=C(S(O)(=O)=O)C=C1 CAERUOHSFJZTJD-UHFFFAOYSA-N 0.000 description 1
- VNEUMNOZRFLRPI-UHFFFAOYSA-N 4-nonanoyloxybenzenesulfonic acid Chemical compound CCCCCCCCC(=O)OC1=CC=C(S(O)(=O)=O)C=C1 VNEUMNOZRFLRPI-UHFFFAOYSA-N 0.000 description 1
- UXEKKQRJIGKQNP-UHFFFAOYSA-N 5-(4-phenyltriazol-2-yl)-2-[2-[4-(4-phenyltriazol-2-yl)-2-sulfophenyl]ethenyl]benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC(N2N=C(C=N2)C=2C=CC=CC=2)=CC=C1C=CC(C(=C1)S(O)(=O)=O)=CC=C1N(N=1)N=CC=1C1=CC=CC=C1 UXEKKQRJIGKQNP-UHFFFAOYSA-N 0.000 description 1
- CNGYZEMWVAWWOB-VAWYXSNFSA-N 5-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-[(e)-2-[4-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid Chemical compound N=1C(NC=2C=C(C(\C=C\C=3C(=CC(NC=4N=C(N=C(NC=5C=CC=CC=5)N=4)N(CCO)CCO)=CC=3)S(O)(=O)=O)=CC=2)S(O)(=O)=O)=NC(N(CCO)CCO)=NC=1NC1=CC=CC=C1 CNGYZEMWVAWWOB-VAWYXSNFSA-N 0.000 description 1
- UZJGVXSQDRSSHU-UHFFFAOYSA-N 6-(1,3-dioxoisoindol-2-yl)hexaneperoxoic acid Chemical compound C1=CC=C2C(=O)N(CCCCCC(=O)OO)C(=O)C2=C1 UZJGVXSQDRSSHU-UHFFFAOYSA-N 0.000 description 1
- 108010013043 Acetylesterase Proteins 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000222518 Agaricus Species 0.000 description 1
- 244000198134 Agave sisalana Species 0.000 description 1
- 241000223600 Alternaria Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000228215 Aspergillus aculeatus Species 0.000 description 1
- 241001513093 Aspergillus awamori Species 0.000 description 1
- 241000892910 Aspergillus foetidus Species 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 241001480052 Aspergillus japonicus Species 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000223651 Aureobasidium Species 0.000 description 1
- 241000193752 Bacillus circulans Species 0.000 description 1
- 241001328122 Bacillus clausii Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000193747 Bacillus firmus Species 0.000 description 1
- 241001328119 Bacillus gibsonii Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 101000740449 Bacillus subtilis (strain 168) Biotin/lipoyl attachment protein Proteins 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 241001453380 Burkholderia Species 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 241000146399 Ceriporiopsis Species 0.000 description 1
- 241000259840 Chaetomidium Species 0.000 description 1
- 241001057137 Chaetomium fimeti Species 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 241000985909 Chrysosporium keratinophilum Species 0.000 description 1
- 241001674013 Chrysosporium lucknowense Species 0.000 description 1
- 241001556045 Chrysosporium merdarium Species 0.000 description 1
- 241000080524 Chrysosporium queenslandicum Species 0.000 description 1
- 241001674001 Chrysosporium tropicum Species 0.000 description 1
- 241000355696 Chrysosporium zonatum Species 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241000221760 Claviceps Species 0.000 description 1
- DBPRUZCKPFOVDV-UHFFFAOYSA-N Clorprenaline hydrochloride Chemical compound O.Cl.CC(C)NCC(O)C1=CC=CC=C1Cl DBPRUZCKPFOVDV-UHFFFAOYSA-N 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000228437 Cochliobolus Species 0.000 description 1
- 241001085790 Coprinopsis Species 0.000 description 1
- 241000222511 Coprinus Species 0.000 description 1
- 244000251987 Coprinus macrorhizus Species 0.000 description 1
- 241001509964 Coptotermes Species 0.000 description 1
- 241001252397 Corynascus Species 0.000 description 1
- 241000221755 Cryphonectria Species 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000016559 DNA Primase Human genes 0.000 description 1
- 108010092681 DNA Primase Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- 241000935926 Diplodia Species 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Chemical group CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 102100029113 Endothelin-converting enzyme 2 Human genes 0.000 description 1
- 101710144982 Endothelin-converting enzyme 2 Proteins 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000221433 Exidia Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000145614 Fusarium bactridioides Species 0.000 description 1
- 241000223194 Fusarium culmorum Species 0.000 description 1
- 241000223195 Fusarium graminearum Species 0.000 description 1
- 241001014439 Fusarium sarcochroum Species 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000626621 Geobacillus Species 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 241001497663 Holomastigotoides Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 241000222342 Irpex Species 0.000 description 1
- 241000222344 Irpex lacteus Species 0.000 description 1
- 102100027612 Kallikrein-11 Human genes 0.000 description 1
- 101710172072 Kexin Proteins 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- HXEACLLIILLPRG-YFKPBYRVSA-N L-pipecolic acid Chemical compound [O-]C(=O)[C@@H]1CCCC[NH2+]1 HXEACLLIILLPRG-YFKPBYRVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
- DZLNHFMRPBPULJ-VKHMYHEASA-N L-thioproline Chemical compound OC(=O)[C@@H]1CSCN1 DZLNHFMRPBPULJ-VKHMYHEASA-N 0.000 description 1
- KKJQZEWNZXRJFG-UHFFFAOYSA-N L-trans-4-Methyl-2-pyrrolidinecarboxylic acid Chemical compound CC1CNC(C(O)=O)C1 KKJQZEWNZXRJFG-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 241000235087 Lachancea kluyveri Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 241000222435 Lentinula Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 101710098556 Lipase A Proteins 0.000 description 1
- 101710099648 Lysosomal acid lipase/cholesteryl ester hydrolase Proteins 0.000 description 1
- 102100026001 Lysosomal acid lipase/cholesteryl ester hydrolase Human genes 0.000 description 1
- 241001344133 Magnaporthe Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 241000183011 Melanocarpus Species 0.000 description 1
- 241001184659 Melanocarpus albomyces Species 0.000 description 1
- 241000123315 Meripilus Species 0.000 description 1
- 241001661345 Moesziomyces antarcticus Species 0.000 description 1
- 102100036617 Monoacylglycerol lipase ABHD2 Human genes 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 241000226677 Myceliophthora Species 0.000 description 1
- 241000863434 Myxococcales Species 0.000 description 1
- PQNASZJZHFPQLE-LURJTMIESA-N N(6)-methyl-L-lysine Chemical compound CNCCCC[C@H](N)C(O)=O PQNASZJZHFPQLE-LURJTMIESA-N 0.000 description 1
- JYXGIOKAKDAARW-UHFFFAOYSA-N N-(2-hydroxyethyl)iminodiacetic acid Chemical compound OCCN(CC(O)=O)CC(O)=O JYXGIOKAKDAARW-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000233892 Neocallimastix Species 0.000 description 1
- 241000221960 Neurospora Species 0.000 description 1
- 241000221961 Neurospora crassa Species 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- TTZMPOZCBFTTPR-UHFFFAOYSA-N O=P1OCO1 Chemical compound O=P1OCO1 TTZMPOZCBFTTPR-UHFFFAOYSA-N 0.000 description 1
- 241001072230 Oceanobacillus Species 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 description 1
- 108010029182 Pectin lyase Proteins 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 241000222385 Phanerochaete Species 0.000 description 1
- 241000222393 Phanerochaete chrysosporium Species 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 241000235379 Piromyces Species 0.000 description 1
- 241001451060 Poitrasia Species 0.000 description 1
- 229920000805 Polyaspartic acid Polymers 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- 101000847786 Porphyra purpurea Anthranilate synthase component 2 Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 101710194948 Protein phosphatase PhpP Proteins 0.000 description 1
- 241000383860 Pseudoplectania Species 0.000 description 1
- 241001497658 Pseudotrichonympha Species 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 101710081551 Pyrolysin Proteins 0.000 description 1
- 241000235402 Rhizomucor Species 0.000 description 1
- 241000235403 Rhizomucor miehei Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 1
- 235000001006 Saccharomyces cerevisiae var diastaticus Nutrition 0.000 description 1
- 244000206963 Saccharomyces cerevisiae var. diastaticus Species 0.000 description 1
- 241000204893 Saccharomyces douglasii Species 0.000 description 1
- 241001407717 Saccharomyces norbensis Species 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000222480 Schizophyllum Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 241000223255 Scytalidium Species 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 208000032005 Spinocerebellar ataxia with axonal neuropathy type 2 Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000264435 Streptococcus dysgalactiae subsp. equisimilis Species 0.000 description 1
- 241000194048 Streptococcus equi Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000194054 Streptococcus uberis Species 0.000 description 1
- 241000958303 Streptomyces achromogenes Species 0.000 description 1
- 241001468227 Streptomyces avermitilis Species 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 241000187398 Streptomyces lividans Species 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 241000228341 Talaromyces Species 0.000 description 1
- 241001215623 Talaromyces cellulolyticus Species 0.000 description 1
- 241001136494 Talaromyces funiculosus Species 0.000 description 1
- 241001540751 Talaromyces ruber Species 0.000 description 1
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
- 241000228178 Thermoascus Species 0.000 description 1
- 241001647802 Thermobifida Species 0.000 description 1
- 241000521303 Thermobifida alba Species 0.000 description 1
- 108090001109 Thermolysin Proteins 0.000 description 1
- 101000984201 Thermomyces lanuginosus Lipase Proteins 0.000 description 1
- 241000183057 Thielavia microspora Species 0.000 description 1
- 241000182980 Thielavia ovispora Species 0.000 description 1
- 241000183053 Thielavia subthermophila Species 0.000 description 1
- 239000003490 Thiodipropionic acid Substances 0.000 description 1
- 241001149964 Tolypocladium Species 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241000223260 Trichoderma harzianum Species 0.000 description 1
- 241000378866 Trichoderma koningii Species 0.000 description 1
- 241000223262 Trichoderma longibrachiatum Species 0.000 description 1
- 241000223261 Trichoderma viride Species 0.000 description 1
- 241000215642 Trichophaea Species 0.000 description 1
- 101710152431 Trypsin-like protease Proteins 0.000 description 1
- 102220470553 Tryptase delta_Q87E_mutation Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 241000202898 Ureaplasma Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000082085 Verticillium <Phyllachorales> Species 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 241001507667 Volvariella Species 0.000 description 1
- 241000409279 Xerochrysium dermatitidis Species 0.000 description 1
- 241001523965 Xylaria Species 0.000 description 1
- 241000235013 Yarrowia Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 238000012867 alanine scanning Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- DNEHKUCSURWDGO-UHFFFAOYSA-N aluminum sodium Chemical compound [Na].[Al] DNEHKUCSURWDGO-UHFFFAOYSA-N 0.000 description 1
- 229940115440 aluminum sodium silicate Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 1
- 230000003254 anti-foaming effect Effects 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 239000004760 aramid Substances 0.000 description 1
- 229920006231 aramid fiber Polymers 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 208000033361 autosomal recessive with axonal neuropathy 2 spinocerebellar ataxia Diseases 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 229940005348 bacillus firmus Drugs 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000009141 biological interaction Effects 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 102220350531 c.80A>G Human genes 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000000085 cashmere Anatomy 0.000 description 1
- 238000012219 cassette mutagenesis Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229920003174 cellulose-based polymer Polymers 0.000 description 1
- JBTHDAVBDKKSRW-UHFFFAOYSA-N chembl1552233 Chemical compound CC1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 JBTHDAVBDKKSRW-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 239000007771 core particle Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229930007927 cymene Natural products 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- GSPKZYJPUDYKPI-UHFFFAOYSA-N diethoxy sulfate Chemical compound CCOOS(=O)(=O)OOCC GSPKZYJPUDYKPI-UHFFFAOYSA-N 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 235000019262 disodium citrate Nutrition 0.000 description 1
- 239000002526 disodium citrate Substances 0.000 description 1
- 229940079896 disodium hydrogen citrate Drugs 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- CDMADVZSLOHIFP-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane;decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 CDMADVZSLOHIFP-UHFFFAOYSA-N 0.000 description 1
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 1
- PYLIXCKOHOHGKQ-UHFFFAOYSA-L disodium;hydrogen phosphate;heptahydrate Chemical compound O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O PYLIXCKOHOHGKQ-UHFFFAOYSA-L 0.000 description 1
- GRWZHXKQBITJKP-UHFFFAOYSA-L dithionite(2-) Chemical compound [O-]S(=O)S([O-])=O GRWZHXKQBITJKP-UHFFFAOYSA-L 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 125000005066 dodecenyl group Chemical group C(=CCCCCCCCCCC)* 0.000 description 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 102220500059 eIF5-mimic protein 2_S54V_mutation Human genes 0.000 description 1
- 238000002003 electron diffraction Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 239000003248 enzyme activator Substances 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- HGVHMIAKUYLQLL-UHFFFAOYSA-N ethene;propane-1,2,3-triol Chemical compound C=C.OCC(O)CO HGVHMIAKUYLQLL-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical class COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 150000002373 hemiacetals Chemical class 0.000 description 1
- 238000009478 high shear granulation Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910001412 inorganic anion Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000017730 intein-mediated protein splicing Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- GCHPUFAZSONQIV-UHFFFAOYSA-N isovaline Chemical compound CCC(C)(N)C(O)=O GCHPUFAZSONQIV-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- HXEACLLIILLPRG-RXMQYKEDSA-N l-pipecolic acid Natural products OC(=O)[C@H]1CCCCN1 HXEACLLIILLPRG-RXMQYKEDSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 238000010412 laundry washing Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 229940097364 magnesium acetate tetrahydrate Drugs 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- XKPKPGCRSHFTKM-UHFFFAOYSA-L magnesium;diacetate;tetrahydrate Chemical compound O.O.O.O.[Mg+2].CC([O-])=O.CC([O-])=O XKPKPGCRSHFTKM-UHFFFAOYSA-L 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-L malate(2-) Chemical compound [O-]C(=O)C(O)CC([O-])=O BJEPYKJPYRNKOW-UHFFFAOYSA-L 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 108010009355 microbial metalloproteinases Proteins 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000050 mohair Anatomy 0.000 description 1
- 229910000150 monocalcium phosphate Inorganic materials 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000004897 n-terminal region Anatomy 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical class CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 150000004968 peroxymonosulfuric acids Chemical class 0.000 description 1
- 125000005342 perphosphate group Chemical group 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical class OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-M phosphinate Chemical compound [O-][PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-M 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000005222 photoaffinity labeling Methods 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920000196 poly(lauryl methacrylate) Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 108010064470 polyaspartate Proteins 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 102000023848 polysaccharide binding proteins Human genes 0.000 description 1
- 108091008395 polysaccharide binding proteins Proteins 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920006306 polyurethane fiber Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 102220214800 rs1060503568 Human genes 0.000 description 1
- 102200131574 rs11556620 Human genes 0.000 description 1
- 102220036452 rs137882485 Human genes 0.000 description 1
- 102200065573 rs140660066 Human genes 0.000 description 1
- 102200118280 rs33918343 Human genes 0.000 description 1
- 102220243297 rs374524755 Human genes 0.000 description 1
- 102200128586 rs397508464 Human genes 0.000 description 1
- 102220047008 rs587776405 Human genes 0.000 description 1
- 102220289974 rs757282628 Human genes 0.000 description 1
- 102220123717 rs759057581 Human genes 0.000 description 1
- 102200025035 rs786203989 Human genes 0.000 description 1
- 102220099575 rs878853725 Human genes 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000429 sodium aluminium silicate Substances 0.000 description 1
- 235000012217 sodium aluminium silicate Nutrition 0.000 description 1
- 229940077386 sodium benzenesulfonate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960000999 sodium citrate dihydrate Drugs 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019795 sodium metasilicate Nutrition 0.000 description 1
- 229940045872 sodium percarbonate Drugs 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- DGSDBJMBHCQYGN-UHFFFAOYSA-M sodium;2-ethylhexyl sulfate Chemical compound [Na+].CCCCC(CC)COS([O-])(=O)=O DGSDBJMBHCQYGN-UHFFFAOYSA-M 0.000 description 1
- OMSMEHWLFJLBSH-UHFFFAOYSA-M sodium;2-hydroxynaphthalene-1-carboxylate Chemical compound [Na+].C1=CC=CC2=C(C([O-])=O)C(O)=CC=C21 OMSMEHWLFJLBSH-UHFFFAOYSA-M 0.000 description 1
- LIAJJWHZAFEJEZ-UHFFFAOYSA-M sodium;2-hydroxynaphthalene-1-sulfonate Chemical compound [Na+].C1=CC=CC2=C(S([O-])(=O)=O)C(O)=CC=C21 LIAJJWHZAFEJEZ-UHFFFAOYSA-M 0.000 description 1
- AXMCIYLNKNGNOT-UHFFFAOYSA-N sodium;3-[[4-[(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)-[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]methyl]-n-ethylanilino]methyl]benzenesulfonate Chemical compound [Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](C)C)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S(O)(=O)=O)=C1 AXMCIYLNKNGNOT-UHFFFAOYSA-N 0.000 description 1
- GSYPNDDXWAZDJB-UHFFFAOYSA-M sodium;4-(3,5,5-trimethylhexanoyloxy)benzenesulfonate Chemical compound [Na+].CC(C)(C)CC(C)CC(=O)OC1=CC=C(S([O-])(=O)=O)C=C1 GSYPNDDXWAZDJB-UHFFFAOYSA-M 0.000 description 1
- MZSDGDXXBZSFTG-UHFFFAOYSA-M sodium;benzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=CC=C1 MZSDGDXXBZSFTG-UHFFFAOYSA-M 0.000 description 1
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- 238000005563 spheronization Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940115922 streptococcus uberis Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 229940073450 sudan red Drugs 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 1
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 108010031354 thermitase Proteins 0.000 description 1
- 235000019303 thiodipropionic acid Nutrition 0.000 description 1
- 150000004764 thiosulfuric acid derivatives Chemical class 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- VRVDFJOCCWSFLI-UHFFFAOYSA-K trisodium 3-[[4-[(6-anilino-1-hydroxy-3-sulfonatonaphthalen-2-yl)diazenyl]-5-methoxy-2-methylphenyl]diazenyl]naphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].[Na+].COc1cc(N=Nc2cc(c3cccc(c3c2)S([O-])(=O)=O)S([O-])(=O)=O)c(C)cc1N=Nc1c(O)c2ccc(Nc3ccccc3)cc2cc1S([O-])(=O)=O VRVDFJOCCWSFLI-UHFFFAOYSA-K 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 108010083879 xyloglucan endo(1-4)-beta-D-glucanase Proteins 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38627—Preparations containing enzymes, e.g. protease or amylase containing lipase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38645—Preparations containing enzymes, e.g. protease or amylase containing cellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
Definitions
- the present invention concerns a detergent composition for removing or releasing greasy stains, the use of a lipase and a cellulase for removing or releasing greasy stains, a method for removing or releasing greasy stains and an item treated according to the method.
- Cellulases are enzymes involved in the hydrolysis of cellulose. Cellulases are synthesized by a large number of microorganisms which include fungi, actinomycetes, myxobacteria and true bacteria, but they are also synthesized by plants. A very important industrial use of cellulases is for laundry, where cellulases are used for stain removal and anti- fuzz treatment of cotton textile.
- Lipases are useful, e.g., as detergent enzymes to remove lipid or fatty stains from clothes and other textiles. Lipase enzymes have been used in detergents since the late 1980s for removal of greasy and oily soils by breakdown of soil into tri-glycerides.
- Current detergents e.g. laundry detergents compositions include a complex combination of active ingredients such as surfactants, enzymes bleaching agents, a builder system, suds suppressors, soil-suspending agents, soil-release agents, optical brighteners, softening agents, dispersants, dye transfer inhibition compounds, abrasives, bactericides, and perfumes.
- Lipolytic enzymes including lipases and cutinases, have been employed in detergent cleaning compositions for the removal of greasy or oily stains.
- the present invention concerns a detergent composition for removing or releasing greasy stains, which composition comprises a surfactant, a lipase and a cellulase.
- the invention concerns the use of a lipase and a cellulase for removing or releasing greasy stains from a textile, a dish or a hard surface.
- the invention also concerns a method for removing or releasing greasy stains from an item having a greasy stain, which method comprises exposing the item to an aqueous solution of a lipase and a cellulase. Further, the invention concerns an item treated according to the method.
- Figure 1 shows the effect obtained in Example 1 after washing with a powder English base.
- Figure 2 shows the effect obtained in Example 1 after washing with a powder Italian base.
- Figure 3 shows the effect obtained in Example 2 with the powder German base 2.
- Figure 4 shows the effect obtained in Example 2 with the powder English base.
- Figure 5 shows the effect obtained in Example 2 with the liquid Spanish base 2.
- Figure 6 shows the effect obtained in Example 2 with the liquid Italian base 2.
- Figure 7 shows the synergy obtained in Example 3 with the powder English base.
- Figure 8 shows the synergy obtained in Example 3 with the liquid Spanish base 2.
- Enzyme Detergency benefit is defined herein as the advantageous effect an enzyme may add to a detergent compared to the same detergent without the enzyme.
- Important detergency benefits which can be provided by enzymes are stain removal with no or very little visible soils after washing and/or cleaning, prevention or reduction of redeposition of soils released in the washing process (an effect that also is termed anti- redeposition), restoring fully or partly the whiteness of textiles which originally were white but after repeated use and wash have obtained a greyish or yellowish appearance (an effect that also is termed whitening).
- Textile care benefits which are not directly related to catalytic stain removal or prevention of redeposition of soils, are also important for enzyme detergency benefits.
- Examples of such textile care benefits are prevention or reduction of dye transfer from one fabric to another fabric or another part of the same fabric (an effect that is also termed dye transfer inhibition or anti-backstaining), removal of protruding or broken fibers from a fabric surface to decrease pilling tendencies or remove already existing pills or fuzz (an effect that also is termed anti-pilling), improvement- of the fabric-softness, colour clarification of the fabric and removal of particulate soils which are trapped in the fibers of the fabric or garment.
- Enzymatic bleaching is a further enzyme detergency benefit where the catalytic activity generally is used to catalyze the formation of bleaching components such as hydrogen peroxide or other peroxides.
- Textile care benefits which are not directly related to catalytic stain removal or prevention of redeposition of soils, are also important for enzyme detergency benefits.
- textile care benefits are prevention or reduction of dye transfer from one textile to another textile or another part of the same textile (an effect that is also termed dye transfer inhibition or anti-backstaining), removal of protruding or broken fibers from a textile surface to decrease pilling tendencies or remove already existing pills or fuzz (an effect that also is termed anti-pilling), improvement of the textile-softness, colour clarification of the textile and removal of particulate soils which are trapped in the fibers of the textile.
- Enzymatic bleaching is a further enzyme detergency benefit where the catalytic activity generally is used to catalyze the formation of bleaching component such as hydrogen peroxide or other peroxides or other bleaching species.”
- greasy stain means a stain comprising a lipid compound such as a fats, waxes, sterols, monoglycerides, diglycerides, triglycerides, phospholipids and/or fat-soluble vitamins,.
- the lipid compound can origin from a vegetable oil, oil from animal source, mineral oil or artificial oil.
- the lipid compound is generally soluble in organic solvents and generally insoluble in water.
- the greasy stain comprises one or more lipids and optionally other stain components such as particulate soil, dye, colorant, dairy components, or the like.
- the terms lipid and grease are used interchangeably.
- a greasy stain When a greasy stain is said to have a "high content of lipids" or “the lipid content of the stain is high", it is meant that the stain consists almost entirely of lipids, such as at least 80% of the stain consists of lipids or at least 85% of the stain consists of lipids or at least 90% of the stain consists of lipids.
- stains are stains having a high content of vegetable oil, mineral oil and/or animal fat, such as vegetable fat, butter or cooked butter.
- the stain comprises a lipid such that at least 40% and up to 80% of the stain consists of lipids or at least 45% of the stain consists of lipids or at least 50% of the stain consists of lipids, or at least 55% of the stain consists of lipids, or at least 60% of the stain consists of lipids, or at least 65% of the stain consists of lipids, or at least 70% of the stain consists of lipids, or at least 75% of the stain consists of lipids.
- stains are stains having a medium content of vegetable oil, mineral oil and/or, animal fat, such as compositions comprising vegetable oil, mineral oil and/or animal fat, e.g. lipstick or compositions comprising vegetable oil/animal fat and milk.
- a greasy stain when said to have a "low-medium content of lipids", it is meant that the stain comprises a lipid such that at least 15% and up to 40% of the stain consists of lipids, or at least 25% of the stain consists of lipids, or at least 25% of the stain consists of lipids, or at least 30% of the stain consists of lipids, or at least 35% of the stain consists of lipids.
- stains are stains having a low-medium content of vegetable oil, mineral oil and/or animal fat, such as compositions comprising vegetable oil, mineral oil and/or animal fat, e.g. ice cream such as chocolate ice cream or compositions of comprising vegetable oil/animal fat and milk.
- particle soil particles with a heterogeneous nature with varying surface energies.
- the particles can be trapped in pores on the surfaces e.g. a textile.
- Mature polypeptide coding sequence means a polynucleotide that encodes a mature polypeptide having lipase activity.
- the mature polypeptide coding sequence is nucleotides 1 to 807 of SEQ ID NO: 1 .
- Subsequence means a polynucleotide having one or more (e.g., several) nucleotides absent from the 5' and/or 3' end of a mature polypeptide coding sequence; wherein the subsequence encodes a fragment having lipase activity.
- a subsequence contains at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% but less than 100% of the number of nucleotides 1 to 807 of SEQ ID NO: 1.
- Insertions For an amino acid insertion, the following nomenclature is used: Original amino acid, position, original amino acid, inserted amino acid. Accordingly the insertion of lysine after glycine at position 195 is designated “Gly195Glyl_ys" or “G195GK”. An insertion of multiple amino acids is designated [Original amino acid, position, original amino acid, inserted amino acid #1 , inserted amino acid #2; etc.]. For example, the insertion of lysine and alanine after glycine at position 195 is indicated as "Gly195Glyl_ysAla" or "G195GKA”. In such cases, the inserted amino acid residue(s) are numbered by the addition of lower case letters to the position number of the amino acid residue preceding the inserted amino acid residue(s). In the above example, the sequence would thus be:
- variants comprising multiple alterations are separated by addition marks ("+"), e.g., "Arg170Tyr+Gly195Glu” or “R170Y+G195E” representing a substitution of arginine and glycine at positions 170 and 195 with tyrosine and glutamic acid, respectively.
- Textile means any textile material including yarns, yarn intermediates, fibers, non-woven materials, natural materials, synthetic materials, and any other textile material, fabrics made of these materials and products made from fabrics (e.g., garments and other articles).
- the textile or fabric may be in the form of knits, wovens, denims, non-wovens, felts, yarns, and towelling.
- the textile may be cellulose based such as natural cellulosics, including cotton, flax/linen, jute, ramie, sisal or coir or manmade cellulosics (e.g. originating from wood pulp) including viscose/rayon, cellulose acetate fibers (tricell), lyocell or blends thereof.
- the textile or fabric may also be non-cellulose based such as natural polyamides including wool, camel, cashmere, mohair, rabbit and silk or synthetic polymers such as nylon, aramid, polyester, acrylic, polypropylene and spandex/elastane, or blends thereof as well as blends of cellulose based and non-cellulose based fibers.
- non-cellulose based such as natural polyamides including wool, camel, cashmere, mohair, rabbit and silk or synthetic polymers such as nylon, aramid, polyester, acrylic, polypropylene and spandex/elastane, or blends thereof as well as blends of cellulose based and non-cellulose based fibers.
- blends are blends of cotton and/or rayon/viscose with one or more companion material such as wool, synthetic fiber (e.g. polyamide fiber, acrylic fiber, polyester fiber, polyvinyl chloride fiber, polyurethane fiber, polyurea fiber, aramid fiber), and/or cellulose-containing fiber (e.g.
- Fabric may be conventional washable laundry, for example stained household laundry.
- fabric or garment it is intended to include the broader term textiles as well.
- Improved wash performance is defined herein as the combination of cellulase and lipase displaying an increased wash performance relative to the wash performance of the base detergent composition or the base detergent composition comprising either lipase or cellulase, e.g. by increased stain removal.
- wash performance includes wash performance in laundry but also e.g. in dish wash.
- Whiteness is defined herein as a broad term with different meanings in different regions and for different consumers. Loss of whiteness can e.g. be due to greying, yellowing, or removal of optical brighteners/hueing agents. Greying and yellowing can be due to soil redeposition, body soils, colouring from e.g. iron and copper ions or dye transfer. Whiteness might include one or several issues from the list below: colourant or dye effects; incomplete stain removal (e.g.
- Detergent Composition refers to compositions that find use in the removal of undesired compounds from items to be cleaned, such as textiles, dishes, and hard surfaces.
- the detergent composition may be used to e.g. clean textiles, dishes and hard surfaces for both household cleaning and industrial cleaning.
- the terms encompass any materials/compounds selected for the particular type of cleaning composition desired and the form of the product (e.g., liquid, gel, powder, granulate, paste, or spray compositions) and includes, but is not limited to, detergent compositions (e.g., liquid and/or solid laundry detergents and fine fabric detergents; hard surface cleaning formulations, such as for glass, wood, ceramic and metal counter tops and windows; carpet cleaners; oven cleaners; fabric fresheners; fabric softeners; and textile and laundry pre-spotters, as well as dish wash detergents).
- detergent compositions e.g., liquid and/or solid laundry detergents and fine fabric detergents
- hard surface cleaning formulations such as for glass, wood, ceramic and metal counter tops and windows
- carpet cleaners oven cleaners
- fabric fresheners fabric softeners
- textile and laundry pre-spotters as well as dish wash detergents
- the detergent formulation may contain one or more additional enzymes (such as proteases, amylases, lipases, cutinases, cellulases, endoglucanases, xyloglucanases, pectinases, pectin lyases, xanthanases, peroxidaes, haloperoxygenases, catalases and mannanases, or any mixture thereof), and/or components such as surfactants, builders, chelators or chelating agents, bleach system or bleach components, polymers, fabric conditioners, foam boosters, suds suppressors, dyes, perfume, tannish inhibitors, optical brighteners, bactericides, fungicides, soil suspending agents, anti-corrosion agents, enzyme inhibitors or stabilizers, enzyme activators, transferase(s), hydrolytic enzymes, oxido reductases, bluing agents and fluorescent dyes, antioxidants, and solubilizers.
- additional enzymes such as proteases, amy
- Dish washing composition refers to compositions including ADW compositions (Automated Dish Wash) intended for cleaning dishes, table ware, pots, pans, cutlery, plates, cups, glasses, bowls, cutlery such as spoons, knives, forks, serving utensils, ceramics, plastics, metals, china, glass, acrylics and all forms of compositions for cleaning hard surfaces areas in kitchens.
- ADW compositions Automated Dish Wash
- Dish wash refers to all forms of washing dishes, e.g. by hand or automatic dish wash (ADW).
- Washing dishes includes, but is not limited to, the cleaning of all forms of crockery such as plates, cups, glasses, bowls, all forms of cutlery such as spoons, knives, forks and serving utensils as well as ceramics, plastics, metals, china, glass and acrylics.
- Hard surface cleaning is defined herein as cleaning of hard surfaces wherein hard surfaces may include floors, tables, walls, roofs etc. as well as surfaces of hard objects such as cars (car wash) and dishes (dish wash). Dish washing includes but are not limited to cleaning of plates, cups, glasses, bowls, cutlery such as spoons, knives, forks, serving utensils, ceramics, plastics, metals, china, glass and acrylics.
- Hard surface cleaning is defined herein as cleaning of hard surfaces, wherein hard surfaces may include floors, tables, walls, roofs etc. as well as surfaces of hard objects such as cars (car wash).
- Laundering relates to both household laundering and industrial laundering and means the process of treating textiles with a solution containing a cleaning or detergent composition of the present invention.
- the laundering process can for example be carried out using e.g. a household or an industrial washing machine or can be carried out by hand.
- the present invention concerns a detergent composition for removing or releasing greasy stains, which composition comprises a surfactant, a lipase and a cellulase.
- the present invention further comprises the use of a lipase in combination with cellulase for releasing removing greasy stains and a method for removing or releasing greasy stains from an item having a greasy stain.
- the method comprises exposing the item to an aqueous solution of a lipase and a cellulase.
- Lipases are traditionally known as enzymes that remove greasy stains and are widely used in detergent composition.
- the lipases catalyse the breakdown of lipids in the greasy stain, which are then released from the item and removed with the waste water/rinse water. When the temperature at the same time is above the melting temperature of the lipids, the removal of the greasy stain is further eased.
- the inventor has found that by using a lipase and a cellulase in combination and optionally with other enzymes, the removal or release of greasy stains are increased.
- the combination of lipase and cellulase is used at low temperatures, e.g. below the melting point of the lipids contained in the greasy stain, the stain release and stain removal is increased.
- the lipase may be of bacterial or fungal origin and it may be chemically modified or protein engineered.
- the stain treated according to the invention may comprise vegetable oil, mineral oil, animal fat or a combination thereof.
- the stain can comprise a vegetable oil such as a mayonnaise, a dressing or the like having a high content of lipids.
- the stain comprises an animal fat such as for example fat from pig, chicken, turkey, cow or fish.
- the stain may be a combination of vegetable oil and animal fat.
- the greasy stain has a high content of lipid.
- the stain can comprise lipstick, which comprises a combination of waxes and pigments, or a stain comprising lard.
- lipase is of bacterial or fungal origin. Chemically modified or protein engineered mutant enzymes are included. Examples include lipase from Thermomyces, e.g. from T. lanuginosus (previously named Humicola lanuginosa) as described in EP258068 and EP305216, cutinase from Humicola, e.g. H. insolens (WO96/13580), lipase from strains of Pseudomonas (some of these now renamed to Burkholderia), e.g. P. alcaligenes or P. pseudoalcaligenes (EP218272), P. cepacia (EP331376), P. sp.
- Thermomyces e.g. from T. lanuginosus (previously named Humicola lanuginosa) as described in EP258068 and EP305216
- cutinase from Humicola e.g. H. insolens (WO
- strain SD705 (WO95/06720 & WO96/27002), P. wisconsinensis (WO96/12012), GDSL-type Streptomyces lipases (W010/065455), cutinase from Magnaporthe grisea (W010/107560), cutinase from Pseudomonas mendocina (US5,389,536), lipase from Thermobifida fusca (W01 1/084412), Geobacillus stearothermophilus lipase (W01 1/084417), lipase from Bacillus subtilis (W01 1/084599), and lipase from Streptomyces griseus (W01 1/150157) and S. pristinaespiralis (W012/137147).
- lipase variants such as those described in EP407225, WO92/05249, WO94/01541 , W094/25578, W095/14783, WO95/30744, W095/35381 , W095/22615, WO96/00292, WO97/04079, WO97/07202, WO00/34450, WO00/60063, WO01/92502, WO07/87508 and WO09/109500.
- Preferred commercial lipase products include include LipolaseTM, LipexTM, LipolexTM and
- LipocleanTM Novozymes A/S
- Lumafast originally from Genencor
- Lipomax originally from Gist-Brocades
- lipases sometimes referred to as acyltransferases or perhydrolases, e.g. acyltransferases with homology to Candida antarctica lipase A (WO10/1 1 1 143), acyltransferase from Mycobacterium smegmatis (WO05/56782), perhydrolases from the CE 7 family (WO09/67279), and variants of the M. smegmatis perhydrolase in particular the S54V variant used in the commercial product Gentle Power Bleach from Huntsman Textile Effects Pte Ltd (W010/100028).
- the lipase is a polypeptide having the amino acid sequence which:
- a) has at least 90% identity with the wild-type lipase derived from Humicola lanuginosa strain DSM 4109; b) compared to said wild-type lipase, comprises a substitution of an electrically neutral or negatively charged amino acid at the surface of the three-dimensional structure within 15 A of E1 or Q249 with a positively charged amino acid; and c) comprises a peptide addition at the C-terminal; and/or
- i. comprises a negative amino acid in position E210 of said wild-type lipase; ii. comprises a negatively charged amino acid in the region corresponding to positions 90-101 of said wild-type lipase; and
- iii. comprises a neutral or negative amino acid at a position corresponding to N94 of said wild-type lipase and/or has a negative or neutral net electric charge in the region corresponding to positions 90-101 of said wild-type lipase.
- the substitution mentioned under b) is within 10 A of E1 or Q249. In one embodiment said substitution is within 15 A (preferably 10 A) of E1 . In one embodiment the lipase comprises 2-4 of said substitutions, where 2 substitutions are preferred. In one embodiment the substitution is of an electrically neutral or negatively charged amino acid within 10 A of E1 with R. In one embodiment a substitution of amino acid S3, S224, P229, T231 , N233, D234 or T244 with a positively charged amino acid, preferably R.
- 1 -5 amino acids have been added to the C-terminal of the peptide.
- the amino acids consist of electrically neutral (preferably hydrophobic) amino acids and are most preferably PGL or PG.
- the amino acids added at the C-terminal consist of neutral (preferably hydrophobic) amino acids and C
- the lipase further comprises substitution of an amino acid with C so as to form a disulfide bridge with the C of the peptide addition.
- the lipase comprises amino acids with negative or unchanged electric charge in at least two of positions N94, D96 and E99 of said wild-type lipase.
- the lipase comprises a substitution G91A, N94D/E/K/R, D96E/I/L/N/S/W, E99N/Q/K/R/H, N 101 S, R209P/S or Q249R/K/H.
- the lipase comprises one of the following sets of substitutions, optionally combined with Q249R/K/H and/or K98X:
- the lipase comprises one of the following sets of substitutions, optionally combined with R209 (neutral or negative):
- the lipase is a variant of a parent lipase which variant has lipase activity, has at least 60% but less than 100% sequence identity with SEQ ID NO: 2, and comprises substitutions at positions corresponding to T231 R+N233R and at least one or more (e.g., several) of D96E, D1 1 1A, D254S, G163K, P256T, G91 T, G38A, D27R, and N33Q of SEQ ID NO: 2.
- the said variant in comparison with the parent lipase has increased stability.
- the stability is stability under storage conditions, protease stability, chemical stability, oxidation stability, pH stability, and/or thermostability.
- the variant is selected from the group consisting of:
- a polypeptide encoded by a polynucleotide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, but less than 100% sequence identity to SEQ ID NO: 1 ;
- the lipase is a variant having activity, has at least 60% but less than 100% sequence identity with SEQ ID NO: 2, and comprises substitutions at positions corresponding to T231 R+N233R and at least one or more (e.g., several) of D96E, D1 1 1A, D254S, G163K, P256T, G91T, G38A, D27R, and N33Q of SEQ ID NO: 2 selected from the group of:
- the parent lipase may be (a) a polypeptide having at least 60% sequence identity to the polypeptide of SEQ ID NO: 2; (b) a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions with (i) the polypeptide coding sequence of SEQ ID NO: 1 , (ii) the full-length complement of (i); or (c) a polypeptide encoded by a polynucleotide having at least 60% sequence identity to the polypeptide coding sequence of SEQ ID NO: 1.
- the parent has a sequence identity to the polypeptide of SEQ ID NO: 2 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%, which have lipase activity.
- the amino acid sequence of the parent differs by up to 40 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 , 22, 23, 24, 25, 26, 27, 28, 29, 30, 31 , 32, 33, 34, 35, 36, 37, 38, 39, or 40 from the polypeptide of SEQ ID NO: 2.
- the parent comprises or consists of the amino acid sequence of SEQ ID NO: 2.
- the parent is a fragment of the polypeptide of SEQ ID NO: 2 containing at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% of the number of amino acids of SEQ ID NO: 2.
- the parent is an allelic variant of the polypeptide of SEQ ID NO: 1
- the parent is encoded by a polynucleotide that hybridizes under very low stringency conditions, low stringency conditions, medium stringency conditions, medium- high stringency conditions, high stringency conditions, or very high stringency conditions with (i) the polypeptide coding sequence of SEQ ID NO: 1 , (ii) the full-length complement of (i) (Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual, 2d edition, Cold Spring Harbor, New York).
- the polynucleotide of SEQ ID NO: 1 or a subsequence thereof, as well as the polypeptide of SEQ ID NO: 2 or a fragment thereof, may be used to design nucleic acid probes to identify and clone DNA encoding a parent from strains of different genera or species according to methods well known in the art.
- probes can be used for hybridization with the genomic DNA or cDNA of a cell of interest, following standard Southern blotting procedures, in order to identify and isolate the corresponding gene therein.
- Such probes can be considerably shorter than the entire sequence, but should be at least 15, e.g., at least 25, at least 35, or at least 70 nucleotides in length.
- the nucleic acid probe is at least 100 nucleotides in length, e.g., at least 200 nucleotides, at least 300 nucleotides, at least 400 nucleotides, at least 500 nucleotides, at least 600 nucleotides, at least 700 nucleotides, at least 800 nucleotides, or at least 900 nucleotides in length.
- Both DNA and RNA probes can be used.
- the probes are typically labeled for detecting the corresponding gene (for example, with 32P, 3H, 35S, biotin, or avidin). Such probes are encompassed by the present invention.
- a genomic DNA or cDNA library prepared from such other strains may be screened for DNA that hybridizes with the probes described above and encodes a parent.
- Genomic or other DNA from such other strains may be separated by agarose or polyacrylamide gel electrophoresis, or other separation techniques.
- DNA from the libraries or the separated DNA may be transferred to and immobilized on nitrocellulose or other suitable carrier material.
- the carrier material is used in a Southern blot.
- hybridization indicates that the polynucleotide hybridizes to a labeled nucleic acid probe corresponding to (i) SEQ ID NO: 1 ; (ii) the polypeptide coding sequence of SEQ ID NO: 1 ; (iii) the full-length complement thereof; or (iv) a subsequence thereof; under very low to very high stringency conditions.
- Molecules to which the nucleic acid probe hybridizes under these conditions can be detected using, for example, X ray film or any other detection means known in the art.
- the nucleic acid probe is the polypeptide coding sequence of SEQ ID NO: 1 .
- the nucleic acid probe is at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% of the number of nucleotides of SEQ ID NO: 1 .
- the nucleic acid probe is a polynucleotide that encodes the polypeptide of SEQ ID NO: 2; the polypeptide thereof; or a fragment thereof.
- the nucleic acid probe is SEQ ID NO: 1.
- the parent is encoded by a polynucleotide having a sequence identity to the polypeptide coding sequence of SEQ ID NO: 1 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%.
- the polypeptide may be a hybrid polypeptide in which a region of one polypeptide is fused at the N terminus or the C terminus of a region of another polypeptide.
- the parent may be a fusion polypeptide or cleavable fusion polypeptide in which another polypeptide is fused at the N terminus or the C terminus of the polypeptide of the present invention.
- a fusion polypeptide is produced by fusing a polynucleotide encoding another polypeptide to a polynucleotide of the present invention.
- Techniques for producing fusion polypeptides are known in the art, and include ligating the coding sequences encoding the polypeptides so that they are in frame and that expression of the fusion polypeptide is under control of the same promoter(s) and terminator.
- Fusion polypeptides may also be constructed using intein technology in which fusion polypeptides are created post-translationally (Cooper et al., 1993, EMBO J. 12: 2575-2583; Dawson et al., 1994, Science 266: 776-779).
- a fusion polypeptide can further comprise a cleavage site between the two polypeptides. Upon secretion of the fusion protein, the site is cleaved releasing the two polypeptides.
- cleavage sites include, but are not limited to, the sites disclosed in Martin et al., 2003, J. Ind. Microbiol. Biotechnol. 3: 568-576; Svetina et al., 2000, J. Biotechnol. 76: 245-251 ; Rasmussen-Wilson et al., 1997, Appl. Environ. Microbiol.
- the parent may be obtained from microorganisms of any genus.
- the term "obtained from” as used herein in connection with a given source shall mean that the parent encoded by a polynucleotide is produced by the source or by a strain in which the polynucleotide from the source has been inserted.
- the parent is secreted extracellularly.
- the parent may be a bacterial lipase.
- the parent may be a Gram-positive bacterial polypeptide such as a Bacillus, Clostridium, Enterococcus, Geobacillus, Lactobacillus, Lactococcus, Oceanobacillus, Staphylococcus, Streptococcus, Streptomyces or Thermobifida lipase, or a Gram-negative bacterial polypeptide such as a Campylobacter, E. coli, Flavobacterium, Fusobacterium, Helicobacter, llyobacter, Neisseria, Pseudomonas, Salmonella, or Ureaplasma lipase.
- a Gram-positive bacterial polypeptide such as a Bacillus, Clostridium, Enterococcus, Geobacillus, Lactobacillus, Lactococcus, Oceanobacillus, Staphylococcus, Streptococcus, Streptomyces or Thermobifida lipase
- the parent is a Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus firmus, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus pumilus, Bacillus stearothermophilus, Bacillus subtilis, or Bacillus thuringiensis lipase.
- the parent is a Streptococcus equisimilis, Streptococcus pyogenes, Streptococcus uberis, or Streptococcus equi subsp. Zooepidemicus lipase.
- the parent is a Streptomyces achromogenes, Streptomyces avermitilis, Streptomyces coelicolor, Streptomyces griseus, or Streptomyces lividans lipase.
- the parent is a Thermobifida alba or Thermobifida fusca (formerly known as Thermomonaspora fusca) lipase.
- the parent may be a fungal lipase.
- the parent may be a yeast lipase such as a Candida, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces, or Yarrowia lipase; or a filamentous fungal lipase such as an Acremonium, Agaricus, Alternaria, Aspergillus, Aureobasidium, Botryospaeria, Ceriporiopsis, Chaetomidium, Chrysosporium, Claviceps, Cochliobolus, Coprinopsis, Coptotermes, Corynascus, Cryphonectria, Cryptococcus, Diplodia, Exidia, Filibasidium, Fusarium, Gibberella, Holomastigotoides, Humicola, Irpex, Lentinula, Leptospaeria, Magnaporthe, Melanocarpus, Meripilus, Mucor, Myceliophthora
- the parent is a Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharomyces diastaticus, Saccharomyces douglasii, Saccharomyces kluyveri, Saccharomyces norbensis, or Saccharomyces oviformis lipase.
- the parent is an Acremonium cellulolyticus, Aspergillus aculeatus, Aspergillus awamori, Aspergillus foetidus, Aspergillus fumigatus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus oryzae, Chrysosporium inops, Chrysosporium keratinophilum, Chrysosporium lucknowense, Chrysosporium merdarium, Chrysosporium pannicola, Chrysosporium queenslandicum, Chrysosporium tropicum, Chrysosporium zonatum, Fusarium bactridioides, Fusarium cerealis, Fusarium crookwellense, Fusarium culmorum, Fusarium graminearum, Fusarium graminum, Fusarium heterosporum, Fusahum neg
- the parent is a Thermomyces lanuginosus lipase, e.g., the lipase of SEQ ID NO: 2.
- the invention encompasses both the perfect and imperfect states, and other taxonomic equivalents, e.g., anamorphs, regardless of the species name by which they are known. Those skilled in the art will readily recognize the identity of appropriate equivalents.
- ATCC American Type Culture Collection
- DSMZ Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH
- CBS Centraalbureau Voor Schimmelcultures
- NRRL Northern Regional Research Center
- the parent may be identified and obtained from other sources including microorganisms isolated from nature (e.g., soil, composts, water, etc.) or DNA samples obtained directly from natural materials (e.g., soil, composts, water, etc.) using the above-mentioned probes. Techniques for isolating microorganisms and DNA directly from natural habitats are well known in the art. A polynucleotide encoding a parent may then be obtained by similarly screening a genomic DNA or cDNA library of another microorganism or mixed DNA sample.
- the polynucleotide can be isolated or cloned by utilizing techniques that are known to those of ordinary skill in the art (see, e.g., Sambrook et al., 1989, supra).
- the present invention also relates to methods for obtaining lipase variants comprising: (a) introducing substitutions at positions corresponding to T231 R+N233R and at least one or more (e.g., several) of D96E, D1 1 1A, D254S, G163K, P256T, G91T, G38A, D27R, and N33Q of SEQ ID NO: 2; (b) selecting the variant which has lipase activity and in comparison with the parent lipase has improved stability; and (c) recovering the variant.
- the variants can be prepared using any mutagenesis procedure known in the art, such as site-directed mutagenesis, synthetic gene construction, semi-synthetic gene construction, random mutagenesis, shuffling, etc.
- Site-directed mutagenesis is a technique in which one or more (e.g., several) mutations are introduced at one or more defined sites in a polynucleotide encoding the parent lipase.
- Site-directed mutagenesis can be accomplished in vitro by PCR involving the use of oligonucleotide primers containing the desired mutation. Site-directed mutagenesis can also be performed in vitro by cassette mutagenesis involving the cleavage by a restriction enzyme at a site in the plasmid comprising a polynucleotide encoding the parent lipase and subsequent ligation of an oligonucleotide containing the mutation in the polynucleotide. Usually the restriction enzyme that digests the plasmid and the oligonucleotide is the same, permitting sticky ends of the plasmid and the insert to ligate to one another.
- Site-directed mutagenesis can also be accomplished in vivo by methods known in the art. See, e.g., US2004/0171 154; Storici et al., 2001 , Nature Biotechnol. 19: 773-776; Kren et al., 1998, Nat. Med. 4: 285-290; and Calissano and Macino, 1996, Fungal Genet. Newslett. 43: 15- 16.
- Any site-directed mutagenesis procedure can be used in the present invention.
- Synthetic gene construction entails in vitro synthesis of a designed polynucleotide molecule to encode a polypeptide of interest. Gene synthesis can be performed utilizing a number of techniques, such as the multiplex microchip-based technology described by Tian et al. (2004, Nature 432: 1050-1054) and similar technologies wherein oligonucleotides are synthesized and assembled upon photo-programmable microfluidic chips.
- Single or multiple amino acid substitutions, deletions, and/or insertions can be made and tested using known methods of mutagenesis, recombination, and/or shuffling, followed by a relevant screening procedure, such as those disclosed by Reidhaar-Olson and Sauer, 1988, Science 241 : 53-57; Bowie and Sauer, 1989, Proc. Natl. Acad. Sci. USA 86: 2152-2156; W095/17413; or W095/22625.
- Other methods that can be used include error-prone PCR, phage display (e.g., Lowman et al., 1991 , Biochemistry 30: 10832-10837; U.S. Patent No. 5,223,409; WO 92/06204) and region-directed mutagenesis (Derbyshire et al., 1986, Gene 46: 145; Ner ei a/., 1988, DNA 7: 127).
- Mutagenesis/shuffling methods can be combined with high-throughput, automated screening methods to detect activity of cloned, mutagenized polypeptides expressed by host cells (Ness et al., 1999, Nature Biotechnology 17: 893-896). Mutagenized DNA molecules that encode active polypeptides can be recovered from the host cells and rapidly sequenced using standard methods in the art. These methods allow the rapid determination of the importance of individual amino acid residues in a polypeptide.
- Semi-synthetic gene construction is accomplished by combining aspects of synthetic gene construction, and/or site-directed mutagenesis, and/or random mutagenesis, and/or shuffling.
- Semi-synthetic construction is typified by a process utilizing polynucleotide fragments that are synthesized, in combination with PCR techniques. Defined regions of genes may thus be synthesized de novo, while other regions may be amplified using site-specific mutagenic primers, while yet other regions may be subjected to error-prone PCR or non-error prone PCR amplification. Polynucleotide subsequences may then be shuffled.
- the lipase is a lipase variant, comprising a substitution at one or more positions corresponding to positions T37A,D,E,F,G,H,I,L,N,P,Q,R,S,V,W,Y, N39A,C,D,E,F,G,I,K,L,M,P,Q,R,T,V,W,Y, and G91 D,H,I,P,Q of the mature polypeptide of SEQ ID NO: 4 , wherein the variant has lipase activity.
- the variant of a parent lipase can be selected from the group consisting of:
- the lipase variant has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100%, sequence identity to the amino acid sequence of the parent lipase.
- the number of substitutions in the lipase variant is 1 -20, e.g., 1 -10 and 1 -5, such as 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20 substitutions.
- the lipase variant may comprises a substitution at one or more positions corresponding to positions D96, T143, A150, E210, G225, T231 , N233 and
- substitution is selected from D96G, T143A, A150G, E210Q, G225R, T231 R, N233R and P250R.
- the lipase variant is:
- the lipase variant is:
- the parent lipase may be (a) a polypeptide having at least 60% sequence identity to the mature polypeptide of SEQ ID NO: 4; (b) a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 3, or (ii) the full-length complement of (i); or (c) a polypeptide encoded by a polynucleotide having at least 60% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 3.
- the parent has a sequence identity to the mature polypeptide of SEQ ID NO: 4 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least
- the amino acid sequence of the parent differs by no more than 20 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, or 20 from the mature polypeptide of SEQ ID NO: 4.
- the parent comprises or consists of the amino acid sequence of SEQ ID NO: 4. In another aspect, the parent comprises or consists of the mature polypeptide of SEQ I D NO: 4. In another aspect, the parent comprises or consists of amino acids 1 to 269 of SEQ ID NO: 4.
- the parent is a fragment of the mature polypeptide of SEQ ID NO: 4 containing at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, and at least 95% of the number of amino acids of the mature polypeptide.
- the parent is an allelic variant of the mature polypeptide of SEQ ID NO: 4.
- the parent is encoded by a polynucleotide that hybridizes under very low stringency conditions, low stringency conditions, medium stringency conditions, medium-high stringency conditions, high stringency conditions, or very high stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 3, or (ii) the full- length complement of (i) (Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual,
- polynucleotide of SEQ ID NO: 3 or a subsequence thereof, as well as the polypeptide of SEQ ID NO: 4 or a fragment thereof, may be used to design nucleic acid probes to identify and clone DNA encoding a parent from strains of different genera or species according to methods well known in the art.
- probes can be used for hybridization with the genomic DNA or cDNA of a cell of interest, following standard
- the nucleic acid probe is at least 100 nucleotides in length, e.g., at least 200 nucleotides, at least 300 nucleotides, at least 400 nucleotides, at least 500 nucleotides, at least 600 nucleotides, at least 700 nucleotides, at least 800 nucleotides, or at least 900 nucleotides in length.
- Both DNA and RNA probes can be used.
- the probes are typically labeled for detecting the corresponding gene (for example, with 32P, 3H, 35S, biotin, or avidin). Such probes are encompassed by the present invention.
- a genomic DNA or cDNA library prepared from such other strains may be screened for
- Genomic or other DNA from such other strains may be separated by agarose or polyacrylamide gel electrophoresis, or other separation techniques.
- DNA from the libraries or the separated DNA may be transferred to and immobilized on nitrocellulose or other suitable carrier material.
- the carrier material is used in a Southern blot.
- hybridization indicates that the polynucleotide hybridizes to a labeled nucleic acid probe corresponding to (i) SEQ ID NO: 3; (ii) the mature polypeptide coding sequence of SEQ ID NO: 3; (iii) the full-length complement thereof; or (iv) a subsequence thereof; under very low to very high stringency conditions.
- Molecules to which the nucleic acid probe hybridizes under these conditions can be detected using, for example, X ray film or any other detection means known in the art.
- the nucleic acid probe is the mature polypeptide coding sequence of SEQ ID NO: 3. In another aspect, the nucleic acid probe is nucleotides 67 to 873 of SEQ ID NO: 3. In another aspect, the nucleic acid probe is a polynucleotide that encodes the polypeptide of SEQ ID NO: 4; the mature polypeptide thereof; or a fragment thereof. In another aspect, the nucleic acid probe is SEQ ID NO: 3.
- the parent is encoded by a polynucleotide having a sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 3 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%.
- the polypeptide may be a hybrid polypeptide in which a region of one polypeptide is fused at the N terminus or the C terminus of a region of another polypeptide.
- variants may be prepared as described in the paragraph "preparation of variants" beginning on page 25 of WO 2013/1 13622.
- the cellulase is comprised by the enzyme classification EC 3.2.1.4.
- the cellulase is of bacterial or fungal origin and can be chemically modified or protein engineered.
- the cellulase can be derived from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia or Acremonium.
- the cellulase is derived from Humicola insolens, Myceliophthora thermophila, Sporotrichum pulverulentum, Fusarium oxysporum, Trichoderma reesei, Thielavia terrestris,
- the cellulase is an enzyme exhibiting endo-beta- 1 ,4-glucanase activity (EC 3.2.1.4), which is selected from one of
- an endo-beta-1 ,4-glucanase enzyme having a sequence of at least 97% identity to the amino acid sequence of position 1 to position 773 of SEQ ID NO:6; or a fragment thereof that has endo-beta-1 ,4-glucanase activity, when identity is determined by GAP provided in the GCG program package using a GAP creation penalty of 3.0 and GAP extension penalty of 0.1 .
- the cellulase exhibiting endo-beta-1 ,4-glucanase activity (EC
- the cellulase may comprise a polypeptide endogeneous to Bacillus sp., DSM 12648.
- the cellulase is active at a pH at least in the range of 4-1 1 , preferably 5.5-10.5.
- an isolated polynucleotide will hybridize to similar sized regions of SEQ ID NO: 5 or a sequence complementary thereto, under at least medium stringency conditions.
- polynucleotides will hybridize to a denatured double-stranded DNA probe comprising either the full sequence encoding the catalytic domain of the enzyme which sequence is shown in positions 1 -2322 of SEQ ID NO: 5 or any probe comprising a subsequence of SEQ ID NO: 5 having a length of at least about 100 base pairs under at least medium stringency conditions, but preferably at high stringency conditions as described in detail below.
- Suitable experimental conditions for determining hybridization at medium, or high stringency between a nucleotide probe and a homologous DNA or RNA sequence involves presoaking of the filter containing the DNA fragments or RNA to hybridize in 5 x SSC (Sodium chloride/Sodium citrate, Sambrook et al.
- Molecules to which the oligonucleotide probe hybridizes under these conditions are detected using an x-ray film.
- the isolated polynucleotides of the present invention include DNA and RNA.
- Methods for isolating DNA and RNA are well known in the art.
- DNA and RNA encoding genes of interest can be cloned in Gene Banks or DNA libraries by means of methods known in the art.
- Polynucleotides encoding polypeptides having endo-glucanase activity of the invention are then identified and isolated by, for example, hybridization or PCR.
- the present invention further provides counterpart polypeptides and polynucleotides from different bacterial strains (orthologs or paralogs).
- bacterial strains orthologs or paralogs.
- endo- glucanase polypeptides from gram-positive alkalophilic strains, including species of Bacillus.
- Species homologues of a polypeptide with endo-glucanase activity of the invention can be cloned using information and compositions provided by the present invention in combination with conventional cloning techniques.
- a DNA sequence of the present invention can be cloned using chromosomal DNA obtained from a cell type that expresses the protein. Suitable sources of DNA can be identified by probing Northern blots with probes designed from the sequences disclosed herein. A library is then prepared from chromosomal DNA of a positive cell line.
- a DNA sequence of the invention encoding an polypeptide having endo-glucanase activity can then be isolated by a variety of methods, such as by probing with probes designed from the sequences disclosed in the present specification and claims or with one or more sets of degenerate probes based on the disclosed sequences.
- a DNA sequence of the invention can also be cloned using the polymerase chain reaction, or PCR (Mullis, U.S. Patent 4,683,202), using primers designed from the sequences disclosed herein.
- the DNA library can be used to transform or transfect host cells, and expression of the DNA of interest can be detected with an antibody (monoclonal or polyclonal) raised against the endo-glucanase cloned from B. sp., DSM 12648, expressed and purified as described in Materials and Methods and Examples 1 and 2 of WO 2002/099091 , or by an activity test relating to a polypeptide having endo-glucanase activity.
- the endo-glucanase encoding part of the DNA sequence shown in SEQ ID NO:5 and/or an analogue DNA sequence of the invention may be cloned from a strain of the bacterial species Bacillus sp., preferably the strain DSM12648, producing the enzyme with endo-glucanase activity, or another or related organism as described herein.
- the disclosed sequence information herein relating to a polynucleotide sequence encoding an endo-beta- 1 ,4-glucanase of the invention can be used as a tool to identify other homologous endo- glucanases.
- PCR polymerase chain reaction
- PCR can be used to amplify sequences encoding other homologous endo-glucanases from a variety of microbial sources, in particular of different Bacillus species.
- the sequence of amino acids in position 1 to position 773 of SEQ ID NO:6 is a mature endo-glucanase sequence with a calculated molecular weight of 86 kDa. It is believed that positions 1 to about 340 of SEQ ID NO: 6 are the catalytically active domain of the of the present endo-glucanase enzyme. It is also believed that positions from about 340 to about 540 are the cellulose binding domain of the present endo-glucanase enzyme. The function of the remainder of the sequence, i.e., from about position 540 to position 773, is at present unknown.
- the present invention provides an endo-glucanase enzyme comprising (i) the amino acid sequence of position 1 to position 773 of SEQ ID NO: 6, or a fragment thereof that has endo-glucanase activity.
- a fragment of position 1 to position 773 of SEQ ID NO: 6 is a polypeptide, which have one or more amino acids deleted from the amino and/or carboxyl terminus of this amino acid sequence.
- the present invention provides an endo-glucanase enzyme comprising (ii) the amino acid sequence of positions 1 to about 340 of SEQ ID NO: 6, since it is contemplated that such a mono-domain endo-glucanase is also useful in the industrial applications described herein.
- the present invention provides an endo-glucanase enzyme comprising (iii) the amino acid sequence of positions 1 to from between about 540 and 773 of SEQ ID NO: 6, since it is contemplated that such an endo- glucanase comprising the catalytically active domain and the cellulose binding domain is also useful in the industrial applications described herein.
- such fragment is a polypeptide which consists of position 1 to position 663 ⁇ 50 amino acids, preferably 1 to 663 ⁇ 25 amino acids.
- the present invention also provides endo-glucanase polypeptides that are substantially homologous to the polypeptide of (i), (ii), or (iii) above and species homologs (paralogs or orthologs) thereof.
- substantially homologous is used herein to denote polypeptides being at least 97%, preferred 98%, more preferred 98.5% identical, and most preferably 99% or more identical to the sequence shown in amino acids nos. 1 -773 of SEQ ID NO: 6, or a fragment thereof that has endo-glucanase activity, or its orthologs or paralogs.
- Percent sequence identity is determined by conventional methods, by means of computer programs known in the art such as GAP provided in the GCG program package (Program Manual for the Wisconsin Package, Version 8, August 1994, Genetics Computer Group, 575 Science Drive, Madison, Wisconsin, USA 5371 1 ) as disclosed in Needleman, S.B. and Wunsch, CD., (1970), Journal of Molecular Biology, 48, 443-453, which is hereby incorporated by reference in its entirety.
- GAP is used with the following settings for polypeptide sequence comparison: GAP creation penalty of 3.0 and GAP extension penalty of 0.1 .
- Sequence identity of polynucleotide molecules is determined by similar methods using GAP with the following settings for DNA sequence comparison: GAP creation penalty of 5.0 and GAP extension penalty of 0.3.
- Substantially homologous proteins and polypeptides are characterized as having one or more amino acid substitutions, deletions or additions. These changes are preferably of a minor nature, that is conservative amino acid substitutions (see Table 1 ) and other substitutions that do not significantly affect the folding or activity of the protein or polypeptide; small deletions, typically of one to about 30 amino acids; and small amino- or carboxyl-terminal extensions, such as an amino-terminal methionine residue, a small linker peptide of up to about 20-25 residues, or a small extension that facilitates purification (an affinity tag), such as a poly-histidine tract, protein A (Nilsson et al., EMBO J. 4:1075, 1985; Nilsson et al., Methods Enzymol. 198:3, 1991. See, in general Ford et al., Protein Expression and Purification 2: 95-107, 1991 , which is incorporated herein by reference.
- DNAs encoding affinity tags are available from commercial suppliers (e.g., Pharmacia Biotech, Piscataway, NJ; New England Biolabs, Beverly, MA).
- Aromatic phenylalanine
- non-standard amino acids such as 4- hydroxyproline, 6-N-methyl lysine, 2-aminoisobutyric acid, isovaline and a-methyl serine
- a limited number of non-conservative amino acids, amino acids that are not encoded by the genetic code, and unnatural amino acids may be substituted for amino acid residues.
- "Unnatural amino acids” have been modified after protein synthesis, and/or have a chemical structure in their side chain(s) different from that of the standard amino acids.
- Unnatural amino acids can be chemically synthesized, or preferably, are commercially available, and include pipecolic acid, thiazolidine carboxylic acid, dehydroproline, 3- and 4-methylproline, and 3,3-dimethylproline.
- Essential amino acids in the endo-glucanase polypeptides of the present invention can be identified according to procedures known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (Cunningham and Wells, Science 244: 1081 -1085, 1989). In the latter technique, single alanine mutations are introduced at every residue in the molecule, and the resultant mutant molecules are tested for biological activity (i.e endo- glucanase activity) to identify amino acid residues that are critical to the activity of the molecule. See also, Hilton et al., J. Biol. Chem. 271 :4699-4708, 1996.
- the active site of the enzyme or other biological interaction can also be determined by physical analysis of structure, as determined by such techniques as nuclear magnetic resonance, crystallography, electron diffraction or photoaffinity labeling, in conjunction with mutation of putative contact site amino acids. See, for example, de Vos et al., Science 255:306-312, 1992; Smith et al., J. Mol. Biol. 224:899-904, 1992; Wlodaver et al., FEBS Lett. 309:59-64, 1992.
- the identities of essential amino acids can also be inferred from analysis of homologies with polypeptides which are related to a polypeptide according to the invention.
- Mutagenesis/shuffling methods as disclosed above can be combined with high- throughput, automated screening methods to detect activity of cloned, mutagenized polypeptides in host cells.
- Mutagenized DNA molecules that encode active polypeptides can be recovered from the host cells and rapidly sequenced using modern equipment. These methods allow the rapid determination of the importance of individual amino acid residues in a polypeptide of interest, and can be applied to polypeptides of unknown structure.
- polypeptides that are substantially homologous to the polypeptides of (I), (II), or (III) above and retain the endo-glucanase activity of the wild-type protein.
- the endo-glucanase enzyme of the invention may, in addition to the enzyme core comprising the catalytically active domain, i.e. positions 1 -about 340 of SEQ ID NO: 6, also comprise a cellulose binding domain (CBD), the cellulose binding domain and the catalytically active domain being operably linked.
- the cellulose binding domain (CBD) may exist as an integral part of the encoded enzyme as described above and in the appended SEQ ID NO:6, or be a CBD from another origin, introduced into the endo-glucanase thus creating an enzyme hybrid.
- the term "cellulose-binding domain" is intended to be understood as defined by Peter Tomme et al.
- CBDs Cellulose-Binding Domains: Classification and Properties
- This definition classifies more than 120 cellulose-binding domains into 10 families (l-X), and demonstrates that CBDs are found in various enzymes such as cellulases (endo-glucanases), xylanases, mannanases, arabinofuranosidases, acetyl esterases and chitinases.
- CBDs have also been found in algae, e.g.
- Enzyme hybrids are known in the art, see e.g. WO 90/00609 and WO 95/16782, and may be prepared by transforming into a host cell a DNA construct comprising at least a fragment of DNA encoding the cellulose-binding domain ligated, with or without a linker, to a DNA sequence encoding the endo-glucanase and growing the host cell to express the fused gene. Enzyme hybrids may be described by the following formula:
- CBD is the N-terminal or the C-terminal region of an amino acid sequence corresponding to at least the cellulose-binding domain
- MR is the middle region (the linker), and may be a bond, or a short linking group preferably of from about 2 to about 100 carbon atoms, more preferably of from 2 to 40 carbon atoms; or is preferably from about 2 to about 100 amino acids, more preferably of from 2 to 40 amino acids
- X is an N-terminal or C- terminal region of a polypeptide corresponding at least to the catalytically active domain encoded by the DNA sequence of the invention.
- the cellulose binding domain corresponding to from about position 340 to about position 540 of SEQ ID NO:6 can be used to form hybrids with endo-glucanases from sources other than Bacillus sp. AA349 and with other proteins.
- endo- glucanases from other sources replacing the endo-glucanase of positions 1 to about 340 of SEQ ID NO:6 include endo-glucanases from: (a) Bacillus lautus for instance Bacillus lautus NCIMB 40250 disclosed in W091 10732, (b) Humicola insolens DSM1800 disclosed in W091 17243 (c) Fusarium oxysporium DSM2672 disclosed in W091 17243 and (d) Bacillus sp. AC13 NCIMB 40482 disclosed in EP0651785.
- the enzymes can be prepared as described in WO 2002/099091 .
- the lipase and the cellulase is used together with further ingredients, such as hydrotropes, builders, co-builders, a bleaching systems, polymers, fabric hueing agents, mediators and/or enzymes.
- further ingredients such as hydrotropes, builders, co-builders, a bleaching systems, polymers, fabric hueing agents, mediators and/or enzymes.
- at least one additional enzyme is used.
- the further ingredients including the at least one additional enzyme may be comprised in a composition comprising the lipase and the cellulase.
- the additional enzyme may be selected from the group consisting of protease, lipase, cutinase, amylase, carbohydrase, cellulase, pectate lyase, pectinase, mannanase, arabinase, galactanase, and/or xylanase.
- the concentration of the lipase is in the range of 0.01 -1 ,0 % w/w enzyme per detergent composition, in the range of 0.02-1 .0% w/w enzyme per detergent composition, in the range of 0.03-0.9% w/w enzyme per detergent composition, in the range of 0.04-0.9% w/w enzyme per detergent composition, in the range of 0.05-0.9% w/w enzyme per detergent composition, in the range of 0.05-0.8% w/w enzyme per detergent composition, in the range of 0.05-0.7% w/w enzyme per detergent composition, in the range of 0.05-0.6% w/w enzyme per detergent composition, in the range of 0.05-0.5 % w/w enzyme per detergent composition or in the range of 0.05-0.2 % w/w enzyme per detergent composition.
- the lipase and the cellulase may be used for removing or releasing greasy stains at a temperature in the range of 0°C to 90°C, in the range of 0°C to 80°C, in the range of 0°C to 70°C, in the range of 0°C to 60°C, in the range of 0°C to 50°C, in the range of 0°C to 40°C, in the range of 0°C to 30°C, in the range of 5°C to 35°C, in the range of 10°C to 30°C, in the range of 15°C to 25°C or in the range of 15°C to 20°C.
- the use of the lipase and a cellulase for removing or releasing greasy stains may result in a cellulase effect is at least 2 points, at least 2.2 points, at least 2.4 points, at least 2.6 points, at least 2.8 points, at least 3.0 points, at least 3.5 points, at least 4.0 points or at least 5.0 points.
- the use of the lipase and the cellulase for removing or releasing greasy stains may result in a synergy effect is at least 2 points, at least 2.2 points, at least 2.4 points, at least 2.6 points, at least 2.8 points, at least 3.0 points, at least 3.5 points, at least 4.0 points or at least 5.0 points.
- the lipase and the cellulase is used as a composition in the form of a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular, compact or concentrated liquid.
- composition comprises granules, which granules comprise a core and a protective coating, wherein:
- the core comprises an enzyme, which is lipase and/or cellulase, and
- the core or the coating comprises a reducing agent or a peroxide decomposing catalyst or an antioxidant
- the core comprises a salt of a multivalent cation
- the core or the coating comprises an acidic buffer component
- the coating comprises a salt.
- the core comprises the enzyme and the salt of a multivalent cation, and it may also comprise the reducing agent/antioxidant/peroxide decomposing catalyst and/or the acidic buffer component, typically as a homogenous blend.
- the blend may also include binders (such as synthetic polymer, wax, fat, or carbohydrate).
- the blend may further include additional materials such as fillers, fibre materials (cellulose or synthetic fibres), stabilizing agents, solubilising agents, suspension agents, viscosity regulating agents, light spheres, plasticizers, salts, lubricants and fragrances.
- the core can be prepared by granulating the blend, e.g. by use of granulation techniques including: crystallisation, precipitation, pan-coating, fluid bed coating, fluid bed agglomeration, rotary atomization, extrusion, prilling, spheronization, size reduction methods, drum granulation, and/or high shear granulation.
- granulation techniques including: crystallisation, precipitation, pan-coating, fluid bed coating, fluid bed agglomeration, rotary atomization, extrusion, prilling, spheronization, size reduction methods, drum granulation, and/or high shear granulation.
- the core may consist of an inert particle with the blend absorbed into it, or with the blend applied on to the surface e.g. via fluid bed coating.
- the core particle may have a diameter of 20-2000 ⁇ , particularly 50-1500 ⁇ , 100- 1500 m or 250-1200 ⁇ .
- the composition comprises granules comprising lipase and granules comprising cellulase.
- the composition further comprises additional enzymes in the granules.
- the lipase, the cellulase and optionally additional enzymes are comprised in the same granule, or the composition may comprise granules, which comprises the lipase, the cellulase and optionally additional enzymes in separate granules.
- the granules of the invention typically include between about 0.005 to about 500 mg/g on a dry weight basis of the enzyme component relative to the core (as active enzyme protein).
- the amount of enzyme in embodiments of the invention comprises about 0.05 to 300 mg/g, about 0.1 to 250 mg/g, about 0.5 to 200 mg/g, about 0.5 to 200 mg/g, about 1 .0 to 150 mg/g in the granule, or about 5.0 to 150 mg/g relative to the core.
- the acidic buffer component of the granule is present in an amount of 0.1 -10 % by weight relative to the core.
- the coating of the granule makes up 5-70 % by weight relative to the core and comprises at least 60% by weight w/w of a salt having a constant humidity at 20°C of at least 60%.
- the granule contains a reducing agent, a peroxide decomposing catalyst and/or an antioxidant (a molecule capable of slowing or preventing the oxidation of other molecules) in the core and/or in the coating.
- a reducing agent e.g. a peroxide decomposing catalyst
- an antioxidant a molecule capable of slowing or preventing the oxidation of other molecules
- examples are sulfites, thiosulfates, erythorbates, ascorbates and nitrites, e.g. as salts of alkali metals and earth alkali metals.
- Other suitable materials are methionine, cysteine, propyl gallate, tert-butyl hydroquinone, tocopherols, thiodipropionic acid, butylated hydroxytoluene (BHT), butylated hydroxyanisol (BHA) or tannic acid.
- transition metals as reducing agents and/or peroxide decomposing catalysts like e.g. V, Co, Mn and Fe, typically as salts, e.g. sulfate-, acetate-, nitrate or chloride- salts or oxides, e.g. FeS0 4 , FeCI 3 , CoS0 4 , MnS0 4 or Mn0 2 . Water soluble salts of the transition metals are preferred.
- peroxide decomposing catalysts also an enzyme can be used, e.g. catalase.
- the amount of the antioxidant, peroxide decomposing catalyst or reducing agent may be at least 0.1 % by weight relative to the core, particularly at least 0.2 %, at least 0.5 %, at least 1 %, or at least 1 % The amount may be at most 10% by weight relative to the core, particularly at most 5%, at most 4 %, at most 3 % or at most 2 %.
- the amount of a salt is calculated in anhydrous form.
- Peroxide decomposing catalysts can be efficient in even lower concentrations, e.g. at least 0.001 %, or at least 0.01 %; the amount may be at most 5 % or at most 1 %.
- the granule contains a salt of a multivalent cation in the core, particularly a divalent or trivalent cation, e.g. a salt of Mg, Zn, Cu, Mn, Ca or Al.
- the salt may include an organic or inorganic anion such as sulfate, chloride or acetate.
- Particular salts include magnesium sulfate and zinc sulfate, e.g. magnesium sulfate heptahydrate.
- the salt may be used in an amount of at least 0.1 % by weight of the core, particularly at least 0.5% by weight, e.g. at least 1 % by weight.
- the amount may be at most 15 %, 10 % or 5 %.
- the percentage indicates the amount of the salt in anhydrous form.
- the multivalent cation may be used in an amount of at least 0.02% by weight of the core, particularly at least 0.1 % by weight, e.g. at least 0.2 % by weight.
- the amount may be at most 6 %, at most 4 % or at most 2 %.
- the percentage indicates the amount of the multivalent cation.
- the granule contains an acidic buffer component (acidic buffering agent) in the core or the coating.
- the amount may be at least 0.1 by weight of the core, particularly at least 1 % by weight.
- the amount is typically at most 10% by weight of the core, particularly at most 5% by weight.
- the percentage indicates the amount in anhydrous form.
- the acidic buffer component has a pH below 7 when measured as a 1 % by weight aqueous solution (or alternatively a 10% solution).
- the acidic buffer component may have a pH of 1 to below 7, e.g. a pH of 3 to below 7, particularly a pH of 4 to 5.
- the acidic buffer component is typically a mixture comprising a weak acid and the corresponding base; it is at least partly in its acid form
- the acidic buffer component has a pKa from 2 to 9, in particular a pK a from 4 to 9, in particular a pK a from 5 to 8, in particular a pK a from 2 to 6, in particular a pK a from 2 to 5, in particular a pK a from 2 to 4, in particular a pK a from 5 to 7.
- a pKa from 2 to 9, in particular a pK a from 4 to 9, in particular a pK a from 5 to 8, in particular a pK a from 2 to 6, in particular a pK a from 2 to 5, in particular a pK a from 2 to 4, in particular a pK a from 5 to 7.
- the pH of an aqueous solution is in general below the pK a .
- Particularly suitable acidic buffer components are salts of H 3 P0 4 e.g. NaH 2 P0 4 ,
- polyphosphates e.g. sodium hexametaphosphate
- polyacrylic acid and partly neutralized polyacrylic acid and co-polymers thereof simple organic acids (less than 10 carbon atoms e.g. 6 or less carbon atoms) such as citric acid and salts thereof such as hydrogen citrate, e.g. disodium hydrogen citrate, malonic, succinic, glutaric, adipic acid.
- the acidic buffer components are selected from the group consisting of polyacrylic acid and partly neutralized polyacrylic acid and co-polymers thereof, citric acid and Na 3 -citrate.
- the granule comprises a core surrounded by at least one coating.
- the coating may comprise at least 60% by weight w/w of a salt, e.g. at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 99% by weight w/w.
- the coating may be applied in an amount of at least 5 % by weight of the core, e.g. at least 10%, 10% or 15%.
- the amount may be at most 70 %, 50 %, 40 % or 30%.
- the salt coating is preferably at least 1 ⁇ thick, particularly at least 2 ⁇ , at least 4 ⁇ or at least 8 ⁇ .
- the thickness of the salt coating is below 100 ⁇ .
- the thickness of the salt coating is below 60 ⁇ .
- the total thickness of the salt coating is below 40 ⁇ .
- the coating should encapsulate the core unit by forming a substantially continuous layer.
- a substantially continuous layer is to be understood as a coating having few or no holes, so that the core unit it is encapsulating has few or none uncoated areas.
- the layer or coating should in particular be homogenous in thickness.
- the salt may be added from a salt solution where the salt is completely dissolved or from a salt suspension wherein the fine particles is less than 50 ⁇ , such as less than 10 ⁇ or less than 5 ⁇ .
- the salt coating is especially effective if it is applied in a fluid bed under relatively high humidity conditions.
- the reducing agent/antioxidant/peroxide decomposing catalyst may be part of the salt coating, either as a homogeneous part of the entire salt coating, or as part of this coating, e.g. only as an inner layer of salt and /antioxidant/peroxide decomposing catalyst.
- Using e.g. FeS0 4 as a reducing agent/peroxide decomposing catalyst may induce a color change as the metal is oxidized, which can be hidden by having the component as an inner layer.
- the salt coating can further contain other materials as known in the art, e.g. fillers, anti- sticking agents, pigments, dyes, plasticizers and/or binders, such as titanium dioxide, kaolin, calcium carbonate or talc.
- fillers e.g. fillers, anti- sticking agents, pigments, dyes, plasticizers and/or binders, such as titanium dioxide, kaolin, calcium carbonate or talc.
- the salt coating may comprise a single salt or a mixture of two or more salts.
- the salt may be water soluble, in particular having a solubility at least 0.1 grams in 100 g of water at 20°C, preferably at least 0.5 g per 100 g water, e.g. at least 1 g per 100 g water, e.g. at least 5 g per 100 g water.
- the salt may be an inorganic salt, e.g. salts of sulfate, sulfite, phosphate, phosphonate, nitrate, chloride or carbonate or salts of simple organic acids (less than 10 carbon atoms e.g. 6 or less carbon atoms) such as citrate, malonate or acetate.
- simple organic acids less than 10 carbon atoms e.g. 6 or less carbon atoms
- Examples of cations in these salts are alkali or earth alkali metal ions, the ammonium ion or metal ions of the first transition series, such as sodium, potassium, magnesium, calcium, zinc or aluminium.
- anions include chloride, bromide, iodide, sulfate, sulfite, bisulfite, thiosulfate, phosphate, monobasic phosphate, dibasic phosphate, hypophosphite, dihydrogen pyrophosphate, tetraborate, borate, carbonate, bicarbonate, metasilicate, citrate, malate, maleate, malonate, succinate, lactate, formate, acetate, butyrate, propionate, benzoate, tartrate, ascorbate or gluconate.
- alkali- or earth alkali metal salts of sulfate, sulfite, phosphate, phosphonate, nitrate, chloride or carbonate or salts of simple organic acids such as citrate, malonate or acetate may be used.
- Specific examples include NaH 2 P0 4 , Na 2 HP0 4 , Na 3 P0 4 , (NH 4 )H 2 P0 4 , K 2 HP0 4 , KH 2 P0 4 , Na 2 S0 4 , K 2 S0 4 , KHS0 4 ,
- the salt may be in anhydrous form, or it may be a hydrated salt, i.e. a crystalline salt hydrate with bound water(s) of crystallization, such as described in WO 99/32595.
- Specific examples include anhydrous sodium sulfate (Na 2 S0 4 ), anhydrous magnesium sulfate (MgS0 4 ), magnesium sulfate heptahydrate (MgS0 4 (7H 2 0)), zinc sulfate heptahydrate (ZnS0 4 (7H 2 0)), sodium phosphate dibasic heptahydrate (Na 2 HP0 4 (7H 2 0)), magnesium nitrate hexahydrate (Mg(N0 3 ) 2 (6H 2 0)), sodium borate decahydrate, sodium citrate dihydrate and magnesium acetate tetrahydrate.
- the salt in the coating may have a constant humidity at 20°C above 60%, particularly above 70%, above 80% or above 85% by weight, or it may be another hydrate form of such a salt (e.g. anhydrate).
- the salt coating may be according to WO 00/01793, which is hereby incorporated by reference.
- the salt is selected from the group consisting of NaCI, Na 2 C0 3 , NaN0 3 , Na 2 HP0 4 , Na 3 P0 4 , NH 4 CI, (NH 4 ) 2 HP0 4 , NH 4 H 2 P0 4 , (NH 4 ) 2 S0 4 , KCI, K 2 HP0 4 , KH 2 P0 4 , KN0 3 , Na 2 S0 4 , K 2 S0 4 , KHS0 4 , MgS0 4 , ZnS0 4 , NaCI and sodium citrate or mixtures thereof.
- the salt is selected from the group consisting of NaCI, Na 2 C0 3 , NaN0 3 , Na 2 HP0 4 , Na 3 P0 4 , NH 4 CI, (NH 4 ) 2 HP0 4 , NH 4 H 2 P0 4 , (NH 4 ) 2 S0 4 , KCI, K 2 HP0 4 , KH 2 P0 4 , KN0 3 , Na 2 S0 4 , K 2 S0 4 , KHS0 4 , NaCI and sodium citrate or mixtures thereof.
- the salt comprised in the coating of the granule is selected from the group consisting of NaCI, Na 2 C0 3 , NaN0 3 , Na 2 HP0 4 , Na 3 P0 4 , NH 4 CI, (NH 4 ) 2 HP0 4 , NH 4 H 2 P0 4 , (NH 4 ) 2 S0 4 , KCI, K 2 HP0 4 , KH 2 P0 4 , KN0 3 , Na 2 S0 4 , K 2 S0 4 , KHS0 4 , MgS0 4 , ZnS0 4 , NaCI and sodium citrate or mixtures thereof.
- the salt it applied as a solution of the salt e.g. using a fluid bed.
- the granule comprises:
- an enzyme which is lipase and/or cellulase
- the core comprises Na-thiosulfate or methionine in an amount of 0.5-5% by weight relative to the core
- the core comprises magnesium sulfate or zinc sulfate in an amount of 2-8% by weight of the core
- the core comprises a mixture of citric acid and a citrate in an amount of 1 -5% by weight relative to the core, and
- the salt coating makes up 10-30% by weight relative to the core, and comprises at least 75% by weight sodium sulfate.
- the granule may include an additional coating on the outside of the salt coating, e.g. in an amount of at least 0.5% by weight of the core, particularly at least 1 %, e.g. at most 20 % or 10 %.
- the additional coating may comprise polyethylene glycol (PEG), hydroxypropyl methyl cellulose (HPMC or MHPC), polyvinyl alcohol (PVA) or other film forming agents and can further contain fillers, antisticking agents, pigment, dye, plasticizers etc.
- PEG polyethylene glycol
- HPMC or MHPC hydroxypropyl methyl cellulose
- PVA polyvinyl alcohol
- Other additional coatings on the inside or outside of the salt coatings may be applied as known for people skilled in the art.
- the lipase and the cellulase may be used for removing or releasing greasy stains in laundry, dishwashing, e.g. ADW, for hard surface cleaning or as a personal care cleaning product.
- the detergent composition may comprise one or more surfactants, which may be anionic and/or cationic and/or non-ionic and/or semi-polar and/or zwitterionic, or a mixture thereof.
- the detergent composition includes a mixture of one or more nonionic surfactants and one or more anionic surfactants.
- the surfactant(s) is typically present at a level of from about 0.1 % to 60% by weight, such as about 1 % to about 40%, or about 3% to about 20%, or about 3% to about 10%.
- the surfactant(s) is chosen based on the desired cleaning application, and may include any conventional surfactant(s) known in the art.
- the detergent When included therein the detergent will usually contain from about 1 % to about 40% by weight of an anionic surfactant, such as from about 5% to about 30%, including from about 5% to about 15%, or from about 15% to about 20%, or from about 20% to about 25% of an anionic surfactant.
- an anionic surfactant such as from about 5% to about 30%, including from about 5% to about 15%, or from about 15% to about 20%, or from about 20% to about 25% of an anionic surfactant.
- Non-limiting examples of anionic surfactants include sulfates and sulfonates, in particular, linear alkylbenzenesulfonat.es (LAS), isomers of LAS, branched alkylbenzenesulfonat.es (BABS), phenylalkanesulfonat.es, alpha-olefinsulfonates (AOS), olefin sulfonates, alkene sulfonates, alkane-2,3-diylbis(sulfates), hydroxyalkanesulfonat.es and disulfonates, alkyl sulfates (AS) such as sodium dodecyl sulfate (SDS), fatty alcohol sulfates (FAS), primary alcohol sulfates (PAS), alcohol ethersulfates (AES or AEOS or FES, also known as alcohol ethoxysulfates or fatty alcohol ether sulf
- the detergent When included therein the detergent will usually contain from about from about 1 % to about 40% by weigh of a cationic surfactant, for example from about 0.5% to about 30%, in particular from about 1 % to about 20%, from about 3% to about 10%, such as from about 3% to about 5%, from about 8% to about 12% or from about 10% to about 12%.
- a cationic surfactant for example from about 0.5% to about 30%, in particular from about 1 % to about 20%, from about 3% to about 10%, such as from about 3% to about 5%, from about 8% to about 12% or from about 10% to about 12%.
- Non-limiting examples of cationic surfactants include alkyldimethylethanolamine quat (ADMEAQ), cetyltrimethylammonium bromide (CTAB), dimethyldistearylammonium chloride (DSDMAC), and alkylbenzyldimethylammonium, alkyl quaternary ammonium compounds, alkoxylated quaternary ammonium (AQA) compounds, ester quats, and combinations thereof.
- ADMEAQ alkyldimethylethanolamine quat
- CAB cetyltrimethylammonium bromide
- DMDMAC dimethyldistearylammonium chloride
- AQA alkoxylated quaternary ammonium
- the detergent When included therein the detergent will usually contain from about 0.2% to about 40% by weight of a nonionic surfactant, for example from about 0.5% to about 30%, in particular from about 1 % to about 20%, from about 3% to about 10%, such as from about 3% to about 5%, from about 8% to about 12%, or from about 10% to about 12%.
- a nonionic surfactant for example from about 0.5% to about 30%, in particular from about 1 % to about 20%, from about 3% to about 10%, such as from about 3% to about 5%, from about 8% to about 12%, or from about 10% to about 12%.
- Non-limiting examples of nonionic surfactants include alcohol ethoxylates (AE or AEO), alcohol propoxylates, propoxylated fatty alcohols (PFA), alkoxylated fatty acid alkyl esters, such as ethoxylated and/or propoxylated fatty acid alkyl esters, alkylphenol ethoxylates (APE), nonylphenol ethoxylates (NPE), alkylpolyglycosides (APG), alkoxylated amines, fatty acid monoethanolamides (FAM), fatty acid diethanolamides (FADA), ethoxylated fatty acid monoethanolamides (EFAM), propoxylated fatty acid monoethanolamides (PFAM), polyhydroxyalkyl fatty acid amides, or /V-acyl /V-alkyl derivatives of glucosamine (glucamides, GA, or fatty acid glucamides, FAGA), as well as products available under the trade names SPAN and TWEEN
- a hydrotrope is a compound that solubilises hydrophobic compounds in aqueous solutions (or oppositely, polar substances in a non-polar environment).
- hydrotropes typically have both hydrophilic and a hydrophobic character (so-called amphiphilic properties as known from surfactants); however the molecular structure of hydrotropes generally do not favor spontaneous self-aggregation, see e.g. review by Hodgdon and Kaler (2007), Current Opinion in Colloid & Interface Science 12: 121 -128.
- Hydrotropes do not display a critical concentration above which self-aggregation occurs as found for surfactants and lipids forming miceller, lamellar or other well defined meso-phases.
- hydrotropes show a continuous-type aggregation process where the sizes of aggregates grow as concentration increases.
- many hydrotropes alter the phase behavior, stability, and colloidal properties of systems containing substances of polar and non-polar character, including mixtures of water, oil, surfactants, and polymers.
- Hydrotropes are classically used across industries from pharma, personal care, food, to technical applications.
- Use of hydrotropes in detergent compositions allow for example more concentrated formulations of surfactants (as in the process of compacting liquid detergents by removing water) without inducing undesired phenomena such as phase separation or high viscosity.
- the detergent may contain 0-10% by weight, for example 0-5% by weight, such as about 0.5 to about 5%, or about 3% to about 5%, of a hydrotrope.
- Any hydrotrope known in the art for use in detergents may be utilized.
- Non-limiting examples of hydrotropes include sodium benzenesulfonate, sodium p-toluene sulfonate (STS), sodium xylene sulfonate (SXS), sodium cumene sulfonate (SCS), sodium cymene sulfonate, amine oxides, alcohols and polyglycolethers, sodium hydroxynaphthoate, sodium hydroxynaphthalene sulfonate, sodium ethylhexyl sulfate, and combinations thereof.
- Builders and Co-Builders include sodium benzenesulfonate, sodium p-toluene sulfonate (STS), sodium xy
- the detergent composition may contain about 0-65% by weight, such as about 5% to about 50% of a detergent builder or co-builder, or a mixture thereof.
- the level of builder is typically 40-65%, particularly 50-65%.
- the builder and/or co-builder may particularly be a chelating agent that forms water-soluble complexes with Ca and Mg. Any builder and/or co-builder known in the art for use in laundry detergents may be utilized.
- Non-limiting examples of builders include zeolites, diphosphates (pyrophosphates), triphosphates such as sodium triphosphate (STP or STPP), carbonates such as sodium carbonate, soluble silicates such as sodium metasilicate, layered silicates (e.g., SKS-6 from Hoechst), ethanolamines such as 2-aminoethan-1 -ol (MEA), diethanolamine (DEA, also known as 2,2'-iminodiethan-1 -ol), triethanolamine (TEA, also known as 2,2',2"-nitrilotriethan-1 -ol), and (carboxymethyl)inulin (CMI), and combinations thereof.
- zeolites such as 2-aminoethan-1 -ol (MEA), diethanolamine (DEA, also known as 2,2'-iminodiethan-1 -ol), triethanolamine (TEA, also known as 2,2',2"-nitrilotriethan-1 -ol), and (carboxy
- the detergent composition may also contain 0-50% by weight, such as about 5% to about 30%, of a detergent co-builder, or a mixture thereof.
- the detergent composition may include include a co-builder alone, or in combination with a builder, for example a zeolite builder.
- co-builders include homopolymers of polyacrylates or copolymers thereof, such as poly(acrylic acid) (PAA) or copoly(acrylic acid/maleic acid) (PAA PMA).
- Further non- limiting examples include citrate, chelators such as aminocarboxylates, aminopolycarboxylates and phosphonates, and alkyl- or alkenylsuccinic acid.
- NTA 2,2',2"- nitrilotriacetic acid
- EDTA ethylenediaminetetraacetic acid
- DTPA diethylenetriaminepentaacetic acid
- IDS iminodisuccinic acid
- EDDS ethylenediamine-/V,/V'-disuccinic acid
- MGDA methylglycinediacetic acid
- GLDA glutamic acid-/V,/V-diacetic acid
- HEDP ethylenediaminetetra(methylenephosphonic acid)
- DTMPA or DTPMPA diethylenetriaminepentakis(methylenephosphonic acid)
- EDG N-(2- hydroxyethyl)iminodiacetic acid
- ASMA aspartic acid-/V-monoacetic acid
- ASDA aspartic acid- ⁇ /,/V-di acetic acid
- ASDA N-(2- hydroxyethyl)iminodiacetic acid
- ASMA as
- the detergent may contain 0-50% of a bleaching system. Any bleaching system known in the art for use in laundry detergents may be utilized. Suitable bleaching system components include bleaching catalysts, photobleaches, bleach activators, sources of hydrogen peroxide such as sodium percarbonate, sodium perborates and hydrogen peroxide— urea (1 :1 ), preformed peracids and mixtures thereof. Suitable preformed peracids include, but are not limited to, peroxycarboxylic acids and salts, diperoxydicarboxylic acids, , perimidic acids and salts, peroxymonosulfuric acids and salts, for example, Oxone (R), and mixtures thereof.
- Non- limiting examples of bleaching systems include peroxide-based bleaching systems, which may comprise, for example, an inorganic salt, including alkali metal salts such as sodium salts of perborate (usually mono- or tetra-hydrate), percarbonate, persulfate, perphosphate, persilicate salts, in combination with a peracid-forming bleach activator.
- the term bleach activator is meant herein as a compound which reacts with hydrogen peroxide to form a peracid via perhydrolysis. The peracid thus formed constitutes the activated bleach.
- Suitable bleach activators to be used herein include those belonging to the class of esters, amides, imides or anhydrides.
- Suitable examples are tetraacetylethylenediamine (TAED), sodium 4-[(3,5,5- trimethylhexanoyl)oxy]benzene-1 -sulfonate (ISONOBS), 4-(dodecanoyloxy)benzene-1 -sulfonate (LOBS), 4-(decanoyloxy)benzene-1 -sulfonate, 4-(decanoyloxy)benzoate (DOBS or DOBA), 4- (nonanoyloxy)benzene-l -sulfonate (NOBS), and/or those disclosed in W098/17767.
- TAED tetraacetylethylenediamine
- ISONOBS 4-[(3,5,5- trimethylhexanoyl)oxy]benzene-1 -sulfonate
- LOBS 4-(dodecanoyloxy)benzene-1 -sulfonate
- DOBS or DOBA 4-(decanoyl
- ATC acetyl triethyl citrate
- ATC or a short chain triglyceride like triacetin has the advantage that it is environmentally friendly
- acetyl triethyl citrate and triacetin have good hydrolytical stability in the product upon storage and are efficient bleach activators.
- ATC is multifunctional, as the citrate released in the perhydrolysis reaction may function as a builder.
- the bleaching system may comprise peroxyacids of, for example, the amide, imide, or sulfone type.
- the bleaching system may also comprise peracids such as 6- (phthalimido)peroxyhexanoic acid (PAP).
- PAP phthalimido
- the bleaching system may also include a bleach catalyst.
- the bleach component may be an organic catalyst selected from the group consisting of organic catalysts having the following formulae:
- each R 1 is independently a branched alkyl group containing from 9 to 24 carbons or linear alkyl group containing from 1 1 to 24 carbons, preferably each R 1 is independently a branched alkyl group containing from 9 to 18 carbons or linear alkyl group containing from 1 1 to 18 carbons, more preferably each R 1 is independently selected from the group consisting of 2- propylheptyl, 2-butyloctyl, 2-pentylnonyl, 2-hexyldecyl, dodecyl, tetradecyl, hexadecyl, octadecyl, isononyl, isodecyl, isotridecyl and isopentadecyl.
- Suitable bleaching systems are described, e.g. in WO2007/087258, WO2007/087244, WO2007/087259, EP1867708 (Vitamin K) and WO2007/087242.
- Suitable photobleaches may for example be sulfonated zinc or aluminium phthalocyanines.
- the detergent may contain 0-10% by weight, such as 0.5-5%, 2-5%, 0.5-2% or 0.2-1 % of a polymer. Any polymer known in the art for use in detergents may be utilized.
- the polymer may function as a co-builder as mentioned above, or may provide antiredeposition, fiber protection, soil release, dye transfer inhibition, grease cleaning and/or anti-foaming properties. Some polymers may have more than one of the above-mentioned properties and/or more than one of the below-mentioned motifs.
- Exemplary polymers include (carboxymethyl)cellulose (CMC), polyvinyl alcohol) (PVA), poly(vinylpyrrolidone) (PVP), poly(ethyleneglycol) or poly(ethylene oxide) (PEG), ethoxylated poly(ethyleneimine), carboxymethyl inulin (CMI), and polycarboxylates such as PAA, PAA PMA, poly-aspartic acid, and lauryl methacrylate/acrylic acid copolymers , hydrophobically modified CMC (HM-CMC) and silicones, copolymers of terephthalic acid and oligomeric glycols, copolymers of poly(ethylene terephthalate) and poly(oxyethene terephthalate) (PET-POET), PVP, poly(vinylimidazole) (PVI), poly(vinylpyridine-/V-oxide) (PVPO or PVPNO) and polyvinylpyrrolidone-vinylimidazole (
- exemplary polymers include sulfonated polycarboxylates, polyethylene oxide and polypropylene oxide (PEO-PPO) and diquaternium ethoxy sulfate.
- PEO-PPO polypropylene oxide
- diquaternium ethoxy sulfate diquaternium ethoxy sulfate.
- Other exemplary polymers are disclosed in, e.g., WO 2006/130575. Salts of the above-mentioned polymers are also contemplated. Fabric hueing agents
- the detergent compositions of the present invention may also include fabric hueing agents such as dyes or pigments, which when formulated in detergent compositions can deposit onto a fabric when said fabric is contacted with a wash liquor comprising said detergent compositions and thus altering the tint of said fabric through absorption/reflection of visible light.
- fabric hueing agents alter the tint of a surface as they absorb at least a portion of the visible light spectrum.
- Suitable fabric hueing agents include dyes and dye-clay conjugates, and may also include pigments.
- Suitable dyes include small molecule dyes and polymeric dyes.
- Suitable small molecule dyes include small molecule dyes selected from the group consisting of dyes falling into the Colour Index (C.I.) classifications of Direct Blue, Direct Red, Direct Violet, Acid Blue, Acid Red, Acid Violet, Basic Blue, Basic Violet and Basic Red, or mixtures thereof, for example as described in WO2005/03274, WO2005/03275, WO2005/03276 and EP1876226 (hereby incorporated by reference).
- the detergent composition preferably comprises from about 0.00003 wt% to about 0.2 wt%, from about 0.00008 wt% to about 0.05 wt%, or even from about 0.0001 wt% to about 0.04 wt% fabric hueing agent.
- the composition may comprise from 0.0001 wt% to 0.2 wt% fabric hueing agent, this may be especially preferred when the composition is in the form of a unit dose pouch.
- Suitable hueing agents are also disclosed in, e.g. WO 2007/087257 and WO2007/087243.
- the detergent additive as well as the detergent composition may comprise one or more additional enzymes such as a protease, lipase, cutinase, an amylase, carbohydrase, cellulase, pectinase, mannanase, arabinase, galactanase, xylanase, oxidase, e.g., a laccase, and/or peroxidase.
- additional enzymes such as a protease, lipase, cutinase, an amylase, carbohydrase, cellulase, pectinase, mannanase, arabinase, galactanase, xylanase, oxidase, e.g., a laccase, and/or peroxidase.
- the properties of the selected enzyme(s) should be compatible with the selected detergent, (i.e., pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts.
- Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g., the fungal cellulases produced from Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum disclosed in US 4,435,307, US 5,648,263, US 5,691 ,178, US 5,776,757 and WO 89/09259.
- cellulases are the alkaline or neutral cellulases having colour care benefits.
- Examples of such cellulases are cellulases described in EP1350843, EP0495257, EP0531372, W096/1 1262, W096/29397, WO98/08940, WO9634108 and WO9734005.
- Other examples are cellulase variants such as those described in WO94/07998, EP0531315, US 5457046, US 5686593, US 5763254, W095/24471 , WO98/12307 and PCT/DK98/00299.
- cellulases include CelluzymeTM, and CarezymeTM (Novozymes A/S), ClazinaseTM, and Puradax HATM (Genencor International Inc.), and KAC-500(B)TM (Kao Corporation).
- Suitable proteases include those of bacterial, fungal, plant, viral or animal origin e.g. vegetable or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included. It may be an alkaline protease, such as a serine protease or a metalloprotease. A serine protease may for example be of the S1 family, such as trypsin, or the S8 family such as subtilisin. A metalloproteases protease may for example be a thermolysin from e.g. family M4 or other metalloprotease such as those from M5, M7 or M8 families.
- subtilases refers to a sub-group of serine protease according to Siezen et al., Protein Engng. 4 (1991 ) 719-737 and Siezen et al. Protein Science 6 (1997) 501 -523.
- Serine proteases are a subgroup of proteases characterized by having a serine in the active site, which forms a covalent adduct with the substrate.
- the subtilases may be divided into 6 sub-divisions, i.e. the Subtilisin family, the Thermitase family, the Proteinase K family, the Lantibiotic peptidase family, the Kexin family and the Pyrolysin family.
- subtilases are those derived from Bacillus such as Bacillus lentus, B. alkalophilus, B. subtilis, B. amyloliquefaciens, Bacillus pumilus and Bacillus gibsonii described in; US7262042 and WO09/021867, and subtilisin lentus, subtilisin Novo, subtilisin Carlsberg, Bacillus licheniformis, subtilisin BPN', subtilisin 309, subtilisin 147 and subtilisin 168 described in WO89/06279 and protease PD138 described in (WO93/18140).
- trypsin-like proteases are trypsin (e.g. of porcine or bovine origin) and the Fusarium protease described in WO89/06270, W094/25583 and WO05/040372, and the chymotrypsin proteases derived from Cellumonas described in WO05/052161 and WO05/052146.
- a further preferred protease is the alkaline protease from Bacillus lentus DSM 5483, as described for example in W095/23221 , and variants thereof which are described in WO92/21760, W095/23221 , EP1921 147 and EP1921 148.
- metalloproteases are the neutral metalloprotease as described in WO07/044993 (Genencor Int.) such as those derived from Bacillus amyloliquefaciens.
- Examples of useful proteases are the variants described in: W092/19729, WO96/034946, WO98/201 15, WO98/201 16, WO99/01 1768, WO01/44452, WO03/006602, WO04/03186, WO04/041979, WO07/006305, W01 1/036263, W01 1/036264, especially the variants with substitutions in one or more of the following positions: 3, 4, 9, 15, 27, 36, 57, 68, 76, 87, 95, 96, 97, 98, 99, 100, 101 , 102, 103, 104, 106, 1 18, 120, 123, 128, 129, 130, 160, 167, 170, 194, 195, 199, 205, 206, 217, 218, 222, 224, 232, 235, 236, 245, 248, 252 and 274 using the BPN' numbering.
- subtilase variants may comprise the mutations: S3T, V4I, S9R, A15T, K27R, * 36D, V68A, N76D, N87S,R, * 97E, A98S, S99G,D,A, S99AD, S101 G,M,R S103A, V104I,Y,N, S106A, G1 18V,R, H120D,N, N123S, S128L, P129Q, S130A, G160D, Y167A, R170S, A194P, G195E, V199M, V205I, L217D, N218D, M222S, A232V, K235L, Q236H, Q245R, N252K, T274A (using BPN' numbering).
- Suitable commercially available protease enzymes include those sold under the trade names Alcalase®, Duralase Tm , Durazym Tm , Relase®, Relase® Ultra, Savinase®, Savinase® Ultra, Primase®, Polarzyme®, Kannase®, Liquanase®, Liquanase® Ultra, Ovozyme®, Coronase®, Coronase® Ultra, Neutrase®, Everlase® and Esperase® (Novozymes A/S), those sold under the tradename Maxatase®, Maxacal®, Maxapem®, Purafect®, Purafect Prime®, Preferenz Tm , Purafect MA®, Purafect Ox®, Purafect OxP®, Puramax®, Properase®, Effectenz Tm , FN2®, FN3® , FN 4®, Excellase®, , Opticlean® and Optimase® (Danisco/DuPont),
- Suitable amylases which can be used together with the cellulase and lipase of the invention may be an alpha-amylase or a glucoamylase and may be of bacterial or fungal origin. Chemically modified or protein engineered mutants are included.
- Amylases include, for example, alpha-amylases obtained from Bacillus, e.g., a special strain of Bacillus licheniformis, described in more detail in GB 1 ,296,839.
- Suitable amylases include amylases having SEQ ID NO: 2 in WO 95/10603 or variants having 90% sequence identity to SEQ ID NO: 3 thereof. Preferred variants are described in WO 94/02597, WO 94/18314, WO 97/43424 and SEQ ID NO: 4 of WO 99/019467, such as variants with substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 178, 179, 181 , 188, 190, 197, 201 , 202, 207, 208, 209, 21 1 , 243, 264, 304, 305, 391 , 408, and 444.
- amylases having SEQ ID NO: 6 in WO 02/010355 or variants thereof having 90% sequence identity to SEQ ID NO: 6.
- Preferred variants of SEQ ID NO: 6 are those having a deletion in positions 181 and 182 and a substitution in position 193.
- amylases which are suitable are hybrid alpha-amylase comprising residues 1 -33 of the alpha-amylase derived from B. amyloliquefaciens shown in SEQ ID NO: 6 of WO 2006/066594 and residues 36-483 of the B. licheniformis alpha-amylase shown in SEQ ID NO: 4 of WO 2006/066594 or variants having 90% sequence identity thereof.
- Preferred variants of this hybrid alpha-amylase are those having a substitution, a deletion or an insertion in one of more of the following positions: G48, T49, G107, H156, A181 , N190, M197, 1201 , A209 and Q264.
- hybrid alpha-amylase comprising residues 1 -33 of the alpha-amylase derived from B. amyloliquefaciens shown in SEQ ID NO: 6 of WO 2006/066594 and residues 36-483 of SEQ ID NO: 4 are those having the substitutions:
- amylases which are suitable are amylases having SEQ ID NO: 6 in WO 99/019467 or variants thereof having 90% sequence identity to SEQ ID NO: 6.
- Preferred variants of SEQ ID NO: 6 are those having a substitution, a deletion or an insertion in one or more of the following positions: R181 , G182, H183, G184, N195, I206, E212, E216 and K269.
- Particularly preferred amylases are those having deletion in positions R181 and G182, or positions H183 and G184.
- Additional amylases which can be used are those having SEQ ID NO: 1 , SEQ ID NO: 3, SEQ ID NO: 2 or SEQ ID NO: 7 of WO 96/023873 or variants thereof having 90% sequence identity to SEQ ID NO: 1 , SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 7.
- Preferred variants of SEQ ID NO: 1 , SEQ ID NO: 2, SEQ I D NO: 3 or SEQ ID NO: 7 are those having a substitution, a deletion or an insertion in one or more of the following positions: 140, 181 , 182, 183, 184, 195, 206, 212, 243, 260, 269, 304 and 476, using SEQ ID 2 of WO 96/023873 for numbering. More preferred variants are those having a deletion in two positions selected from 181 , 182, 183 and 184, such as 181 and 182, 182 and 183, or positions 183 and 184.
- Most preferred amylase variants of SEQ ID NO: 1 , SEQ ID NO: 2 or SEQ ID NO: 7 of WO 96/023873 are those having a deletion in positions 183 and 184 and a substitution in one or more of positions 140, 195, 206, 243, 260, 304 and 476.
- amylases which can be used are amylases having SEQ ID NO: 2 of WO
- SEQ ID NO: 10 in WO 01/66712 or variants thereof having 90% sequence identity to SEQ ID NO: 2 of WO 08/153815 or 90% sequence identity to SEQ ID NO: 10 in WO 01/66712.
- Preferred variants of SEQ ID NO: 10 in WO 01/66712 are those having a substitution, a deletion or an insertion in one of more of the following positions: 176, 177, 178, 179, 190, 201 , 207, 21 1 and 264.
- amylases having SEQ ID NO: 2 of WO 09/061380 or variants having 90% sequence identity to SEQ ID NO: 2 thereof.
- Preferred variants of SEQ ID NO: 2 are those having a truncation of the C-terminus and/or a substitution, a deletion or an insertion in one of more of the following positions: Q87, Q98, S125, N128, T131 , T165, K178, R180, S181 , T182, G183, M201 , F202, N225, S243, N272, N282, Y305, R309, D319, Q320, Q359, K444 and G475.
- More preferred variants of SEQ ID NO: 2 are those having the substitution in one of more of the following positions: Q87E,R, Q98R, S125A, N128C, T131 I, T165I, K178L, T182G, M201 L, F202Y, N225E,R, N272E,R, S243Q,A,E,D, Y305R, R309A, Q320R, Q359E, K444E and G475K and/or deletion in position R180 and/or S181 or of T182 and/or G183.
- Most preferred amylase variants of SEQ ID NO: 2 are those having the substitutions:
- variants are C-terminally truncated and optionally further comprises a substitution at position 243 and/or a deletion at position 180 and/or position 181 .
- amylases are the alpha-amylase having SEQ ID NO: 12 in WO01/66712 or a variant having at least 90% sequence identity to SEQ ID NO: 12.
- Preferred amylase variants are those having a substitution, a deletion or an insertion in one of more of the following positions of SEQ ID NO: 12 in WO01/66712: R28, R1 18, N174; R181 , G182, D183, G184, G186, W189, N195, M202, Y298, N299, K302, S303, N306, R310, N314; R320, H324, E345, Y396, R400, W439, R444, N445, K446, Q449, R458, N471 , N484.
- Particular preferred amylases include variants having a deletion of D183 and G184 and having the substitutions R1 18K, N195F, R320K and R458K, and a variant additionally having substitutions in one or more position selected from the group: M9, G149, G182, G186, M202, T257, Y295, N299, M323, E345 and A339, most preferred a variant that additionally has substitutions in all these positions.
- amylase variants such as those described in WO201 1/098531 , WO2013/001078 and WO2013/001087.
- amylases are DuramylTM, TermamylTM, FungamylTM, Stainzyme TM, Stainzyme PlusTM, NatalaseTM, Liquozyme X and BANTM (from Novozymes A/S), and RapidaseTM, PurastarTM/EffectenzTM, Powerase and Preferenz S100 (from Genencor International Inc./DuPont).
- Peroxidases/Oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus, e.g., from C. cinereus, and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257.
- peroxidases include GuardzymeTM (Novozymes A/S).
- the detergent enzyme(s) may be included in a detergent composition by adding separate additives containing one or more enzymes, or by adding a combined additive comprising all of these enzymes.
- a detergent additive of the invention i.e., a separate additive or a combined additive, can be formulated, for example, as a granulate, liquid, slurry, etc.
- Preferred detergent additive formulations are granulates, in particular non-dusting granulates, liquids, in particular stabilized liquids, or slurries.
- Non-dusting granulates may be produced, e.g. as disclosed in US 4,106,991 and 4,661 ,452 and may optionally be coated by methods known in the art.
- waxy coating materials are poly(ethylene oxide) products (polyethyleneglycol, PEG) with mean molar weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids.
- film-forming coating materials suitable for application by fluid bed techniques are given in GB 1483591.
- Liquid enzyme preparations may, for instance, be stabilized by adding a polyol such as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid according to established methods.
- Protected enzymes may be prepared according to the method disclosed in EP 238,216.
- any detergent components known in the art for use in laundry detergents may also be utilized.
- Other optional detergent components include anti-corrosion agents, anti-shrink agents, anti-soil redeposition agents, anti-wrinkling agents, bactericides, binders, corrosion inhibitors, disintegrants/disintegration agents, dyes, enzyme stabilizers (including boric acid, borates, CMC, and/or polyols such as propylene glycol), fabric conditioners including clays, fillers/processing aids, fluorescent whitening agents/optical brighteners, foam boosters, foam (suds) regulators, perfumes, soil-suspending agents, softeners, suds suppressors, tarnish inhibitors, and wicking agents, either alone or in combination.
- Any ingredient known in the art for use in laundry detergents may be utilized. The choice of such ingredients is well within the skill of the artisan.
- Dispersants - The detergent compositions of the present invention can also contain dispersants.
- powdered detergents may comprise dispersants.
- Suitable water-soluble organic materials include the homo- or co-polymeric acids or their salts, in which the polycarboxylic acid comprises at least two carboxyl radicals separated from each other by not more than two carbon atoms.
- Suitable dispersants are for example described in Powdered Detergents, Surfactant science series volume 71 , Marcel Dekker, Inc.
- the detergent compositions of the present invention may also include one or more dye transfer inhibiting agents.
- Suitable polymeric dye transfer inhibiting agents include, but are not limited to, polyvinylpyrrolidone polymers, polyamine /V-oxide polymers, copolymers of /V-vinylpyrrolidone and /V-vinylimidazole, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof.
- the dye transfer inhibiting agents may be present at levels from about 0.0001 % to about 10%, from about 0.01 % to about 5% or even from about 0.1 % to about 3% by weight of the composition.
- Fluorescent whitening agent - The detergent compositions of the present invention will preferably also contain additional components that may tint articles being cleaned, such as fluorescent whitening agent or optical brighteners. Where present the brightener is preferably at a level of about 0.01 % to about 0.5%. Any fluorescent whitening agent suitable for use in a laundry detergent composition may be used in the composition of the present invention. The most commonly used fluorescent whitening agents are those belonging to the classes of diaminostilbene-sulfonic acid derivatives, diarylpyrazoline derivatives and bisphenyl-distyryl derivatives.
- diaminostilbene-sulfonic acid derivative type of fluorescent whitening agents include the sodium salts of: 4,4'-bis-(2-diethanolamino-4-anilino-s-triazin-6- ylamino) stilbene-2,2'-disulfonate, 4,4'-bis-(2,4-dianilino-s-triazin-6-ylamino) stilbene-2.2'- disulfonate, 4,4'-bis-(2-anilino-4-(/V-methyl-/V-2-hydroxy-ethylamino)-s-triazin-6-ylamino) stilbene-2,2'-disulfonate, 4,4'-bis-(4-phenyl-1 ,2,3-triazol-2-yl)stilbene-2,2'-disulfonate and sodium 5-(2/-/-naphtho[1 ,2-c ][1 ,2,3]triazol-2-yl)-2-[(2-d
- Preferred fluorescent whitening agents are Tinopal DMS and Tinopal CBS available from Ciba-Geigy AG, Basel, Switzerland.
- Tinopal DMS is the disodium salt of 4,4'-bis-(2-morpholino-4-anilino-s- triazin-6-ylamino) stilbene-2,2'-disulfonate.
- Tinopal CBS is the disodium salt of 2,2'-bis-(phenyl- styryl)-disulfonate.
- fluorescent whitening agents is the commercially available Parawhite KX, supplied by Paramount Minerals and Chemicals, Mumbai, India.
- Other fluorescers suitable for use in the invention include the 1 -3-diaryl pyrazolines and the 7- alkylaminocoumarins.
- Suitable fluorescent brightener levels include lower levels of from about 0.01 , from 0.05, from about 0.1 or even from about 0.2 wt % to upper levels of 0.5 or even 0.75 wt%.
- Soil release polymers - The detergent compositions of the present invention may also include one or more soil release polymers which aid the removal of soils from fabrics such as cotton and polyester based fabrics, in particular the removal of hydrophobic soils from polyester based fabrics.
- the soil release polymers may for example be nonionic or anionic terephthalte based polymers, polyvinyl caprolactam and related copolymers, vinyl graft copolymers, polyester polyamides see for example Chapter 7 in Powdered Detergents, Surfactant science series volume 71 , Marcel Dekker, Inc.
- Another type of soil release polymers are amphiphilic alkoxylated grease cleaning polymers comprising a core structure and a plurality of alkoxylate groups attached to that core structure.
- the core structure may comprise a polyalkylenimine structure or a polyalkanolamine structure as described in detail in WO 2009/087523 (hereby incorporated by reference).
- random graft co-polymers are suitable soil release polymers. Suitable graft co-polymers are described in more detail in WO 2007/138054, WO 2006/108856 and WO 2006/1 13314 (hereby incorporated by reference).
- Other soil release polymers are substituted polysaccharide structures especially substituted cellulosic structures such as modified cellulose deriviatives such as those described in EP 1867808 or WO 2003/040279 (both are hereby incorporated by reference).
- Suitable cellulosic polymers include cellulose, cellulose ethers, cellulose esters, cellulose amides and mixtures thereof. Suitable cellulosic polymers include anionically modified cellulose, nonionically modified cellulose, cationically modified cellulose, zwitterionically modified cellulose, and mixtures thereof. Suitable cellulosic polymers include methyl cellulose, carboxy methyl cellulose, ethyl cellulose, hydroxyl ethyl cellulose, hydroxyl propyl methyl cellulose, ester carboxy methyl cellulose, and mixtures thereof.
- the detergent compositions of the present invention may also include one or more anti-redeposition agents such as carboxymethylcellulose (CMC), polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP), polyoxyethylene and/or polyethyleneglycol (PEG), homopolymers of acrylic acid, copolymers of acrylic acid and maleic acid, and ethoxylated polyethyleneimines.
- CMC carboxymethylcellulose
- PVA polyvinyl alcohol
- PVP polyvinylpyrrolidone
- PEG polyethyleneglycol
- homopolymers of acrylic acid copolymers of acrylic acid and maleic acid
- the cellulose based polymers described under soil release polymers above may also function as anti-redeposition agents.
- adjunct materials include, but are not limited to, anti-shrink agents, anti-wrinkling agents, bactericides, binders, carriers, dyes, enzyme stabilizers, fabric softeners, fillers, foam regulators, hydrotropes, perfumes, pigments, sod suppressors, solvents, and structurants for liquid detergents and/or structure elasticizing agents.
- bactericides binders
- carriers dyes, enzyme stabilizers, fabric softeners, fillers, foam regulators, hydrotropes, perfumes, pigments, sod suppressors, solvents, and structurants for liquid detergents and/or structure elasticizing agents.
- the detergent composition of the invention may be in any convenient form, e.g., a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular, compact or concentrated liquid.
- Detergent formulation forms Layers (same or different phases), Pouches, versus forms for
- Pouches can be configured as single or multicompartments. It can be of any form, shape and material which is suitable for hold the composition, e.g. without allowing the release of the composition to release of the composition from the pouch prior to water contact.
- the pouch is made from water soluble film which encloses an inner volume. Said inner volume can be divided into compartments of the pouch.
- Preferred films are polymeric materials preferably polymers which are formed into a film or sheet.
- Preferred polymers, copolymers or derivates thereof are selected polyacrylates, and water soluble acrylate copolymers, methyl cellulose, carboxy methyl cellulose, sodium dextrin, ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, malto dextrin, poly methacrylates, most preferably polyvinyl alcohol copolymers and, hydroxypropyl methyl cellulose (HPMC).
- the level of polymer in the film for example PVA is at least about 60%.
- Preferred average molecular weight will typically be about 20,000 to about 150,000.
- Films can also be of blended compositions comprising hydrolytically degradable and water soluble polymer blends such as polylactide and polyvinyl alcohol (known under the Trade reference M8630 as sold by MonoSol LLC, Indiana, USA) plus plasticisers like glycerol, ethylene glycerol, propylene glycol, sorbitol and mixtures thereof.
- the pouches can comprise a solid laundry cleaning composition or part components and/or a liquid cleaning composition or part components separated by the water soluble film.
- the compartment for liquid components can be different in composition than compartments containing solids: US2009/001 1970 A1.
- Detergent ingredients can be separated physically from each other by compartments in water dissolvable pouches or in different layers of tablets. Thereby negative storage interaction between components can be avoided. Different dissolution profiles of each of the compartments can also give rise to delayed dissolution of selected components in the wash solution.
- a liquid or gel detergent which is not unit dosed, may be aqueous, typically containing at least 20% by weight and up to 95% water, such as up to about 70% water, up to about 65% water, up to about 55% water, up to about 45% water, up to about 35% water.
- Other types of liquids including without limitation, alkanols, amines, diols, ethers and polyols may be included in an aqueous liquid or gel.
- An aqueous liquid or gel detergent may contain from 0-30% organic solvent.
- a liquid or gel detergent may be non-aqueous.
- the enzymes of the invention may be added to laundry soap bars and used for hand washing laundry, fabrics and/or textiles.
- laundry soap bar includes laundry bars, soap bars, combo bars, syndet bars and detergent bars.
- the types of bar usually differ in the type of surfactant they contain, and the term laundry soap bar includes those containing soaps from fatty acids and/or synthetic soaps.
- the laundry soap bar has a physical form which is solid and not a liquid, gel or a powder at room temperature.
- the term solid is defined as a physical form which does not significantly change over time, i.e. if a solid object (e.g. laundry soap bar) is placed inside a container, the solid object does not change to fill the container it is placed in.
- the bar is a solid typically in bar form but can be in other solid shapes such as round or oval.
- the laundry soap bar may contain one or more additional enzymes, protease inhibitors such as peptide aldehydes (or hydrosulfite adduct or hemiacetal adduct), boric acid, borate, borax and/or phenylboronic acid derivatives such as 4-formylphenylboronic acid, one or more soaps or synthetic surfactants, polyols such as glycerine, pH controlling compounds such as fatty acids, citric acid, acetic acid and/or formic acid, and/or a salt of a monovalent cation and an organic anion wherein the monovalent cation may be for example Na + , K + or NH 4 + and the organic anion may be for example formate, acetate, citrate or lactate such that the salt of a monovalent cation and an organic anion may be, for example, sodium formate.
- protease inhibitors such as peptide aldehydes (or hydrosulfite adduct or hem
- the laundry soap bar may also contain complexing agents like EDTA and HEDP, perfumes and/or different type of fillers, surfactants e.g. anionic synthetic surfactants, builders, polymeric soil release agents, detergent chelators, stabilizing agents, fillers, dyes, colorants, dye transfer inhibitors, alkoxylated polycarbonates, suds suppressers, structurants, binders, leaching agents, bleaching activators, clay soil removal agents, anti-redeposition agents, polymeric dispersing agents, brighteners, fabric softeners, perfumes and/or other compounds known in the art.
- the laundry soap bar may be processed in conventional laundry soap bar making equipment such as but not limited to: mixers, plodders, e.g a two stage vacuum plodder, extruders, cutters, logo-stampers, cooling tunnels and wrappers.
- the invention is not limited to preparing the laundry soap bars by any single method.
- the premix of the invention may be added to the soap at different stages of the process.
- the premix containing a soap, lipase and cellulase, optionally one or more additional enzymes, a protease inhibitor, and a salt of a monovalent cation and an organic anion may be prepared and and the mixture is then plodded.
- the combination of lipase and cellulase and optional additional enzymes may be added at the same time as the protease inhibitor for example in liquid form.
- the process may further comprise the steps of milling, extruding, cutting, stamping, cooling and/or wrapping.
- a granular detergent may be formulated as described in WO09/092699, EP1705241 ,
- EP1382668, WO07/001262, US6472364, WO04/074419 or WO09/102854 Other useful detergent formulations are described in WO09/124162, WO09/124163, WO09/1 17340, WO09/1 17341 , WO09/1 17342, WO09/072069, WO09/063355, WO09/132870, WO09/121757, WO09/1 12296, WO09/1 12298, WO09/103822, WO09/087033, WO09/050026, WO09/047125, WO09/047126, WO09/047127, WO09/047128, WO09/021784, WO09/010375, WO09/000605, WO09/122125, WO09/095645, WO09/040544, WO09/040545, WO09/024780, WO09/004295, WO09/004294, WO09/121725
- the present invention includes a method for cleaning any surface including treating a textile or a hard surface or other surfaces in the field of fabric and/or home care.
- the method comprises the step of contacting the surface to be treated in a pre- treatment step or main wash step of a washing process, most preferably for use in a textile washing step or alternatively for use in dishwashing including both manual as well as automated/mechanical dishwashing.
- the lipase and cellulase and other components are added sequentially into the method for cleaning and/or treating the surface. Alternatively, the lipase and cellulase and other components are added simultaneously.
- washing includes but is not limited to, scrubbing, and mechanical agitation. Washing may be conducted with a foam composition as described in WO08/101958 and/or by applying alternating pressure (pressure/vaccum) as an addition or as an alternative to scrubbing and mechanical agitation. Drying of such surfaces or fabrics may be accomplished by any one of the common means employed either in domestic or industrial settings.
- the cleaning compositions of the present invention are ideally suited for use in laundry as well as dishwashing applications. Accordingly, the present invention includes a method for cleaning an object including but not limiting to fabric, tableware, cutlery and kitchenware.
- the method comprises the steps of contacting the object to be cleaned with a said cleaning composition comprising at least one embodiment of Applicants' cleaning composition, cleaning additive or mixture thereof.
- the fabric may comprise most any fabric capable of being laundered in normal consumer or institutional use conditions.
- the solution may have a pH from 8 to 10.5.
- the compositions may be employed at concentrations from 500 to 15.000ppm in solution.
- the water temperatures typically range from 5°C to 90°C.
- the water to fabric ratio is typically from 1 :1 to 30:1 . Use in detergents
- the lipase and cellulase may be added to and thus become a component of a detergent composition.
- the detergent composition of the present invention may be formulated, for example, as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre-treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use in general household hard surface cleaning operations, or be formulated for hand or machine dishwashing operations.
- the present invention provides a detergent additive comprising a polypeptide of the present invention as described herein.
- Detergent composition for removing or releasing greasy stains which composition comprises a surfactant, a lipase and a cellulase.
- composition according to paragraph 1 wherein the lipase is of bacterial or fungal origin. 3. Composition according to any of the preceding paragraphs, wherein the lipase is chemically modified or protein engineered.
- the lipase is derived from Thermomyces, e.g. from T. lanuginosus, cutinase from Humicola, e.g. H. insolens, strains of Pseudomonas, e.g. P. alcaligenes or P. pseudoalcaligenes, P. cepacia, P. sp. strain SD705, P. wisconsinensis, GDSL-type Streptomyces lipases, cutinase from Thermomyces, e.g. from T. lanuginosus, cutinase from Humicola, e.g. H. insolens, strains of Pseudomonas, e.g. P. alcaligenes or P. pseudoalcaligenes, P. cepacia, P. sp. strain SD705, P. wisconsinensis, GDSL-type Streptomyces lipases, cutin
- Magnaporthe grisea cutinase from Pseudomonas mendocina, Thermobifida fusca, Geobacillus stearothermophilus, Bacillus subtilis, Streptomyces griseus and S. pristinaespiralis.
- composition according to any of the preceding paragraphs, wherein the lipase is a polypeptide having an amino acid sequence which:
- a) has at least 90 % identity with tSEQ ID NO: 2
- b) compared to said SEQ ID NO: 2 comprises a substitution of an electrically neutral or negatively charged amino acid at the surface of the three- dimensional structure within 15 A of E1 or Q249 with a positively charged amino acid;
- c) comprises a peptide addition at the C-terminal;
- ii. comprises a neutral or negative amino acid at a position corresponding to N94 of said SEQ ID NO: 2 and/or has a negative or neutral net electric charge in the region corresponding to positions 90-101 of said SEQ ID NO: 2.
- composition according to any of paragraphs 5-1 1 wherein the peptide addition consists of electrically neutral (preferably hydrophobic) amino acids, and is most preferably PGL or PG.
- composition according to any of paragraphs 5-12 wherein the peptide addition consists of neutral (preferably hydrophobic) amino acids and C, and the lipase further comprises substitution of an amino acid with C so as to form a disulfide bridge with the C of the peptide addition.
- composition according to any of paragraphs 5-13, wherein the lipase comprises amino acids with negative or unchanged electric charge in at least two of positions N94, D96 and E99 of said SEQ ID NO: 2.
- composition according to any of paragraphs 5-16, wherein the lipase comprises one of the following sets of substitutions, optionally combined with R209 (neutral or negative): a) E99R/K/H + Q249R/K/H,
- composition according to any of the preceding paragraphs, wherein the lipase is a variant of a parent lipase which variant has lipase activity, has at least 60% but less than 100% sequence identity with SEQ ID NO: 2, and comprises substitutions at positions corresponding to T231 R+N233R of SEQ ID NO: 2.
- composition according to any of the preceding paragraphs, wherein the lipase is a variant of a parent lipase which variant has lipase activity, has at least 60% but less than 100% sequence identity with SEQ ID NO: 2, and comprises substitutions at positions corresponding to D96E, D1 1 1A, D254S, G163K, P256T, G91T, G38A, D27R or N33Q of SEQ ID NO: 2.
- composition according to any of the preceding paragraphs wherein said variant in comparison with the parent lipase has increased stability.
- composition according to any of the preceding paragraphs, wherein the stability is stability under storage conditions, protease stability, chemical stability, oxidation stability, pH stability, and/or thermostability.
- a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% identity, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100%, sequence identity to
- a polypeptide encoded by a polynucleotide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, but less than 100% sequence identity to SEQ ID NO: 1 ;
- composition according to any of the preceding paragraphs, wherein the lipase is a variant having activity, has at least 60% but less than 100% sequence identity with SEQ ID NO: 2, and comprises substitutions at positions corresponding to T231R+N233R and at least one or more (e.g., several) of D96E, D111A, D254S, G163K, P256T, G91T, G38A, D27R, and N33Q of SEQ ID NO: 2 selected from the group of:
- the lipase is a lipase variant, comprising a substitution at one or more positions corresponding to positions T37A,D,E,F,G,H,I,L,N,P,Q,R,S,V,W,Y, N39A,C,D,E,F,G,I,K,L,M,P,Q,R,T,V,W,Y, and G91 D,H,I,P,Q of the mature polypeptide of SEQ ID NO: 4 , wherein the variant has lipase activity.
- composition according to any of the preceding paragraphs wherein the lipase variant has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100%, sequence identity to the amino acid sequence of the parent lipase.
- composition according to any of the preceding paragraphs, wherein the substitution is selected from D96G, T143A, A150G, E210Q, G225R, T231 R, N233R and P250R.
- composition according to any of the preceding paragraphs, wherein the cellulase is chemically modified or protein engineered.
- composition according to any of the preceding paragraphs, wherein the cellulase is derived from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia or Acremonium.
- composition according to any of the preceding paragraphs, wherein the cellulase is derived from Humicola insolens, Myceliophthora thermophila, Sporotrichum pulverulentum, Fusarium oxysporum, Trichoderma reesei, Thielavia terrestris, ,
- Acremonium sp. Acremonium sp. CBS 478.94, Macrophomina phaseolina CBS 281.96, Crinipellis scabella CBS 280.96, Volutella colletotrichoides or Sordaria fimicola ATCC 52644 or Bacillus SP-KSMS237.
- composition according to any of the preceding paragraphs, wherein the cellulase is an enzyme exhibiting endo-beta-1 ,4-glucanase activity (EC 3.2.1.4), which is selected from one of
- an endo-beta-1 ,4-glucanase enzyme having a sequence of at least 97% identity to the amino acid sequence of position 1 to position 773 of SEQ ID NO:6; or a fragment thereof that has endo-beta-1 ,4-glucanase activity, when identity is determined by GAP provided in the GCG program package using a GAP creation penalty of 3.0 and GAP extension penalty of 0.1.
- the cellulase exhibiting endo-beta-1 ,4-glucanase activity (EC 3.2.1 .4) has a polypeptide having endo- beta-1 ,4-glucanase activity that is encoded by a polynucleotide that hybridizes with the nucleotide sequence shown in positions 1 -2322 of SEQ ID NO:5 under hybridization conditions comprising 5 x SSC at 45°C and washing conditions comprising 2 x SC at
- composition according to any of the preceding paragraphs, wherein the cellulase comprises a polypeptide endogeneous to Bacillus sp., DSM 12648.
- composition according to any of the preceding paragraphs, wherein the cellulase is active at a pH at least in the range of 4-1 1 , preferably 5.5-10.5.
- composition according to any of the preceding paragraphs, wherein the composition further comprises: hydrotropes, builders, co-builders, a bleaching systems, polymers, fabric hueing agents, mediators and/or enzymes.
- composition according to any of the preceding paragraphs, wherein composition comprises at least one additional enzyme.
- composition according to any of the preceding paragraphs, wherein the additional enzyme is selected from the group consisting of protease, lipase, cutinase, amylase, carbohydrase, cellulase, pectate lyase, pectinase, mannanase, arabinase, galactanase, and/or xylanase.
- the additional enzyme is selected from the group consisting of protease, lipase, cutinase, amylase, carbohydrase, cellulase, pectate lyase, pectinase, mannanase, arabinase, galactanase, and/or xylanase.
- composition according to any of the preceding paragraphs wherein the concentration of the lipase is in the range of 0.01 -1 ,0 % w/w enzyme per detergent composition, in the range of 0.02-1 .0% w/w enzyme per detergent composition, in the range of 0.03-0.9% w/w enzyme per detergent composition, in the range of 0.04-0.9% w/w enzyme per detergent composition, in the range of 0.05-0.9% w/w enzyme per detergent composition, in the range of 0.05-0.8% w/w enzyme per detergent composition, in the range of 0.05-0.7% w/w enzyme per detergent composition, in the range of 0.05-0.6% w/w enzyme per detergent composition, in the range of 0.05-0.5 % w/w enzyme per detergent composition or in the range of 0.05-0.2% w/w enzyme per detergent composition.
- composition according to any of the preceding composition paragraphs wherein the concentration of the lipase is in the range of 0.05-0.15 % w/w enzyme per detergent composition.
- composition according to any of the preceding paragraphs wherein the concentration of the cellulase is in the range of 0.01 -1 ,0 % w/w enzyme per detergent composition, in the range of 0.02-1 .0% w/w enzyme per detergent composition, in the range of 0.03-0.9% w/w enzyme per detergent composition, in the range of 0.04-0.9% w/w enzyme per detergent composition, in the range of 0.05-0.9% w/w enzyme per detergent composition, in the range of 0.05-0.8% w/w enzyme per detergent composition, in the range of 0.05-0.7% w/w enzyme per detergent composition, in the range of 0.05-0.6% w/w enzyme per detergent composition, in the range of 0.05-0.5 % w/w enzyme per detergent composition or in the range of 0.05-0.2 % w/w enzyme per detergent composition.
- composition according to any of the preceding paragraphs wherein the composition is a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular, compact or concentrated liquid.
- composition according to any of the preceding paragraphs, wherein the composition comprises granules, which granules comprises a core and a protective coating, wherein: a. the core comprises an enzyme, which is lipase and/or cellulase, and
- the core or the coating comprises a reducing agent or a peroxide decomposing catalyst or an antioxidant
- the core comprises a salt of a multivalent cation
- the core or the coating comprises an acidic buffer component
- the coating comprises a salt.
- composition according to any of the preceding paragraphs, wherein the composition further comprises granules comprising additional enzymes.
- composition according to any of the preceding paragraphs wherein the coating of the granule makes up 5-70 % by weight relative to the core and comprises at least 60% by weight w/w of a salt having a constant humidity at 20°C of at least 60%.
- composition according to any of the preceding paragraphs wherein the reducing agent of the granule is present in an amount of 0.1 -10 % by weight relative to the core.
- composition according to any of the preceding paragraphs wherein the salt of a multivalent cation of the granule is present in an amount of 0.1 -15% as anhydrous salt by weight of the core, or 0.02-6% as multivalent cation by weight of the core.
- the core comprises Na-thiosulfate or methionine in an amount of 0.5-5% by weight relative to the core
- the core comprises magnesium sulfate or zinc sulfate in an amount of 2-8% by weight of the core
- the core comprises a mixture of citric acid and a citrate in an amount of 1 -5% by weight relative to the core, and
- the salt coating makes up 10-30% by weight relative to the core, and comprises at least 75% by weight sodium sulfate.
- composition according to any of the preceding paragraphs where the granule further comprises an additional coating on the outside of the salt coating, wherein the additional coating comprises a film-forming agent, particularly polyethylene glycol, hydroxypropyl methyl cellulose (HPMC or MHPC), or polyvinyl alcohol (PVA).
- a film-forming agent particularly polyethylene glycol, hydroxypropyl methyl cellulose (HPMC or MHPC), or polyvinyl alcohol (PVA).
- composition according to any of the preceding paragraphs, wherein the composition is a laundry cleaning composition, a dishwashing cleaning composition, a hard-surface cleaning composition and/or a personal care cleaning composition.
- stain comprises vegetable oil, animal fat, mineral oil or a combination thereof.
- the cellulase effect is at least 2 points, at least 2.2 points, at least 2.4 points, at least 2.6 points, at least 2.8 points, at least 3.0 points, at least 3.5 points, at least 4.0 points or at least 5.0 points.
- synergy effect is at least 2 points, at least 2.2 points, at least 2.4 points, at least 2.6 points, at least 2.8 points, at least 3.0 points, at least 3.5 points, at least 4.0 points or at least 5.0 points.
- a method for removing or releasing greasy stains from an item having a greasy stain comprises exposing the item to an aqueous solution of a lipase and a cellulase.
- a method for removing or releasing greasy stains from an item having a greasy stain comprises exposing the item to an aqueous solution of a detergent composition of paragraphs 1 -66.
- stain comprises vegetable oil, animal fat or a mineral oil combination thereof.
- Method according to any of the preceding paragraphs wherein the item is soaked in an aqueous solution.
- the soaking step comprises exposing the item to the lipase and the cellulase.
- test swatches and ballast are added to each wash together with detergent and enzyme. After wash, the test swatches are dried and the remission is measured on a MacBeth Color Eye spectrophotometer.
- the enzymes are added on basis of weight percent of the detergent dosage in each wash,
- test swatches are commercial available ones. The most used suppliers are: CFT, EMPA, wfk and Equest. The same batch of stains is used in all washes in a trial. Different swatch sizes are used:
- Swatches at 10x10 cm and some with a circular spot e.g. the Equest swatches The swatches are attached to t-towels by sewing or by a stapler; the same swatch types are placed on different towels or in different positions on the towel. Each swatch is marked individually for identification and to indicate the front side.
- the ballast consists of clean white cloth without optical whitener made of cotton, polyester or cotton/polyester.
- the composition of the ballast is a mix of different items at a cotton/polyester ratio of 65/35 based on weight.
- the ballast weight, dryness and item composition must be the same in each wash.
- ballast is inactivated in an industrial washer at 85°C/15 min or in a 95°C wash (EU machine) without detergent
- Enzyme dosage given in study plan.
- Liquid enzymes the enzyme amount is solubilised in 100 ml deionised water.
- Granulated enzymes the enzyme is added directly or dissolved in deionised water before use; if dissolved, stir 10 min. on a magnetic stirrer. Detailed steps to carry out full scale wash trial
- the detergent is placed in the wash drum in a "washing ball" (both liquid and powder detergents). Place them at the bottom. • Place the ballast and test swatches in the wash drum.
- test swatches are removed from the T-towel and placed on the tray for drying, and make sure the swatches are dried in completely darkness, as many stains are sensitive to light.
- Drying room Put stains on tray or hang in line and dry at room temperature.
- the room has a de-humidifier working for 24h per day to keep the room dry
- the swatches are measured according to swatch/stain type
- Wash performance is expressed as a remission value. After washing and rinsing the swatches were spread out flat and allowed to air dry at room temperature overnight. All washes are evaluated the day after the wash. Light reflectance evaluations of the swatches were done using a Macbeth Color Eye 7000 reflectance spectrophotometer with very small aperture. The measurements were made without UV in the incident light and remission at 460 nm was extracted. Measurements were made on unwashed and washed swatches. The test swatch to be measured was placed on top of another swatch of same type and colour (twin swatch). Two swatches of each kind were used per wash, therefore they are used together for measuring one on top of each other.
- Combination effect Rem yipase + Rem C eiiuiase - Rem base
- base is meant the detergent composition without any enzymes.
- Example 1 The values that are below 2 points difference are classified as a medium effect while the cells with values above 2 are classified as strong effect.
- English base is composed of: anionic surfactants (5-15%), oxygen-based bleaching agents (5-15%), zeolite ( ⁇ 5%), non-ionic surfactants ( ⁇ 5%), soap ( ⁇ 5%), polycarboxylates ( ⁇ 5%), phosphonates ( ⁇ 5%), optical brighteners ( ⁇ 5%), perfume ( ⁇ 5%).
- Danish base 1 is composed of: sodium aluminum silicate, sodium carbonate, sodium sulphate, fatty alcohol ethoxylate-7, polycarboxylates, sodium tallow soap, sodium citrate, CMC, protease, methylene phosphonate, amylase and silicone.
- Italian base 1 was analysed and found to be composed of: 3,46% LAS and 2,1 1 % soap plus other components such as builders and co-builders.
- German base 1 (WFK ECE-2) base is composed of: 9,7% linear sodium alkyl benzene sulfonate, 5,2% ethoxylated fatty alcohol C12-18 (7 EO), 3,6% sodium soap, 4,5% foam inhibitor (silicone based), 1 1 ,8% sodium aluminium silicate (Zeolith 4A), 1 1 ,8% sodium carbonate, 5,2% sodium salt of a copolymer from acrylic and maleic acid, 3,4% sodium silicate, 1 ,3% carboxymethylcellulose (CMC), 0,8% diethylene triamine penta (methylene phosphonic acid, 9,8% sodium sulphate and 12,2% water.
- CMC carboxymethylcellulose
- the Danish color base 1 is composed of 10,5% anionic surfactants, 6% non-ionic surfactants, 52% builders, 12% filler and rest are additives such as perfume or dye trasfer inhibitors.
- Spanish base 1 was analysed and found to be composed of: 10,82% LAS and 0.88% soap plus other components such as builders and co-builders.
- compositions are standard commercial detergent compositions for laundering.
- Water hardness was adjusted by addition of CaCI 2 , MgCI 2 and NaHC0 3 to the test system. After washing, the textiles were rinsed in a Miele washing machine using a rinse program (STIVN).
- the stained swatches are commercially available from CFT (Center for Testmaterials BV, AC Vlaardingen, the Netherlands) and Equest (Warwick Equest Ltd Consett, County Durham, UK).
- the ballast is commercially available from WFK (wfk Testgewebe GmbH, Christenfeld 10, D-41379 Brijggen, Germany).
- the performance of the enzyme is evaluated by measuring the remission of the textile swatches using the ColorEye at 460 nm.
- the cellulase effect is shown in Table 4 below.
- the underlined cells correspond to the stains where the effect was evident, meaning that the difference in the remission value between 2 textiles is higher than 2 points. For these remission values the human eye will be able to detect the difference.
- the values that are below 2 points difference are classified as a medium effect while the cells with values above 2 are classified as strong effect.
- Figure 1 shows the remission values obtained after washing with the English base (powder) without any enzymes and with either lipase or a combination of lipase and cellulase. Data is given as the sum of the remission at 460nm for five stains: WFK W20PF (Pigment/veg. fat), Equest 68KC (Ice Cream (chocolate) premium), WFK W10LS (Lipstick), WFK W10PPM (Pigment/veg. oil/milk), Equest 132KC (Cooked butter).
- Figure 2 shows the remission values obtained after washing with the Italian base (powder) without any enzymes and with either lipase or a combination of lipase and cellulase. Data is given as the sum of the remission at 460nm for eight stains: WFK W20PF (Pigment/veg. fat), WFK W10D (Sebum w. pigment), CFT C-H1 13 (Lard + Sudan Red), WFK W10B (Olive oil w. pigment), WFK W10LS (Lipstick), WFK W20D (pigment/sebum), CFT C-H126 (Veg. oil/violet dye), Equest 132KC (Cooked butter).
- German base 2 was analysed and found to be composed of: 12,00% LAS and 1.13% soap plus other components such as builders and co-builders.
- Italian base 2 is composed of: 1 1 .7% anionic surfactants, 4,5% non-ioinic surfactants,
- German base 3 was analysed and found to be composed of: 4,5% AES plus other additives and stabilizers.
- Spanish base 2 was analysed and found to be composed of: 13.22% AES plus other additives and stabilizers.
- Italian base 3 was analysed and found to be composed of: 1 1.05% AES plus other additives and stabilizers
- Water hardness was adjusted by addition of CaCI 2 , MgCI 2 , and NaHC0 3 to the test system. After washing, the textiles were rinsed in a Miele washing machine using a rinse program (STIVN).
- the stained swatches are commercially available from CFT.
- the ballast is commercially available from WFK.
- the performance of the enzyme is evaluated by measuring the remission of the textile swatches using the ColorEye at 460 nm.
- the cellulase effect is shown in Table 7.
- the underlined cells correspond to the stains where the effect was evident, meaning that the difference in the remission value between 2 textiles is higher than 2 points. For these remission values the human eye will be able to detect the difference.
- the values that are below 2 points difference are classified as a medium effect while the cells with values above 2 are classified as strong effect.
- Figure 3 shows the remission value obtained after washing with the German base 2 (powder) without any enzymes and with either lipase or a combination of lipase and cellulase. Data is shown as the sum of the remission at 460nm for four stains: WFK W20PF (Pigment/veg. fat), Equest 132KC (Cooked butter), WFK W20D (Pigment/Sebum), CFT C-H078 (lipstick handmade),
- Figure 4 shows the remission value obtained after washing with the English base (powder) without any enzymes and with either lipase or a combination of lipase and cellulase. Data is shown as the sum of the remission at 460nm for four stains: WFK W20PF (Pigment/veg. fat), Equest 68KC (Ice Cream (chocolate) - premium), CFT C-H078 (lipsiick handmade), Equest 022KC (Black olives).
- Figure 5 shows the remission value obtained after washing with the Spanish base 2 (liquid) without any enzymes and with either lipase or a combination of lipase and cellulase. Data is shown as the sum of the remission at 460nm for six stains: WFK W20PF (Pigment/veg. fat), Equest 68KC (Ice Cream (chocolate) - premium), WFK W10LS (lipstick), CFT C-G1 13 (Lard + Sudan Red), Equest 132KC (Cooked butter) and Equest 131 KC (Cooked beef fat).
- Figure 6 shows the remission value obtained after washing with the Italian base 2 (liquid) without any enzymes and with either lipase or a combination of lipase and cellulase. Data is shown as the sum of the remission at 460nm for four stains: WFK W20PF (Pigment/veg. fat), Equest 68KC (Ice Cream (chocolate) - premium), Equest 132KC (Cooked butter) and Equest 131 KC (Cooked beef fat).
- the lipase variant of SEQ ID NO: 2 has the following modifications: D27R G38A D96E D1 1 1A G163K T231 R N233R D254S P256T.
- Water hardness was adjusted by addition of CaCI 2 , MgCI 2 , and NaHC0 3 to the test system. After washing, the textiles were rinsed in a Miele washing machine using a rinse program (STIVN).
- the stained swatches are commercially available from CFT.
- the ballast is commercially available from WFK.
- the performance of the enzyme is evaluated by measuring the remission of the textile swatches using the ColorEye at 460 nm.
- the synergy effect is shown in Table 1 1
- the highlighted cells correspond to the stains where the effect was evident. It is commonly known that if the remission value between 2 textiles is higher than 2 points the human eye will be able to detect the difference. That is why the highlighted cells contain values around 2 and higher than 2.
- Figure 7 shows the remission value obtained after washing with the English base (powder) without any enzymes and with lipase, cellulase or a combination of lipase and cellulase. Data is shown as the sum of the remission at 460nm for four stains: WFK W20PF (Pigment/veg. fat), Equest 68KC (Ice Cream (chocolate) - premium), WFK W10LS (Lipstick) and CFT C-H126 (Veg. oil/violet dye).
- Figure 8 shows the remission value obtained after washing with the Spanish base 2 (liquid) without any enzymes and with either lipase, cellulase or a combination of lipase and cellulase. Data is shown as the sum of the remission at 460nm for four stains: WFK W20PF (Pigment/veg. fat), Equest 68KC (Ice Cream (chocolate) - premium), WFK W10LS (Lipstick) and CFT C-H126 (Veg. oil/violet dye).
Abstract
The present invention concerns a detergent composition for removing or releasing greasy stains, the use of a lipase and a cellulase for removing or releasing greasy stains, a method for removing or releasing greasy stains and an item treated according to the method.
Description
DETERGENT COMPOSITION AND USE OF DETERGENT COMPOSITION
Reference to a Sequence Listing
This application contains a Sequence Listing in computer readable form, which is incorporated herein by reference.
Field of the invention
The present invention concerns a detergent composition for removing or releasing greasy stains, the use of a lipase and a cellulase for removing or releasing greasy stains, a method for removing or releasing greasy stains and an item treated according to the method.
Background of the Invention
Cellulases are enzymes involved in the hydrolysis of cellulose. Cellulases are synthesized by a large number of microorganisms which include fungi, actinomycetes, myxobacteria and true bacteria, but they are also synthesized by plants. A very important industrial use of cellulases is for laundry, where cellulases are used for stain removal and anti- fuzz treatment of cotton textile.
Lipases are useful, e.g., as detergent enzymes to remove lipid or fatty stains from clothes and other textiles. Lipase enzymes have been used in detergents since the late 1980s for removal of greasy and oily soils by breakdown of soil into tri-glycerides. Current detergents e.g. laundry detergents compositions include a complex combination of active ingredients such as surfactants, enzymes bleaching agents, a builder system, suds suppressors, soil-suspending agents, soil-release agents, optical brighteners, softening agents, dispersants, dye transfer inhibition compounds, abrasives, bactericides, and perfumes. Lipolytic enzymes, including lipases and cutinases, have been employed in detergent cleaning compositions for the removal of greasy or oily stains.
One challenge for developing detergent compositions products for the low temperature area is that the detergent compositions need to perform optimally at both warm and cold wash conditions due to marked expectations. Therefore only chemicals and enzymes which in their functionality are robust towards a change in temperature will find their way into such products.
Currently available detergent composition products have a higher wash performance at
40°C as compared to 20°C and the detergency becomes even worse when the temperature is lowered from 20°C to 10°C. Especially dirt and stains comprising grease, oil or fat are difficult to remove at low temperatures, as the temperature helps melting the grease and thereby it is easier to remove the greasy dirt and stains.
It would be advantageous to optimize detergent compositions both powder and liquid and wash processes whereby stain removal may be improved without simultaneously also
reducing the cleaning efficiency and particularly in light of the growing desire to reduce the overall energy consumption.
Summary of the Invention
The present invention concerns a detergent composition for removing or releasing greasy stains, which composition comprises a surfactant, a lipase and a cellulase. In addition the invention concerns the use of a lipase and a cellulase for removing or releasing greasy stains from a textile, a dish or a hard surface. The invention also concerns a method for removing or releasing greasy stains from an item having a greasy stain, which method comprises exposing the item to an aqueous solution of a lipase and a cellulase. Further, the invention concerns an item treated according to the method.
Brief Description of the Figures
Figure 1 shows the effect obtained in Example 1 after washing with a powder English base. Figure 2 shows the effect obtained in Example 1 after washing with a powder Italian base.
Figure 3 shows the effect obtained in Example 2 with the powder German base 2.
Figure 4 shows the effect obtained in Example 2 with the powder English base.
Figure 5 shows the effect obtained in Example 2 with the liquid Spanish base 2.
Figure 6 shows the effect obtained in Example 2 with the liquid Italian base 2.
Figure 7 shows the synergy obtained in Example 3 with the powder English base.
Figure 8 shows the synergy obtained in Example 3 with the liquid Spanish base 2.
Definitions
Enzyme Detergency benefit: The term "enzyme detergency benefit" is defined herein as the advantageous effect an enzyme may add to a detergent compared to the same detergent without the enzyme. Important detergency benefits which can be provided by enzymes are stain removal with no or very little visible soils after washing and/or cleaning, prevention or reduction of redeposition of soils released in the washing process (an effect that also is termed anti- redeposition), restoring fully or partly the whiteness of textiles which originally were white but after repeated use and wash have obtained a greyish or yellowish appearance (an effect that also is termed whitening). Textile care benefits, which are not directly related to catalytic stain removal or prevention of redeposition of soils, are also important for enzyme detergency benefits. Examples of such textile care benefits are prevention or reduction of dye transfer from one fabric to another fabric or another part of the same fabric (an effect that is also termed dye transfer inhibition or anti-backstaining), removal of protruding or broken fibers from a fabric
surface to decrease pilling tendencies or remove already existing pills or fuzz (an effect that also is termed anti-pilling), improvement- of the fabric-softness, colour clarification of the fabric and removal of particulate soils which are trapped in the fibers of the fabric or garment. Enzymatic bleaching is a further enzyme detergency benefit where the catalytic activity generally is used to catalyze the formation of bleaching components such as hydrogen peroxide or other peroxides.
Textile care benefit: "Textile care benefits, which are not directly related to catalytic stain removal or prevention of redeposition of soils, are also important for enzyme detergency benefits. Examples of such textile care benefits are prevention or reduction of dye transfer from one textile to another textile or another part of the same textile (an effect that is also termed dye transfer inhibition or anti-backstaining), removal of protruding or broken fibers from a textile surface to decrease pilling tendencies or remove already existing pills or fuzz (an effect that also is termed anti-pilling), improvement of the textile-softness, colour clarification of the textile and removal of particulate soils which are trapped in the fibers of the textile. Enzymatic bleaching is a further enzyme detergency benefit where the catalytic activity generally is used to catalyze the formation of bleaching component such as hydrogen peroxide or other peroxides or other bleaching species."
The term "greasy stain" means a stain comprising a lipid compound such as a fats, waxes, sterols, monoglycerides, diglycerides, triglycerides, phospholipids and/or fat-soluble vitamins,. The lipid compound can origin from a vegetable oil, oil from animal source, mineral oil or artificial oil. The lipid compound is generally soluble in organic solvents and generally insoluble in water. The greasy stain comprises one or more lipids and optionally other stain components such as particulate soil, dye, colorant, dairy components, or the like. The terms lipid and grease are used interchangeably.
When a greasy stain is said to have a "high content of lipids" or "the lipid content of the stain is high", it is meant that the stain consists almost entirely of lipids, such as at least 80% of the stain consists of lipids or at least 85% of the stain consists of lipids or at least 90% of the stain consists of lipids. Examples of such stains are stains having a high content of vegetable oil, mineral oil and/or animal fat, such as vegetable fat, butter or cooked butter.
When a greasy stain is said to have a "medium content of lipids", it is meant that the stain comprises a lipid such that at least 40% and up to 80% of the stain consists of lipids or at least 45% of the stain consists of lipids or at least 50% of the stain consists of lipids, or at least 55% of the stain consists of lipids, or at least 60% of the stain consists of lipids, or at least 65% of the stain consists of lipids, or at least 70% of the stain consists of lipids, or at least 75% of the stain consists of lipids. Examples of such stains are stains having a medium content of vegetable oil, mineral oil and/or, animal fat, such as compositions comprising vegetable oil, mineral oil and/or animal fat, e.g. lipstick or compositions comprising vegetable oil/animal fat
and milk.
When a greasy stain is said to have a "low-medium content of lipids", it is meant that the stain comprises a lipid such that at least 15% and up to 40% of the stain consists of lipids, or at least 25% of the stain consists of lipids, or at least 25% of the stain consists of lipids, or at least 30% of the stain consists of lipids, or at least 35% of the stain consists of lipids. Examples of such stains are stains having a low-medium content of vegetable oil, mineral oil and/or animal fat, such as compositions comprising vegetable oil, mineral oil and/or animal fat, e.g. ice cream such as chocolate ice cream or compositions of comprising vegetable oil/animal fat and milk.
By the term "particulate soil" is meant particles with a heterogeneous nature with varying surface energies. The particles can be trapped in pores on the surfaces e.g. a textile.
Mature polypeptide coding sequence: The term "mature polypeptide coding sequence" means a polynucleotide that encodes a mature polypeptide having lipase activity. In one aspect, the mature polypeptide coding sequence is nucleotides 1 to 807 of SEQ ID NO: 1 .
Subsequence: The term "subsequence" means a polynucleotide having one or more (e.g., several) nucleotides absent from the 5' and/or 3' end of a mature polypeptide coding sequence; wherein the subsequence encodes a fragment having lipase activity. In one aspect, a subsequence contains at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% but less than 100% of the number of nucleotides 1 to 807 of SEQ ID NO: 1.
Substitutions. For an amino acid substitution, the following nomenclature is used:
Original amino acid, position, substituted amino acid. Accordingly, the substitution of threonine at position 226 with alanine is designated as "Thr226Ala" or "T226A". Multiple mutations are separated by addition marks ("+"), e.g., "Gly205Arg + Ser41 1 Phe" or "G205R + S41 1 F", representing substitutions at positions 205 and 41 1 of glycine (G) with arginine (R) and serine (S) with phenylalanine (F), respectively.
Deletions. For an amino acid deletion, the following nomenclature is used: Original amino acid, position, *. Accordingly, the deletion of glycine at position 195 is designated as "Gly195*" or "G195*". Multiple deletions are separated by addition marks ("+"), e.g., "Gly195* + Ser41 1 *" or "G195* + S41 1 *".
Insertions. For an amino acid insertion, the following nomenclature is used: Original amino acid, position, original amino acid, inserted amino acid. Accordingly the insertion of lysine after glycine at position 195 is designated "Gly195Glyl_ys" or "G195GK". An insertion of multiple amino acids is designated [Original amino acid, position, original amino acid, inserted amino acid #1 , inserted amino acid #2; etc.]. For example, the insertion of lysine and alanine after glycine at position 195 is indicated as "Gly195Glyl_ysAla" or "G195GKA".
In such cases, the inserted amino acid residue(s) are numbered by the addition of lower case letters to the position number of the amino acid residue preceding the inserted amino acid residue(s). In the above example, the sequence would thus be:
Multiple alterations. Variants comprising multiple alterations are separated by addition marks ("+"), e.g., "Arg170Tyr+Gly195Glu" or "R170Y+G195E" representing a substitution of arginine and glycine at positions 170 and 195 with tyrosine and glutamic acid, respectively.
Different alterations. Where different alterations can be introduced at a position, the different alterations are separated by a comma, e.g., "Arg170Tyr,Glu" represents a substitution of arginine at position 170 with tyrosine or glutamic acid. Thus, "Tyr167Gly,Ala + Arg170Gly,Ala" designates the following variants:
"Tyr167Gly+Arg170Gly", "Tyr167Gly+Arg170Ala", "Tyr167Ala+Arg170Gly", and "Tyr167Ala+Arg170Ala".
Textile: The term "textile" means any textile material including yarns, yarn intermediates, fibers, non-woven materials, natural materials, synthetic materials, and any other textile material, fabrics made of these materials and products made from fabrics (e.g., garments and other articles). The textile or fabric may be in the form of knits, wovens, denims, non-wovens, felts, yarns, and towelling. The textile may be cellulose based such as natural cellulosics, including cotton, flax/linen, jute, ramie, sisal or coir or manmade cellulosics (e.g. originating from wood pulp) including viscose/rayon, cellulose acetate fibers (tricell), lyocell or blends thereof. The textile or fabric may also be non-cellulose based such as natural polyamides including wool, camel, cashmere, mohair, rabbit and silk or synthetic polymers such as nylon, aramid, polyester, acrylic, polypropylene and spandex/elastane, or blends thereof as well as blends of cellulose based and non-cellulose based fibers. Examples of blends are blends of cotton and/or rayon/viscose with one or more companion material such as wool, synthetic fiber (e.g. polyamide fiber, acrylic fiber, polyester fiber, polyvinyl chloride fiber, polyurethane fiber, polyurea fiber, aramid fiber), and/or cellulose-containing fiber (e.g. rayon/viscose, ramie, flax/linen, jute, cellulose acetate fiber, lyocell). Fabric may be conventional washable laundry, for example stained household laundry. When the term fabric or garment is used it is intended to include the broader term textiles as well.
Improved wash performance: The term "improved wash performance" is defined herein as the combination of cellulase and lipase displaying an increased wash performance relative to the wash performance of the base detergent composition or the base detergent composition
comprising either lipase or cellulase, e.g. by increased stain removal. The term "wash performance" includes wash performance in laundry but also e.g. in dish wash.
Whiteness: The term "Whiteness" is defined herein as a broad term with different meanings in different regions and for different consumers. Loss of whiteness can e.g. be due to greying, yellowing, or removal of optical brighteners/hueing agents. Greying and yellowing can be due to soil redeposition, body soils, colouring from e.g. iron and copper ions or dye transfer. Whiteness might include one or several issues from the list below: colourant or dye effects; incomplete stain removal (e.g. body soils, sebum etc.); redeposition (greying, yellowing or other discolourations of the object) (removed soils reassociate with other parts of textile, soiled or unsoiled); chemical changes in textile during application; and clarification or brightening of colours.
Detergent Composition: The term "detergent composition" refers to compositions that find use in the removal of undesired compounds from items to be cleaned, such as textiles, dishes, and hard surfaces. The detergent composition may be used to e.g. clean textiles, dishes and hard surfaces for both household cleaning and industrial cleaning. The terms encompass any materials/compounds selected for the particular type of cleaning composition desired and the form of the product (e.g., liquid, gel, powder, granulate, paste, or spray compositions) and includes, but is not limited to, detergent compositions (e.g., liquid and/or solid laundry detergents and fine fabric detergents; hard surface cleaning formulations, such as for glass, wood, ceramic and metal counter tops and windows; carpet cleaners; oven cleaners; fabric fresheners; fabric softeners; and textile and laundry pre-spotters, as well as dish wash detergents). In addition to containing a bifunctional compound of the invention, the detergent formulation may contain one or more additional enzymes (such as proteases, amylases, lipases, cutinases, cellulases, endoglucanases, xyloglucanases, pectinases, pectin lyases, xanthanases, peroxidaes, haloperoxygenases, catalases and mannanases, or any mixture thereof), and/or components such as surfactants, builders, chelators or chelating agents, bleach system or bleach components, polymers, fabric conditioners, foam boosters, suds suppressors, dyes, perfume, tannish inhibitors, optical brighteners, bactericides, fungicides, soil suspending agents, anti-corrosion agents, enzyme inhibitors or stabilizers, enzyme activators, transferase(s), hydrolytic enzymes, oxido reductases, bluing agents and fluorescent dyes, antioxidants, and solubilizers.
Dish washing composition: The term "dish washing composition" refers to compositions including ADW compositions (Automated Dish Wash) intended for cleaning dishes, table ware, pots, pans, cutlery, plates, cups, glasses, bowls, cutlery such as spoons, knives, forks, serving utensils, ceramics, plastics, metals, china, glass, acrylics and all forms of compositions for cleaning hard surfaces areas in kitchens. The present invention is not restricted to any particular type of dish wash composition.
Dish wash: The term "dish wash" refers to all forms of washing dishes, e.g. by hand or automatic dish wash (ADW). Washing dishes includes, but is not limited to, the cleaning of all forms of crockery such as plates, cups, glasses, bowls, all forms of cutlery such as spoons, knives, forks and serving utensils as well as ceramics, plastics, metals, china, glass and acrylics.
Hard surface cleaning: The term "Hard surface cleaning" is defined herein as cleaning of hard surfaces wherein hard surfaces may include floors, tables, walls, roofs etc. as well as surfaces of hard objects such as cars (car wash) and dishes (dish wash). Dish washing includes but are not limited to cleaning of plates, cups, glasses, bowls, cutlery such as spoons, knives, forks, serving utensils, ceramics, plastics, metals, china, glass and acrylics.
Hard surface cleaning: The term "Hard surface cleaning" is defined herein as cleaning of hard surfaces, wherein hard surfaces may include floors, tables, walls, roofs etc. as well as surfaces of hard objects such as cars (car wash).
Laundering: The term "laundering" relates to both household laundering and industrial laundering and means the process of treating textiles with a solution containing a cleaning or detergent composition of the present invention. The laundering process can for example be carried out using e.g. a household or an industrial washing machine or can be carried out by hand. Detailed Description of the Invention
The present invention concerns a detergent composition for removing or releasing greasy stains, which composition comprises a surfactant, a lipase and a cellulase. The present invention further comprises the use of a lipase in combination with cellulase for releasing removing greasy stains and a method for removing or releasing greasy stains from an item having a greasy stain. The method comprises exposing the item to an aqueous solution of a lipase and a cellulase.
Lipases are traditionally known as enzymes that remove greasy stains and are widely used in detergent composition. The lipases catalyse the breakdown of lipids in the greasy stain, which are then released from the item and removed with the waste water/rinse water. When the temperature at the same time is above the melting temperature of the lipids, the removal of the greasy stain is further eased.
The inventor has found that by using a lipase and a cellulase in combination and optionally with other enzymes, the removal or release of greasy stains are increased. When the combination of lipase and cellulase is used at low temperatures, e.g. below the melting point of the lipids contained in the greasy stain, the stain release and stain removal is increased.
The lipase may be of bacterial or fungal origin and it may be chemically modified or protein engineered.
The stain treated according to the invention may comprise vegetable oil, mineral oil, animal fat or a combination thereof. For example the stain can comprise a vegetable oil such as a mayonnaise, a dressing or the like having a high content of lipids. In one embodiment the stain comprises an animal fat such as for example fat from pig, chicken, turkey, cow or fish. In one embodiment of the invention the stain may be a combination of vegetable oil and animal fat.
In one embodiment of the invention, the greasy stain has a high content of lipid. For example the stain can comprise lipstick, which comprises a combination of waxes and pigments, or a stain comprising lard.
In one embodiment, lipase is of bacterial or fungal origin. Chemically modified or protein engineered mutant enzymes are included. Examples include lipase from Thermomyces, e.g. from T. lanuginosus (previously named Humicola lanuginosa) as described in EP258068 and EP305216, cutinase from Humicola, e.g. H. insolens (WO96/13580), lipase from strains of Pseudomonas (some of these now renamed to Burkholderia), e.g. P. alcaligenes or P. pseudoalcaligenes (EP218272), P. cepacia (EP331376), P. sp. strain SD705 (WO95/06720 & WO96/27002), P. wisconsinensis (WO96/12012), GDSL-type Streptomyces lipases (W010/065455), cutinase from Magnaporthe grisea (W010/107560), cutinase from Pseudomonas mendocina (US5,389,536), lipase from Thermobifida fusca (W01 1/084412), Geobacillus stearothermophilus lipase (W01 1/084417), lipase from Bacillus subtilis (W01 1/084599), and lipase from Streptomyces griseus (W01 1/150157) and S. pristinaespiralis (W012/137147).
Other examples are lipase variants such as those described in EP407225, WO92/05249, WO94/01541 , W094/25578, W095/14783, WO95/30744, W095/35381 , W095/22615, WO96/00292, WO97/04079, WO97/07202, WO00/34450, WO00/60063, WO01/92502, WO07/87508 and WO09/109500.
Preferred commercial lipase products include include Lipolase™, Lipex™, Lipolex™ and
Lipoclean™ (Novozymes A/S), Lumafast (originally from Genencor) and Lipomax (originally from Gist-Brocades).
Still other examples are lipases sometimes referred to as acyltransferases or perhydrolases, e.g. acyltransferases with homology to Candida antarctica lipase A (WO10/1 1 1 143), acyltransferase from Mycobacterium smegmatis (WO05/56782), perhydrolases from the CE 7 family (WO09/67279), and variants of the M. smegmatis perhydrolase in particular the S54V variant used in the commercial product Gentle Power Bleach from Huntsman Textile Effects Pte Ltd (W010/100028).
In one embodiment of the invention, the lipase is a polypeptide having the amino acid sequence which:
a) has at least 90% identity with the wild-type lipase derived from Humicola lanuginosa strain DSM 4109;
b) compared to said wild-type lipase, comprises a substitution of an electrically neutral or negatively charged amino acid at the surface of the three-dimensional structure within 15 A of E1 or Q249 with a positively charged amino acid; and c) comprises a peptide addition at the C-terminal; and/or
d) meets the following limitations:
i. comprises a negative amino acid in position E210 of said wild-type lipase; ii. comprises a negatively charged amino acid in the region corresponding to positions 90-101 of said wild-type lipase; and
iii. comprises a neutral or negative amino acid at a position corresponding to N94 of said wild-type lipase and/or has a negative or neutral net electric charge in the region corresponding to positions 90-101 of said wild-type lipase.
In one embodiment, the substitution mentioned under b) is within 10 A of E1 or Q249. In one embodiment said substitution is within 15 A (preferably 10 A) of E1 . In one embodiment the lipase comprises 2-4 of said substitutions, where 2 substitutions are preferred. In one embodiment the substitution is of an electrically neutral or negatively charged amino acid within 10 A of E1 with R. In one embodiment a substitution of amino acid S3, S224, P229, T231 , N233, D234 or T244 with a positively charged amino acid, preferably R.
In one embodiment, 1 -5 amino acids have been added to the C-terminal of the peptide. In one embodiment, the amino acids consist of electrically neutral (preferably hydrophobic) amino acids and are most preferably PGL or PG.
In one embodiment of the invention, the amino acids added at the C-terminal consist of neutral (preferably hydrophobic) amino acids and C, and the lipase further comprises substitution of an amino acid with C so as to form a disulfide bridge with the C of the peptide addition.
In one embodiment, the lipase comprises amino acids with negative or unchanged electric charge in at least two of positions N94, D96 and E99 of said wild-type lipase.
In one embodiment, the lipase comprises a substitution G91A, N94D/E/K/R, D96E/I/L/N/S/W, E99N/Q/K/R/H, N 101 S, R209P/S or Q249R/K/H.
In one embodiment of the invention, the lipase comprises one of the following sets of substitutions, optionally combined with Q249R/K/H and/or K98X:
G91 G/A/S/T + N94 (neutral or negative) + D96D/E/C/Y + E99E/D/C/Y,
G91 G/A/S/T + N94 (neutral or negative) + D96D/E/C/Y + E99N + N101 S,
G91 G/A/S/T + N94R/K/H + D96D/E/C/Y + E99E/D/C/Y,
G91 G/A/S/T + N94 (neutral or negative) + D96 (neutral or positive) + E99E/D/C Y, or
G91 G/A/S/T + N94 (neutral or negative) + D96D/E/C Y + E99 (neutral or positive).
In one embodiment, the lipase comprises one of the following sets of substitutions, optionally combined with R209 (neutral or negative):
E99R/K/H + Q249R/K/H,
N94R/K/H + Q249R/K/H, or
D96 (neutral or positive) + Q249R/K/H.
In one embodiment of the invention, the lipase is a variant of a parent lipase which variant has lipase activity, has at least 60% but less than 100% sequence identity with SEQ ID NO: 2, and comprises substitutions at positions corresponding to T231 R+N233R and at least one or more (e.g., several) of D96E, D1 1 1A, D254S, G163K, P256T, G91 T, G38A, D27R, and N33Q of SEQ ID NO: 2.
In one embodiment, the said variant in comparison with the parent lipase has increased stability. The stability is stability under storage conditions, protease stability, chemical stability, oxidation stability, pH stability, and/or thermostability.
In one embodiment, the variant is selected from the group consisting of:
a) a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% identity, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100%, sequence identity to SEQ ID NO: 2;
b) a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions, medium stringency conditions, medium-high stringency conditions, high stringency conditions, or very high stringency conditions with (i) the polypeptide coding sequence of SEQ ID NO: 1 or (ii) the full-length complement of (i);
c) a polypeptide encoded by a polynucleotide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, but less than 100% sequence identity to SEQ ID NO: 1 ; and
d) a fragment of the polypeptide of SEQ ID NO: 2.
In one embodiment, the lipase is a variant having activity, has at least 60% but less than 100% sequence identity with SEQ ID NO: 2, and comprises substitutions at positions corresponding to T231 R+N233R and at least one or more (e.g., several) of D96E, D1 1 1A, D254S, G163K, P256T, G91T, G38A, D27R, and N33Q of SEQ ID NO: 2 selected from the group of:
a) D96E T231 R N233R;
b) N33Q D96E T231 R N233R;
c) N33Q T231 R N233R;
d) N33Q D1 1 1A T231 R N233R;
e) N33Q T231 R N233R P256T;
f) N33Q G38A G91 T G163K T231 R N233R D254S;
g) N33Q G38A G91T D96E D1 1 1 A G163K T231 R N233R D254S P256T; h) D27R N33Q G38A D96E D1 1 1 A G163K T231 R N233R D254S P256T; i) D27R N33Q G38A G91T D96E D1 1 1A G163K T231 R N233R P256T; j) D27R N33Q G38A G91T D96E D1 1 1A G163K T231 R N233R D254S; k) D27R G38A G91T D96E D1 1 1A G163K T231 R N233R D254S P256T; I) D96E T231 R N233R D254S;
m) T231 R N233R D254S P256T;
n) G163K T231 R N233R D254S;
o) D27R N33Q G38A G91T D96E G163K T231 R N233R D254S P256T; p) D27R G91 T D96E D1 1 1 A G163K T231 R N233R D254S P256T;
q) D96E G163K T231 R N233R D254S;
r) D27R G163K T231 R N233R D254S;
s) D27R G38A G91 T D96E D1 1 1A G163K T231 R N233R D254S;
t) D27R G38A G91 T D96E G163K T231 R N233R D254S P256T;
u) D27R G38A D96E D1 1 1A G163K T231 R N233R D254S P256T:
v) D27R D96E G163K T231 R N233R D254S;
w) D27R D96E D1 1 1 A G163K T231 R N233R D254S P256T;
x) D27R G38A D96E G163K T231 R N233R D254S P256T.
The parent lipase may be (a) a polypeptide having at least 60% sequence identity to the polypeptide of SEQ ID NO: 2; (b) a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions with (i) the polypeptide coding sequence of SEQ ID NO: 1 , (ii) the full-length complement of (i); or (c) a polypeptide encoded by a polynucleotide having at least 60% sequence identity to the polypeptide coding sequence of SEQ ID NO: 1.
In an aspect, the parent has a sequence identity to the polypeptide of SEQ ID NO: 2 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%, which have lipase activity. In one aspect, the amino acid sequence of the parent differs by up to 40 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 , 22, 23, 24, 25, 26, 27, 28, 29, 30, 31 , 32, 33, 34, 35, 36, 37, 38, 39, or 40 from the polypeptide of SEQ ID NO: 2.
In another aspect, the parent comprises or consists of the amino acid sequence of SEQ ID NO: 2.
In another aspect, the parent is a fragment of the polypeptide of SEQ ID NO: 2 containing at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at
least 80%, at least 85%, at least 90%, or at least 95% of the number of amino acids of SEQ ID NO: 2.
In another embodiment, the parent is an allelic variant of the polypeptide of SEQ ID
NO: 2.
In another aspect, the parent is encoded by a polynucleotide that hybridizes under very low stringency conditions, low stringency conditions, medium stringency conditions, medium- high stringency conditions, high stringency conditions, or very high stringency conditions with (i) the polypeptide coding sequence of SEQ ID NO: 1 , (ii) the full-length complement of (i) (Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual, 2d edition, Cold Spring Harbor, New York).
The polynucleotide of SEQ ID NO: 1 or a subsequence thereof, as well as the polypeptide of SEQ ID NO: 2 or a fragment thereof, may be used to design nucleic acid probes to identify and clone DNA encoding a parent from strains of different genera or species according to methods well known in the art. In particular, such probes can be used for hybridization with the genomic DNA or cDNA of a cell of interest, following standard Southern blotting procedures, in order to identify and isolate the corresponding gene therein. Such probes can be considerably shorter than the entire sequence, but should be at least 15, e.g., at least 25, at least 35, or at least 70 nucleotides in length. Preferably, the nucleic acid probe is at least 100 nucleotides in length, e.g., at least 200 nucleotides, at least 300 nucleotides, at least 400 nucleotides, at least 500 nucleotides, at least 600 nucleotides, at least 700 nucleotides, at least 800 nucleotides, or at least 900 nucleotides in length. Both DNA and RNA probes can be used. The probes are typically labeled for detecting the corresponding gene (for example, with 32P, 3H, 35S, biotin, or avidin). Such probes are encompassed by the present invention.
A genomic DNA or cDNA library prepared from such other strains may be screened for DNA that hybridizes with the probes described above and encodes a parent. Genomic or other DNA from such other strains may be separated by agarose or polyacrylamide gel electrophoresis, or other separation techniques. DNA from the libraries or the separated DNA may be transferred to and immobilized on nitrocellulose or other suitable carrier material. In order to identify a clone or DNA that hybridizes with SEQ ID NO: 1 or a subsequence thereof, the carrier material is used in a Southern blot.
For purposes of the present invention, hybridization indicates that the polynucleotide hybridizes to a labeled nucleic acid probe corresponding to (i) SEQ ID NO: 1 ; (ii) the polypeptide coding sequence of SEQ ID NO: 1 ; (iii) the full-length complement thereof; or (iv) a subsequence thereof; under very low to very high stringency conditions. Molecules to which the nucleic acid probe hybridizes under these conditions can be detected using, for example, X ray film or any other detection means known in the art.
In one aspect, the nucleic acid probe is the polypeptide coding sequence of SEQ ID NO: 1 . In another aspect, the nucleic acid probe is at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% of the number of nucleotides of SEQ ID NO: 1 . In another aspect, the nucleic acid probe is a polynucleotide that encodes the polypeptide of SEQ ID NO: 2; the polypeptide thereof; or a fragment thereof. In another aspect, the nucleic acid probe is SEQ ID NO: 1.
In another embodiment, the parent is encoded by a polynucleotide having a sequence identity to the polypeptide coding sequence of SEQ ID NO: 1 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%.
The polypeptide may be a hybrid polypeptide in which a region of one polypeptide is fused at the N terminus or the C terminus of a region of another polypeptide.
The parent may be a fusion polypeptide or cleavable fusion polypeptide in which another polypeptide is fused at the N terminus or the C terminus of the polypeptide of the present invention. A fusion polypeptide is produced by fusing a polynucleotide encoding another polypeptide to a polynucleotide of the present invention. Techniques for producing fusion polypeptides are known in the art, and include ligating the coding sequences encoding the polypeptides so that they are in frame and that expression of the fusion polypeptide is under control of the same promoter(s) and terminator. Fusion polypeptides may also be constructed using intein technology in which fusion polypeptides are created post-translationally (Cooper et al., 1993, EMBO J. 12: 2575-2583; Dawson et al., 1994, Science 266: 776-779).
A fusion polypeptide can further comprise a cleavage site between the two polypeptides. Upon secretion of the fusion protein, the site is cleaved releasing the two polypeptides. Examples of cleavage sites include, but are not limited to, the sites disclosed in Martin et al., 2003, J. Ind. Microbiol. Biotechnol. 3: 568-576; Svetina et al., 2000, J. Biotechnol. 76: 245-251 ; Rasmussen-Wilson et al., 1997, Appl. Environ. Microbiol. 63: 3488-3493; Ward et al., 1995, Biotechnology 13: 498-503; and Contreras et al., 1991 , Biotechnology 9: 378-381 ; Eaton et al., 1986, Biochemistry 25: 505-512; Collins-Racie et al., 1995, Biotechnology 13: 982- 987; Carter et al., 1989, Proteins: Structure, Function, and Genetics 6: 240-248; and Stevens, 2003, Drug Discovery World 4: 35-48.
The parent may be obtained from microorganisms of any genus. For purposes of the present invention, the term "obtained from" as used herein in connection with a given source shall mean that the parent encoded by a polynucleotide is produced by the source or by a strain in which the polynucleotide from the source has been inserted. In one aspect, the parent is secreted extracellularly.
The parent may be a bacterial lipase. For example, the parent may be a Gram-positive bacterial polypeptide such as a Bacillus, Clostridium, Enterococcus, Geobacillus, Lactobacillus, Lactococcus, Oceanobacillus, Staphylococcus, Streptococcus, Streptomyces or Thermobifida lipase, or a Gram-negative bacterial polypeptide such as a Campylobacter, E. coli, Flavobacterium, Fusobacterium, Helicobacter, llyobacter, Neisseria, Pseudomonas, Salmonella, or Ureaplasma lipase.
In one aspect, the parent is a Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus firmus, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus pumilus, Bacillus stearothermophilus, Bacillus subtilis, or Bacillus thuringiensis lipase.
In another aspect, the parent is a Streptococcus equisimilis, Streptococcus pyogenes, Streptococcus uberis, or Streptococcus equi subsp. Zooepidemicus lipase.
In another aspect, the parent is a Streptomyces achromogenes, Streptomyces avermitilis, Streptomyces coelicolor, Streptomyces griseus, or Streptomyces lividans lipase.
In another aspect, the parent is a Thermobifida alba or Thermobifida fusca (formerly known as Thermomonaspora fusca) lipase.
The parent may be a fungal lipase. For example, the parent may be a yeast lipase such as a Candida, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces, or Yarrowia lipase; or a filamentous fungal lipase such as an Acremonium, Agaricus, Alternaria, Aspergillus, Aureobasidium, Botryospaeria, Ceriporiopsis, Chaetomidium, Chrysosporium, Claviceps, Cochliobolus, Coprinopsis, Coptotermes, Corynascus, Cryphonectria, Cryptococcus, Diplodia, Exidia, Filibasidium, Fusarium, Gibberella, Holomastigotoides, Humicola, Irpex, Lentinula, Leptospaeria, Magnaporthe, Melanocarpus, Meripilus, Mucor, Myceliophthora, Neocallimastix, Neurospora, Paecilomyces, Penicillium, Phanerochaete, Piromyces, Poitrasia, Pseudoplectania, Pseudotrichonympha, Rhizomucor, Schizophyllum, Scytalidium, Talaromyces, Thermoascus, Thielavia, Tolypocladium, Trichoderma, Trichophaea, Verticillium, Volvariella, or Xylaria lipase.
In another aspect, the parent is a Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharomyces diastaticus, Saccharomyces douglasii, Saccharomyces kluyveri, Saccharomyces norbensis, or Saccharomyces oviformis lipase.
In another aspect, the parent is an Acremonium cellulolyticus, Aspergillus aculeatus, Aspergillus awamori, Aspergillus foetidus, Aspergillus fumigatus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus oryzae, Chrysosporium inops, Chrysosporium keratinophilum, Chrysosporium lucknowense, Chrysosporium merdarium, Chrysosporium pannicola, Chrysosporium queenslandicum, Chrysosporium tropicum, Chrysosporium zonatum, Fusarium bactridioides, Fusarium cerealis, Fusarium crookwellense, Fusarium culmorum, Fusarium graminearum, Fusarium graminum, Fusarium heterosporum,
Fusahum negundi, Fusarium oxysporum, Fusahum reticulatum, Fusarium roseum, Fusarium sambucinum, Fusarium sarcochroum, Fusahum sporotrichioides, Fusahum sulphureum, Fusahum torulosum, Fusahum trichothecioides, Fusahum venenatum, Humicola ghsea, Humicola insolens, Humicola lanuginosa, Irpex lacteus, Mucor miehei, Myceliophthora thermophila, Neurospora crassa, Penicillium funiculosum, Penicillium purpurogenum, Phanerochaete chrysosporium, Thielavia achromatica, Thielavia albomyces, Thielavia albopilosa, Thielavia australeinsis, Thielavia fimeti, Thielavia microspora, Thielavia ovispora, Thielavia peruviana, Thielavia setosa, Thielavia spededonium, Thielavia subthermophila, Thielavia terrestris, Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei, or Trichoderma viride lipase.
In another aspect, the parent is a Thermomyces lanuginosus lipase, e.g., the lipase of SEQ ID NO: 2.
It will be understood that for the aforementioned species, the invention encompasses both the perfect and imperfect states, and other taxonomic equivalents, e.g., anamorphs, regardless of the species name by which they are known. Those skilled in the art will readily recognize the identity of appropriate equivalents.
Strains of these species are readily accessible to the public in a number of culture collections, such as the American Type Culture Collection (ATCC), Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ), Centraalbureau Voor Schimmelcultures (CBS), and Agricultural Research Service Patent Culture Collection, Northern Regional Research Center (NRRL).
The parent may be identified and obtained from other sources including microorganisms isolated from nature (e.g., soil, composts, water, etc.) or DNA samples obtained directly from natural materials (e.g., soil, composts, water, etc.) using the above-mentioned probes. Techniques for isolating microorganisms and DNA directly from natural habitats are well known in the art. A polynucleotide encoding a parent may then be obtained by similarly screening a genomic DNA or cDNA library of another microorganism or mixed DNA sample. Once a polynucleotide encoding a parent has been detected with the probe(s), the polynucleotide can be isolated or cloned by utilizing techniques that are known to those of ordinary skill in the art (see, e.g., Sambrook et al., 1989, supra).
Preparation of Variants
The present invention also relates to methods for obtaining lipase variants comprising: (a) introducing substitutions at positions corresponding to T231 R+N233R and at least one or more (e.g., several) of D96E, D1 1 1A, D254S, G163K, P256T, G91T, G38A, D27R, and N33Q of SEQ ID NO: 2; (b) selecting the variant which has lipase activity and in comparison with the parent lipase has improved stability; and (c) recovering the variant.
The variants can be prepared using any mutagenesis procedure known in the art, such as site-directed mutagenesis, synthetic gene construction, semi-synthetic gene construction, random mutagenesis, shuffling, etc.
Site-directed mutagenesis is a technique in which one or more (e.g., several) mutations are introduced at one or more defined sites in a polynucleotide encoding the parent lipase.
Site-directed mutagenesis can be accomplished in vitro by PCR involving the use of oligonucleotide primers containing the desired mutation. Site-directed mutagenesis can also be performed in vitro by cassette mutagenesis involving the cleavage by a restriction enzyme at a site in the plasmid comprising a polynucleotide encoding the parent lipase and subsequent ligation of an oligonucleotide containing the mutation in the polynucleotide. Usually the restriction enzyme that digests the plasmid and the oligonucleotide is the same, permitting sticky ends of the plasmid and the insert to ligate to one another. See, e.g., Scherer and Davis, 1979, Proc. Natl. Acad. Sci. USA 76: 4949-4955; and Barton et al., 1990, Nucleic Acids Res. 18: 7349-4966.
Site-directed mutagenesis can also be accomplished in vivo by methods known in the art. See, e.g., US2004/0171 154; Storici et al., 2001 , Nature Biotechnol. 19: 773-776; Kren et al., 1998, Nat. Med. 4: 285-290; and Calissano and Macino, 1996, Fungal Genet. Newslett. 43: 15- 16.
Any site-directed mutagenesis procedure can be used in the present invention. There are many commercial kits available that can be used to prepare variants.
Synthetic gene construction entails in vitro synthesis of a designed polynucleotide molecule to encode a polypeptide of interest. Gene synthesis can be performed utilizing a number of techniques, such as the multiplex microchip-based technology described by Tian et al. (2004, Nature 432: 1050-1054) and similar technologies wherein oligonucleotides are synthesized and assembled upon photo-programmable microfluidic chips.
Single or multiple amino acid substitutions, deletions, and/or insertions can be made and tested using known methods of mutagenesis, recombination, and/or shuffling, followed by a relevant screening procedure, such as those disclosed by Reidhaar-Olson and Sauer, 1988, Science 241 : 53-57; Bowie and Sauer, 1989, Proc. Natl. Acad. Sci. USA 86: 2152-2156; W095/17413; or W095/22625. Other methods that can be used include error-prone PCR, phage display (e.g., Lowman et al., 1991 , Biochemistry 30: 10832-10837; U.S. Patent No. 5,223,409; WO 92/06204) and region-directed mutagenesis (Derbyshire et al., 1986, Gene 46: 145; Ner ei a/., 1988, DNA 7: 127).
Mutagenesis/shuffling methods can be combined with high-throughput, automated screening methods to detect activity of cloned, mutagenized polypeptides expressed by host cells (Ness et al., 1999, Nature Biotechnology 17: 893-896). Mutagenized DNA molecules that encode active polypeptides can be recovered from the host cells and rapidly sequenced using
standard methods in the art. These methods allow the rapid determination of the importance of individual amino acid residues in a polypeptide.
Semi-synthetic gene construction is accomplished by combining aspects of synthetic gene construction, and/or site-directed mutagenesis, and/or random mutagenesis, and/or shuffling. Semi-synthetic construction is typified by a process utilizing polynucleotide fragments that are synthesized, in combination with PCR techniques. Defined regions of genes may thus be synthesized de novo, while other regions may be amplified using site-specific mutagenic primers, while yet other regions may be subjected to error-prone PCR or non-error prone PCR amplification. Polynucleotide subsequences may then be shuffled.
In one embodiment of the invention, the lipase is a lipase variant, comprising a substitution at one or more positions corresponding to positions T37A,D,E,F,G,H,I,L,N,P,Q,R,S,V,W,Y, N39A,C,D,E,F,G,I,K,L,M,P,Q,R,T,V,W,Y, and G91 D,H,I,P,Q of the mature polypeptide of SEQ ID NO: 4 , wherein the variant has lipase activity.
The variant of a parent lipase can be selected from the group consisting of:
a) a polypeptide having at least 60% sequence identity to the mature polypeptide of SEQ ID NO: 4;
b) a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 3, or (ii) the full-length complement of (i);
c) a polypeptide encoded by a polynucleotide having at least 60 % identity to the mature polypeptide coding sequence of SEQ ID NO: 3; and
d) a fragment of the mature polypeptide of SEQ ID NO: 4, which has lipase activity. In one embodiment of the invention, the lipase variant has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100%, sequence identity to the amino acid sequence of the parent lipase. The number of substitutions in the lipase variant is 1 -20, e.g., 1 -10 and 1 -5, such as 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20 substitutions. The lipase variant may comprises a substitution at one or more positions corresponding to positions D96, T143, A150, E210, G225, T231 , N233 and
P250. In one embodiment the substitution is selected from D96G, T143A, A150G, E210Q, G225R, T231 R, N233R and P250R.
In one embodiment of the invention, the lipase variant is:
a) G91 Q +T143A +E210Q +T231 R +N233R +P250R;
b) G91 Q +A150G +E210Q +T231 R +N233R +P250R;
c) T37R +N39R +G91A +D96G +T231 R +N233R;
d) G91 Q +E210Q +T231 R +N233R +P250R; or
e) G91 1 +E210Q +T231 R +N233R +P250R;
In one embodiment of the invention, the lipase variant is:
a) G91A +D96G +T231 R +N233R;
b) G91A +D96G +G225R +T231 R +N233R;
c) G91 N +E21 OQ +T231 R +N233R +P250R;
d) G91 L +E210Q +T231 R +N233R; or
e) G91A +D96G +A150G +T231 R +N233R.
The parent lipase may be (a) a polypeptide having at least 60% sequence identity to the mature polypeptide of SEQ ID NO: 4; (b) a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 3, or (ii) the full-length complement of (i); or (c) a polypeptide encoded by a polynucleotide having at least 60% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 3.
In an aspect, the parent has a sequence identity to the mature polypeptide of SEQ ID NO: 4 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least
85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%, which have lipase activity. In one aspect, the amino acid sequence of the parent differs by no more than 20 amino acids, e.g., 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, or 20 from the mature polypeptide of SEQ ID NO: 4.
In another aspect, the parent comprises or consists of the amino acid sequence of SEQ ID NO: 4. In another aspect, the parent comprises or consists of the mature polypeptide of SEQ I D NO: 4. In another aspect, the parent comprises or consists of amino acids 1 to 269 of SEQ ID NO: 4.
In another aspect, the parent is a fragment of the mature polypeptide of SEQ ID NO: 4 containing at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, and at least 95% of the number of amino acids of the mature polypeptide.
In another embodiment, the parent is an allelic variant of the mature polypeptide of SEQ ID NO: 4.
In another aspect, the parent is encoded by a polynucleotide that hybridizes under very low stringency conditions, low stringency conditions, medium stringency conditions, medium-high stringency conditions, high stringency conditions, or very high stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 3, or (ii) the full- length complement of (i) (Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual,
2d edition, Cold Spring Harbor, New York).
The polynucleotide of SEQ ID NO: 3 or a subsequence thereof, as well as the polypeptide of SEQ ID NO: 4 or a fragment thereof, may be used to design nucleic acid probes to identify and clone DNA encoding a parent from strains of different genera or species according to methods well known in the art. In particular, such probes can be used for hybridization with the genomic DNA or cDNA of a cell of interest, following standard
Southern blotting procedures, in order to identify and isolate the corresponding gene therein. Such probes can be considerably shorter than the entire sequence, but should be at least 15, e.g., at least 25, at least 35, or at least 70 nucleotides in length. Preferably, the nucleic acid probe is at least 100 nucleotides in length, e.g., at least 200 nucleotides, at least 300 nucleotides, at least 400 nucleotides, at least 500 nucleotides, at least 600 nucleotides, at least 700 nucleotides, at least 800 nucleotides, or at least 900 nucleotides in length. Both DNA and RNA probes can be used. The probes are typically labeled for detecting the corresponding gene (for example, with 32P, 3H, 35S, biotin, or avidin). Such probes are encompassed by the present invention.
A genomic DNA or cDNA library prepared from such other strains may be screened for
DNA that hybridizes with the probes described above and encodes a parent. Genomic or other DNA from such other strains may be separated by agarose or polyacrylamide gel electrophoresis, or other separation techniques. DNA from the libraries or the separated DNA may be transferred to and immobilized on nitrocellulose or other suitable carrier material. In order to identify a clone or DNA that hybridizes with SEQ ID NO: 3 or a subsequence thereof, the carrier material is used in a Southern blot.
For purposes of the present invention, hybridization indicates that the polynucleotide hybridizes to a labeled nucleic acid probe corresponding to (i) SEQ ID NO: 3; (ii) the mature polypeptide coding sequence of SEQ ID NO: 3; (iii) the full-length complement thereof; or (iv) a subsequence thereof; under very low to very high stringency conditions. Molecules to which the nucleic acid probe hybridizes under these conditions can be detected using, for example, X ray film or any other detection means known in the art.
In one aspect, the nucleic acid probe is the mature polypeptide coding sequence of SEQ ID NO: 3. In another aspect, the nucleic acid probe is nucleotides 67 to 873 of SEQ ID NO: 3. In another aspect, the nucleic acid probe is a polynucleotide that encodes the polypeptide of SEQ ID NO: 4; the mature polypeptide thereof; or a fragment thereof. In another aspect, the nucleic acid probe is SEQ ID NO: 3.
In another embodiment, the parent is encoded by a polynucleotide having a sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 3 of at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91 %, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%.
The polypeptide may be a hybrid polypeptide in which a region of one polypeptide is fused at the N terminus or the C terminus of a region of another polypeptide.
The variants may be prepared as described in the paragraph "preparation of variants" beginning on page 25 of WO 2013/1 13622.
In one embodiment of the invention, the cellulase is comprised by the enzyme classification EC 3.2.1.4. The cellulase is of bacterial or fungal origin and can be chemically modified or protein engineered. The cellulase can be derived from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia or Acremonium. In one embodiment of the invention the cellulase is derived from Humicola insolens, Myceliophthora thermophila, Sporotrichum pulverulentum, Fusarium oxysporum, Trichoderma reesei, Thielavia terrestris,
, Acremonium sp., Acremonium sp. CBS 478.94, Macrophomina phaseolina CBS 281.96, Crinipellis scabella CBS 280.96, Volutella colletotrichoides or Sordaria fimicola ATCC 52644 or Bacillus SP-KSMS237.
In one embodiment of the invention, the cellulase is an enzyme exhibiting endo-beta- 1 ,4-glucanase activity (EC 3.2.1.4), which is selected from one of
a) a polypeptide encoded by the DNA sequence of positions 1 to 2322 of SEQ ID NO:5;
b) a polypeptide produced by culturing a cell comprising the sequence of SEQ ID NO:5 under conditions wherein the DNA sequence is expressed;
c) an endo-beta-1 ,4-glucanase enzyme having a sequence of at least 97% identity to the amino acid sequence of position 1 to position 773 of SEQ ID NO:6; or a fragment thereof that has endo-beta-1 ,4-glucanase activity, when identity is determined by GAP provided in the GCG program package using a GAP creation penalty of 3.0 and GAP extension penalty of 0.1 .
In one embodiment, the cellulase exhibiting endo-beta-1 ,4-glucanase activity (EC
3.2.1.4) has a polypeptide having endo-beta-1 ,4-glucanase activity that is encoded by a polynucleotide that hybridizes with the nucleotide sequence shown in positions 1 -2322 of SEQ ID NO:5 under hybridization conditions comprising 5 x SSC at 45°C and washing conditions comprising 2 x SC at 60°C. The cellulase may comprise a polypeptide endogeneous to Bacillus sp., DSM 12648. In one embodiment of the invention the cellulase is active at a pH at least in the range of 4-1 1 , preferably 5.5-10.5.
In one embodiment of the invention, an isolated polynucleotide will hybridize to similar sized regions of SEQ ID NO: 5 or a sequence complementary thereto, under at least medium stringency conditions.
In particular, polynucleotides will hybridize to a denatured double-stranded DNA probe comprising either the full sequence encoding the catalytic domain of the enzyme which sequence is shown in positions 1 -2322 of SEQ ID NO: 5 or any probe comprising a
subsequence of SEQ ID NO: 5 having a length of at least about 100 base pairs under at least medium stringency conditions, but preferably at high stringency conditions as described in detail below. Suitable experimental conditions for determining hybridization at medium, or high stringency between a nucleotide probe and a homologous DNA or RNA sequence involves presoaking of the filter containing the DNA fragments or RNA to hybridize in 5 x SSC (Sodium chloride/Sodium citrate, Sambrook et al. (1989) Molecular cloning: A laboratory manual, Cold Spring Harbor lab., Cold Spring Harbor, NY) for 10 min, and prehybridization of the filter in a solution of 5 x SSC, 5 x Denhardt's solution (Sambrook et al. 1989), 0.5 % SDS and 100 μg ml of denatured sonicated salmon sperm DNA (Sambrook et al. 1989), followed by hybridization in the same solution containing a concentration of 10ng/ml of a random-primed (Feinberg, A. P. and Vogelstein, B. (1983) Anal. Biochem. 132:6-13), 32P-dCTP-labeled (specific activity higher than 1 x 109 cpm/microgram) probe for 12 hours at about 45°C. The filter is then washed twice for 30 minutes in 2 x SSC, 0.5 % SDS at least 60°C (medium stringency), still more preferably at least 65°C (medium/high stringency), even more preferably at least 70°C (high stringency), and even more preferably at least 75°C (very high stringency).
Molecules to which the oligonucleotide probe hybridizes under these conditions are detected using an x-ray film.
As previously noted, the isolated polynucleotides of the present invention include DNA and RNA. Methods for isolating DNA and RNA are well known in the art. DNA and RNA encoding genes of interest can be cloned in Gene Banks or DNA libraries by means of methods known in the art.
Polynucleotides encoding polypeptides having endo-glucanase activity of the invention are then identified and isolated by, for example, hybridization or PCR.
The present invention further provides counterpart polypeptides and polynucleotides from different bacterial strains (orthologs or paralogs). Of particular interest are endo- glucanase polypeptides from gram-positive alkalophilic strains, including species of Bacillus.
Species homologues of a polypeptide with endo-glucanase activity of the invention can be cloned using information and compositions provided by the present invention in combination with conventional cloning techniques. For example, a DNA sequence of the present invention can be cloned using chromosomal DNA obtained from a cell type that expresses the protein. Suitable sources of DNA can be identified by probing Northern blots with probes designed from the sequences disclosed herein. A library is then prepared from chromosomal DNA of a positive cell line. A DNA sequence of the invention encoding an polypeptide having endo-glucanase activity can then be isolated by a variety of methods, such as by probing with probes designed from the sequences disclosed in the present specification and claims or with one or more sets of degenerate probes based on the
disclosed sequences. A DNA sequence of the invention can also be cloned using the polymerase chain reaction, or PCR (Mullis, U.S. Patent 4,683,202), using primers designed from the sequences disclosed herein. Within an additional method, the DNA library can be used to transform or transfect host cells, and expression of the DNA of interest can be detected with an antibody (monoclonal or polyclonal) raised against the endo-glucanase cloned from B. sp., DSM 12648, expressed and purified as described in Materials and Methods and Examples 1 and 2 of WO 2002/099091 , or by an activity test relating to a polypeptide having endo-glucanase activity.
The endo-glucanase encoding part of the DNA sequence shown in SEQ ID NO:5 and/or an analogue DNA sequence of the invention may be cloned from a strain of the bacterial species Bacillus sp., preferably the strain DSM12648, producing the enzyme with endo-glucanase activity, or another or related organism as described herein.
How to use a sequence of the invention to get other related sequences: The disclosed sequence information herein relating to a polynucleotide sequence encoding an endo-beta- 1 ,4-glucanase of the invention can be used as a tool to identify other homologous endo- glucanases. For instance, polymerase chain reaction (PCR) can be used to amplify sequences encoding other homologous endo-glucanases from a variety of microbial sources, in particular of different Bacillus species.
The sequence of amino acids in position 1 to position 773 of SEQ ID NO:6 is a mature endo-glucanase sequence with a calculated molecular weight of 86 kDa. It is believed that positions 1 to about 340 of SEQ ID NO: 6 are the catalytically active domain of the of the present endo-glucanase enzyme. It is also believed that positions from about 340 to about 540 are the cellulose binding domain of the present endo-glucanase enzyme. The function of the remainder of the sequence, i.e., from about position 540 to position 773, is at present unknown.
The present invention provides an endo-glucanase enzyme comprising (i) the amino acid sequence of position 1 to position 773 of SEQ ID NO: 6, or a fragment thereof that has endo-glucanase activity.
A fragment of position 1 to position 773 of SEQ ID NO: 6 is a polypeptide, which have one or more amino acids deleted from the amino and/or carboxyl terminus of this amino acid sequence. In an embodiment the present invention provides an endo-glucanase enzyme comprising (ii) the amino acid sequence of positions 1 to about 340 of SEQ ID NO: 6, since it is contemplated that such a mono-domain endo-glucanase is also useful in the industrial applications described herein. In another embodiment the present invention provides an endo-glucanase enzyme comprising (iii) the amino acid sequence of positions 1 to from between about 540 and 773 of SEQ ID NO: 6, since it is contemplated that such an endo- glucanase comprising the catalytically active domain and the cellulose binding domain is
also useful in the industrial applications described herein. In a preferred embodiment such fragment is a polypeptide which consists of position 1 to position 663 ±50 amino acids, preferably 1 to 663 ± 25 amino acids.
The present invention also provides endo-glucanase polypeptides that are substantially homologous to the polypeptide of (i), (ii), or (iii) above and species homologs (paralogs or orthologs) thereof. The term "substantially homologous" is used herein to denote polypeptides being at least 97%, preferred 98%, more preferred 98.5% identical, and most preferably 99% or more identical to the sequence shown in amino acids nos. 1 -773 of SEQ ID NO: 6, or a fragment thereof that has endo-glucanase activity, or its orthologs or paralogs. Percent sequence identity is determined by conventional methods, by means of computer programs known in the art such as GAP provided in the GCG program package (Program Manual for the Wisconsin Package, Version 8, August 1994, Genetics Computer Group, 575 Science Drive, Madison, Wisconsin, USA 5371 1 ) as disclosed in Needleman, S.B. and Wunsch, CD., (1970), Journal of Molecular Biology, 48, 443-453, which is hereby incorporated by reference in its entirety. GAP is used with the following settings for polypeptide sequence comparison: GAP creation penalty of 3.0 and GAP extension penalty of 0.1 .
Sequence identity of polynucleotide molecules is determined by similar methods using GAP with the following settings for DNA sequence comparison: GAP creation penalty of 5.0 and GAP extension penalty of 0.3.
Substantially homologous proteins and polypeptides are characterized as having one or more amino acid substitutions, deletions or additions. These changes are preferably of a minor nature, that is conservative amino acid substitutions (see Table 1 ) and other substitutions that do not significantly affect the folding or activity of the protein or polypeptide; small deletions, typically of one to about 30 amino acids; and small amino- or carboxyl-terminal extensions, such as an amino-terminal methionine residue, a small linker peptide of up to about 20-25 residues, or a small extension that facilitates purification (an affinity tag), such as a poly-histidine tract, protein A (Nilsson et al., EMBO J. 4:1075, 1985; Nilsson et al., Methods Enzymol. 198:3, 1991. See, in general Ford et al., Protein Expression and Purification 2: 95-107, 1991 , which is incorporated herein by reference.
DNAs encoding affinity tags are available from commercial suppliers (e.g., Pharmacia Biotech, Piscataway, NJ; New England Biolabs, Beverly, MA).
However, even though the changes described above preferably are of a minor nature, such changes may also be of a larger nature such as fusion of larger polypeptides of up to 300 amino acids or more both as amino- or carboxyl-terminal extensions to a polypeptide of the invention having endo-glucanase activity.
Table 1
Conservative amino acid substitutions
Basic: arginine
lysine
histidine
Acidic: glutamic acid
aspartic acid
Polar: glutamine
asparagine
Hydrophobic: leucine
isoleucine
valine
Aromatic: phenylalanine
tryptophan
tyrosine
Small: glycine
alanine
serine
threonine
methionine
In addition to the 20 standard amino acids, non-standard amino acids (such as 4- hydroxyproline, 6-N-methyl lysine, 2-aminoisobutyric acid, isovaline and a-methyl serine) may be substituted for amino acid residues of a polypeptide according to the invention. A limited number of non-conservative amino acids, amino acids that are not encoded by the genetic code, and unnatural amino acids may be substituted for amino acid residues. "Unnatural amino acids" have been modified after protein synthesis, and/or have a chemical structure in their side chain(s) different from that of the standard amino acids. Unnatural amino acids can be chemically synthesized, or preferably, are commercially available, and include pipecolic acid, thiazolidine carboxylic acid, dehydroproline, 3- and 4-methylproline, and 3,3-dimethylproline.
Essential amino acids in the endo-glucanase polypeptides of the present invention can be identified according to procedures known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (Cunningham and Wells, Science 244: 1081 -1085, 1989). In the latter technique, single alanine mutations are introduced at every residue in the molecule, and the resultant mutant molecules are tested for biological activity (i.e endo- glucanase activity) to identify amino acid residues that are critical to the activity of the
molecule. See also, Hilton et al., J. Biol. Chem. 271 :4699-4708, 1996. The active site of the enzyme or other biological interaction can also be determined by physical analysis of structure, as determined by such techniques as nuclear magnetic resonance, crystallography, electron diffraction or photoaffinity labeling, in conjunction with mutation of putative contact site amino acids. See, for example, de Vos et al., Science 255:306-312, 1992; Smith et al., J. Mol. Biol. 224:899-904, 1992; Wlodaver et al., FEBS Lett. 309:59-64, 1992. The identities of essential amino acids can also be inferred from analysis of homologies with polypeptides which are related to a polypeptide according to the invention.
Multiple amino acid substitutions can be made and tested using known methods of mutagenesis, recombination and/or shuffling followed by a relevant screening procedure, such as those disclosed by Reidhaar-Olson and Sauer (Science 241 :53-57, 1988), Bowie and Sauer (Proc. Natl. Acad. Sci. USA 86:2152-2156, 1989), W095/17413, or WO 95/22625. Briefly, these authors disclose methods for simultaneously randomizing two or more positions in a polypeptide, or recombination/shuffling of different mutations (WO 95/17413, WO 95/22625), followed by selecting for functional a polypeptide, and then sequencing the mutagenized polypeptides to determine the spectrum of allowable substitutions at each position. Other methods that can be used include phage display (e.g., Lowman et al., Biochem. 30:10832-10837, 1991 ; Ladner et al., U.S. Patent No. 5,223,409; Huse, WIPO Publication WO 92/06204) and region-directed mutagenesis (Derbyshire et al., Gene 46:145, 1986; Ner et al., DNA 7:127, 1988).
Mutagenesis/shuffling methods as disclosed above can be combined with high- throughput, automated screening methods to detect activity of cloned, mutagenized polypeptides in host cells. Mutagenized DNA molecules that encode active polypeptides can be recovered from the host cells and rapidly sequenced using modern equipment. These methods allow the rapid determination of the importance of individual amino acid residues in a polypeptide of interest, and can be applied to polypeptides of unknown structure.
Using the methods discussed above, one of ordinary skill in the art can identify and/or prepare a variety of polypeptides that are substantially homologous to the polypeptides of (I), (II), or (III) above and retain the endo-glucanase activity of the wild-type protein.
The endo-glucanase enzyme of the invention may, in addition to the enzyme core comprising the catalytically active domain, i.e. positions 1 -about 340 of SEQ ID NO: 6, also comprise a cellulose binding domain (CBD), the cellulose binding domain and the catalytically active domain being operably linked. The cellulose binding domain (CBD) may exist as an integral part of the encoded enzyme as described above and in the appended SEQ ID NO:6, or be a CBD from another origin, introduced into the endo-glucanase thus creating an enzyme hybrid. In this context, the term "cellulose-binding domain" is intended to be understood as defined by Peter Tomme et al. "Cellulose-Binding Domains: Classification
and Properties" in "Enzymatic Degradation of Insoluble Carbohydrates", John N. Saddler and Michael H. Penner (Eds.), ACS Symposium Series, No. 618, 1996. This definition classifies more than 120 cellulose-binding domains into 10 families (l-X), and demonstrates that CBDs are found in various enzymes such as cellulases (endo-glucanases), xylanases, mannanases, arabinofuranosidases, acetyl esterases and chitinases. CBDs have also been found in algae, e.g. the red alga Porphyra purpurea as a non-hydrolytic polysaccharide- binding protein, see Tomme et al., op.cit. However, most of the CBDs are from cellulases and xylanases, CBDs are found at the N and C termini of proteins or are internal. Enzyme hybrids are known in the art, see e.g. WO 90/00609 and WO 95/16782, and may be prepared by transforming into a host cell a DNA construct comprising at least a fragment of DNA encoding the cellulose-binding domain ligated, with or without a linker, to a DNA sequence encoding the endo-glucanase and growing the host cell to express the fused gene. Enzyme hybrids may be described by the following formula:
CBD - MR - X
wherein CBD is the N-terminal or the C-terminal region of an amino acid sequence corresponding to at least the cellulose-binding domain; MR is the middle region (the linker), and may be a bond, or a short linking group preferably of from about 2 to about 100 carbon atoms, more preferably of from 2 to 40 carbon atoms; or is preferably from about 2 to about 100 amino acids, more preferably of from 2 to 40 amino acids; and X is an N-terminal or C- terminal region of a polypeptide corresponding at least to the catalytically active domain encoded by the DNA sequence of the invention.
In a similar way, the cellulose binding domain corresponding to from about position 340 to about position 540 of SEQ ID NO:6 can be used to form hybrids with endo-glucanases from sources other than Bacillus sp. AA349 and with other proteins. Examples of endo- glucanases from other sources replacing the endo-glucanase of positions 1 to about 340 of SEQ ID NO:6 include endo-glucanases from: (a) Bacillus lautus for instance Bacillus lautus NCIMB 40250 disclosed in W091 10732, (b) Humicola insolens DSM1800 disclosed in W091 17243 (c) Fusarium oxysporium DSM2672 disclosed in W091 17243 and (d) Bacillus sp. AC13 NCIMB 40482 disclosed in EP0651785. The enzymes can be prepared as described in WO 2002/099091 .
In one embodiment, the lipase and the cellulase is used together with further ingredients, such as hydrotropes, builders, co-builders, a bleaching systems, polymers, fabric hueing agents, mediators and/or enzymes. In one embodiment at least one additional enzyme is used. The further ingredients including the at least one additional enzyme may be comprised in a composition comprising the lipase and the cellulase. The additional enzyme may be selected from the group consisting of protease, lipase, cutinase, amylase,
carbohydrase, cellulase, pectate lyase, pectinase, mannanase, arabinase, galactanase, and/or xylanase.
The concentration of the lipase is in the range of 0.01 -1 ,0 % w/w enzyme per detergent composition, in the range of 0.02-1 .0% w/w enzyme per detergent composition, in the range of 0.03-0.9% w/w enzyme per detergent composition, in the range of 0.04-0.9% w/w enzyme per detergent composition, in the range of 0.05-0.9% w/w enzyme per detergent composition, in the range of 0.05-0.8% w/w enzyme per detergent composition, in the range of 0.05-0.7% w/w enzyme per detergent composition, in the range of 0.05-0.6% w/w enzyme per detergent composition, in the range of 0.05-0.5 % w/w enzyme per detergent composition or in the range of 0.05-0.2 % w/w enzyme per detergent composition. The lipase and the cellulase may be used for removing or releasing greasy stains at a temperature in the range of 0°C to 90°C, in the range of 0°C to 80°C, in the range of 0°C to 70°C, in the range of 0°C to 60°C, in the range of 0°C to 50°C, in the range of 0°C to 40°C, in the range of 0°C to 30°C, in the range of 5°C to 35°C, in the range of 10°C to 30°C, in the range of 15°C to 25°C or in the range of 15°C to 20°C.
The use of the lipase and a cellulase for removing or releasing greasy stains may result in a cellulase effect is at least 2 points, at least 2.2 points, at least 2.4 points, at least 2.6 points, at least 2.8 points, at least 3.0 points, at least 3.5 points, at least 4.0 points or at least 5.0 points. Or the use of the lipase and the cellulase for removing or releasing greasy stains may result in a synergy effect is at least 2 points, at least 2.2 points, at least 2.4 points, at least 2.6 points, at least 2.8 points, at least 3.0 points, at least 3.5 points, at least 4.0 points or at least 5.0 points.
In one embodiment of the invention, the lipase and the cellulase is used as a composition in the form of a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular, compact or concentrated liquid.
The composition comprises granules, which granules comprise a core and a protective coating, wherein:
a) the core comprises an enzyme, which is lipase and/or cellulase, and
b) the core or the coating comprises a reducing agent or a peroxide decomposing catalyst or an antioxidant, and
c) the core comprises a salt of a multivalent cation, and
d) the core or the coating comprises an acidic buffer component, and
e) the coating comprises a salt.
The core comprises the enzyme and the salt of a multivalent cation, and it may also comprise the reducing agent/antioxidant/peroxide decomposing catalyst and/or the acidic buffer component, typically as a homogenous blend. The blend may also include binders
(such as synthetic polymer, wax, fat, or carbohydrate). The blend may further include additional materials such as fillers, fibre materials (cellulose or synthetic fibres), stabilizing agents, solubilising agents, suspension agents, viscosity regulating agents, light spheres, plasticizers, salts, lubricants and fragrances.
The core can be prepared by granulating the blend, e.g. by use of granulation techniques including: crystallisation, precipitation, pan-coating, fluid bed coating, fluid bed agglomeration, rotary atomization, extrusion, prilling, spheronization, size reduction methods, drum granulation, and/or high shear granulation.
The core may consist of an inert particle with the blend absorbed into it, or with the blend applied on to the surface e.g. via fluid bed coating.
The core particle may have a diameter of 20-2000 μηη, particularly 50-1500 μηη, 100- 1500 m or 250-1200 μηι.
The composition comprises granules comprising lipase and granules comprising cellulase. In one embodiment of the invention the composition further comprises additional enzymes in the granules. The lipase, the cellulase and optionally additional enzymes are comprised in the same granule, or the composition may comprise granules, which comprises the lipase, the cellulase and optionally additional enzymes in separate granules.
The granules of the invention typically include between about 0.005 to about 500 mg/g on a dry weight basis of the enzyme component relative to the core (as active enzyme protein). For instance, the amount of enzyme in embodiments of the invention comprises about 0.05 to 300 mg/g, about 0.1 to 250 mg/g, about 0.5 to 200 mg/g, about 0.5 to 200 mg/g, about 1 .0 to 150 mg/g in the granule, or about 5.0 to 150 mg/g relative to the core.
In one embodiment of the invention, the acidic buffer component of the granule is present in an amount of 0.1 -10 % by weight relative to the core. The coating of the granule makes up 5-70 % by weight relative to the core and comprises at least 60% by weight w/w of a salt having a constant humidity at 20°C of at least 60%.
The granule contains a reducing agent, a peroxide decomposing catalyst and/or an antioxidant (a molecule capable of slowing or preventing the oxidation of other molecules) in the core and/or in the coating. Examples are sulfites, thiosulfates, erythorbates, ascorbates and nitrites, e.g. as salts of alkali metals and earth alkali metals. Other suitable materials are methionine, cysteine, propyl gallate, tert-butyl hydroquinone, tocopherols, thiodipropionic acid, butylated hydroxytoluene (BHT), butylated hydroxyanisol (BHA) or tannic acid.
Further suitable examples are transition metals as reducing agents and/or peroxide decomposing catalysts like e.g. V, Co, Mn and Fe, typically as salts, e.g. sulfate-, acetate-, nitrate or chloride- salts or oxides, e.g. FeS04, FeCI3, CoS04, MnS04 or Mn02. Water soluble salts of the transition metals are preferred. As peroxide decomposing catalysts also an enzyme can be used, e.g. catalase.
The amount of the antioxidant, peroxide decomposing catalyst or reducing agent may be at least 0.1 % by weight relative to the core, particularly at least 0.2 %, at least 0.5 %, at least
1 %, or at least 1 % The amount may be at most 10% by weight relative to the core, particularly at most 5%, at most 4 %, at most 3 % or at most 2 %. Here, the amount of a salt is calculated in anhydrous form. Peroxide decomposing catalysts can be efficient in even lower concentrations, e.g. at least 0.001 %, or at least 0.01 %; the amount may be at most 5 % or at most 1 %.
The granule contains a salt of a multivalent cation in the core, particularly a divalent or trivalent cation, e.g. a salt of Mg, Zn, Cu, Mn, Ca or Al. The salt may include an organic or inorganic anion such as sulfate, chloride or acetate. Particular salts include magnesium sulfate and zinc sulfate, e.g. magnesium sulfate heptahydrate.
The salt may be used in an amount of at least 0.1 % by weight of the core, particularly at least 0.5% by weight, e.g. at least 1 % by weight. The amount may be at most 15 %, 10 % or 5 %. The percentage indicates the amount of the salt in anhydrous form.
The multivalent cation may be used in an amount of at least 0.02% by weight of the core, particularly at least 0.1 % by weight, e.g. at least 0.2 % by weight. The amount may be at most 6 %, at most 4 % or at most 2 %. The percentage indicates the amount of the multivalent cation. Acidic buffer component
The granule contains an acidic buffer component (acidic buffering agent) in the core or the coating. The amount may be at least 0.1 by weight of the core, particularly at least 1 % by weight. The amount is typically at most 10% by weight of the core, particularly at most 5% by weight. The percentage indicates the amount in anhydrous form.
The acidic buffer component has a pH below 7 when measured as a 1 % by weight aqueous solution (or alternatively a 10% solution). The acidic buffer component may have a pH of 1 to below 7, e.g. a pH of 3 to below 7, particularly a pH of 4 to 5. The acidic buffer component is typically a mixture comprising a weak acid and the corresponding base; it is at least partly in its acid form
Furthermore, the acidic buffer component has a pKa from 2 to 9, in particular a pKa from 4 to 9, in particular a pKa from 5 to 8, in particular a pKa from 2 to 6, in particular a pKa from 2 to 5, in particular a pKa from 2 to 4, in particular a pKa from 5 to 7. To utilize most of the potential buffer capacity the pH of an aqueous solution is in general below the pKa.
Particularly suitable acidic buffer components are salts of H3P04 e.g. NaH2P04,
KH2P04, and Ca(H2P04)2, polyphosphates e.g. sodium hexametaphosphate, polyacrylic acid and partly neutralized polyacrylic acid and co-polymers thereof, simple organic acids (less than 10 carbon atoms e.g. 6 or less carbon atoms) such as citric acid and salts thereof such as hydrogen citrate, e.g. disodium hydrogen citrate, malonic, succinic, glutaric, adipic acid.
In a particular embodiment, the acidic buffer components are selected from the group consisting of polyacrylic acid and partly neutralized polyacrylic acid and co-polymers thereof, citric acid and Na3-citrate.
The granule comprises a core surrounded by at least one coating. The coating may comprise at least 60% by weight w/w of a salt, e.g. at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 99% by weight w/w.
The coating may be applied in an amount of at least 5 % by weight of the core, e.g. at least 10%, 10% or 15%. The amount may be at most 70 %, 50 %, 40 % or 30%.
To provide acceptable protection, the salt coating is preferably at least 1 μηη thick, particularly at least 2 μηη, at least 4 μηη or at least 8 μηη. The thicker the coating the more time consuming and expensive it gets to produce the granule. In a particular embodiment the thickness of the salt coating is below 100 μηη. In a more particular embodiment the thickness of the salt coating is below 60 μηη. In an even more particular embodiment the total thickness of the salt coating is below 40 μηη.
The coating should encapsulate the core unit by forming a substantially continuous layer. A substantially continuous layer is to be understood as a coating having few or no holes, so that the core unit it is encapsulating has few or none uncoated areas. The layer or coating should in particular be homogenous in thickness. The salt may be added from a salt solution where the salt is completely dissolved or from a salt suspension wherein the fine particles is less than 50 μηη, such as less than 10 μηη or less than 5 μηη.
The salt coating is especially effective if it is applied in a fluid bed under relatively high humidity conditions.
The reducing agent/antioxidant/peroxide decomposing catalyst may be part of the salt coating, either as a homogeneous part of the entire salt coating, or as part of this coating, e.g. only as an inner layer of salt and /antioxidant/peroxide decomposing catalyst. Using e.g. FeS04 as a reducing agent/peroxide decomposing catalyst may induce a color change as the metal is oxidized, which can be hidden by having the component as an inner layer.
The salt coating can further contain other materials as known in the art, e.g. fillers, anti- sticking agents, pigments, dyes, plasticizers and/or binders, such as titanium dioxide, kaolin, calcium carbonate or talc.
The salt coating may comprise a single salt or a mixture of two or more salts. The salt may be water soluble, in particular having a solubility at least 0.1 grams in 100 g of water at 20°C, preferably at least 0.5 g per 100 g water, e.g. at least 1 g per 100 g water, e.g. at least 5 g per 100 g water.
The salt may be an inorganic salt, e.g. salts of sulfate, sulfite, phosphate, phosphonate, nitrate, chloride or carbonate or salts of simple organic acids (less than 10 carbon atoms e.g. 6 or less carbon atoms) such as citrate, malonate or acetate. Examples of cations in these salts are alkali or earth alkali metal ions, the ammonium ion or metal ions of the first transition series, such as sodium, potassium, magnesium, calcium, zinc or aluminium. Examples of anions include chloride, bromide, iodide, sulfate, sulfite, bisulfite, thiosulfate, phosphate, monobasic phosphate, dibasic phosphate, hypophosphite, dihydrogen pyrophosphate, tetraborate, borate, carbonate, bicarbonate, metasilicate, citrate, malate,
maleate, malonate, succinate, lactate, formate, acetate, butyrate, propionate, benzoate, tartrate, ascorbate or gluconate. In particular alkali- or earth alkali metal salts of sulfate, sulfite, phosphate, phosphonate, nitrate, chloride or carbonate or salts of simple organic acids such as citrate, malonate or acetate may be used. Specific examples include NaH2P04, Na2HP04, Na3P04, (NH4)H2P04, K2HP04, KH2P04, Na2S04, K2S04, KHS04,
ZnS04, MgS04, CuS04, Mg(N03)2, (NH4)2S04, sodium borate, magnesium acetate and sodium citrate.
The salt may be in anhydrous form, or it may be a hydrated salt, i.e. a crystalline salt hydrate with bound water(s) of crystallization, such as described in WO 99/32595. Specific examples include anhydrous sodium sulfate (Na2S04), anhydrous magnesium sulfate (MgS04), magnesium sulfate heptahydrate (MgS04(7H20)), zinc sulfate heptahydrate (ZnS04(7H20)), sodium phosphate dibasic heptahydrate (Na2HP04(7H20)), magnesium nitrate hexahydrate (Mg(N03)2(6H20)), sodium borate decahydrate, sodium citrate dihydrate and magnesium acetate tetrahydrate.
The salt in the coating may have a constant humidity at 20°C above 60%, particularly above 70%, above 80% or above 85% by weight, or it may be another hydrate form of such a salt (e.g. anhydrate). The salt coating may be according to WO 00/01793, which is hereby incorporated by reference.
Specific examples of suitable salts are NaCI (CH20°c=76% by weight), Na2C03 (CH20°c=92% by weight), NaN03 (CH20°C=73% by weight), Na2HP04 (CH20°C=95% by weight), Na3P04 (CH25°C=92% by weight), NH4CI (CH20°C = 79.5% by weight), (NH4)2HP04 (CH20°c = 93,0% by weight), NH4H2P04 (CH20°C = 93.1 % by weight), (NH4)2S04 (CH20°c=81.1 % by weight), KCI (CH20°C=85% by weight), K2HP04 (CH20°C=92% by weight), KH2P04 (CH20°c=96.5% by weight), KN03 (CH20°C=93.5% by weight), Na2S04 (CH20°C=93% by weight), K2S04 (CH20°C=98% by weight), KHS04 (CH20°C=86% by weight), MgS04
(CH20°c=90% by weight), ZnS04 (CH20°C=90% by weight) and sodium citrate (CH25°C=86% by weight).
In a particular embodiment, the salt is selected from the group consisting of NaCI, Na2C03, NaN03, Na2HP04, Na3P04, NH4CI, (NH4)2HP04, NH4H2P04, (NH4)2S04, KCI, K2HP04, KH2P04, KN03, Na2S04, K2S04, KHS04, MgS04, ZnS04, NaCI and sodium citrate or mixtures thereof. In a more particular embodiment the salt is selected from the group consisting of NaCI, Na2C03, NaN03, Na2HP04, Na3P04, NH4CI, (NH4)2HP04, NH4H2P04, (NH4)2S04, KCI, K2HP04, KH2P04, KN03, Na2S04, K2S04, KHS04, NaCI and sodium citrate or mixtures thereof.
In a particular embodiment, the salt comprised in the coating of the granule is selected from the group consisting of NaCI, Na2C03, NaN03, Na2HP04, Na3P04, NH4CI, (NH4)2HP04, NH4H2P04, (NH4)2S04, KCI, K2HP04, KH2P04, KN03, Na2S04, K2S04, KHS04, MgS04, ZnS04, NaCI and sodium citrate or mixtures thereof.
Preferably the salt it applied as a solution of the salt e.g. using a fluid bed.
In one embodiment of the invention, the granule comprises:
a) an enzyme, which is lipase and/or cellulase,
b) the core comprises Na-thiosulfate or methionine in an amount of 0.5-5% by weight relative to the core,
c) the core comprises magnesium sulfate or zinc sulfate in an amount of 2-8% by weight of the core,
d) the core comprises a mixture of citric acid and a citrate in an amount of 1 -5% by weight relative to the core, and
e) the salt coating makes up 10-30% by weight relative to the core, and comprises at least 75% by weight sodium sulfate.
Optionally, the granule may include an additional coating on the outside of the salt coating, e.g. in an amount of at least 0.5% by weight of the core, particularly at least 1 %, e.g. at most 20 % or 10 %. The additional coating may comprise polyethylene glycol (PEG), hydroxypropyl methyl cellulose (HPMC or MHPC), polyvinyl alcohol (PVA) or other film forming agents and can further contain fillers, antisticking agents, pigment, dye, plasticizers etc. Other additional coatings on the inside or outside of the salt coatings may be applied as known for people skilled in the art.
The lipase and the cellulase may be used for removing or releasing greasy stains in laundry, dishwashing, e.g. ADW, for hard surface cleaning or as a personal care cleaning product.
Surfactants
The detergent composition may comprise one or more surfactants, which may be anionic and/or cationic and/or non-ionic and/or semi-polar and/or zwitterionic, or a mixture thereof. In a particular embodiment, the detergent composition includes a mixture of one or more nonionic surfactants and one or more anionic surfactants. The surfactant(s) is typically present at a level of from about 0.1 % to 60% by weight, such as about 1 % to about 40%, or about 3% to about 20%, or about 3% to about 10%. The surfactant(s) is chosen based on the desired cleaning application, and may include any conventional surfactant(s) known in the art.
When included therein the detergent will usually contain from about 1 % to about 40% by weight of an anionic surfactant, such as from about 5% to about 30%, including from about 5% to about 15%, or from about 15% to about 20%, or from about 20% to about 25% of an anionic surfactant. Non-limiting examples of anionic surfactants include sulfates and sulfonates, in particular, linear alkylbenzenesulfonat.es (LAS), isomers of LAS, branched alkylbenzenesulfonat.es (BABS), phenylalkanesulfonat.es, alpha-olefinsulfonates (AOS), olefin sulfonates, alkene sulfonates, alkane-2,3-diylbis(sulfates), hydroxyalkanesulfonat.es and disulfonates, alkyl sulfates (AS) such as sodium dodecyl sulfate (SDS), fatty alcohol sulfates (FAS), primary alcohol sulfates (PAS), alcohol ethersulfates (AES or AEOS or FES, also known as alcohol ethoxysulfates or fatty
alcohol ether sulfates), secondary alkanesulfonates (SAS), paraffin sulfonates (PS), ester sulfonates, sulfonated fatty acid glycerol esters, alpha-sulfo fatty acid methyl esters (alpha-SFMe or SES) including methyl ester sulfonate (MES), alkyl- or alkenylsuccinic acid, dodecenyl/tetradecenyl succinic acid (DTSA), fatty acid derivatives of amino acids, diesters and monoesters of sulfo-succinic acid or salt of fatty acids (soap), and combinations thereof.
When included therein the detergent will usually contain from about from about 1 % to about 40% by weigh of a cationic surfactant, for example from about 0.5% to about 30%, in particular from about 1 % to about 20%, from about 3% to about 10%, such as from about 3% to about 5%, from about 8% to about 12% or from about 10% to about 12%. Non-limiting examples of cationic surfactants include alkyldimethylethanolamine quat (ADMEAQ), cetyltrimethylammonium bromide (CTAB), dimethyldistearylammonium chloride (DSDMAC), and alkylbenzyldimethylammonium, alkyl quaternary ammonium compounds, alkoxylated quaternary ammonium (AQA) compounds, ester quats, and combinations thereof.
When included therein the detergent will usually contain from about 0.2% to about 40% by weight of a nonionic surfactant, for example from about 0.5% to about 30%, in particular from about 1 % to about 20%, from about 3% to about 10%, such as from about 3% to about 5%, from about 8% to about 12%, or from about 10% to about 12%. Non-limiting examples of nonionic surfactants include alcohol ethoxylates (AE or AEO), alcohol propoxylates, propoxylated fatty alcohols (PFA), alkoxylated fatty acid alkyl esters, such as ethoxylated and/or propoxylated fatty acid alkyl esters, alkylphenol ethoxylates (APE), nonylphenol ethoxylates (NPE), alkylpolyglycosides (APG), alkoxylated amines, fatty acid monoethanolamides (FAM), fatty acid diethanolamides (FADA), ethoxylated fatty acid monoethanolamides (EFAM), propoxylated fatty acid monoethanolamides (PFAM), polyhydroxyalkyl fatty acid amides, or /V-acyl /V-alkyl derivatives of glucosamine (glucamides, GA, or fatty acid glucamides, FAGA), as well as products available under the trade names SPAN and TWEEN, and combinations thereof.
Hydrotropes
A hydrotrope is a compound that solubilises hydrophobic compounds in aqueous solutions (or oppositely, polar substances in a non-polar environment). Typically, hydrotropes have both hydrophilic and a hydrophobic character (so-called amphiphilic properties as known from surfactants); however the molecular structure of hydrotropes generally do not favor spontaneous self-aggregation, see e.g. review by Hodgdon and Kaler (2007), Current Opinion in Colloid & Interface Science 12: 121 -128. Hydrotropes do not display a critical concentration above which self-aggregation occurs as found for surfactants and lipids forming miceller, lamellar or other well defined meso-phases. Instead, many hydrotropes show a continuous-type aggregation process where the sizes of aggregates grow as concentration increases. However, many hydrotropes alter the phase behavior, stability, and colloidal properties of systems
containing substances of polar and non-polar character, including mixtures of water, oil, surfactants, and polymers. Hydrotropes are classically used across industries from pharma, personal care, food, to technical applications. Use of hydrotropes in detergent compositions allow for example more concentrated formulations of surfactants (as in the process of compacting liquid detergents by removing water) without inducing undesired phenomena such as phase separation or high viscosity.
The detergent may contain 0-10% by weight, for example 0-5% by weight, such as about 0.5 to about 5%, or about 3% to about 5%, of a hydrotrope. Any hydrotrope known in the art for use in detergents may be utilized. Non-limiting examples of hydrotropes include sodium benzenesulfonate, sodium p-toluene sulfonate (STS), sodium xylene sulfonate (SXS), sodium cumene sulfonate (SCS), sodium cymene sulfonate, amine oxides, alcohols and polyglycolethers, sodium hydroxynaphthoate, sodium hydroxynaphthalene sulfonate, sodium ethylhexyl sulfate, and combinations thereof. Builders and Co-Builders
The detergent composition may contain about 0-65% by weight, such as about 5% to about 50% of a detergent builder or co-builder, or a mixture thereof. In a dish wash detergent, the level of builder is typically 40-65%, particularly 50-65%. The builder and/or co-builder may particularly be a chelating agent that forms water-soluble complexes with Ca and Mg. Any builder and/or co-builder known in the art for use in laundry detergents may be utilized. Non-limiting examples of builders include zeolites, diphosphates (pyrophosphates), triphosphates such as sodium triphosphate (STP or STPP), carbonates such as sodium carbonate, soluble silicates such as sodium metasilicate, layered silicates (e.g., SKS-6 from Hoechst), ethanolamines such as 2-aminoethan-1 -ol (MEA), diethanolamine (DEA, also known as 2,2'-iminodiethan-1 -ol), triethanolamine (TEA, also known as 2,2',2"-nitrilotriethan-1 -ol), and (carboxymethyl)inulin (CMI), and combinations thereof.
The detergent composition may also contain 0-50% by weight, such as about 5% to about 30%, of a detergent co-builder, or a mixture thereof. The detergent composition may include include a co-builder alone, or in combination with a builder, for example a zeolite builder. Non- limiting examples of co-builders include homopolymers of polyacrylates or copolymers thereof, such as poly(acrylic acid) (PAA) or copoly(acrylic acid/maleic acid) (PAA PMA). Further non- limiting examples include citrate, chelators such as aminocarboxylates, aminopolycarboxylates and phosphonates, and alkyl- or alkenylsuccinic acid. Additional specific examples include 2,2',2"- nitrilotriacetic acid (NTA), ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), iminodisuccinic acid (IDS), ethylenediamine-/V,/V'-disuccinic acid (EDDS), methylglycinediacetic acid (MGDA), glutamic acid-/V,/V-diacetic acid (GLDA), 1 -hydroxyethane-1 ,1 - diphosphonic acid (HEDP), ethylenediaminetetra(methylenephosphonic acid) (EDTMPA), diethylenetriaminepentakis(methylenephosphonic acid) (DTMPA or DTPMPA), N-(2-
hydroxyethyl)iminodiacetic acid (EDG), aspartic acid-/V-monoacetic acid (ASMA), aspartic acid- Λ/,/V-di acetic acid (ASDA), aspartic acid-/V-monopropionic acid (ASMP), iminodisuccinic acid (IDA), /V-(2-sulfomethyl)-aspartic acid (SMAS), /V-(2-sulfoethyl)-aspartic acid (SEAS), /V-(2-sulfomethyl)- glutamic acid (SMGL), /V-(2-sulfoethyl)-glutamic acid (SEGL), /V-methyliminodiacetic acid (Ml DA), a-alanine-/V,/V-diacetic acid (a-ALDA), serine-/V,/V-diacetic acid (SEDA), isoserine-/V,/V-diacetic acid (ISDA), phenylalanine-/V,/V-diacetic acid (PHDA), anthranilic acid-/V,/V-diacetic acid (ANDA), sulfanilic acid-/V,/V-diacetic acid (SLDA) , taurine-/V,/V-diacetic acid (TUDA) and sulfomethyl-/V,/V- diacetic acid (SMDA), /V-(2-hydroxyethyl)ethylenediamine-/V,/V',/V"-triacetic acid (HEDTA), diethanolglycine (DEG), diethylenetriamine penta(methylenephosphonic acid) (DTPMP), aminotris(methylenephosphonic acid) (ATMP), and combinations and salts thereof. Further exemplary builders and/or co-builders are described in, e.g., WO 09/102854, US 5977053
Bleaching Systems
The detergent may contain 0-50% of a bleaching system. Any bleaching system known in the art for use in laundry detergents may be utilized. Suitable bleaching system components include bleaching catalysts, photobleaches, bleach activators, sources of hydrogen peroxide such as sodium percarbonate, sodium perborates and hydrogen peroxide— urea (1 :1 ), preformed peracids and mixtures thereof. Suitable preformed peracids include, but are not limited to, peroxycarboxylic acids and salts, diperoxydicarboxylic acids, , perimidic acids and salts, peroxymonosulfuric acids and salts, for example, Oxone (R), and mixtures thereof. Non- limiting examples of bleaching systems include peroxide-based bleaching systems, which may comprise, for example, an inorganic salt, including alkali metal salts such as sodium salts of perborate (usually mono- or tetra-hydrate), percarbonate, persulfate, perphosphate, persilicate salts, in combination with a peracid-forming bleach activator. The term bleach activator is meant herein as a compound which reacts with hydrogen peroxide to form a peracid via perhydrolysis. The peracid thus formed constitutes the activated bleach. Suitable bleach activators to be used herein include those belonging to the class of esters, amides, imides or anhydrides. Suitable examples are tetraacetylethylenediamine (TAED), sodium 4-[(3,5,5- trimethylhexanoyl)oxy]benzene-1 -sulfonate (ISONOBS), 4-(dodecanoyloxy)benzene-1 -sulfonate (LOBS), 4-(decanoyloxy)benzene-1 -sulfonate, 4-(decanoyloxy)benzoate (DOBS or DOBA), 4- (nonanoyloxy)benzene-l -sulfonate (NOBS), and/or those disclosed in W098/17767. A particular family of bleach activators of interest was disclosed in EP624154 and particulary preferred in that family is acetyl triethyl citrate (ATC). ATC or a short chain triglyceride like triacetin has the advantage that it is environmentally friendly Furthermore acetyl triethyl citrate and triacetin have good hydrolytical stability in the product upon storage and are efficient bleach activators. Finally ATC is multifunctional, as the citrate released in the perhydrolysis reaction may function as a builder. Alternatively, the bleaching system may comprise peroxyacids of, for example, the amide,
imide, or sulfone type. The bleaching system may also comprise peracids such as 6- (phthalimido)peroxyhexanoic acid (PAP). The bleaching system may also include a bleach catalyst. In some embodiments the bleach component may be an organic catalyst selected from the group consisting of organic catalysts having the following formulae:
wherein each R1 is independently a branched alkyl group containing from 9 to 24 carbons or linear alkyl group containing from 1 1 to 24 carbons, preferably each R1 is independently a branched alkyl group containing from 9 to 18 carbons or linear alkyl group containing from 1 1 to 18 carbons, more preferably each R1 is independently selected from the group consisting of 2- propylheptyl, 2-butyloctyl, 2-pentylnonyl, 2-hexyldecyl, dodecyl, tetradecyl, hexadecyl, octadecyl, isononyl, isodecyl, isotridecyl and isopentadecyl. Other exemplary bleaching systems are described, e.g. in WO2007/087258, WO2007/087244, WO2007/087259, EP1867708 (Vitamin K) and WO2007/087242. Suitable photobleaches may for example be sulfonated zinc or aluminium phthalocyanines.
Polymers
The detergent may contain 0-10% by weight, such as 0.5-5%, 2-5%, 0.5-2% or 0.2-1 % of a polymer. Any polymer known in the art for use in detergents may be utilized. The polymer may function as a co-builder as mentioned above, or may provide antiredeposition, fiber protection, soil release, dye transfer inhibition, grease cleaning and/or anti-foaming properties. Some polymers may have more than one of the above-mentioned properties and/or more than one of the below-mentioned motifs. Exemplary polymers include (carboxymethyl)cellulose (CMC), polyvinyl alcohol) (PVA), poly(vinylpyrrolidone) (PVP), poly(ethyleneglycol) or poly(ethylene oxide) (PEG), ethoxylated poly(ethyleneimine), carboxymethyl inulin (CMI), and polycarboxylates such as PAA, PAA PMA, poly-aspartic acid, and lauryl methacrylate/acrylic acid copolymers , hydrophobically modified CMC (HM-CMC) and silicones, copolymers of terephthalic acid and oligomeric glycols, copolymers of poly(ethylene terephthalate) and poly(oxyethene terephthalate) (PET-POET), PVP, poly(vinylimidazole) (PVI), poly(vinylpyridine-/V-oxide) (PVPO or PVPNO) and polyvinylpyrrolidone-vinylimidazole (PVPVI). Further exemplary polymers include sulfonated polycarboxylates, polyethylene oxide and polypropylene oxide (PEO-PPO) and diquaternium ethoxy sulfate. Other exemplary polymers are disclosed in, e.g., WO 2006/130575. Salts of the above-mentioned polymers are also contemplated.
Fabric hueing agents
The detergent compositions of the present invention may also include fabric hueing agents such as dyes or pigments, which when formulated in detergent compositions can deposit onto a fabric when said fabric is contacted with a wash liquor comprising said detergent compositions and thus altering the tint of said fabric through absorption/reflection of visible light. Fluorescent whitening agents emit at least some visible light. In contrast, fabric hueing agents alter the tint of a surface as they absorb at least a portion of the visible light spectrum. Suitable fabric hueing agents include dyes and dye-clay conjugates, and may also include pigments. Suitable dyes include small molecule dyes and polymeric dyes. Suitable small molecule dyes include small molecule dyes selected from the group consisting of dyes falling into the Colour Index (C.I.) classifications of Direct Blue, Direct Red, Direct Violet, Acid Blue, Acid Red, Acid Violet, Basic Blue, Basic Violet and Basic Red, or mixtures thereof, for example as described in WO2005/03274, WO2005/03275, WO2005/03276 and EP1876226 (hereby incorporated by reference). The detergent composition preferably comprises from about 0.00003 wt% to about 0.2 wt%, from about 0.00008 wt% to about 0.05 wt%, or even from about 0.0001 wt% to about 0.04 wt% fabric hueing agent. The composition may comprise from 0.0001 wt% to 0.2 wt% fabric hueing agent, this may be especially preferred when the composition is in the form of a unit dose pouch. Suitable hueing agents are also disclosed in, e.g. WO 2007/087257 and WO2007/087243.
Additional enzymes
The detergent additive as well as the detergent composition may comprise one or more additional enzymes such as a protease, lipase, cutinase, an amylase, carbohydrase, cellulase, pectinase, mannanase, arabinase, galactanase, xylanase, oxidase, e.g., a laccase, and/or peroxidase.
In general, the properties of the selected enzyme(s) should be compatible with the selected detergent, (i.e., pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts.
Cellulases: Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g., the fungal cellulases produced from Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum disclosed in US 4,435,307, US 5,648,263, US 5,691 ,178, US 5,776,757 and WO 89/09259.
Especially suitable cellulases are the alkaline or neutral cellulases having colour care benefits. Examples of such cellulases are cellulases described in EP1350843, EP0495257,
EP0531372, W096/1 1262, W096/29397, WO98/08940, WO9634108 and WO9734005. Other examples are cellulase variants such as those described in WO94/07998, EP0531315, US 5457046, US 5686593, US 5763254, W095/24471 , WO98/12307 and PCT/DK98/00299.
Commercially available cellulases include Celluzyme™, and Carezyme™ (Novozymes A/S), Clazinase™, and Puradax HA™ (Genencor International Inc.), and KAC-500(B)™ (Kao Corporation).
Proteases: Suitable proteases include those of bacterial, fungal, plant, viral or animal origin e.g. vegetable or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included. It may be an alkaline protease, such as a serine protease or a metalloprotease. A serine protease may for example be of the S1 family, such as trypsin, or the S8 family such as subtilisin. A metalloproteases protease may for example be a thermolysin from e.g. family M4 or other metalloprotease such as those from M5, M7 or M8 families.
The term "subtilases" refers to a sub-group of serine protease according to Siezen et al., Protein Engng. 4 (1991 ) 719-737 and Siezen et al. Protein Science 6 (1997) 501 -523. Serine proteases are a subgroup of proteases characterized by having a serine in the active site, which forms a covalent adduct with the substrate. The subtilases may be divided into 6 sub-divisions, i.e. the Subtilisin family, the Thermitase family, the Proteinase K family, the Lantibiotic peptidase family, the Kexin family and the Pyrolysin family.
Examples of subtilases are those derived from Bacillus such as Bacillus lentus, B. alkalophilus, B. subtilis, B. amyloliquefaciens, Bacillus pumilus and Bacillus gibsonii described in; US7262042 and WO09/021867, and subtilisin lentus, subtilisin Novo, subtilisin Carlsberg, Bacillus licheniformis, subtilisin BPN', subtilisin 309, subtilisin 147 and subtilisin 168 described in WO89/06279 and protease PD138 described in (WO93/18140). Other useful proteases may be those described in W092/175177, WO01/016285, WO02/026024 and WO02/016547. Examples of trypsin-like proteases are trypsin (e.g. of porcine or bovine origin) and the Fusarium protease described in WO89/06270, W094/25583 and WO05/040372, and the chymotrypsin proteases derived from Cellumonas described in WO05/052161 and WO05/052146.
A further preferred protease is the alkaline protease from Bacillus lentus DSM 5483, as described for example in W095/23221 , and variants thereof which are described in WO92/21760, W095/23221 , EP1921 147 and EP1921 148.
Examples of metalloproteases are the neutral metalloprotease as described in WO07/044993 (Genencor Int.) such as those derived from Bacillus amyloliquefaciens.
Examples of useful proteases are the variants described in: W092/19729, WO96/034946, WO98/201 15, WO98/201 16, WO99/01 1768, WO01/44452, WO03/006602, WO04/03186, WO04/041979, WO07/006305, W01 1/036263, W01 1/036264, especially the variants with
substitutions in one or more of the following positions: 3, 4, 9, 15, 27, 36, 57, 68, 76, 87, 95, 96, 97, 98, 99, 100, 101 , 102, 103, 104, 106, 1 18, 120, 123, 128, 129, 130, 160, 167, 170, 194, 195, 199, 205, 206, 217, 218, 222, 224, 232, 235, 236, 245, 248, 252 and 274 using the BPN' numbering. More preferred the subtilase variants may comprise the mutations: S3T, V4I, S9R, A15T, K27R, *36D, V68A, N76D, N87S,R, *97E, A98S, S99G,D,A, S99AD, S101 G,M,R S103A, V104I,Y,N, S106A, G1 18V,R, H120D,N, N123S, S128L, P129Q, S130A, G160D, Y167A, R170S, A194P, G195E, V199M, V205I, L217D, N218D, M222S, A232V, K235L, Q236H, Q245R, N252K, T274A (using BPN' numbering).
Suitable commercially available protease enzymes include those sold under the trade names Alcalase®, DuralaseTm, DurazymTm, Relase®, Relase® Ultra, Savinase®, Savinase® Ultra, Primase®, Polarzyme®, Kannase®, Liquanase®, Liquanase® Ultra, Ovozyme®, Coronase®, Coronase® Ultra, Neutrase®, Everlase® and Esperase® (Novozymes A/S), those sold under the tradename Maxatase®, Maxacal®, Maxapem®, Purafect®, Purafect Prime®, PreferenzTm, Purafect MA®, Purafect Ox®, Purafect OxP®, Puramax®, Properase®, EffectenzTm, FN2®, FN3® , FN 4®, Excellase®, , Opticlean® and Optimase® (Danisco/DuPont), Axapem™ (Gist-Brocases N.V.), BLAP (sequence shown in Figure 29 of US5352604) and variants hereof (Henkel AG) and KAP (Bacillus alkalophilus subtilisin) from Kao.
Amylases:
Suitable amylases which can be used together with the cellulase and lipase of the invention may be an alpha-amylase or a glucoamylase and may be of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, alpha-amylases obtained from Bacillus, e.g., a special strain of Bacillus licheniformis, described in more detail in GB 1 ,296,839.
Suitable amylases include amylases having SEQ ID NO: 2 in WO 95/10603 or variants having 90% sequence identity to SEQ ID NO: 3 thereof. Preferred variants are described in WO 94/02597, WO 94/18314, WO 97/43424 and SEQ ID NO: 4 of WO 99/019467, such as variants with substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 178, 179, 181 , 188, 190, 197, 201 , 202, 207, 208, 209, 21 1 , 243, 264, 304, 305, 391 , 408, and 444.
Different suitable amylases include amylases having SEQ ID NO: 6 in WO 02/010355 or variants thereof having 90% sequence identity to SEQ ID NO: 6. Preferred variants of SEQ ID NO: 6 are those having a deletion in positions 181 and 182 and a substitution in position 193.
Other amylases which are suitable are hybrid alpha-amylase comprising residues 1 -33 of the alpha-amylase derived from B. amyloliquefaciens shown in SEQ ID NO: 6 of WO 2006/066594 and residues 36-483 of the B. licheniformis alpha-amylase shown in SEQ ID NO: 4 of WO 2006/066594 or variants having 90% sequence identity thereof. Preferred variants of this hybrid alpha-amylase are those having a substitution, a deletion or an insertion in one of
more of the following positions: G48, T49, G107, H156, A181 , N190, M197, 1201 , A209 and Q264. Most preferred variants of the hybrid alpha-amylase comprising residues 1 -33 of the alpha-amylase derived from B. amyloliquefaciens shown in SEQ ID NO: 6 of WO 2006/066594 and residues 36-483 of SEQ ID NO: 4 are those having the substitutions:
M197T;
H156Y+A181T+N190F+A209V+Q264S; or
G48A+T49I+G107A+H156Y+A181 T+N190F+I201 F+A209V+Q264S.
Further amylases which are suitable are amylases having SEQ ID NO: 6 in WO 99/019467 or variants thereof having 90% sequence identity to SEQ ID NO: 6. Preferred variants of SEQ ID NO: 6 are those having a substitution, a deletion or an insertion in one or more of the following positions: R181 , G182, H183, G184, N195, I206, E212, E216 and K269. Particularly preferred amylases are those having deletion in positions R181 and G182, or positions H183 and G184.
Additional amylases which can be used are those having SEQ ID NO: 1 , SEQ ID NO: 3, SEQ ID NO: 2 or SEQ ID NO: 7 of WO 96/023873 or variants thereof having 90% sequence identity to SEQ ID NO: 1 , SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 7. Preferred variants of SEQ ID NO: 1 , SEQ ID NO: 2, SEQ I D NO: 3 or SEQ ID NO: 7 are those having a substitution, a deletion or an insertion in one or more of the following positions: 140, 181 , 182, 183, 184, 195, 206, 212, 243, 260, 269, 304 and 476, using SEQ ID 2 of WO 96/023873 for numbering. More preferred variants are those having a deletion in two positions selected from 181 , 182, 183 and 184, such as 181 and 182, 182 and 183, or positions 183 and 184. Most preferred amylase variants of SEQ ID NO: 1 , SEQ ID NO: 2 or SEQ ID NO: 7 of WO 96/023873 are those having a deletion in positions 183 and 184 and a substitution in one or more of positions 140, 195, 206, 243, 260, 304 and 476.
Other amylases which can be used are amylases having SEQ ID NO: 2 of WO
08/153815, SEQ ID NO: 10 in WO 01/66712 or variants thereof having 90% sequence identity to SEQ ID NO: 2 of WO 08/153815 or 90% sequence identity to SEQ ID NO: 10 in WO 01/66712. Preferred variants of SEQ ID NO: 10 in WO 01/66712 are those having a substitution, a deletion or an insertion in one of more of the following positions: 176, 177, 178, 179, 190, 201 , 207, 21 1 and 264.
Further suitable amylases are amylases having SEQ ID NO: 2 of WO 09/061380 or variants having 90% sequence identity to SEQ ID NO: 2 thereof. Preferred variants of SEQ ID NO: 2 are those having a truncation of the C-terminus and/or a substitution, a deletion or an insertion in one of more of the following positions: Q87, Q98, S125, N128, T131 , T165, K178, R180, S181 , T182, G183, M201 , F202, N225, S243, N272, N282, Y305, R309, D319, Q320, Q359, K444 and G475. More preferred variants of SEQ ID NO: 2 are those having the substitution in one of more of the following positions: Q87E,R, Q98R, S125A, N128C, T131 I,
T165I, K178L, T182G, M201 L, F202Y, N225E,R, N272E,R, S243Q,A,E,D, Y305R, R309A, Q320R, Q359E, K444E and G475K and/or deletion in position R180 and/or S181 or of T182 and/or G183. Most preferred amylase variants of SEQ ID NO: 2 are those having the substitutions:
N128C+K178L+T182G+Y305R+G475K;
N 128C+K178L+T182G+F202Y+Y305R+D319T+G475K;
S125A+N128C+K178L+T182G+Y305R+G475K; or
S125A+N 128C+T131 I+T165I+K178L+T182G+Y305R+G475K wherein the variants are C-terminally truncated and optionally further comprises a substitution at position 243 and/or a deletion at position 180 and/or position 181 .
Other suitable amylases are the alpha-amylase having SEQ ID NO: 12 in WO01/66712 or a variant having at least 90% sequence identity to SEQ ID NO: 12. Preferred amylase variants are those having a substitution, a deletion or an insertion in one of more of the following positions of SEQ ID NO: 12 in WO01/66712: R28, R1 18, N174; R181 , G182, D183, G184, G186, W189, N195, M202, Y298, N299, K302, S303, N306, R310, N314; R320, H324, E345, Y396, R400, W439, R444, N445, K446, Q449, R458, N471 , N484. Particular preferred amylases include variants having a deletion of D183 and G184 and having the substitutions R1 18K, N195F, R320K and R458K, and a variant additionally having substitutions in one or more position selected from the group: M9, G149, G182, G186, M202, T257, Y295, N299, M323, E345 and A339, most preferred a variant that additionally has substitutions in all these positions.
Other examples are amylase variants such as those described in WO201 1/098531 , WO2013/001078 and WO2013/001087.
Commercially available amylases are Duramyl™, Termamyl™, Fungamyl™, Stainzyme ™, Stainzyme Plus™, Natalase™, Liquozyme X and BAN™ (from Novozymes A/S), and Rapidase™, Purastar™/Effectenz™, Powerase and Preferenz S100 (from Genencor International Inc./DuPont).
Peroxidases/Oxidases: Suitable peroxidases/oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus, e.g., from C. cinereus, and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257.
Commercially available peroxidases include Guardzyme™ (Novozymes A/S).
The detergent enzyme(s) may be included in a detergent composition by adding separate additives containing one or more enzymes, or by adding a combined additive comprising all of these enzymes. A detergent additive of the invention, i.e., a separate additive or a combined additive, can be formulated, for example, as a granulate, liquid, slurry, etc. Preferred detergent additive formulations are granulates, in particular non-dusting granulates, liquids, in particular
stabilized liquids, or slurries.
Non-dusting granulates may be produced, e.g. as disclosed in US 4,106,991 and 4,661 ,452 and may optionally be coated by methods known in the art. Examples of waxy coating materials are poly(ethylene oxide) products (polyethyleneglycol, PEG) with mean molar weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids. Examples of film-forming coating materials suitable for application by fluid bed techniques are given in GB 1483591. Liquid enzyme preparations may, for instance, be stabilized by adding a polyol such as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid according to established methods. Protected enzymes may be prepared according to the method disclosed in EP 238,216.
Adjunct materials
Any detergent components known in the art for use in laundry detergents may also be utilized. Other optional detergent components include anti-corrosion agents, anti-shrink agents, anti-soil redeposition agents, anti-wrinkling agents, bactericides, binders, corrosion inhibitors, disintegrants/disintegration agents, dyes, enzyme stabilizers (including boric acid, borates, CMC, and/or polyols such as propylene glycol), fabric conditioners including clays, fillers/processing aids, fluorescent whitening agents/optical brighteners, foam boosters, foam (suds) regulators, perfumes, soil-suspending agents, softeners, suds suppressors, tarnish inhibitors, and wicking agents, either alone or in combination. Any ingredient known in the art for use in laundry detergents may be utilized. The choice of such ingredients is well within the skill of the artisan.
Dispersants - The detergent compositions of the present invention can also contain dispersants. In particular powdered detergents may comprise dispersants. Suitable water-soluble organic materials include the homo- or co-polymeric acids or their salts, in which the polycarboxylic acid comprises at least two carboxyl radicals separated from each other by not more than two carbon atoms. Suitable dispersants are for example described in Powdered Detergents, Surfactant science series volume 71 , Marcel Dekker, Inc.
Dye Transfer Inhibiting Agents - The detergent compositions of the present invention may also include one or more dye transfer inhibiting agents. Suitable polymeric dye transfer inhibiting agents include, but are not limited to, polyvinylpyrrolidone polymers, polyamine /V-oxide polymers, copolymers of /V-vinylpyrrolidone and /V-vinylimidazole, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof. When present in a subject composition, the dye transfer
inhibiting agents may be present at levels from about 0.0001 % to about 10%, from about 0.01 % to about 5% or even from about 0.1 % to about 3% by weight of the composition.
Fluorescent whitening agent - The detergent compositions of the present invention will preferably also contain additional components that may tint articles being cleaned, such as fluorescent whitening agent or optical brighteners. Where present the brightener is preferably at a level of about 0.01 % to about 0.5%. Any fluorescent whitening agent suitable for use in a laundry detergent composition may be used in the composition of the present invention. The most commonly used fluorescent whitening agents are those belonging to the classes of diaminostilbene-sulfonic acid derivatives, diarylpyrazoline derivatives and bisphenyl-distyryl derivatives. Examples of the diaminostilbene-sulfonic acid derivative type of fluorescent whitening agents include the sodium salts of: 4,4'-bis-(2-diethanolamino-4-anilino-s-triazin-6- ylamino) stilbene-2,2'-disulfonate, 4,4'-bis-(2,4-dianilino-s-triazin-6-ylamino) stilbene-2.2'- disulfonate, 4,4'-bis-(2-anilino-4-(/V-methyl-/V-2-hydroxy-ethylamino)-s-triazin-6-ylamino) stilbene-2,2'-disulfonate, 4,4'-bis-(4-phenyl-1 ,2,3-triazol-2-yl)stilbene-2,2'-disulfonate and sodium 5-(2/-/-naphtho[1 ,2-c ][1 ,2,3]triazol-2-yl)-2-[(£)-2-phenylvinyl]benzenesulfonate. Preferred fluorescent whitening agents are Tinopal DMS and Tinopal CBS available from Ciba-Geigy AG, Basel, Switzerland. Tinopal DMS is the disodium salt of 4,4'-bis-(2-morpholino-4-anilino-s- triazin-6-ylamino) stilbene-2,2'-disulfonate. Tinopal CBS is the disodium salt of 2,2'-bis-(phenyl- styryl)-disulfonate. Also preferred are fluorescent whitening agents is the commercially available Parawhite KX, supplied by Paramount Minerals and Chemicals, Mumbai, India. Other fluorescers suitable for use in the invention include the 1 -3-diaryl pyrazolines and the 7- alkylaminocoumarins.
Suitable fluorescent brightener levels include lower levels of from about 0.01 , from 0.05, from about 0.1 or even from about 0.2 wt % to upper levels of 0.5 or even 0.75 wt%.
Soil release polymers - The detergent compositions of the present invention may also include one or more soil release polymers which aid the removal of soils from fabrics such as cotton and polyester based fabrics, in particular the removal of hydrophobic soils from polyester based fabrics. The soil release polymers may for example be nonionic or anionic terephthalte based polymers, polyvinyl caprolactam and related copolymers, vinyl graft copolymers, polyester polyamides see for example Chapter 7 in Powdered Detergents, Surfactant science series volume 71 , Marcel Dekker, Inc. Another type of soil release polymers are amphiphilic alkoxylated grease cleaning polymers comprising a core structure and a plurality of alkoxylate groups attached to that core structure. The core structure may comprise a polyalkylenimine structure or a polyalkanolamine structure as described in detail in WO 2009/087523 (hereby incorporated by reference). Furthermore random graft co-polymers are suitable soil release
polymers. Suitable graft co-polymers are described in more detail in WO 2007/138054, WO 2006/108856 and WO 2006/1 13314 (hereby incorporated by reference). Other soil release polymers are substituted polysaccharide structures especially substituted cellulosic structures such as modified cellulose deriviatives such as those described in EP 1867808 or WO 2003/040279 (both are hereby incorporated by reference). Suitable cellulosic polymers include cellulose, cellulose ethers, cellulose esters, cellulose amides and mixtures thereof. Suitable cellulosic polymers include anionically modified cellulose, nonionically modified cellulose, cationically modified cellulose, zwitterionically modified cellulose, and mixtures thereof. Suitable cellulosic polymers include methyl cellulose, carboxy methyl cellulose, ethyl cellulose, hydroxyl ethyl cellulose, hydroxyl propyl methyl cellulose, ester carboxy methyl cellulose, and mixtures thereof.
Anti-redeposition agents - The detergent compositions of the present invention may also include one or more anti-redeposition agents such as carboxymethylcellulose (CMC), polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP), polyoxyethylene and/or polyethyleneglycol (PEG), homopolymers of acrylic acid, copolymers of acrylic acid and maleic acid, and ethoxylated polyethyleneimines. The cellulose based polymers described under soil release polymers above may also function as anti-redeposition agents. Other suitable adjunct materials include, but are not limited to, anti-shrink agents, anti-wrinkling agents, bactericides, binders, carriers, dyes, enzyme stabilizers, fabric softeners, fillers, foam regulators, hydrotropes, perfumes, pigments, sod suppressors, solvents, and structurants for liquid detergents and/or structure elasticizing agents. Formulation of detergent products
The detergent composition of the invention may be in any convenient form, e.g., a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular, compact or concentrated liquid.
Detergent formulation forms: Layers (same or different phases), Pouches, versus forms for
Machine dosing unit.
Pouches can be configured as single or multicompartments. It can be of any form, shape and material which is suitable for hold the composition, e.g. without allowing the release of the composition to release of the composition from the pouch prior to water contact. The pouch is made from water soluble film which encloses an inner volume. Said inner volume can be divided into compartments of the pouch. Preferred films are polymeric materials preferably polymers which are formed into a film or sheet. Preferred polymers, copolymers or derivates thereof are selected
polyacrylates, and water soluble acrylate copolymers, methyl cellulose, carboxy methyl cellulose, sodium dextrin, ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, malto dextrin, poly methacrylates, most preferably polyvinyl alcohol copolymers and, hydroxypropyl methyl cellulose (HPMC). Preferably the level of polymer in the film for example PVA is at least about 60%. Preferred average molecular weight will typically be about 20,000 to about 150,000. Films can also be of blended compositions comprising hydrolytically degradable and water soluble polymer blends such as polylactide and polyvinyl alcohol (known under the Trade reference M8630 as sold by MonoSol LLC, Indiana, USA) plus plasticisers like glycerol, ethylene glycerol, propylene glycol, sorbitol and mixtures thereof. The pouches can comprise a solid laundry cleaning composition or part components and/or a liquid cleaning composition or part components separated by the water soluble film. The compartment for liquid components can be different in composition than compartments containing solids: US2009/001 1970 A1.
Detergent ingredients can be separated physically from each other by compartments in water dissolvable pouches or in different layers of tablets. Thereby negative storage interaction between components can be avoided. Different dissolution profiles of each of the compartments can also give rise to delayed dissolution of selected components in the wash solution.
Definition/characteristics of the forms :
A liquid or gel detergent , which is not unit dosed, may be aqueous, typically containing at least 20% by weight and up to 95% water, such as up to about 70% water, up to about 65% water, up to about 55% water, up to about 45% water, up to about 35% water. Other types of liquids, including without limitation, alkanols, amines, diols, ethers and polyols may be included in an aqueous liquid or gel. An aqueous liquid or gel detergent may contain from 0-30% organic solvent.
A liquid or gel detergent may be non-aqueous.
Laundry soap bars
The enzymes of the invention may be added to laundry soap bars and used for hand washing laundry, fabrics and/or textiles. The term laundry soap bar includes laundry bars, soap bars, combo bars, syndet bars and detergent bars. The types of bar usually differ in the type of surfactant they contain, and the term laundry soap bar includes those containing soaps from fatty acids and/or synthetic soaps. The laundry soap bar has a physical form which is solid and not a liquid, gel or a powder at room temperature. The term solid is defined as a physical form which does not significantly change over time, i.e. if a solid object (e.g. laundry soap bar) is placed inside a container, the solid object does not change to fill the container it is placed in. The bar is a solid typically in bar form but can be in other solid shapes such as round or oval.
The laundry soap bar may contain one or more additional enzymes, protease inhibitors such as peptide aldehydes (or hydrosulfite adduct or hemiacetal adduct), boric acid, borate, borax and/or phenylboronic acid derivatives such as 4-formylphenylboronic acid, one or more soaps or
synthetic surfactants, polyols such as glycerine, pH controlling compounds such as fatty acids, citric acid, acetic acid and/or formic acid, and/or a salt of a monovalent cation and an organic anion wherein the monovalent cation may be for example Na+, K+ or NH4 + and the organic anion may be for example formate, acetate, citrate or lactate such that the salt of a monovalent cation and an organic anion may be, for example, sodium formate.
The laundry soap bar may also contain complexing agents like EDTA and HEDP, perfumes and/or different type of fillers, surfactants e.g. anionic synthetic surfactants, builders, polymeric soil release agents, detergent chelators, stabilizing agents, fillers, dyes, colorants, dye transfer inhibitors, alkoxylated polycarbonates, suds suppressers, structurants, binders, leaching agents, bleaching activators, clay soil removal agents, anti-redeposition agents, polymeric dispersing agents, brighteners, fabric softeners, perfumes and/or other compounds known in the art.
The laundry soap bar may be processed in conventional laundry soap bar making equipment such as but not limited to: mixers, plodders, e.g a two stage vacuum plodder, extruders, cutters, logo-stampers, cooling tunnels and wrappers. The invention is not limited to preparing the laundry soap bars by any single method. The premix of the invention may be added to the soap at different stages of the process. For example, the premix containing a soap, lipase and cellulase, optionally one or more additional enzymes, a protease inhibitor, and a salt of a monovalent cation and an organic anion may be prepared and and the mixture is then plodded. The combination of lipase and cellulase and optional additional enzymes may be added at the same time as the protease inhibitor for example in liquid form. Besides the mixing step and the plodding step, the process may further comprise the steps of milling, extruding, cutting, stamping, cooling and/or wrapping.
Granular detergent formulations
A granular detergent may be formulated as described in WO09/092699, EP1705241 ,
EP1382668, WO07/001262, US6472364, WO04/074419 or WO09/102854. Other useful detergent formulations are described in WO09/124162, WO09/124163, WO09/1 17340, WO09/1 17341 , WO09/1 17342, WO09/072069, WO09/063355, WO09/132870, WO09/121757, WO09/1 12296, WO09/1 12298, WO09/103822, WO09/087033, WO09/050026, WO09/047125, WO09/047126, WO09/047127, WO09/047128, WO09/021784, WO09/010375, WO09/000605, WO09/122125, WO09/095645, WO09/040544, WO09/040545, WO09/024780, WO09/004295, WO09/004294, WO09/121725, WO09/1 15391 , WO09/1 15392, WO09/074398, WO09/074403, WO09/068501 , WO09/065770, WO09/021813, WO09/030632, and WO09/015951.
WO201 1025615, WO201 1016958, WO201 1005803, WO201 1005623, WO201 1005730, WO201 1005844, WO201 1005904, WO201 1005630, WO201 1005830, WO201 1005912, WO201 1005905, WO201 1005910, WO201 1005813, WO2010135238, WO2010120863, WO2010108002, WO20101 1 1365, WO2010108000, WO2010107635, WO2010090915, WO2010033976, WO2010033746, WO2010033747, WO2010033897,
WO2010033979, WO2010030540, WO2010030541 , WO2010030539, WO2010024467, WO2010024469, WO2010024470, WO2010025161 , WO2010014395, WO2010044905,
WO2010145887, WO2010142503, WO2010122051 , WO2010102861 ,
WO2010099997, WO2010084039, WO2010076292, WO2010069742, WO2010069718, WO2010069957, WO2010057784, WO2010054986, WO2010018043, WO2010003783, WO2010003792,
WO201 1023716, WO2010142539, WO20101 18959, WO20101 15813,
WO2010105942, WO2010105961 , WO2010105962, WO2010094356, WO2010084203,
WO2010078979, WO2010072456, WO2010069905, WO2010076165, WO2010072603, WO2010066486, WO2010066631 , WO2010066632, WO2010063689, WO2010060821 , WO2010049187, WO2010031607, WO2010000636,
Uses
The present invention includes a method for cleaning any surface including treating a textile or a hard surface or other surfaces in the field of fabric and/or home care. In one aspect of the invention, the method comprises the step of contacting the surface to be treated in a pre- treatment step or main wash step of a washing process, most preferably for use in a textile washing step or alternatively for use in dishwashing including both manual as well as automated/mechanical dishwashing. In one embodiment of the invention the lipase and cellulase and other components are added sequentially into the method for cleaning and/or treating the surface. Alternatively, the lipase and cellulase and other components are added simultaneously.
As used herein, washing includes but is not limited to, scrubbing, and mechanical agitation. Washing may be conducted with a foam composition as described in WO08/101958 and/or by applying alternating pressure (pressure/vaccum) as an addition or as an alternative to scrubbing and mechanical agitation. Drying of such surfaces or fabrics may be accomplished by any one of the common means employed either in domestic or industrial settings. The cleaning compositions of the present invention are ideally suited for use in laundry as well as dishwashing applications. Accordingly, the present invention includes a method for cleaning an object including but not limiting to fabric, tableware, cutlery and kitchenware. The method comprises the steps of contacting the object to be cleaned with a said cleaning composition comprising at least one embodiment of Applicants' cleaning composition, cleaning additive or mixture thereof. The fabric may comprise most any fabric capable of being laundered in normal consumer or institutional use conditions. The solution may have a pH from 8 to 10.5. The compositions may be employed at concentrations from 500 to 15.000ppm in solution. The water temperatures typically range from 5°C to 90°C. The water to fabric ratio is typically from 1 :1 to 30:1 .
Use in detergents
The lipase and cellulase may be added to and thus become a component of a detergent composition. The detergent composition of the present invention may be formulated, for example, as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre-treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use in general household hard surface cleaning operations, or be formulated for hand or machine dishwashing operations.
In a specific aspect, the present invention provides a detergent additive comprising a polypeptide of the present invention as described herein.
The invention is further summarized in the following paragraphs:
1 . Detergent composition for removing or releasing greasy stains, which composition comprises a surfactant, a lipase and a cellulase.
2. Composition according to paragraph 1 , wherein the lipase is of bacterial or fungal origin. 3. Composition according to any of the preceding paragraphs, wherein the lipase is chemically modified or protein engineered.
4. Composition according to any of the preceding paragraphs, wherein the lipase is derived from Thermomyces, e.g. from T. lanuginosus, cutinase from Humicola, e.g. H. insolens, strains of Pseudomonas, e.g. P. alcaligenes or P. pseudoalcaligenes, P. cepacia, P. sp. strain SD705, P. wisconsinensis, GDSL-type Streptomyces lipases, cutinase from
Magnaporthe grisea, cutinase from Pseudomonas mendocina, Thermobifida fusca, Geobacillus stearothermophilus, Bacillus subtilis, Streptomyces griseus and S. pristinaespiralis.
5. Composition according to any of the preceding paragraphs, wherein the lipase is a polypeptide having an amino acid sequence which:
a) has at least 90 % identity with tSEQ ID NO: 2
b) compared to said SEQ ID NO: 2, comprises a substitution of an electrically neutral or negatively charged amino acid at the surface of the three- dimensional structure within 15 A of E1 or Q249 with a positively charged amino acid; and
c) comprises a peptide addition at the C-terminal; and/or
d) meets the following limitations:
i. comprises a negative amino acid in position E210 of said SEQ ID NO:
2;comprises a negatively charged amino acid in the region corresponding to positions 90-101 of said SEQ ID NO: 2; and
ii. comprises a neutral or negative amino acid at a position corresponding to N94 of said SEQ ID NO: 2 and/or has a negative or neutral net electric
charge in the region corresponding to positions 90-101 of said SEQ ID NO: 2.
6. Composition according to paragraph 5, wherein the said substitution is within 10 A of E1 or Q249.
7. Composition according to any of paragraphs 5-6, wherein said substitution is within 15 A
(preferably 10 A) of E1 .
8. Composition according to any of paragraphs 5-7, wherein the lipase comprises 2-4 (preferably two) of said substitutions.
9. Composition according to any of paragraphs 5-8, wherein the lipase comprises a substitution of an electrically neutral or negatively charged amino acid within 10 A of E1 with R.
10. Composition according to any of paragraphs 5-9, wherein the lipase comprises a substitution of amino acid S3, S224, P229, T231 , N233, D234 or T244 with a positively charged amino acid, preferably R.
1 1 . Composition according to any of paragraphs 5-10, wherein the peptide addition consists of 1 -5 amino acids.
12. Composition according to any of paragraphs 5-1 1 , wherein the peptide addition consists of electrically neutral (preferably hydrophobic) amino acids, and is most preferably PGL or PG.
13. Composition according to any of paragraphs 5-12, wherein the peptide addition consists of neutral (preferably hydrophobic) amino acids and C, and the lipase further comprises substitution of an amino acid with C so as to form a disulfide bridge with the C of the peptide addition.
14. Composition according to any of paragraphs 5-13, wherein the lipase comprises amino acids with negative or unchanged electric charge in at least two of positions N94, D96 and E99 of said SEQ ID NO: 2.
15. Composition according to any of paragraphs 5-14, wherein the lipase comprises a substitution G91A, N94D/E/K/R, D96E/I/L/N/S/W, E99N/Q/K/R/H, N101 S, R209P/S or Q249R/K/H.
16. Composition according to any of paragraphs 5-15, wherein the lipase comprises one of the following sets of substitutions, optionally combined with Q249R/K H and/or K98X: a) G91 G/A/S/T + N94(neutral or negative) + D96D/E/C/Y + E99E/D/C/Y, b) G91 G/A/S/T + N94(neutral or negative) + D96D/E/C/Y + E99N + N101 S, c) G91 G/A/S/T + N94R/K/H + D96D/E/C/Y + E99E/D/C/Y,
d) G91 G/A/S/T + N94(neutral or negative) + D96(neutral or positive) + E99E/D/C/Y, or
e) G91 G/A/S/T + N94 (neutral or negative) + D96D/E/C/Y + E99(neutral or
positive).
Composition according to any of paragraphs 5-16, wherein the lipase comprises one of the following sets of substitutions, optionally combined with R209 (neutral or negative): a) E99R/K/H + Q249R/K/H,
b) N94R/K/H + Q249R/K/H, or
c) D96(neutral or positive) + Q249R/K/H.
Composition according to any of the preceding paragraphs, wherein the lipase is a variant of a parent lipase which variant has lipase activity, has at least 60% but less than 100% sequence identity with SEQ ID NO: 2, and comprises substitutions at positions corresponding to T231 R+N233R of SEQ ID NO: 2.
Composition according to any of the preceding paragraphs, wherein the lipase is a variant of a parent lipase which variant has lipase activity, has at least 60% but less than 100% sequence identity with SEQ ID NO: 2, and comprises substitutions at positions corresponding to D96E, D1 1 1A, D254S, G163K, P256T, G91T, G38A, D27R or N33Q of SEQ ID NO: 2.
Composition according to any of the preceding paragraphs, wherein said variant in comparison with the parent lipase has increased stability.
Composition according to any of the preceding paragraphs, wherein the stability is stability under storage conditions, protease stability, chemical stability, oxidation stability, pH stability, and/or thermostability.
Composition according to any of the preceding paragraphs, wherein the variant is selected from the group consisting of:
a. a polypeptide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% identity, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100%, sequence identity to
SEQ ID NO: 2;
b. a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions, medium stringency conditions, medium-high stringency conditions, high stringency conditions, or very high stringency conditions with (i) the polypeptide coding sequence of SEQ ID NO: 1 or (ii) the full-length complement of (i);
c. a polypeptide encoded by a polynucleotide having at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, but less than 100% sequence identity to SEQ ID NO: 1 ; and
d. a fragment of the polypeptide of SEQ ID NO: 2.
Composition according to any of the preceding paragraphs, wherein the lipase is a
variant having activity, has at least 60% but less than 100% sequence identity with SEQ ID NO: 2, and comprises substitutions at positions corresponding to T231R+N233R and at least one or more (e.g., several) of D96E, D111A, D254S, G163K, P256T, G91T, G38A, D27R, and N33Q of SEQ ID NO: 2 selected from the group of:
a) D96E T231R N233R;
b) N33Q D96E T231R N233R;
c) N33QT231R N233R;
d) N33Q D111AT231R N233R;
e) N33Q T231R N233R P256T;
f) N33QG38AG91TG163KT231RN233RD254S;
g) N33Q G38A G91T D96E D111 A G163K T231 R N233R D254S P256T;
h) D27R N33Q G38A D96E D111 A G163K T231 R N233R D254S P256T;
i) D27R N33Q G38AG91T D96E D111A G163K T231 R N233R P256T;
j) D27R N33Q G38A G91T D96E D111A G163K T231R N233R D254S;
k) D27RG38AG91TD96E D111AG163KT231RN233RD254SP256T;
I) D96E T231R N233R D254S;
m) T231R N233R D254S P256T;
n) G163KT231R N233R D254S;
o) D27R N33Q G38AG91T D96E G163K T231R N233R D254S P256T;
p) D27R G91T D96E D111 A G163K T231 R N233R D254S P256T;
q) D96E G163KT231R N233R D254S;
r) D27R G163KT231R N233R D254S;
s) D27R G38AG91T D96E D111A G163K T231 R N233R D254S;
t) D27R G38AG91T D96E G163K T231R N233R D254S P256T;
u) D27RG38AD96ED111AG163KT231RN233RD254S P256T:
v) D27R D96E G163K T231R N233R D254S;
w) D27R D96E D111 A G163K T231R N233R D254S P256T;
x) D27R G38A D96E G163K T231 R N233R D254S P256T.
Composition according to any of the preceding paragraphs, wherein the lipase is a lipase variant, comprising a substitution at one or more positions corresponding to positions T37A,D,E,F,G,H,I,L,N,P,Q,R,S,V,W,Y, N39A,C,D,E,F,G,I,K,L,M,P,Q,R,T,V,W,Y, and G91 D,H,I,P,Q of the mature polypeptide of SEQ ID NO: 4 , wherein the variant has lipase activity.
Composition according to any of paragraphs 1-4 and 23, which is a variant of a parent lipase selected from the group consisting of:
e) a polypeptide having at least 60% sequence identity to the mature polypeptide of SEQ ID NO: 4;
f) a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 3, or (ii) the full-length complement of (i);
g) a polypeptide encoded by a polynucleotide having at least 60 % identity to the mature polypeptide coding sequence of SEQ ID NO: 3; and
h) a fragment of the mature polypeptide of SEQ ID NO: 4, which has lipase activity.
26. Composition according to any of the preceding paragraphs, wherein the lipase variant has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100%, sequence identity to the amino acid sequence of the parent lipase.
27. Composition according to any of the preceding paragraphs, wherein the number of substitutions in the lipase variant is 1 -20, e.g., 1 -10 and 1 -5, such as 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20 substitutions.
28. Composition according to any of the preceding paragraphs, wherein the lipase variant further comprises a substitution at one or more positions corresponding to positions D96,
T143, A150, E210, G225, T231 , N233 and P250.
29. Composition according to any of the preceding paragraphs, wherein the substitution is selected from D96G, T143A, A150G, E210Q, G225R, T231 R, N233R and P250R.
30. Composition according to any of the preceding paragraphs, wherein said variant is: f) G91 Q +T143A +E210Q +T231 R +N233R +P250R;
g) G91 Q +A150G +E210Q +T231 R +N233R +P250R;
h) T37R +N39R +G91A +D96G +T231 R +N233R;
i) G91 Q +E210Q +T231 R +N233R +P250R; or
j) G91 1 +E210Q +T231 R +N233R +P250R;
31 . Composition according to any of the preceding paragraphs, wherein said variant is: f) G91A +D96G +T231 R +N233R;
g) G91A +D96G +G225R +T231 R +N233R;
h) G91 N +E210Q +T231 R +N233R +P250R;
i) G91 L +E210Q +T231 R +N233R; or
j) G91A +D96G +A150G +T231 R +N233R.
32. Composition according to any of the preceding paragraphs, wherein the cellulase is comprised by the enzyme classification EC 3.2.1 .4.
33. Composition according to any of the preceding paragraphs, wherein the cellulase is of bacterial or fungal origin.
34. Composition according to any of the preceding paragraphs, wherein the cellulase is chemically modified or protein engineered.
35. Composition according to any of the preceding paragraphs, wherein the cellulase is
derived from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia or Acremonium.
Composition according to any of the preceding paragraphs, wherein the cellulase is derived from Humicola insolens, Myceliophthora thermophila, Sporotrichum pulverulentum, Fusarium oxysporum, Trichoderma reesei, Thielavia terrestris, ,
Acremonium sp., Acremonium sp. CBS 478.94, Macrophomina phaseolina CBS 281.96, Crinipellis scabella CBS 280.96, Volutella colletotrichoides or Sordaria fimicola ATCC 52644 or Bacillus SP-KSMS237.
Composition according to any of the preceding paragraphs, wherein the cellulase is an enzyme exhibiting endo-beta-1 ,4-glucanase activity (EC 3.2.1.4), which is selected from one of
a) a polypeptide encoded by the DNA sequence of positions 1 to 2322 of SEQ ID NO:5;
b) a polypeptide produced by culturing a cell comprising the sequence of SEQ ID NO:5 under conditions wherein the DNA sequence is expressed;
c) an endo-beta-1 ,4-glucanase enzyme having a sequence of at least 97% identity to the amino acid sequence of position 1 to position 773 of SEQ ID NO:6; or a fragment thereof that has endo-beta-1 ,4-glucanase activity, when identity is determined by GAP provided in the GCG program package using a GAP creation penalty of 3.0 and GAP extension penalty of 0.1.
Composition according to any of the preceding paragraphs, wherein the cellulase exhibiting endo-beta-1 ,4-glucanase activity (EC 3.2.1 .4) has a polypeptide having endo- beta-1 ,4-glucanase activity that is encoded by a polynucleotide that hybridizes with the nucleotide sequence shown in positions 1 -2322 of SEQ ID NO:5 under hybridization conditions comprising 5 x SSC at 45°C and washing conditions comprising 2 x SC at
60°C.
Composition according to any of the preceding paragraphs, wherein the cellulase comprises a polypeptide endogeneous to Bacillus sp., DSM 12648.
Composition according to any of the preceding paragraphs, wherein the cellulase is active at a pH at least in the range of 4-1 1 , preferably 5.5-10.5.
Composition according to any of the preceding paragraphs, wherein the composition further comprises: hydrotropes, builders, co-builders, a bleaching systems, polymers, fabric hueing agents, mediators and/or enzymes.
Composition according to any of the preceding paragraphs, wherein composition comprises at least one additional enzyme.
Composition according to any of the preceding paragraphs, wherein the additional enzyme is selected from the group consisting of protease, lipase, cutinase, amylase,
carbohydrase, cellulase, pectate lyase, pectinase, mannanase, arabinase, galactanase, and/or xylanase.
44. Composition according to any of the preceding paragraphs, wherein the concentration of the lipase is in the range of 0.01 -1 ,0 % w/w enzyme per detergent composition, in the range of 0.02-1 .0% w/w enzyme per detergent composition, in the range of 0.03-0.9% w/w enzyme per detergent composition, in the range of 0.04-0.9% w/w enzyme per detergent composition, in the range of 0.05-0.9% w/w enzyme per detergent composition, in the range of 0.05-0.8% w/w enzyme per detergent composition, in the range of 0.05-0.7% w/w enzyme per detergent composition, in the range of 0.05-0.6% w/w enzyme per detergent composition, in the range of 0.05-0.5 % w/w enzyme per detergent composition or in the range of 0.05-0.2% w/w enzyme per detergent composition.
45. Composition according to any of the preceding composition paragraphs, wherein the concentration of the lipase is in the range of 0.05-0.15 % w/w enzyme per detergent composition.
46. Composition according to any of the preceding paragraphs, wherein the concentration of the cellulase is in the range of 0.01 -1 ,0 % w/w enzyme per detergent composition, in the range of 0.02-1 .0% w/w enzyme per detergent composition, in the range of 0.03-0.9% w/w enzyme per detergent composition, in the range of 0.04-0.9% w/w enzyme per detergent composition, in the range of 0.05-0.9% w/w enzyme per detergent composition, in the range of 0.05-0.8% w/w enzyme per detergent composition, in the range of 0.05-0.7% w/w enzyme per detergent composition, in the range of 0.05-0.6% w/w enzyme per detergent composition, in the range of 0.05-0.5 % w/w enzyme per detergent composition or in the range of 0.05-0.2 % w/w enzyme per detergent composition.
47. Composition according to any of the preceding paragraphs, wherein the composition is a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular, compact or concentrated liquid.
48. Composition according to any of the preceding paragraphs, wherein the composition comprises granules, which granules comprises a core and a protective coating, wherein: a. the core comprises an enzyme, which is lipase and/or cellulase, and
b. the core or the coating comprises a reducing agent or a peroxide decomposing catalyst or an antioxidant, and
c. the core comprises a salt of a multivalent cation, and
d. the core or the coating comprises an acidic buffer component, and
e. the coating comprises a salt.
49. Composition according to any of the preceding paragraphs, wherein the composition comprises granules comprising lipase and granules comprising cellulase.
50. Composition according to any of the preceding paragraphs, wherein the composition further comprises granules comprising additional enzymes.
51 . Composition according to any of paragraphs 1 to 26, wherein the composition comprises granules, wherein the lipase, the cellulase and optionally additional enzymes are comprised in the same granule.
52. Composition according to any of the preceding paragraphs, wherein the acidic buffer component of the granule is present in an amount of 0.1 -10 % by weight relative to the core.
53. Composition according to any of the preceding paragraphs, wherein the coating of the granule makes up 5-70 % by weight relative to the core and comprises at least 60% by weight w/w of a salt having a constant humidity at 20°C of at least 60%.
54. Composition according to any of the preceding paragraphs, wherein the reducing agent or peroxide decomposing catalyst of the granule is a thiosulfate, cysteine, methionine or a transition metal salt.
55. Composition according to any of the preceding paragraphs, wherein the reducing agent of the granule is present in an amount of 0.1 -10 % by weight relative to the core.
56. Composition according to any of the preceding paragraphs, wherein the salt of a multivalent cation of the granule is magnesium sulfate or zinc sulfate.
57. Composition according to any of the preceding paragraphs, wherein the salt of a multivalent cation of the granule is present in an amount of 0.1 -15% as anhydrous salt by weight of the core, or 0.02-6% as multivalent cation by weight of the core.
58. Composition according to any of the preceding paragraphs, wherein the acidic buffer component of the granule comprises a mixture of citric acid and a citrate.
59. Composition according to any of the preceding paragraphs, wherein the acidic buffer component of the granule is present in an amount of 1 -5% by weight relative to the core.
60. Composition according to any of the preceding paragraphs, wherein the salt in the coating of the granule has a constant humidity of at least 80% by weight.
61 . Composition according to any of the preceding paragraphs, wherein the coating of the granule comprises at least 75% by weight of the salt.
62. Composition according to any of the preceding paragraphs, wherein the salt coating of the granule comprises sodium sulfate.
63. Composition according to any of the preceding paragraphs, wherein the coating of the granule constitutes 10-30% by weight relative to the core.
64. Composition according to any of the preceding paragraphs, wherein the granule comprises:
a. an enzyme, which is lipase and/or cellulase,
b. the core comprises Na-thiosulfate or methionine in an amount of 0.5-5% by weight relative to the core,
c. the core comprises magnesium sulfate or zinc sulfate in an amount of 2-8% by weight of the core,
d. the core comprises a mixture of citric acid and a citrate in an amount of 1 -5% by weight relative to the core, and
e. the salt coating makes up 10-30% by weight relative to the core, and comprises at least 75% by weight sodium sulfate.
65. Composition according to any of the preceding paragraphs, where the granule further comprises an additional coating on the outside of the salt coating, wherein the additional coating comprises a film-forming agent, particularly polyethylene glycol, hydroxypropyl methyl cellulose (HPMC or MHPC), or polyvinyl alcohol (PVA).
66. Composition according to any of the preceding paragraphs, wherein the composition is a laundry cleaning composition, a dishwashing cleaning composition, a hard-surface cleaning composition and/or a personal care cleaning composition.
67. Use of a lipase and a cellulase for removing or releasing a greasy stain.
68. Use of a detergent composition according to any of paragraphs 1 -66 for removing or releasing a greasy stain
69. Use according to paragraph 68, wherein the greasy stain is removed or released from a textile having a greasy stain, from a dish having a greasy stain or from a hard surface having a greasy stain.
70. Use according to any of the preceding use paragraphs, wherein the stain comprises vegetable oil, animal fat, mineral oil or a combination thereof.
71 . Use according to any of the preceding use paragraphs, wherein the stain has a low- medium content of lipid.
72. Use according to any of the preceding use paragraphs, wherein the stain has a medium content of lipid.
73. Use according to any of the preceding use paragraphs, wherein the stain has a high content of lipid.
74. Use according to any of the preceding use paragraphs, wherein the textile comprises cotton and/or polyester.
75. Use according to any of the preceding use paragraphs, wherein the greasy stain is released or removed at a temperature in the range of 0°C to 90°C, in the range of 0°C to 80°C, in the range of 0°C to 70°C, in the range of 0°C to 60°C, in the range of 0°C to
50°C, in the range of 0°C to 40°C, in the range of 0°C to 30°C, in the range of 5°C to
35°C, in the range of 10°C to 30°C, in the range of 15°C to 25°C or in the range of 15°C to 20°C.
76. Use according to any of the preceding paragraphs, wherein the wash performance is increased.
77. Use according to any of the preceding paragraphs, wherein the cellulase effect is at least 2 points, at least 2.2 points, at least 2.4 points, at least 2.6 points, at least 2.8 points, at least 3.0 points, at least 3.5 points, at least 4.0 points or at least 5.0 points.
78. Use according to any of the preceding paragraphs, wherein the synergy effect is at least 2 points, at least 2.2 points, at least 2.4 points, at least 2.6 points, at least 2.8 points, at least 3.0 points, at least 3.5 points, at least 4.0 points or at least 5.0 points.
79. A method for removing or releasing greasy stains from an item having a greasy stain, which method comprises exposing the item to an aqueous solution of a lipase and a cellulase.
80. A method for removing or releasing greasy stains from an item having a greasy stain, which method comprises exposing the item to an aqueous solution of a detergent composition of paragraphs 1 -66.
81 . Method according to paragraph 80, wherein the item is a textile, a dish or a hard surface.
82. Method according to any of the preceding method paragraphs, wherein the stain comprises vegetable oil, animal fat or a mineral oil combination thereof.
83. Method according to any of paragraphs 79-82, wherein the stain comprises a particulate soil.
84. Method according to any of the preceding method paragraphs, wherein the stain has a low-medium content of lipid.
85. Method according to any of the preceding method paragraphs, wherein the stain has a medium content of lipid.
86. Method according to any of the preceding method paragraphs, wherein the stain has a high content of lipid.
87. Method according to any of the preceding method paragraphs, wherein the textile comprises cotton and/or polyester.
88. Method according to any of the preceding method paragraphs, wherein the greasy stain is released or removed at a temperature in the range of 0°C to 90°C, in the range of 0°C to 80°C, in the range of 0°C to 70°C, in the range of 0°C to 60°C, in the range of 0°C to 50°C, in the range of 0°C to 40°C, in the range of 0°C to 30°C, in the range of 5°C to 35°C, in the range of 10°C to 30°C, in the range of 15°C to 25°C or in the range of 15°C to 20°C.
89. Method according to any of the preceding paragraphs, wherein the item is soaked in an aqueous solution.
90. Method according to any of the preceding paragraphs, wherein the soaking step comprises exposing the item to the lipase and the cellulase.
91 . Method according to any of the preceding method paragraphs, wherein the item is rinsed after being exposed to the lipase and cellulase.
92. Method according to any of the preceding method paragraphs, wherein the item is rinsed with water optionally comprising a softener.
93. Item treated according to any of the preceding method paragraphs.
Examples
Full scale wash
This is the test method used to test the wash performance of enzymes e.g. proteases, amylases and lipases in full scale wash under EU conditions.
The test swatches and ballast are added to each wash together with detergent and enzyme. After wash, the test swatches are dried and the remission is measured on a MacBeth Color Eye spectrophotometer.
The enzymes are added on basis of weight percent of the detergent dosage in each wash,
Equipment used:
Washing machine: Miele Softtronic W2445
Water meters and automatically data collection system
MacBeth Color Eye spectrophotometer
Scanner-Epson Expression 10000XL
Color Vector software; ADT-AN-028
For the preparation and adjustment of water hardness the following ingredients are needed:
Calcium chloride (CaCI2 « 2H20)
Magnesium chloride (MgCL2 « 6H20)
· Sodium Hydrogen Carbonate (NaHC03)
The test swatches are commercial available ones. The most used suppliers are: CFT, EMPA, wfk and Equest. The same batch of stains is used in all washes in a trial. Different swatch sizes are used:
Commercial swatches cut into 4 x 9cm or equal to 36cm2 (standard)
Swatches at 10x10 cm and some with a circular spot e.g. the Equest swatches
The swatches are attached to t-towels by sewing or by a stapler; the same swatch types are placed on different towels or in different positions on the towel. Each swatch is marked individually for identification and to indicate the front side.
For lipase trials: The swatches are attached to T-towels in three corners. The bigger swatch should be floating around in the wash, unattached.
Ballast
The ballast consists of clean white cloth without optical whitener made of cotton, polyester or cotton/polyester. The composition of the ballast is a mix of different items at a cotton/polyester ratio of 65/35 based on weight. The ballast weight, dryness and item composition must be the same in each wash.
After each wash the ballast is inactivated in an industrial washer at 85°C/15 min or in a 95°C wash (EU machine) without detergent
Ballast Example: (Standard EU ballast composition, total 3kg)
· 3 T-shirts (100% cotton)
10 shirts, short sleeves (55% cotton 45% polyester)
4 pillow cases (35% cotton, 65% polyester), 1 10x75cm
1 small bed sheets, size 100x75cm (100% cotton)
3 Tea towels (100% cotton)
· Socks (80% cotton 20% polyester) as balance
Wash conditions
Information about stain/test fabric, number of swatches, detergent, detergent dosage, eventual inactivation of detergent, how to add detergent, enzyme, enzyme dosage, wash temperature, washing time, way of drying, treatment of swatches after termination of trial and information for data treatment if relevant are found in the Study Plan.
• Temperature: (20, 30, 40 or 60°C) is given in the Study Plan.
• Washing programme: Normal cotton wash without pre-wash: "Cottons".
• Water level 13-14L with "water plus"
· Water hardness: std. EU conditions: 15°dH, Ca2+/Mg2+/HC03 - ratio = 4:1 :7.5
• Enzyme dosage: given in study plan. Liquid enzymes: the enzyme amount is solubilised in 100 ml deionised water. Granulated enzymes: the enzyme is added directly or dissolved in deionised water before use; if dissolved, stir 10 min. on a magnetic stirrer. Detailed steps to carry out full scale wash trial
• Select wash program as in study plan.
• The detergent is placed in the wash drum in a "washing ball" (both liquid and powder detergents). Place them at the bottom.
• Place the ballast and test swatches in the wash drum.
• Put enzyme solution in a "washing ball" and place it carefully in the drum on the top of the ballast-make sure the enzyme stays in the ball until the water intake.
■ Note: enzyme should be added in 100ml deionised water before wash
• Start digital water meter
• Start the washer by pressing the knob START
• Measure pH after 20 min from the start. Open the front door and take out manually a small sample. There is 1 -1.5°C temperature increasing after the door is opened but no influence on wash program.
• After wash, take out all ballast and swatches, put swatches into drying room.
• After the wash is completed, the test swatches are removed from the T-towel and placed on the tray for drying, and make sure the swatches are dried in completely darkness, as many stains are sensitive to light.
Drying procedure
Drying room Put stains on tray or hang in line and dry at room temperature. The room has a de-humidifier working for 24h per day to keep the room dry
Measurement
The swatches are measured according to swatch/stain type
If Color Eye is used:
• Measure same swatch type in stacks on grey background
• Some lipase swatches at measured after 24 hours, precisely e.g.: CS-10 and DN-18 If Scanner is used (for greasy stains on blue textile):
· Place and scan 2 swatches at the same time
• Place swatch no. 1 approx. 5cm from edge
• Use the Color Vector program to transfer colours into numbers
Evaluation of stains
Wash performance is expressed as a remission value. After washing and rinsing the swatches were spread out flat and allowed to air dry at room temperature overnight. All washes are evaluated the day after the wash. Light reflectance evaluations of the swatches were done using a Macbeth Color Eye 7000 reflectance spectrophotometer with very small aperture. The measurements were made without UV in the incident light and remission at 460 nm was extracted. Measurements were made on unwashed and washed swatches. The test swatch to be measured was placed on top of another swatch of same type and colour (twin swatch). Two swatches of each kind were used per wash, therefore they are used together for measuring one on top of each other. With only one swatch of each kind per beaker, a swatch from a replicate
wash was used in this way. Remission values for individual swatches were calculated by subtracting the remission value of the unwashed swatch from the remission value of the washed swatch. The total wash performance for each stained swatch set was calculated as the sum of individual ARem.
Evaluation of the cellulase effect on greasy stains
A specific performance is seen with each formulation, which is obtained as described above. In order to evaluate the additional cellulase effect apart from the lipase effect the following calculation is made:
Cellulase effect = Rem Ceiiuiase+ii ase - Rem u ase
To calculate the combination and the synergy effect the following calculation is made: Combination effect = Rem yipase + Rem Ceiiuiase - Rem base
Synergy effectCeiiuiase + li ase = Rem ceiiuiase+npase - Combination effect
By "base" is meant the detergent composition without any enzymes.
The values that are below 2 points difference are classified as a medium effect while the cells with values above 2 are classified as strong effect. Example 1
The experimental conditions for the experiments are specified in Table 1 , Table 2 and Table 3 below.
Table 1 : Experimental conditions for full scale
Italian base 1 (powder) IT 75 0,2 0,1
German base 1 (powder) DE 65 0,2 0,1
Danish color base 2 (powder) DK 70 0,2 0,1
Spanish base 1 (powder) ES 60 0,2 0,1
English base is composed of: anionic surfactants (5-15%), oxygen-based bleaching agents (5-15%), zeolite (<5%), non-ionic surfactants (<5%), soap (<5%), polycarboxylates (<5%), phosphonates (<5%), optical brighteners (<5%), perfume (<5%).
Danish base 1 is composed of: sodium aluminum silicate, sodium carbonate, sodium sulphate, fatty alcohol ethoxylate-7, polycarboxylates, sodium tallow soap, sodium citrate, CMC, protease, methylene phosphonate, amylase and silicone.
Italian base 1 was analysed and found to be composed of: 3,46% LAS and 2,1 1 % soap plus other components such as builders and co-builders.
German base 1 (WFK ECE-2) base is composed of: 9,7% linear sodium alkyl benzene sulfonate, 5,2% ethoxylated fatty alcohol C12-18 (7 EO), 3,6% sodium soap, 4,5% foam inhibitor (silicone based), 1 1 ,8% sodium aluminium silicate (Zeolith 4A), 1 1 ,8% sodium carbonate, 5,2% sodium salt of a copolymer from acrylic and maleic acid, 3,4% sodium silicate, 1 ,3% carboxymethylcellulose (CMC), 0,8% diethylene triamine penta (methylene phosphonic acid, 9,8% sodium sulphate and 12,2% water.
The Danish color base 1 is composed of 10,5% anionic surfactants, 6% non-ionic surfactants, 52% builders, 12% filler and rest are additives such as perfume or dye trasfer inhibitors.
Spanish base 1 was analysed and found to be composed of: 10,82% LAS and 0.88% soap plus other components such as builders and co-builders.
The remaining compositions are standard commercial detergent compositions for laundering.
Table 3: Swatches with stains used
Producer Code Name Fat content
Equest 64BKC hamburger grease (blue textile)
Equest 125BKC Vegetable oil (blue textile)
Equest 71 BKC Lard (blue textile)
Equest 1 1 BKC Bacon grease (blue textile)
Equest 17BKC Beef dripping (blue textile)
WFK W20PF Pigment /veg. Fat >50%
WFK W10D Sebum w. pigment >50%
Equest 68KC Ice Cream chocolate- premium >15%
WFK W10LS Lipstick >80%
CFT C-H1 13 Lard + Sudan Red >90%
WFK W10PPM Pigment/vegt. oil/milk >20%
WFK W10B Oliveoil w. pigment >50%
Equest 132KC Cooked butter >80%
CFT C-S-62 Lard with colorant
CFT C-H126 Vegetable Oil/Violet Dye >90%
WFK W20D Pigment /Sebum >50%
Water hardness was adjusted by addition of CaCI2, MgCI2 and NaHC03 to the test system. After washing, the textiles were rinsed in a Miele washing machine using a rinse program (STIVN). The stained swatches are commercially available from CFT (Center for Testmaterials BV, AC Vlaardingen, the Netherlands) and Equest (Warwick Equest Ltd Consett, County Durham, UK). The ballast is commercially available from WFK (wfk Testgewebe GmbH, Christenfeld 10, D-41379 Brijggen, Germany).
The performance of the enzyme is evaluated by measuring the remission of the textile swatches using the ColorEye at 460 nm. The cellulase effect is shown in Table 4 below.
The underlined cells correspond to the stains where the effect was evident, meaning that the difference in the remission value between 2 textiles is higher than 2 points. For these remission values the human eye will be able to detect the difference. The values that are below 2 points difference are classified as a medium effect while the cells with values above 2 are classified as strong effect.
Table 4: CELLULASE EFFECT POWDER
dripping
WFK W20PF Pigmen 1 ,95 2,15 2,57 0,03 0,97 1 ,24
t /veg.
Fat
WFK W10D Sebum -0,20 1 ,00 1 ,16 -0,89 0,25 -0,27
w.
pigment
Equest 68KC Ice 2,99 -0,34 -2,67 6,61 -0,30 8,80
Cream
(chocol
ate) - premiu
m
WFK W10LS Lipstick 2,31 0,65 0,82 -1 ,23 -0,31 0,90
CFT C-H1 13 Lard + -0,88 -1 ,44 3,50 -1 ,07 2,08 -1 ,40
Sudan
Red
WFK W10PP Pigmen 1 ,89 -0,03 -1 ,52 -0,31 0,33 -0,96
M t/vegt.oi
l/milk
WFK W10B Oliveoil 0,64 0,40 1 ,21 -0,79 0,20 -0,39
w.
pigment
Equest 132KC Cooked 1 ,39 -0,16 1 ,36 -1 ,49 -2,67 -2,31
butter
CFT C-S-62 Lard -0,57 -0,69 0,30 -2,18 -2,39 0,78
with
colorant
CFT C-H126 Vegeta -0,70 1 ,92 1 ,54 2,22 -0,92 0,80
ble
OilA iol
et Dye
WFK W20D Pigmen -0,92 0,36 2,71 -0,65 -0,69 -0,74
t
/Sebum
The data is further illustrated in figures 1 and 2:
Figure 1 shows the remission values obtained after washing with the English base (powder) without any enzymes and with either lipase or a combination of lipase and cellulase. Data is given as the sum of the remission at 460nm for five stains: WFK W20PF (Pigment/veg. fat), Equest 68KC (Ice Cream (chocolate) premium), WFK W10LS (Lipstick), WFK W10PPM (Pigment/veg. oil/milk), Equest 132KC (Cooked butter).
Figure 2 shows the remission values obtained after washing with the Italian base (powder) without any enzymes and with either lipase or a combination of lipase and cellulase. Data is given as the sum of the remission at 460nm for eight stains: WFK W20PF (Pigment/veg. fat), WFK W10D (Sebum w. pigment), CFT C-H1 13 (Lard + Sudan Red), WFK W10B (Olive oil
w. pigment), WFK W10LS (Lipstick), WFK W20D (pigment/sebum), CFT C-H126 (Veg. oil/violet dye), Equest 132KC (Cooked butter).
Example 2
The experimental conditions for the experiments are specified in Table 5, Table 6 and
Table 7 below.
Table 5: Experimental conditions for full scale
English base is the same as described in Example 1 .
German base 2 was analysed and found to be composed of: 12,00% LAS and 1.13% soap plus other components such as builders and co-builders.
Italian base 2 is composed of: 1 1 .7% anionic surfactants, 4,5% non-ioinic surfactants,
0,5% sodium formate and other additives such as citric acid and preservative.
German base 3 was analysed and found to be composed of: 4,5% AES plus other additives and stabilizers.
Spanish base 2 was analysed and found to be composed of: 13.22% AES plus other additives and stabilizers.
Italian base 3 was analysed and found to be composed of: 1 1.05% AES plus other additives and stabilizers
Table 6: Swatches with stains used
Water hardness was adjusted by addition of CaCI2, MgCI2, and NaHC03 to the test system. After washing, the textiles were rinsed in a Miele washing machine using a rinse program (STIVN). The stained swatches are commercially available from CFT. The ballast is commercially available from WFK.
The performance of the enzyme is evaluated by measuring the remission of the textile swatches using the ColorEye at 460 nm. The cellulase effect is shown in Table 7.
The underlined cells correspond to the stains where the effect was evident, meaning that the difference in the remission value between 2 textiles is higher than 2 points. For these remission values the human eye will be able to detect the difference. The values that are below 2 points difference are classified as a medium effect while the cells with values above 2 are classified as strong effect.
Table 7: CELLULASE EFFECT POWDER AND LIQUID
Producer Code Name English German Italian German Spanish Italian base base 2 base 1 base 3 base 2 base 2
Equest 64BKC hamburger 0,3 -1 ,9 4,7 1 ,4 2,8 5,3
beef fat
The data is further illustrated in figures 3-6:
Figure 3 shows the remission value obtained after washing with the German base 2 (powder) without any enzymes and with either lipase or a combination of lipase and cellulase. Data is shown as the sum of the remission at 460nm for four stains: WFK W20PF (Pigment/veg. fat), Equest 132KC (Cooked butter), WFK W20D (Pigment/Sebum), CFT C-H078 (lipstick handmade),
Figure 4 shows the remission value obtained after washing with the English base (powder) without any enzymes and with either lipase or a combination of lipase and cellulase. Data is shown as the sum of the remission at 460nm for four stains: WFK W20PF (Pigment/veg. fat), Equest 68KC (Ice Cream (chocolate) - premium), CFT C-H078 (lipsiick handmade), Equest 022KC (Black olives).
Figure 5 shows the remission value obtained after washing with the Spanish base 2 (liquid) without any enzymes and with either lipase or a combination of lipase and cellulase. Data is shown as the sum of the remission at 460nm for six stains: WFK W20PF (Pigment/veg.
fat), Equest 68KC (Ice Cream (chocolate) - premium), WFK W10LS (lipstick), CFT C-G1 13 (Lard + Sudan Red), Equest 132KC (Cooked butter) and Equest 131 KC (Cooked beef fat).
Figure 6 shows the remission value obtained after washing with the Italian base 2 (liquid) without any enzymes and with either lipase or a combination of lipase and cellulase. Data is shown as the sum of the remission at 460nm for four stains: WFK W20PF (Pigment/veg. fat), Equest 68KC (Ice Cream (chocolate) - premium), Equest 132KC (Cooked butter) and Equest 131 KC (Cooked beef fat).
Example 3:
The experimental conditions for the experiments are specified in Table 8, Table 9 and Table 10 below.
Table 8: Experimental conditions for full scale
Table 9: Formulations for full scale
The compositions of all the detergents used in this experiment have previously been shown in Example 1 and 2.
The lipase variant of SEQ ID NO: 2 has the following modifications: D27R G38A D96E D1 1 1A G163K T231 R N233R D254S P256T.
Equest 68KC Ice Cream (chocolate) - premium >15%
WFK W10LS Lipstick >80%
CFT C-H1 13 Lard + Sudan Red >90%
Equest 132KC Cooked butter >80%
CFT C-H126 Vegetable Oil/Violet Dye >90%
WFK W20D Pigment /Sebum >50%
EM PA 101 Oliveoil carbon
Equest 022KC Black olives >15%
Equest 131 KC Cooked beef fat >10%
CFT CS-34 Curry
CFT CS-88 Indian curry
Water hardness was adjusted by addition of CaCI2, MgCI2, and NaHC03 to the test system. After washing, the textiles were rinsed in a Miele washing machine using a rinse program (STIVN). The stained swatches are commercially available from CFT. The ballast is commercially available from WFK.
The performance of the enzyme is evaluated by measuring the remission of the textile swatches using the ColorEye at 460 nm. The synergy effect is shown in Table 1 1
The highlighted cells correspond to the stains where the effect was evident. It is commonly known that if the remission value between 2 textiles is higher than 2 points the human eye will be able to detect the difference. That is why the highlighted cells contain values around 2 and higher than 2.
The values that are below 2 points difference are classified as a medium effect while the cells with values above 2 are classified as strong effect. Table 1 1 : SYNERGY EFFECT
Equest 132KC Cooked butter -0,92 -0,17 -1 ,50
WFK W10LS Lipstick -0,99 0,89 0,27
CFT C-H1 13 Lard + Sudan Red -0,61 1 ,42 -2,53
Equest 022KC Black olives -0,63 0,91 1 ,51
Equest 131 KC Cooked beef fat -3,00 2,93 0,03
EM PA EMPA 101 Oliveoil carbon 0,75 0,09 -1 ,45
CFT CS-34 Curry -0,04 -0,35 -0,33
CFT CS-88 Indian curry -0,27 0,29 0,00
Figure 7 shows the remission value obtained after washing with the English base (powder) without any enzymes and with lipase, cellulase or a combination of lipase and cellulase. Data is shown as the sum of the remission at 460nm for four stains: WFK W20PF (Pigment/veg. fat), Equest 68KC (Ice Cream (chocolate) - premium), WFK W10LS (Lipstick) and CFT C-H126 (Veg. oil/violet dye).
Figure 8 shows the remission value obtained after washing with the Spanish base 2 (liquid) without any enzymes and with either lipase, cellulase or a combination of lipase and cellulase. Data is shown as the sum of the remission at 460nm for four stains: WFK W20PF (Pigment/veg. fat), Equest 68KC (Ice Cream (chocolate) - premium), WFK W10LS (Lipstick) and CFT C-H126 (Veg. oil/violet dye).
Overall it is observed that the following stains show a strong cellulase effect (Example 1 and Example 2) and synergy effect (Example 3). These stains are considered as high fatty stains.
WFK W20PF Pigment/veg.fat
Equest 68KC Ice Cream chocolate
CFT C-H126 Vegetable oil/Violet dye
In two out of the three examples above, the following stains were easier to remove if a lipase and cellulase were present than the enzymes separately: WFK W10LS Lipstick, CFT C- H1 13 Lard + sudan red, Equest 022KC Black olives, Equest 131 KC Cooked beef fat.
Claims
Detergent composition for removing or releasing greasy stains, which composition comprises a surfactant, a lipase and a cellulase.
Composition according to claim 1 , wherein the lipase is a polypeptide having an amino acid sequence which:
a) has at least 90% identity with SEQ ID NO: 2
b) compared to said SEQ ID NO: 2 comprises a substitution of an electrically neutral or negatively charged amino acid at the surface of the three- dimensional structure within 15 A of E1 or Q249 with a positively charged amino acid; and
c) comprises a peptide addition at the C-terminal; and/or
d) meets the following limitations:
i. comprises a negative amino acid in position E210 of said SEQ ID NO: 2; comprises a negatively charged amino acid in the region corresponding to positions 90-101 of said SEQ ID NO: 2; and
ii. comprises a neutral or negative amino acid at a position corresponding to N94 of said SEQ ID NO: 2 and/or has a negative or neutral net electric charge in the region corresponding to positions 90-101 of said SEQ ID NO: 2.
Composition according to any of the preceding claims, wherein the lipase is a variant of a parent lipase which variant has lipase activity, has at least 60% but less than 100% sequence identity with SEQ ID NO: 2, and comprises substitutions at positions corresponding to T231 R+N233R of SEQ ID NO: 2.
Composition according to any of the preceding claims, wherein the cellulase is comprised by the enzyme classification EC 3.2.1 .4.
Composition according to any of the preceding claims, wherein the cellulase is an enzyme exhibiting endo-beta-1 ,4-glucanase activity (EC 3.2.1.4), which is selected from one of
d) a polypeptide encoded by the DNA sequence of positions 1 to 2322 of SEQ ID NO: 5;
e) a polypeptide produced by culturing a cell comprising the sequence of SEQ ID NO: 5 under conditions wherein the DNA sequence is expressed; f) an endo-beta-1 ,4-glucanase enzyme having a sequence of at least 97% identity to the amino acid sequence of position 1 to position 773 of SEQ ID NO: 6; or a fragment thereof that has endo-beta-1 ,4-glucanase activity, when identity is
determined by GAP provided in the GCG program package using a GAP creation penalty of 3.0 and GAP extension penalty of 0.1.
6. Composition according to any of the preceding claims, wherein the composition comprises granules, which granules comprises a core and a protective coating, wherein: f. the core comprises an enzyme, which is lipase and/or cellulase, and
g. the core or the coating comprises a reducing agent or a peroxide decomposing catalyst or an antioxidant, and
h. the core comprises a salt of a multivalent cation, and
i. the core or the coating comprises an acidic buffer component, and
j. the coating comprises a salt.
7. Use of a detergent composition according to any of claims 1 -6 for removing or releasing a greasy stain
8. Use according to claim 7, wherein the greasy stain is removed or released from a textile having a greasy stain, from a dish having a greasy stain or from a hard surface having a greasy stain.
9. Use according to any of the preceding use claims, wherein the stain has a low-medium content of lipid, a medium content of lipid or a high content of lipid.
10. Use according to any of the preceding claims, wherein the cellulase effect is at least 2 points, at least 2.2 points, at least 2.4 points, at least 2.6 points, at least 2.8 points, at least 3.0 points, at least 3.5 points, at least 4.0 points or at least 5.0 points.
1 1 . Use according to any of the preceding claims, wherein the synergy effect is at least 2 points, at least 2.2 points, at least 2.4 points, at least 2.6 points, at least 2.8 points, at least 3.0 points, at least 3.5 points, at least 4.0 points or at least 5.0 points.
12. A method for removing or releasing greasy stains from an item having a greasy stain, which method comprises exposing the item to an aqueous solution of a lipase and a cellulase, wherein the item is a textile, a dish or a hard surface
13. A method according to claim 12, which method comprises exposing the item to an aqueous solution of a detergent composition of claims 1 -6.
14. Method according to any of the preceding claims, wherein the item is soaked in an aqueous solution, optionally comprising lipase and cellulase, the item is then exposed to the aqueous solution of a lipase and a cellulase and the item is rinsed with water optionally comprising a softener.
15. Item treated according to any of the preceding method claims.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13187202 | 2013-10-03 | ||
EP13187202.0 | 2013-10-03 | ||
EP13197686 | 2013-12-17 | ||
EP13197686.2 | 2013-12-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015049370A1 true WO2015049370A1 (en) | 2015-04-09 |
Family
ID=51659656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2014/071231 WO2015049370A1 (en) | 2013-10-03 | 2014-10-03 | Detergent composition and use of detergent composition |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2015049370A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017060471A1 (en) | 2015-10-09 | 2017-04-13 | Novozymes A/S | Enzymatic or non-enzymatic biodiesel polishing process |
WO2020047215A1 (en) * | 2018-08-30 | 2020-03-05 | Danisco Us Inc | Enzyme-containing granules |
WO2023039270A3 (en) * | 2021-09-13 | 2023-04-20 | Danisco Us Inc. | Bioactive-containing granules |
Citations (256)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1296839A (en) | 1969-05-29 | 1972-11-22 | ||
GB1483591A (en) | 1973-07-23 | 1977-08-24 | Novo Industri As | Process for coating water soluble or water dispersible particles by means of the fluid bed technique |
US4106991A (en) | 1976-07-07 | 1978-08-15 | Novo Industri A/S | Enzyme granulate composition and process for forming enzyme granulates |
US4435307A (en) | 1980-04-30 | 1984-03-06 | Novo Industri A/S | Detergent cellulase |
EP0218272A1 (en) | 1985-08-09 | 1987-04-15 | Gist-Brocades N.V. | Novel lipolytic enzymes and their use in detergent compositions |
US4661452A (en) | 1984-05-29 | 1987-04-28 | Novo Industri A/S | Enzyme containing granulates useful as detergent additives |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
EP0238216A1 (en) | 1986-02-20 | 1987-09-23 | Albright & Wilson Limited | Protected enzyme systems |
EP0258068A2 (en) | 1986-08-29 | 1988-03-02 | Novo Nordisk A/S | Enzymatic detergent additive |
EP0305216A1 (en) | 1987-08-28 | 1989-03-01 | Novo Nordisk A/S | Recombinant Humicola lipase and process for the production of recombinant humicola lipases |
WO1989006279A1 (en) | 1988-01-07 | 1989-07-13 | Novo-Nordisk A/S | Mutated subtilisin genes |
WO1989006270A1 (en) | 1988-01-07 | 1989-07-13 | Novo-Nordisk A/S | Enzymatic detergent |
EP0331376A2 (en) | 1988-02-28 | 1989-09-06 | Amano Pharmaceutical Co., Ltd. | Recombinant DNA, bacterium of the genus pseudomonas containing it, and process for preparing lipase by using it |
WO1989009259A1 (en) | 1988-03-24 | 1989-10-05 | Novo-Nordisk A/S | A cellulase preparation |
WO1990000609A1 (en) | 1988-07-08 | 1990-01-25 | The University Of British Columbia | Cellulose binding fusion proteins |
EP0407225A1 (en) | 1989-07-07 | 1991-01-09 | Unilever Plc | Enzymes and enzymatic detergent compositions |
WO1991010732A1 (en) | 1990-01-19 | 1991-07-25 | Novo Nordisk A/S | An enzyme exhibiting cellulase activity |
WO1991017243A1 (en) | 1990-05-09 | 1991-11-14 | Novo Nordisk A/S | A cellulase preparation comprising an endoglucanase enzyme |
WO1992005249A1 (en) | 1990-09-13 | 1992-04-02 | Novo Nordisk A/S | Lipase variants |
WO1992006204A1 (en) | 1990-09-28 | 1992-04-16 | Ixsys, Inc. | Surface expression libraries of heteromeric receptors |
EP0495257A1 (en) | 1991-01-16 | 1992-07-22 | The Procter & Gamble Company | Compact detergent compositions with high activity cellulase |
WO1992017577A1 (en) | 1991-04-03 | 1992-10-15 | Novo Nordisk A/S | Novel proteases |
WO1992019729A1 (en) | 1991-05-01 | 1992-11-12 | Novo Nordisk A/S | Stabilized enzymes and detergent compositions |
WO1992021760A1 (en) | 1991-05-29 | 1992-12-10 | Cognis, Inc. | Mutant proteolytic enzymes from bacillus |
EP0531315A1 (en) | 1990-05-09 | 1993-03-17 | Novo Nordisk As | An enzyme capable of degrading cellulose or hemicellulose. |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
WO1993018140A1 (en) | 1992-03-04 | 1993-09-16 | Novo Nordisk A/S | Novel proteases |
WO1993024618A1 (en) | 1992-06-01 | 1993-12-09 | Novo Nordisk A/S | Peroxidase variants with improved hydrogen peroxide stability |
WO1994001541A1 (en) | 1992-07-06 | 1994-01-20 | Novo Nordisk A/S | C. antarctica lipase and lipase variants |
WO1994002597A1 (en) | 1992-07-23 | 1994-02-03 | Novo Nordisk A/S | MUTANT α-AMYLASE, DETERGENT, DISH WASHING AGENT, AND LIQUEFACTION AGENT |
WO1994007998A1 (en) | 1992-10-06 | 1994-04-14 | Novo Nordisk A/S | Cellulase variants |
WO1994018314A1 (en) | 1993-02-11 | 1994-08-18 | Genencor International, Inc. | Oxidatively stable alpha-amylase |
US5352604A (en) | 1989-08-25 | 1994-10-04 | Henkel Research Corporation | Alkaline proteolytic enzyme and method of production |
WO1994025583A1 (en) | 1993-05-05 | 1994-11-10 | Novo Nordisk A/S | A recombinant trypsin-like protease |
WO1994025578A1 (en) | 1993-04-27 | 1994-11-10 | Gist-Brocades N.V. | New lipase variants for use in detergent applications |
EP0624154A1 (en) | 1991-12-13 | 1994-11-17 | The Procter & Gamble Company | Acylated citrate esters as peracid precursors |
US5389536A (en) | 1986-11-19 | 1995-02-14 | Genencor, Inc. | Lipase from Pseudomonas mendocina having cutinase activity |
WO1995006720A1 (en) | 1993-08-30 | 1995-03-09 | Showa Denko K.K. | Novel lipase, microorganism producing the lipase, process for producing the lipase, and use of the lipase |
WO1995010603A1 (en) | 1993-10-08 | 1995-04-20 | Novo Nordisk A/S | Amylase variants |
WO1995010602A1 (en) | 1993-10-13 | 1995-04-20 | Novo Nordisk A/S | H2o2-stable peroxidase variants |
EP0651785A1 (en) | 1992-07-02 | 1995-05-10 | Novo Nordisk A/S | ALKALOPHILIC $i(BACILLUS sp. AC13) AND PROTEASE, XYLANASE, CELLULASE OBTAINABLE THEREFROM |
WO1995014783A1 (en) | 1993-11-24 | 1995-06-01 | Showa Denko K.K. | Lipase gene and variant lipase |
WO1995016782A1 (en) | 1993-12-17 | 1995-06-22 | Genencor International, Inc. | Novel cellulase enzymes and systems for their expression |
WO1995017413A1 (en) | 1993-12-21 | 1995-06-29 | Evotec Biosystems Gmbh | Process for the evolutive design and synthesis of functional polymers based on designer elements and codes |
WO1995022625A1 (en) | 1994-02-17 | 1995-08-24 | Affymax Technologies N.V. | Dna mutagenesis by random fragmentation and reassembly |
WO1995022615A1 (en) | 1994-02-22 | 1995-08-24 | Novo Nordisk A/S | A method of preparing a variant of a lipolytic enzyme |
WO1995023221A1 (en) | 1994-02-24 | 1995-08-31 | Cognis, Inc. | Improved enzymes and detergents containing them |
WO1995024471A1 (en) | 1994-03-08 | 1995-09-14 | Novo Nordisk A/S | Novel alkaline cellulases |
WO1995030744A2 (en) | 1994-05-04 | 1995-11-16 | Genencor International Inc. | Lipases with improved surfactant resistance |
WO1995035381A1 (en) | 1994-06-20 | 1995-12-28 | Unilever N.V. | Modified pseudomonas lipases and their use |
WO1996000292A1 (en) | 1994-06-23 | 1996-01-04 | Unilever N.V. | Modified pseudomonas lipases and their use |
WO1996011262A1 (en) | 1994-10-06 | 1996-04-18 | Novo Nordisk A/S | An enzyme and enzyme preparation with endoglucanase activity |
WO1996012012A1 (en) | 1994-10-14 | 1996-04-25 | Solvay S.A. | Lipase, microorganism producing same, method for preparing said lipase and uses thereof |
WO1996013580A1 (en) | 1994-10-26 | 1996-05-09 | Novo Nordisk A/S | An enzyme with lipolytic activity |
WO1996023873A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | Amylase variants |
WO1996027002A1 (en) | 1995-02-27 | 1996-09-06 | Novo Nordisk A/S | Novel lipase gene and process for the production of lipase with the use of the same |
WO1996029397A1 (en) | 1995-03-17 | 1996-09-26 | Novo Nordisk A/S | Novel endoglucanases |
WO1996034108A2 (en) | 1995-04-28 | 1996-10-31 | Genencor International, Inc. | Alkaline cellulase and method for producing the same |
WO1996034946A1 (en) | 1995-05-05 | 1996-11-07 | Novo Nordisk A/S | Protease variants and compositions |
WO1997004079A1 (en) | 1995-07-14 | 1997-02-06 | Novo Nordisk A/S | A modified enzyme with lipolytic activity |
WO1997007202A1 (en) | 1995-08-11 | 1997-02-27 | Novo Nordisk A/S | Novel lipolytic enzymes |
US5648263A (en) | 1988-03-24 | 1997-07-15 | Novo Nordisk A/S | Methods for reducing the harshness of a cotton-containing fabric |
WO1997034005A1 (en) | 1996-03-12 | 1997-09-18 | Genencor International, Inc. | Alkaline cellulase and method of producing same |
WO1997043424A1 (en) | 1996-05-14 | 1997-11-20 | Genencor International, Inc. | MODIFIED α-AMYLASES HAVING ALTERED CALCIUM BINDING PROPERTIES |
WO1998008940A1 (en) | 1996-08-26 | 1998-03-05 | Novo Nordisk A/S | A novel endoglucanase |
WO1998012307A1 (en) | 1996-09-17 | 1998-03-26 | Novo Nordisk A/S | Cellulase variants |
WO1998015257A1 (en) | 1996-10-08 | 1998-04-16 | Novo Nordisk A/S | Diaminobenzoic acid derivatives as dye precursors |
WO1998017767A1 (en) | 1996-10-18 | 1998-04-30 | The Procter & Gamble Company | Detergent compositions |
WO1998020116A1 (en) | 1996-11-04 | 1998-05-14 | Novo Nordisk A/S | Subtilase variants and compositions |
WO1998020115A1 (en) | 1996-11-04 | 1998-05-14 | Novo Nordisk A/S | Subtilase variants and compositions |
BR9701341A (en) * | 1997-03-19 | 1998-11-17 | Unilever Nv | Detergent composition for washing fabrics preferably cotton and process for washing fabrics |
WO1999011768A1 (en) | 1997-08-29 | 1999-03-11 | Novo Nordisk A/S | Protease variants and compositions |
WO1999019467A1 (en) | 1997-10-13 | 1999-04-22 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
WO1999032595A1 (en) | 1997-12-20 | 1999-07-01 | Genencor International, Inc. | Granule with hydrated barrier material |
US5977053A (en) | 1995-07-31 | 1999-11-02 | Bayer Ag | Detergents and cleaners containing iminodisuccinates |
WO1999064619A2 (en) * | 1998-06-10 | 1999-12-16 | Novozymes A/S | Novel mannanases |
WO2000001793A1 (en) | 1998-06-30 | 2000-01-13 | Novozymes A/S | A new improved enzyme containing granule |
WO2000034450A1 (en) | 1998-12-04 | 2000-06-15 | Novozymes A/S | Cutinase variants |
WO2000060063A1 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Lipase variant |
WO2001016285A2 (en) | 1999-08-31 | 2001-03-08 | Novozymes A/S | Novel proteases and variants thereof |
WO2001044452A1 (en) | 1999-12-15 | 2001-06-21 | Novozymes A/S | Subtilase variants having an improved wash performance on egg stains |
WO2001066712A2 (en) | 2000-03-08 | 2001-09-13 | Novozymes A/S | Variants with altered properties |
WO2001092502A1 (en) | 2000-06-02 | 2001-12-06 | Novozymes A/S | Cutinase variants |
WO2002010355A2 (en) | 2000-08-01 | 2002-02-07 | Novozymes A/S | Alpha-amylase mutants with altered stability |
WO2002016547A2 (en) | 2000-08-21 | 2002-02-28 | Novozymes A/S | Subtilase enzymes |
WO2002026024A1 (en) | 2000-08-05 | 2002-04-04 | Haiquan Li | An apparatus using recyclable resource |
US6472364B1 (en) | 1998-10-13 | 2002-10-29 | The Procter & Gamble Company | Detergent compositions or components |
WO2002099091A2 (en) | 2001-06-06 | 2002-12-12 | Novozymes A/S | Endo-beta-1,4-glucanase from bacillus |
WO2003006602A2 (en) | 2001-07-12 | 2003-01-23 | Novozymes A/S | Subtilase variants |
WO2003040279A1 (en) | 2001-11-09 | 2003-05-15 | Unilever Plc | Polymers for laundry applications |
EP1350843A2 (en) | 2002-03-27 | 2003-10-08 | Kao Corporation | Alkaline cellulase variants |
WO2004003186A2 (en) | 2002-06-26 | 2004-01-08 | Novozymes A/S | Subtilases and subtilase variants having altered immunogenicity |
EP1382668A1 (en) | 2002-06-11 | 2004-01-21 | Unilever N.V. | Detergent tablets |
WO2004041979A2 (en) | 2002-11-06 | 2004-05-21 | Novozymes A/S | Subtilase variants |
JP2004175882A (en) * | 2002-11-26 | 2004-06-24 | Kao Corp | Composition for washing |
US20040171154A1 (en) | 2001-07-27 | 2004-09-02 | Francesca Storici | Systems for in vivo site-directed mutagenesis using oligonucleotides |
WO2004074419A2 (en) | 2003-02-18 | 2004-09-02 | Novozymes A/S | Detergent compositions |
WO2005003274A1 (en) | 2003-06-18 | 2005-01-13 | Unilever Plc | Laundry treatment compositions |
WO2005003276A1 (en) | 2003-06-18 | 2005-01-13 | Unilever Plc | Laundry treatment compositions |
WO2005003275A1 (en) | 2003-06-18 | 2005-01-13 | Unilever Plc | Laundry treatment compositions |
WO2005040372A1 (en) | 2003-10-23 | 2005-05-06 | Novozymes A/S | Protease with improved stability in detergents |
WO2005052146A2 (en) | 2003-11-19 | 2005-06-09 | Genencor International, Inc. | Serine proteases, nucleic acids encoding serine enzymes and vectors and host cells incorporating same |
WO2005056782A2 (en) | 2003-12-03 | 2005-06-23 | Genencor International, Inc. | Perhydrolase |
WO2006066594A2 (en) | 2004-12-23 | 2006-06-29 | Novozymes A/S | Alpha-amylase variants |
EP1705241A1 (en) | 2005-03-23 | 2006-09-27 | Unilever N.V. | Detergent compositions in tablet form |
WO2006108856A2 (en) | 2005-04-15 | 2006-10-19 | Basf Aktiengesellschaft | Amphiphilic water-soluble alkoxylated polyalkylenimines with an internal polyethylene oxide block and an external polypropylene oxide block |
WO2006113314A1 (en) | 2005-04-15 | 2006-10-26 | The Procter & Gamble Company | Liquid laundry detergent compositions with modified polyethyleneimine polymers and lipase enzyme |
WO2006130575A2 (en) | 2005-05-31 | 2006-12-07 | The Procter & Gamble Company | Polymer-containing detergent compositions and their use |
WO2007001262A1 (en) | 2005-06-17 | 2007-01-04 | The Procter & Gamble Company | Organic catalyst with enhanced enzyme compatibility |
WO2007006305A1 (en) | 2005-07-08 | 2007-01-18 | Novozymes A/S | Subtilase variants |
WO2007044993A2 (en) | 2005-10-12 | 2007-04-19 | Genencor International, Inc. | Use and production of storage-stable neutral metalloprotease |
WO2007087259A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Enzyme and photobleach containing compositions |
WO2007087242A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | A composition comprising a lipase and a bleach catalyst |
WO2007087508A2 (en) | 2006-01-23 | 2007-08-02 | Novozymes A/S | Lipase variants |
WO2007087244A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Detergent compositions |
WO2007087257A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Enzyme and fabric hueing agent containing compositions |
WO2007087258A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | A composition comprising a lipase and a bleach catalyst |
WO2007087243A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Detergent compositions |
US7262042B2 (en) | 2001-12-20 | 2007-08-28 | Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) | Alkaline protease from Bacillus gibsonii (DSM 14393) and washing and cleaning products comprising said alkaline protease |
WO2007138054A1 (en) | 2006-05-31 | 2007-12-06 | The Procter & Gamble Company | Cleaning compositions with amphiphilic graft polymers based on polyalkylene oxides and vinyl esters |
EP1867707A1 (en) * | 2006-06-16 | 2007-12-19 | The Procter and Gamble Company | Detergent compositions |
EP1867708A1 (en) | 2006-06-16 | 2007-12-19 | The Procter and Gamble Company | Detergent Compositions |
EP1876226A1 (en) | 2006-07-07 | 2008-01-09 | The Procter and Gamble Company | Detergent compositions |
WO2008101958A1 (en) | 2007-02-20 | 2008-08-28 | Novozymes A/S | Enzyme foam treatment for laundry |
WO2008153815A2 (en) | 2007-05-30 | 2008-12-18 | Danisco Us, Inc., Genencor Division | Variants of an alpha-amylase with improved production levels in fermentation processes |
WO2009000605A1 (en) | 2007-06-22 | 2008-12-31 | Unilever N.V. | Granular enzymatic detergent compositions |
WO2009004294A1 (en) | 2007-07-05 | 2009-01-08 | Reckitt Benckiser N.V. | Laundry cleaning product |
US20090011970A1 (en) | 2007-07-02 | 2009-01-08 | Marc Francois Theophile Evers | Laundry multi-compartment pouch composition |
WO2009004295A1 (en) | 2007-07-05 | 2009-01-08 | Reckitt Benckiser N.V. | Laundry cleaning product |
WO2009010375A1 (en) | 2007-07-16 | 2009-01-22 | Unilever Plc | A solid detergent composition |
WO2009015951A1 (en) | 2007-07-31 | 2009-02-05 | Henkel Ag & Co. Kgaa | Compositions comprising perhydrolases and alkylene glycol diacetates |
WO2009021784A1 (en) | 2007-08-14 | 2009-02-19 | Unilever N.V. | Detergent tablet |
WO2009021813A2 (en) | 2007-08-10 | 2009-02-19 | Henkel Ag & Co. Kgaa | Washing or cleaning agent having polyester-based soil-release polymer |
WO2009021867A2 (en) | 2007-08-10 | 2009-02-19 | Henkel Ag & Co. Kgaa | Agents containing proteases |
WO2009024780A1 (en) | 2007-08-20 | 2009-02-26 | Reckitt Benckiser N.V. | Detergent composition |
WO2009030632A1 (en) | 2007-09-04 | 2009-03-12 | Henkel Ag & Co. Kgaa | Polycyclic compounds as enzyme stabilizers |
WO2009040545A1 (en) | 2007-09-26 | 2009-04-02 | Reckitt Benckiser N.V. | Composition |
WO2009040544A1 (en) | 2007-09-28 | 2009-04-02 | Reckitt Benckiser N.V. | Detergent composition |
WO2009047126A2 (en) | 2007-10-12 | 2009-04-16 | Unilever Plc | Laundry detergent with pretreatment additive and its use |
WO2009047125A1 (en) | 2007-10-12 | 2009-04-16 | Unilever Plc | Improved visual cues for perfumed laundry detergents |
WO2009047127A1 (en) | 2007-10-12 | 2009-04-16 | Unilever Plc | Granular detergent compositions with contrasting lamellar visual cues |
WO2009047128A1 (en) | 2007-10-12 | 2009-04-16 | Unilever Plc | Performance ingredients in film particles |
WO2009050026A2 (en) | 2007-10-17 | 2009-04-23 | Unilever Nv | Laundry compositions |
WO2009061380A2 (en) | 2007-11-05 | 2009-05-14 | Danisco Us Inc., Genencor Division | VARIANTS OF BACILLUS sp. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES |
WO2009063355A1 (en) | 2007-11-13 | 2009-05-22 | The Procter & Gamble Company | Process for creating a unit dose product with a printed water soluble material |
WO2009067279A1 (en) | 2007-11-21 | 2009-05-28 | E.I. Du Pont De Nemours And Company | Production of peracids using an enzyme having perhydrolysis activity |
WO2009065770A1 (en) | 2007-11-21 | 2009-05-28 | Henkel Ag & Co. Kgaa | Granulate of a sensitive ingredient of a washing or cleaning agent |
WO2009068501A1 (en) | 2007-11-28 | 2009-06-04 | Henkel Ag & Co. Kgaa | Washing agent having stabilized enzymes |
WO2009072069A1 (en) | 2007-12-05 | 2009-06-11 | The Procter & Gamble Company | Package comprising detergent |
WO2009074403A1 (en) | 2007-12-11 | 2009-06-18 | Henkel Ag & Co. Kgaa | Cleaning agent |
WO2009074398A1 (en) | 2007-12-10 | 2009-06-18 | Henkel Ag & Co. Kgaa | Cleaning agent |
WO2009087033A1 (en) | 2008-01-10 | 2009-07-16 | Unilever Plc | Granules |
WO2009087523A2 (en) | 2008-01-04 | 2009-07-16 | The Procter & Gamble Company | A laundry detergent composition comprising glycosyl hydrolase |
WO2009092699A1 (en) | 2008-01-24 | 2009-07-30 | Unilever Nv | Machine dishwash detergent compositions |
WO2009095645A1 (en) | 2008-01-28 | 2009-08-06 | Reckitt Benckiser N.V. | Composition |
WO2009102854A1 (en) | 2008-02-15 | 2009-08-20 | The Procter & Gamble Company | Cleaning compositions |
WO2009103822A1 (en) | 2008-04-01 | 2009-08-27 | Unilever Nv | Preparation of free flowing granules of methyglycine diacetic acid |
WO2009109500A1 (en) | 2008-02-29 | 2009-09-11 | Novozymes A/S | Polypeptides having lipase activity and polynucleotides encoding same |
WO2009112298A1 (en) | 2008-03-14 | 2009-09-17 | Unilever Plc | Laundry treatment composition comprising polymeric lubricants |
WO2009112296A1 (en) | 2008-03-14 | 2009-09-17 | Unilever Plc | Laundry treatment compositions |
WO2009117342A1 (en) | 2008-03-18 | 2009-09-24 | The Procter & Gamble Company | A laundry detergent composition comprising the magnesium salt of ethylene diamine-n'n'-disuccinic acid |
WO2009117341A1 (en) | 2008-03-18 | 2009-09-24 | The Procter & Gamble Company | Detergent composition comprising cellulosic polymer |
WO2009117340A1 (en) | 2008-03-18 | 2009-09-24 | The Procter & Gamble Company | Detergent composition comprising a co-polyester of dicarboxylic acids and diols |
WO2009115391A1 (en) | 2008-03-18 | 2009-09-24 | Henkel Ag & Co. Kgaa | Use of imidazolium salts in detergents and cleaning products |
WO2009115392A1 (en) | 2008-03-18 | 2009-09-24 | Henkel Ag & Co. Kgaa | Imidazolium salts as enzyme stabilizers |
WO2009121725A1 (en) | 2008-04-02 | 2009-10-08 | Henkel Ag & Co. Kgaa | Detergents and cleaners comprising proteases from xanthomonas |
WO2009124163A1 (en) | 2008-04-02 | 2009-10-08 | The Procter & Gamble Company | Detergent composition comprising reactive dye |
WO2009124162A1 (en) | 2008-04-02 | 2009-10-08 | The Procter & Gamble Company | Detergent composition comprising non-ionic detersive surfactant and reactive dye |
WO2009121757A2 (en) | 2008-04-04 | 2009-10-08 | Unilever Plc | A novel personal wash bar |
WO2009122125A1 (en) | 2008-04-01 | 2009-10-08 | Reckitt Benckiser Inc. | Laundry treatment compositions |
WO2009132870A1 (en) | 2008-05-02 | 2009-11-05 | Unilever Plc | Reduced spotting granules |
WO2010000636A1 (en) | 2008-07-03 | 2010-01-07 | Henkel Ag & Co. Kgaa | Solid fabric care composition with a polysaccharide |
WO2010003792A1 (en) | 2008-07-09 | 2010-01-14 | Unilever Plc | Laundry compositions |
WO2010003783A1 (en) | 2008-07-11 | 2010-01-14 | Unilever Nv | Copolymers and detergent compositions |
WO2010014395A1 (en) | 2008-07-28 | 2010-02-04 | The Procter & Gamble Company | Process for preparing a detergent composition |
WO2010018043A1 (en) | 2008-08-14 | 2010-02-18 | Unilever Nv | Builder composition |
WO2010024470A1 (en) | 2008-09-01 | 2010-03-04 | The Procter & Gamble Company | Composition comprising polyoxyalkylene-based polymer composition |
WO2010025161A1 (en) | 2008-08-27 | 2010-03-04 | The Procter & Gamble Company | A detergent composition comprising carbohydrate:acceptor oxidoreductase |
WO2010024469A1 (en) | 2008-09-01 | 2010-03-04 | The Procter & Gamble Company | Hydrophobic group-containing copolymer and process for the production thereof |
WO2010024467A1 (en) | 2008-09-01 | 2010-03-04 | The Procter & Gamble Company | Polymer composition and process for the production thereof |
WO2010030541A1 (en) | 2008-09-12 | 2010-03-18 | The Procter & Gamble Company | Laundry particle made by extrusion comprising a hueing dye |
WO2010030539A1 (en) | 2008-09-12 | 2010-03-18 | The Procter & Gamble Company | Laundry particle made by extrusion comprising a hueing dye and fatty acid soap |
WO2010030540A1 (en) | 2008-09-12 | 2010-03-18 | The Procter & Gamble Company | Particles comprising a hueing dye |
WO2010033747A1 (en) | 2008-09-19 | 2010-03-25 | The Procter & Gamble Company | Dual character biopolymer useful in cleaning products |
WO2010033979A2 (en) | 2008-09-22 | 2010-03-25 | The Procter & Gamble Company | Specific polybranched polyaldehydes, polyalcohols, and surfactants and consumer products based thereon |
WO2010031607A1 (en) | 2008-09-18 | 2010-03-25 | Henkel Ag & Co. Kgaa | Bleach-containing cleaning agent |
WO2010033746A1 (en) | 2008-09-19 | 2010-03-25 | The Procter & Gamble Company | Detergent composition containing suds boosting and suds stabilizing modified biopolymer |
WO2010044905A2 (en) | 2008-04-02 | 2010-04-22 | The Procter & Gamble Company | A kit of parts comprising a solid laundry detergent composition and a dosing device |
WO2010049187A1 (en) | 2008-10-31 | 2010-05-06 | Henkel Ag & Co. Kgaa | Dishwasher detergent |
WO2010054986A1 (en) | 2008-11-12 | 2010-05-20 | Unilever Plc | Fabric whiteness measurement system |
WO2010057784A1 (en) | 2008-11-20 | 2010-05-27 | Unilever Plc | Fabric whiteness measurement system |
WO2010060821A2 (en) | 2008-11-27 | 2010-06-03 | Henkel Ag & Co. Kgaa | Detergents and cleaning agents containing proteases from bacillus pumilus |
WO2010065455A2 (en) | 2008-12-01 | 2010-06-10 | Danisco Us Inc. | Enzymes with lipase activity |
WO2010063689A1 (en) | 2008-12-05 | 2010-06-10 | Henkel Ag & Co. Kgaa | Automatic dishwashing detergent tablets |
WO2010066632A1 (en) | 2008-12-12 | 2010-06-17 | Henkel Ag & Co. Kgaa | Laundry article having cleaning and conditioning properties |
WO2010066631A1 (en) | 2008-12-12 | 2010-06-17 | Henkel Ag & Co. Kgaa | Laundry article having cleaning and conditioning properties |
WO2010066486A2 (en) | 2008-12-09 | 2010-06-17 | Henkel Ag & Co. Kgaa | Photolabile fragrance storage substances |
WO2010069957A1 (en) | 2008-12-17 | 2010-06-24 | Unilever Plc | Laundry detergent composition |
WO2010069905A1 (en) | 2008-12-19 | 2010-06-24 | Henkel Ag & Co. Kgaa | Dishwasher detergent |
WO2010069742A1 (en) | 2008-12-18 | 2010-06-24 | Unilever Nv | Laundry detergent composition |
WO2010069718A1 (en) | 2008-12-16 | 2010-06-24 | Unilever Nv | Solid builder composition |
WO2010072603A1 (en) | 2008-12-15 | 2010-07-01 | Henkel Ag & Co. Kgaa | Dishwasher detergent |
WO2010072456A1 (en) | 2008-12-23 | 2010-07-01 | Henkel Ag & Co. Kgaa | Use of star-shaped polymers having peripheral negatively charged groups and/or peripheral silyl groups for finishing surfaces |
WO2010076165A1 (en) | 2008-12-15 | 2010-07-08 | Henkel Ag & Co. Kgaa | Machine dishwashing detergent |
WO2010076292A1 (en) | 2008-12-29 | 2010-07-08 | Unilever Plc | Structured aqueous detergent compositions |
WO2010078979A1 (en) | 2009-01-09 | 2010-07-15 | Henkel Ag & Co. Kgaa | Color-protecting dishwasher detergent |
WO2010084203A1 (en) | 2009-01-26 | 2010-07-29 | Henkel Ag & Co. Kgaa | Additional laundry item |
WO2010084039A1 (en) | 2009-01-26 | 2010-07-29 | Unilever Plc | Incorporation of dye into granular laundry composition |
WO2010090915A1 (en) | 2009-02-09 | 2010-08-12 | The Procter & Gamble Company | Detergent composition |
WO2010094356A1 (en) | 2009-02-18 | 2010-08-26 | Henkel Ag & Co. Kgaa | Pro-fragrance copolymeric compounds |
WO2010099997A1 (en) | 2009-03-05 | 2010-09-10 | Unilever Plc | Dye radical initiators |
WO2010100028A2 (en) | 2009-03-06 | 2010-09-10 | Huntsman Advanced Materials (Switzerland) Gmbh | Enzymatic textile bleach-whitening methods |
WO2010102861A1 (en) | 2009-03-12 | 2010-09-16 | Unilever Plc | Dye-polymers formulations |
WO2010105962A1 (en) | 2009-03-20 | 2010-09-23 | Henkel Ag & Co. Kgaa | Detergent or cleaning agent comprising a bleach-boosting transition metal complex which is optionally produced in situ |
WO2010108002A1 (en) | 2009-03-18 | 2010-09-23 | The Procter & Gamble Company | Structured fluid detergent compositions comprising dibenzylidene sorbitol acetal derivatives |
WO2010107560A2 (en) | 2009-03-18 | 2010-09-23 | Danisco Us Inc. | Fungal cutinase from magnaporthe grisea |
WO2010108000A1 (en) | 2009-03-18 | 2010-09-23 | The Procter & Gamble Company | Structured fluid detergent compositions comprising dibenzylidene polyol acetal derivatives and detersive enzymes |
WO2010105942A1 (en) | 2009-03-20 | 2010-09-23 | Henkel Ag & Co. Kgaa | 4-aminopyridine derivatives as catalysts for the cleavage of organic esters |
WO2010105961A1 (en) | 2009-03-20 | 2010-09-23 | Henkel Ag & Co. Kgaa | Detergent or cleaning agent comprising a bleach-boosting transition metal complex which is optionally produced in situ |
WO2010107635A1 (en) | 2009-03-16 | 2010-09-23 | The Procter & Gamble Company | Method of industrial or institutional laundry for a polyester load |
WO2010111143A2 (en) | 2009-03-23 | 2010-09-30 | Danisco Us Inc. | Cal a-related acyltransferases and methods of use, thereof |
WO2010111365A1 (en) | 2009-03-26 | 2010-09-30 | The Procter & Gamble Company | A perfume encapsulate, a laundry detergent composition comprising a perfume encapsulate, and a process for preparing a perfume encapsulate |
WO2010115813A1 (en) | 2009-04-07 | 2010-10-14 | Henkel Ag & Co. Kgaa | Use of a prebiotically effective surfactant combination |
WO2010120863A1 (en) | 2009-04-17 | 2010-10-21 | The Procter & Gamble Company | Fabric care compositions comprising organosiloxane polymers |
WO2010118959A1 (en) | 2009-04-15 | 2010-10-21 | Henkel Ag & Co. Kgaa | Granular washing, cleaning or treatment agent additive |
WO2010122051A1 (en) | 2009-04-24 | 2010-10-28 | Unilever Plc | High active detergent particles |
WO2010135238A1 (en) | 2009-05-19 | 2010-11-25 | The Procter & Gamble Company | A method for printing water-soluble film |
WO2010142503A1 (en) | 2009-06-12 | 2010-12-16 | Unilever Plc | Cationic dye polymers |
WO2010142539A1 (en) | 2009-06-08 | 2010-12-16 | Henkel Ag & Co. Kgaa | Nanoparticulate manganese dioxide |
WO2010145887A1 (en) | 2009-06-15 | 2010-12-23 | Unilever Plc | Anionic dye polymers |
WO2011005813A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Method of laundering fabric using a compacted laundry detergent composition |
WO2011005905A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | A mildly alkaline, low-built, solid fabric treatment detergent composition comprising phthalimido peroxy caproic acid |
WO2011005912A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Method of laundering fabric |
WO2011005844A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Method of laundering fabric using a compacted laundry detergent composition |
WO2011005904A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Detergent composition |
WO2011005630A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Method of laundering fabric using a compacted laundry detergent composition |
WO2011005730A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | A catalytic laundry detergent composition comprising relatively low levels of water-soluble electrolyte |
US20110005003A1 (en) * | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Catalytic laundry detergent composition comprising relatively low levels of water-soluble electrolyte |
WO2011005830A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Laundry detergent composition comprising low level of sulphate |
WO2011005910A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Method of laundering fabric using a compacted laundry detergent composition |
WO2011005803A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Continuous process for making a laundry detergent composition |
WO2011005623A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Laundry detergent composition comprising low level of bleach |
WO2011016958A2 (en) | 2009-07-27 | 2011-02-10 | The Procter & Gamble Company | Detergent composition |
WO2011023716A1 (en) | 2009-08-26 | 2011-03-03 | Henkel Ag & Co. Kgaa | Improved washing performance using radical traps |
WO2011025615A2 (en) | 2009-08-13 | 2011-03-03 | The Procter & Gamble Company | Method of laundering fabrics at low temperature |
WO2011036263A1 (en) | 2009-09-25 | 2011-03-31 | Novozymes A/S | Subtilase variants |
WO2011036264A1 (en) | 2009-09-25 | 2011-03-31 | Novozymes A/S | Use of protease variants |
WO2011084412A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing thermobifida fusca lipase and methods of use thereof |
WO2011084417A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing geobacillus stearothermophilus lipase and methods of use thereof |
WO2011084599A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing bacillus subtilis lipase and methods of use thereof |
WO2011098531A1 (en) | 2010-02-10 | 2011-08-18 | Novozymes A/S | Variants and compositions comprising variants with high stability in presence of a chelating agent |
WO2011150157A2 (en) | 2010-05-28 | 2011-12-01 | Danisco Us Inc. | Detergent compositions containing streptomyces griseus lipase and methods of use thereof |
WO2012137147A1 (en) | 2011-04-08 | 2012-10-11 | Danisco Us, Inc. | Compositions |
WO2013001078A1 (en) | 2011-06-30 | 2013-01-03 | Novozymes A/S | Alpha-amylase variants |
WO2013001087A2 (en) | 2011-06-30 | 2013-01-03 | Novozymes A/S | Method for screening alpha-amylases |
WO2013113622A1 (en) | 2012-02-03 | 2013-08-08 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
-
2014
- 2014-10-03 WO PCT/EP2014/071231 patent/WO2015049370A1/en active Application Filing
Patent Citations (268)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1296839A (en) | 1969-05-29 | 1972-11-22 | ||
GB1483591A (en) | 1973-07-23 | 1977-08-24 | Novo Industri As | Process for coating water soluble or water dispersible particles by means of the fluid bed technique |
US4106991A (en) | 1976-07-07 | 1978-08-15 | Novo Industri A/S | Enzyme granulate composition and process for forming enzyme granulates |
US4435307A (en) | 1980-04-30 | 1984-03-06 | Novo Industri A/S | Detergent cellulase |
US4661452A (en) | 1984-05-29 | 1987-04-28 | Novo Industri A/S | Enzyme containing granulates useful as detergent additives |
US4683202B1 (en) | 1985-03-28 | 1990-11-27 | Cetus Corp | |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
EP0218272A1 (en) | 1985-08-09 | 1987-04-15 | Gist-Brocades N.V. | Novel lipolytic enzymes and their use in detergent compositions |
EP0238216A1 (en) | 1986-02-20 | 1987-09-23 | Albright & Wilson Limited | Protected enzyme systems |
EP0258068A2 (en) | 1986-08-29 | 1988-03-02 | Novo Nordisk A/S | Enzymatic detergent additive |
US5389536A (en) | 1986-11-19 | 1995-02-14 | Genencor, Inc. | Lipase from Pseudomonas mendocina having cutinase activity |
EP0305216A1 (en) | 1987-08-28 | 1989-03-01 | Novo Nordisk A/S | Recombinant Humicola lipase and process for the production of recombinant humicola lipases |
WO1989006270A1 (en) | 1988-01-07 | 1989-07-13 | Novo-Nordisk A/S | Enzymatic detergent |
WO1989006279A1 (en) | 1988-01-07 | 1989-07-13 | Novo-Nordisk A/S | Mutated subtilisin genes |
EP0331376A2 (en) | 1988-02-28 | 1989-09-06 | Amano Pharmaceutical Co., Ltd. | Recombinant DNA, bacterium of the genus pseudomonas containing it, and process for preparing lipase by using it |
US5691178A (en) | 1988-03-22 | 1997-11-25 | Novo Nordisk A/S | Fungal cellulase composition containing alkaline CMC-endoglucanase and essentially no cellobiohydrolase |
WO1989009259A1 (en) | 1988-03-24 | 1989-10-05 | Novo-Nordisk A/S | A cellulase preparation |
US5776757A (en) | 1988-03-24 | 1998-07-07 | Novo Nordisk A/S | Fungal cellulase composition containing alkaline CMC-endoglucanase and essentially no cellobiohydrolase and method of making thereof |
US5648263A (en) | 1988-03-24 | 1997-07-15 | Novo Nordisk A/S | Methods for reducing the harshness of a cotton-containing fabric |
WO1990000609A1 (en) | 1988-07-08 | 1990-01-25 | The University Of British Columbia | Cellulose binding fusion proteins |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
EP0407225A1 (en) | 1989-07-07 | 1991-01-09 | Unilever Plc | Enzymes and enzymatic detergent compositions |
US5352604A (en) | 1989-08-25 | 1994-10-04 | Henkel Research Corporation | Alkaline proteolytic enzyme and method of production |
WO1991010732A1 (en) | 1990-01-19 | 1991-07-25 | Novo Nordisk A/S | An enzyme exhibiting cellulase activity |
EP0531315A1 (en) | 1990-05-09 | 1993-03-17 | Novo Nordisk As | An enzyme capable of degrading cellulose or hemicellulose. |
US5457046A (en) | 1990-05-09 | 1995-10-10 | Novo Nordisk A/S | Enzyme capable of degrading cellullose or hemicellulose |
EP0531372A1 (en) | 1990-05-09 | 1993-03-17 | Novo Nordisk As | A cellulase preparation comprising an endoglucanase enzyme. |
US5686593A (en) | 1990-05-09 | 1997-11-11 | Novo Nordisk A/S | Enzyme capable of degrading cellulose or hemicellulose |
US5763254A (en) | 1990-05-09 | 1998-06-09 | Novo Nordisk A/S | Enzyme capable of degrading cellulose or hemicellulose |
WO1991017243A1 (en) | 1990-05-09 | 1991-11-14 | Novo Nordisk A/S | A cellulase preparation comprising an endoglucanase enzyme |
WO1992005249A1 (en) | 1990-09-13 | 1992-04-02 | Novo Nordisk A/S | Lipase variants |
WO1992006204A1 (en) | 1990-09-28 | 1992-04-16 | Ixsys, Inc. | Surface expression libraries of heteromeric receptors |
EP0495257A1 (en) | 1991-01-16 | 1992-07-22 | The Procter & Gamble Company | Compact detergent compositions with high activity cellulase |
WO1992017577A1 (en) | 1991-04-03 | 1992-10-15 | Novo Nordisk A/S | Novel proteases |
WO1992019729A1 (en) | 1991-05-01 | 1992-11-12 | Novo Nordisk A/S | Stabilized enzymes and detergent compositions |
WO1992021760A1 (en) | 1991-05-29 | 1992-12-10 | Cognis, Inc. | Mutant proteolytic enzymes from bacillus |
EP0624154A1 (en) | 1991-12-13 | 1994-11-17 | The Procter & Gamble Company | Acylated citrate esters as peracid precursors |
WO1993018140A1 (en) | 1992-03-04 | 1993-09-16 | Novo Nordisk A/S | Novel proteases |
WO1993024618A1 (en) | 1992-06-01 | 1993-12-09 | Novo Nordisk A/S | Peroxidase variants with improved hydrogen peroxide stability |
EP0651785A1 (en) | 1992-07-02 | 1995-05-10 | Novo Nordisk A/S | ALKALOPHILIC $i(BACILLUS sp. AC13) AND PROTEASE, XYLANASE, CELLULASE OBTAINABLE THEREFROM |
WO1994001541A1 (en) | 1992-07-06 | 1994-01-20 | Novo Nordisk A/S | C. antarctica lipase and lipase variants |
WO1994002597A1 (en) | 1992-07-23 | 1994-02-03 | Novo Nordisk A/S | MUTANT α-AMYLASE, DETERGENT, DISH WASHING AGENT, AND LIQUEFACTION AGENT |
WO1994007998A1 (en) | 1992-10-06 | 1994-04-14 | Novo Nordisk A/S | Cellulase variants |
WO1994018314A1 (en) | 1993-02-11 | 1994-08-18 | Genencor International, Inc. | Oxidatively stable alpha-amylase |
WO1994025578A1 (en) | 1993-04-27 | 1994-11-10 | Gist-Brocades N.V. | New lipase variants for use in detergent applications |
WO1994025583A1 (en) | 1993-05-05 | 1994-11-10 | Novo Nordisk A/S | A recombinant trypsin-like protease |
WO1995006720A1 (en) | 1993-08-30 | 1995-03-09 | Showa Denko K.K. | Novel lipase, microorganism producing the lipase, process for producing the lipase, and use of the lipase |
WO1995010603A1 (en) | 1993-10-08 | 1995-04-20 | Novo Nordisk A/S | Amylase variants |
WO1995010602A1 (en) | 1993-10-13 | 1995-04-20 | Novo Nordisk A/S | H2o2-stable peroxidase variants |
WO1995014783A1 (en) | 1993-11-24 | 1995-06-01 | Showa Denko K.K. | Lipase gene and variant lipase |
WO1995016782A1 (en) | 1993-12-17 | 1995-06-22 | Genencor International, Inc. | Novel cellulase enzymes and systems for their expression |
WO1995017413A1 (en) | 1993-12-21 | 1995-06-29 | Evotec Biosystems Gmbh | Process for the evolutive design and synthesis of functional polymers based on designer elements and codes |
WO1995022625A1 (en) | 1994-02-17 | 1995-08-24 | Affymax Technologies N.V. | Dna mutagenesis by random fragmentation and reassembly |
WO1995022615A1 (en) | 1994-02-22 | 1995-08-24 | Novo Nordisk A/S | A method of preparing a variant of a lipolytic enzyme |
WO1995023221A1 (en) | 1994-02-24 | 1995-08-31 | Cognis, Inc. | Improved enzymes and detergents containing them |
EP1921147A2 (en) | 1994-02-24 | 2008-05-14 | Henkel Kommanditgesellschaft auf Aktien | Improved enzymes and detergents containing them |
EP1921148A2 (en) | 1994-02-24 | 2008-05-14 | Henkel Kommanditgesellschaft auf Aktien | Improved enzymes and detergents containing them |
WO1995024471A1 (en) | 1994-03-08 | 1995-09-14 | Novo Nordisk A/S | Novel alkaline cellulases |
WO1995030744A2 (en) | 1994-05-04 | 1995-11-16 | Genencor International Inc. | Lipases with improved surfactant resistance |
WO1995035381A1 (en) | 1994-06-20 | 1995-12-28 | Unilever N.V. | Modified pseudomonas lipases and their use |
WO1996000292A1 (en) | 1994-06-23 | 1996-01-04 | Unilever N.V. | Modified pseudomonas lipases and their use |
WO1996011262A1 (en) | 1994-10-06 | 1996-04-18 | Novo Nordisk A/S | An enzyme and enzyme preparation with endoglucanase activity |
WO1996012012A1 (en) | 1994-10-14 | 1996-04-25 | Solvay S.A. | Lipase, microorganism producing same, method for preparing said lipase and uses thereof |
WO1996013580A1 (en) | 1994-10-26 | 1996-05-09 | Novo Nordisk A/S | An enzyme with lipolytic activity |
WO1996023873A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | Amylase variants |
WO1996027002A1 (en) | 1995-02-27 | 1996-09-06 | Novo Nordisk A/S | Novel lipase gene and process for the production of lipase with the use of the same |
WO1996029397A1 (en) | 1995-03-17 | 1996-09-26 | Novo Nordisk A/S | Novel endoglucanases |
WO1996034108A2 (en) | 1995-04-28 | 1996-10-31 | Genencor International, Inc. | Alkaline cellulase and method for producing the same |
WO1996034946A1 (en) | 1995-05-05 | 1996-11-07 | Novo Nordisk A/S | Protease variants and compositions |
WO1997004079A1 (en) | 1995-07-14 | 1997-02-06 | Novo Nordisk A/S | A modified enzyme with lipolytic activity |
US5977053A (en) | 1995-07-31 | 1999-11-02 | Bayer Ag | Detergents and cleaners containing iminodisuccinates |
WO1997007202A1 (en) | 1995-08-11 | 1997-02-27 | Novo Nordisk A/S | Novel lipolytic enzymes |
WO1997034005A1 (en) | 1996-03-12 | 1997-09-18 | Genencor International, Inc. | Alkaline cellulase and method of producing same |
WO1997043424A1 (en) | 1996-05-14 | 1997-11-20 | Genencor International, Inc. | MODIFIED α-AMYLASES HAVING ALTERED CALCIUM BINDING PROPERTIES |
WO1998008940A1 (en) | 1996-08-26 | 1998-03-05 | Novo Nordisk A/S | A novel endoglucanase |
WO1998012307A1 (en) | 1996-09-17 | 1998-03-26 | Novo Nordisk A/S | Cellulase variants |
WO1998015257A1 (en) | 1996-10-08 | 1998-04-16 | Novo Nordisk A/S | Diaminobenzoic acid derivatives as dye precursors |
WO1998017767A1 (en) | 1996-10-18 | 1998-04-30 | The Procter & Gamble Company | Detergent compositions |
WO1998020116A1 (en) | 1996-11-04 | 1998-05-14 | Novo Nordisk A/S | Subtilase variants and compositions |
WO1998020115A1 (en) | 1996-11-04 | 1998-05-14 | Novo Nordisk A/S | Subtilase variants and compositions |
BR9701341A (en) * | 1997-03-19 | 1998-11-17 | Unilever Nv | Detergent composition for washing fabrics preferably cotton and process for washing fabrics |
WO1999011768A1 (en) | 1997-08-29 | 1999-03-11 | Novo Nordisk A/S | Protease variants and compositions |
WO1999019467A1 (en) | 1997-10-13 | 1999-04-22 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
WO1999032595A1 (en) | 1997-12-20 | 1999-07-01 | Genencor International, Inc. | Granule with hydrated barrier material |
WO1999064619A2 (en) * | 1998-06-10 | 1999-12-16 | Novozymes A/S | Novel mannanases |
WO2000001793A1 (en) | 1998-06-30 | 2000-01-13 | Novozymes A/S | A new improved enzyme containing granule |
US6472364B1 (en) | 1998-10-13 | 2002-10-29 | The Procter & Gamble Company | Detergent compositions or components |
WO2000034450A1 (en) | 1998-12-04 | 2000-06-15 | Novozymes A/S | Cutinase variants |
WO2000060063A1 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Lipase variant |
WO2001016285A2 (en) | 1999-08-31 | 2001-03-08 | Novozymes A/S | Novel proteases and variants thereof |
WO2001044452A1 (en) | 1999-12-15 | 2001-06-21 | Novozymes A/S | Subtilase variants having an improved wash performance on egg stains |
WO2001066712A2 (en) | 2000-03-08 | 2001-09-13 | Novozymes A/S | Variants with altered properties |
WO2001092502A1 (en) | 2000-06-02 | 2001-12-06 | Novozymes A/S | Cutinase variants |
WO2002010355A2 (en) | 2000-08-01 | 2002-02-07 | Novozymes A/S | Alpha-amylase mutants with altered stability |
WO2002026024A1 (en) | 2000-08-05 | 2002-04-04 | Haiquan Li | An apparatus using recyclable resource |
WO2002016547A2 (en) | 2000-08-21 | 2002-02-28 | Novozymes A/S | Subtilase enzymes |
WO2002099091A2 (en) | 2001-06-06 | 2002-12-12 | Novozymes A/S | Endo-beta-1,4-glucanase from bacillus |
WO2003006602A2 (en) | 2001-07-12 | 2003-01-23 | Novozymes A/S | Subtilase variants |
US20040171154A1 (en) | 2001-07-27 | 2004-09-02 | Francesca Storici | Systems for in vivo site-directed mutagenesis using oligonucleotides |
WO2003040279A1 (en) | 2001-11-09 | 2003-05-15 | Unilever Plc | Polymers for laundry applications |
US7262042B2 (en) | 2001-12-20 | 2007-08-28 | Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) | Alkaline protease from Bacillus gibsonii (DSM 14393) and washing and cleaning products comprising said alkaline protease |
EP1350843A2 (en) | 2002-03-27 | 2003-10-08 | Kao Corporation | Alkaline cellulase variants |
EP1382668A1 (en) | 2002-06-11 | 2004-01-21 | Unilever N.V. | Detergent tablets |
WO2004003186A2 (en) | 2002-06-26 | 2004-01-08 | Novozymes A/S | Subtilases and subtilase variants having altered immunogenicity |
WO2004041979A2 (en) | 2002-11-06 | 2004-05-21 | Novozymes A/S | Subtilase variants |
JP2004175882A (en) * | 2002-11-26 | 2004-06-24 | Kao Corp | Composition for washing |
WO2004074419A2 (en) | 2003-02-18 | 2004-09-02 | Novozymes A/S | Detergent compositions |
WO2005003275A1 (en) | 2003-06-18 | 2005-01-13 | Unilever Plc | Laundry treatment compositions |
WO2005003276A1 (en) | 2003-06-18 | 2005-01-13 | Unilever Plc | Laundry treatment compositions |
WO2005003274A1 (en) | 2003-06-18 | 2005-01-13 | Unilever Plc | Laundry treatment compositions |
WO2005040372A1 (en) | 2003-10-23 | 2005-05-06 | Novozymes A/S | Protease with improved stability in detergents |
WO2005052146A2 (en) | 2003-11-19 | 2005-06-09 | Genencor International, Inc. | Serine proteases, nucleic acids encoding serine enzymes and vectors and host cells incorporating same |
WO2005052161A2 (en) | 2003-11-19 | 2005-06-09 | Genencor International, Inc. | Serine proteases, nucleic acids encoding serine enzymes and vectors and host cells incorporating same |
WO2005056782A2 (en) | 2003-12-03 | 2005-06-23 | Genencor International, Inc. | Perhydrolase |
WO2006066594A2 (en) | 2004-12-23 | 2006-06-29 | Novozymes A/S | Alpha-amylase variants |
EP1705241A1 (en) | 2005-03-23 | 2006-09-27 | Unilever N.V. | Detergent compositions in tablet form |
WO2006108856A2 (en) | 2005-04-15 | 2006-10-19 | Basf Aktiengesellschaft | Amphiphilic water-soluble alkoxylated polyalkylenimines with an internal polyethylene oxide block and an external polypropylene oxide block |
WO2006113314A1 (en) | 2005-04-15 | 2006-10-26 | The Procter & Gamble Company | Liquid laundry detergent compositions with modified polyethyleneimine polymers and lipase enzyme |
WO2006130575A2 (en) | 2005-05-31 | 2006-12-07 | The Procter & Gamble Company | Polymer-containing detergent compositions and their use |
WO2007001262A1 (en) | 2005-06-17 | 2007-01-04 | The Procter & Gamble Company | Organic catalyst with enhanced enzyme compatibility |
WO2007006305A1 (en) | 2005-07-08 | 2007-01-18 | Novozymes A/S | Subtilase variants |
WO2007044993A2 (en) | 2005-10-12 | 2007-04-19 | Genencor International, Inc. | Use and production of storage-stable neutral metalloprotease |
WO2007087259A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Enzyme and photobleach containing compositions |
WO2007087257A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Enzyme and fabric hueing agent containing compositions |
WO2007087258A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | A composition comprising a lipase and a bleach catalyst |
WO2007087243A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Detergent compositions |
WO2007087244A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Detergent compositions |
WO2007087508A2 (en) | 2006-01-23 | 2007-08-02 | Novozymes A/S | Lipase variants |
WO2007087242A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | A composition comprising a lipase and a bleach catalyst |
WO2007138054A1 (en) | 2006-05-31 | 2007-12-06 | The Procter & Gamble Company | Cleaning compositions with amphiphilic graft polymers based on polyalkylene oxides and vinyl esters |
EP1867707A1 (en) * | 2006-06-16 | 2007-12-19 | The Procter and Gamble Company | Detergent compositions |
EP1867708A1 (en) | 2006-06-16 | 2007-12-19 | The Procter and Gamble Company | Detergent Compositions |
EP1876226A1 (en) | 2006-07-07 | 2008-01-09 | The Procter and Gamble Company | Detergent compositions |
WO2008101958A1 (en) | 2007-02-20 | 2008-08-28 | Novozymes A/S | Enzyme foam treatment for laundry |
WO2008153815A2 (en) | 2007-05-30 | 2008-12-18 | Danisco Us, Inc., Genencor Division | Variants of an alpha-amylase with improved production levels in fermentation processes |
WO2009000605A1 (en) | 2007-06-22 | 2008-12-31 | Unilever N.V. | Granular enzymatic detergent compositions |
US20090011970A1 (en) | 2007-07-02 | 2009-01-08 | Marc Francois Theophile Evers | Laundry multi-compartment pouch composition |
WO2009004294A1 (en) | 2007-07-05 | 2009-01-08 | Reckitt Benckiser N.V. | Laundry cleaning product |
WO2009004295A1 (en) | 2007-07-05 | 2009-01-08 | Reckitt Benckiser N.V. | Laundry cleaning product |
WO2009010375A1 (en) | 2007-07-16 | 2009-01-22 | Unilever Plc | A solid detergent composition |
WO2009015951A1 (en) | 2007-07-31 | 2009-02-05 | Henkel Ag & Co. Kgaa | Compositions comprising perhydrolases and alkylene glycol diacetates |
WO2009021813A2 (en) | 2007-08-10 | 2009-02-19 | Henkel Ag & Co. Kgaa | Washing or cleaning agent having polyester-based soil-release polymer |
WO2009021867A2 (en) | 2007-08-10 | 2009-02-19 | Henkel Ag & Co. Kgaa | Agents containing proteases |
WO2009021784A1 (en) | 2007-08-14 | 2009-02-19 | Unilever N.V. | Detergent tablet |
WO2009024780A1 (en) | 2007-08-20 | 2009-02-26 | Reckitt Benckiser N.V. | Detergent composition |
WO2009030632A1 (en) | 2007-09-04 | 2009-03-12 | Henkel Ag & Co. Kgaa | Polycyclic compounds as enzyme stabilizers |
WO2009040545A1 (en) | 2007-09-26 | 2009-04-02 | Reckitt Benckiser N.V. | Composition |
WO2009040544A1 (en) | 2007-09-28 | 2009-04-02 | Reckitt Benckiser N.V. | Detergent composition |
WO2009047126A2 (en) | 2007-10-12 | 2009-04-16 | Unilever Plc | Laundry detergent with pretreatment additive and its use |
WO2009047125A1 (en) | 2007-10-12 | 2009-04-16 | Unilever Plc | Improved visual cues for perfumed laundry detergents |
WO2009047127A1 (en) | 2007-10-12 | 2009-04-16 | Unilever Plc | Granular detergent compositions with contrasting lamellar visual cues |
WO2009047128A1 (en) | 2007-10-12 | 2009-04-16 | Unilever Plc | Performance ingredients in film particles |
WO2009050026A2 (en) | 2007-10-17 | 2009-04-23 | Unilever Nv | Laundry compositions |
WO2009061380A2 (en) | 2007-11-05 | 2009-05-14 | Danisco Us Inc., Genencor Division | VARIANTS OF BACILLUS sp. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES |
WO2009063355A1 (en) | 2007-11-13 | 2009-05-22 | The Procter & Gamble Company | Process for creating a unit dose product with a printed water soluble material |
WO2009067279A1 (en) | 2007-11-21 | 2009-05-28 | E.I. Du Pont De Nemours And Company | Production of peracids using an enzyme having perhydrolysis activity |
WO2009065770A1 (en) | 2007-11-21 | 2009-05-28 | Henkel Ag & Co. Kgaa | Granulate of a sensitive ingredient of a washing or cleaning agent |
WO2009068501A1 (en) | 2007-11-28 | 2009-06-04 | Henkel Ag & Co. Kgaa | Washing agent having stabilized enzymes |
WO2009072069A1 (en) | 2007-12-05 | 2009-06-11 | The Procter & Gamble Company | Package comprising detergent |
WO2009074398A1 (en) | 2007-12-10 | 2009-06-18 | Henkel Ag & Co. Kgaa | Cleaning agent |
WO2009074403A1 (en) | 2007-12-11 | 2009-06-18 | Henkel Ag & Co. Kgaa | Cleaning agent |
WO2009087523A2 (en) | 2008-01-04 | 2009-07-16 | The Procter & Gamble Company | A laundry detergent composition comprising glycosyl hydrolase |
WO2009087033A1 (en) | 2008-01-10 | 2009-07-16 | Unilever Plc | Granules |
WO2009092699A1 (en) | 2008-01-24 | 2009-07-30 | Unilever Nv | Machine dishwash detergent compositions |
WO2009095645A1 (en) | 2008-01-28 | 2009-08-06 | Reckitt Benckiser N.V. | Composition |
WO2009102854A1 (en) | 2008-02-15 | 2009-08-20 | The Procter & Gamble Company | Cleaning compositions |
WO2009109500A1 (en) | 2008-02-29 | 2009-09-11 | Novozymes A/S | Polypeptides having lipase activity and polynucleotides encoding same |
WO2009112298A1 (en) | 2008-03-14 | 2009-09-17 | Unilever Plc | Laundry treatment composition comprising polymeric lubricants |
WO2009112296A1 (en) | 2008-03-14 | 2009-09-17 | Unilever Plc | Laundry treatment compositions |
WO2009117342A1 (en) | 2008-03-18 | 2009-09-24 | The Procter & Gamble Company | A laundry detergent composition comprising the magnesium salt of ethylene diamine-n'n'-disuccinic acid |
WO2009117341A1 (en) | 2008-03-18 | 2009-09-24 | The Procter & Gamble Company | Detergent composition comprising cellulosic polymer |
WO2009117340A1 (en) | 2008-03-18 | 2009-09-24 | The Procter & Gamble Company | Detergent composition comprising a co-polyester of dicarboxylic acids and diols |
WO2009115391A1 (en) | 2008-03-18 | 2009-09-24 | Henkel Ag & Co. Kgaa | Use of imidazolium salts in detergents and cleaning products |
WO2009115392A1 (en) | 2008-03-18 | 2009-09-24 | Henkel Ag & Co. Kgaa | Imidazolium salts as enzyme stabilizers |
WO2009103822A1 (en) | 2008-04-01 | 2009-08-27 | Unilever Nv | Preparation of free flowing granules of methyglycine diacetic acid |
WO2009122125A1 (en) | 2008-04-01 | 2009-10-08 | Reckitt Benckiser Inc. | Laundry treatment compositions |
WO2009121725A1 (en) | 2008-04-02 | 2009-10-08 | Henkel Ag & Co. Kgaa | Detergents and cleaners comprising proteases from xanthomonas |
WO2009124163A1 (en) | 2008-04-02 | 2009-10-08 | The Procter & Gamble Company | Detergent composition comprising reactive dye |
WO2009124162A1 (en) | 2008-04-02 | 2009-10-08 | The Procter & Gamble Company | Detergent composition comprising non-ionic detersive surfactant and reactive dye |
WO2010044905A2 (en) | 2008-04-02 | 2010-04-22 | The Procter & Gamble Company | A kit of parts comprising a solid laundry detergent composition and a dosing device |
WO2009121757A2 (en) | 2008-04-04 | 2009-10-08 | Unilever Plc | A novel personal wash bar |
WO2009132870A1 (en) | 2008-05-02 | 2009-11-05 | Unilever Plc | Reduced spotting granules |
WO2010000636A1 (en) | 2008-07-03 | 2010-01-07 | Henkel Ag & Co. Kgaa | Solid fabric care composition with a polysaccharide |
WO2010003792A1 (en) | 2008-07-09 | 2010-01-14 | Unilever Plc | Laundry compositions |
WO2010003783A1 (en) | 2008-07-11 | 2010-01-14 | Unilever Nv | Copolymers and detergent compositions |
WO2010014395A1 (en) | 2008-07-28 | 2010-02-04 | The Procter & Gamble Company | Process for preparing a detergent composition |
WO2010018043A1 (en) | 2008-08-14 | 2010-02-18 | Unilever Nv | Builder composition |
WO2010025161A1 (en) | 2008-08-27 | 2010-03-04 | The Procter & Gamble Company | A detergent composition comprising carbohydrate:acceptor oxidoreductase |
WO2010024470A1 (en) | 2008-09-01 | 2010-03-04 | The Procter & Gamble Company | Composition comprising polyoxyalkylene-based polymer composition |
WO2010024469A1 (en) | 2008-09-01 | 2010-03-04 | The Procter & Gamble Company | Hydrophobic group-containing copolymer and process for the production thereof |
WO2010024467A1 (en) | 2008-09-01 | 2010-03-04 | The Procter & Gamble Company | Polymer composition and process for the production thereof |
WO2010030541A1 (en) | 2008-09-12 | 2010-03-18 | The Procter & Gamble Company | Laundry particle made by extrusion comprising a hueing dye |
WO2010030539A1 (en) | 2008-09-12 | 2010-03-18 | The Procter & Gamble Company | Laundry particle made by extrusion comprising a hueing dye and fatty acid soap |
WO2010030540A1 (en) | 2008-09-12 | 2010-03-18 | The Procter & Gamble Company | Particles comprising a hueing dye |
WO2010031607A1 (en) | 2008-09-18 | 2010-03-25 | Henkel Ag & Co. Kgaa | Bleach-containing cleaning agent |
WO2010033747A1 (en) | 2008-09-19 | 2010-03-25 | The Procter & Gamble Company | Dual character biopolymer useful in cleaning products |
WO2010033746A1 (en) | 2008-09-19 | 2010-03-25 | The Procter & Gamble Company | Detergent composition containing suds boosting and suds stabilizing modified biopolymer |
WO2010033897A1 (en) | 2008-09-19 | 2010-03-25 | The Procter & Gamble Company | Cleaning composition containing substituted starch |
WO2010033979A2 (en) | 2008-09-22 | 2010-03-25 | The Procter & Gamble Company | Specific polybranched polyaldehydes, polyalcohols, and surfactants and consumer products based thereon |
WO2010033976A2 (en) | 2008-09-22 | 2010-03-25 | The Procter & Gamble Company | Specific branched aldehydes, alcohols, surfactants and consumer products based thereon |
WO2010049187A1 (en) | 2008-10-31 | 2010-05-06 | Henkel Ag & Co. Kgaa | Dishwasher detergent |
WO2010054986A1 (en) | 2008-11-12 | 2010-05-20 | Unilever Plc | Fabric whiteness measurement system |
WO2010057784A1 (en) | 2008-11-20 | 2010-05-27 | Unilever Plc | Fabric whiteness measurement system |
WO2010060821A2 (en) | 2008-11-27 | 2010-06-03 | Henkel Ag & Co. Kgaa | Detergents and cleaning agents containing proteases from bacillus pumilus |
WO2010065455A2 (en) | 2008-12-01 | 2010-06-10 | Danisco Us Inc. | Enzymes with lipase activity |
WO2010063689A1 (en) | 2008-12-05 | 2010-06-10 | Henkel Ag & Co. Kgaa | Automatic dishwashing detergent tablets |
WO2010066486A2 (en) | 2008-12-09 | 2010-06-17 | Henkel Ag & Co. Kgaa | Photolabile fragrance storage substances |
WO2010066632A1 (en) | 2008-12-12 | 2010-06-17 | Henkel Ag & Co. Kgaa | Laundry article having cleaning and conditioning properties |
WO2010066631A1 (en) | 2008-12-12 | 2010-06-17 | Henkel Ag & Co. Kgaa | Laundry article having cleaning and conditioning properties |
WO2010072603A1 (en) | 2008-12-15 | 2010-07-01 | Henkel Ag & Co. Kgaa | Dishwasher detergent |
WO2010076165A1 (en) | 2008-12-15 | 2010-07-08 | Henkel Ag & Co. Kgaa | Machine dishwashing detergent |
WO2010069718A1 (en) | 2008-12-16 | 2010-06-24 | Unilever Nv | Solid builder composition |
WO2010069957A1 (en) | 2008-12-17 | 2010-06-24 | Unilever Plc | Laundry detergent composition |
WO2010069742A1 (en) | 2008-12-18 | 2010-06-24 | Unilever Nv | Laundry detergent composition |
WO2010069905A1 (en) | 2008-12-19 | 2010-06-24 | Henkel Ag & Co. Kgaa | Dishwasher detergent |
WO2010072456A1 (en) | 2008-12-23 | 2010-07-01 | Henkel Ag & Co. Kgaa | Use of star-shaped polymers having peripheral negatively charged groups and/or peripheral silyl groups for finishing surfaces |
WO2010076292A1 (en) | 2008-12-29 | 2010-07-08 | Unilever Plc | Structured aqueous detergent compositions |
WO2010078979A1 (en) | 2009-01-09 | 2010-07-15 | Henkel Ag & Co. Kgaa | Color-protecting dishwasher detergent |
WO2010084203A1 (en) | 2009-01-26 | 2010-07-29 | Henkel Ag & Co. Kgaa | Additional laundry item |
WO2010084039A1 (en) | 2009-01-26 | 2010-07-29 | Unilever Plc | Incorporation of dye into granular laundry composition |
WO2010090915A1 (en) | 2009-02-09 | 2010-08-12 | The Procter & Gamble Company | Detergent composition |
WO2010094356A1 (en) | 2009-02-18 | 2010-08-26 | Henkel Ag & Co. Kgaa | Pro-fragrance copolymeric compounds |
WO2010099997A1 (en) | 2009-03-05 | 2010-09-10 | Unilever Plc | Dye radical initiators |
WO2010100028A2 (en) | 2009-03-06 | 2010-09-10 | Huntsman Advanced Materials (Switzerland) Gmbh | Enzymatic textile bleach-whitening methods |
WO2010102861A1 (en) | 2009-03-12 | 2010-09-16 | Unilever Plc | Dye-polymers formulations |
WO2010107635A1 (en) | 2009-03-16 | 2010-09-23 | The Procter & Gamble Company | Method of industrial or institutional laundry for a polyester load |
WO2010108000A1 (en) | 2009-03-18 | 2010-09-23 | The Procter & Gamble Company | Structured fluid detergent compositions comprising dibenzylidene polyol acetal derivatives and detersive enzymes |
WO2010107560A2 (en) | 2009-03-18 | 2010-09-23 | Danisco Us Inc. | Fungal cutinase from magnaporthe grisea |
WO2010108002A1 (en) | 2009-03-18 | 2010-09-23 | The Procter & Gamble Company | Structured fluid detergent compositions comprising dibenzylidene sorbitol acetal derivatives |
WO2010105942A1 (en) | 2009-03-20 | 2010-09-23 | Henkel Ag & Co. Kgaa | 4-aminopyridine derivatives as catalysts for the cleavage of organic esters |
WO2010105961A1 (en) | 2009-03-20 | 2010-09-23 | Henkel Ag & Co. Kgaa | Detergent or cleaning agent comprising a bleach-boosting transition metal complex which is optionally produced in situ |
WO2010105962A1 (en) | 2009-03-20 | 2010-09-23 | Henkel Ag & Co. Kgaa | Detergent or cleaning agent comprising a bleach-boosting transition metal complex which is optionally produced in situ |
WO2010111143A2 (en) | 2009-03-23 | 2010-09-30 | Danisco Us Inc. | Cal a-related acyltransferases and methods of use, thereof |
WO2010111365A1 (en) | 2009-03-26 | 2010-09-30 | The Procter & Gamble Company | A perfume encapsulate, a laundry detergent composition comprising a perfume encapsulate, and a process for preparing a perfume encapsulate |
WO2010115813A1 (en) | 2009-04-07 | 2010-10-14 | Henkel Ag & Co. Kgaa | Use of a prebiotically effective surfactant combination |
WO2010118959A1 (en) | 2009-04-15 | 2010-10-21 | Henkel Ag & Co. Kgaa | Granular washing, cleaning or treatment agent additive |
WO2010120863A1 (en) | 2009-04-17 | 2010-10-21 | The Procter & Gamble Company | Fabric care compositions comprising organosiloxane polymers |
WO2010122051A1 (en) | 2009-04-24 | 2010-10-28 | Unilever Plc | High active detergent particles |
WO2010135238A1 (en) | 2009-05-19 | 2010-11-25 | The Procter & Gamble Company | A method for printing water-soluble film |
WO2010142539A1 (en) | 2009-06-08 | 2010-12-16 | Henkel Ag & Co. Kgaa | Nanoparticulate manganese dioxide |
WO2010142503A1 (en) | 2009-06-12 | 2010-12-16 | Unilever Plc | Cationic dye polymers |
WO2010145887A1 (en) | 2009-06-15 | 2010-12-23 | Unilever Plc | Anionic dye polymers |
WO2011005910A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Method of laundering fabric using a compacted laundry detergent composition |
US20110005003A1 (en) * | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Catalytic laundry detergent composition comprising relatively low levels of water-soluble electrolyte |
WO2011005912A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Method of laundering fabric |
WO2011005844A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Method of laundering fabric using a compacted laundry detergent composition |
WO2011005904A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Detergent composition |
WO2011005630A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Method of laundering fabric using a compacted laundry detergent composition |
WO2011005730A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | A catalytic laundry detergent composition comprising relatively low levels of water-soluble electrolyte |
WO2011005905A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | A mildly alkaline, low-built, solid fabric treatment detergent composition comprising phthalimido peroxy caproic acid |
WO2011005830A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Laundry detergent composition comprising low level of sulphate |
WO2011005813A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Method of laundering fabric using a compacted laundry detergent composition |
WO2011005803A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Continuous process for making a laundry detergent composition |
WO2011005623A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | Laundry detergent composition comprising low level of bleach |
WO2011016958A2 (en) | 2009-07-27 | 2011-02-10 | The Procter & Gamble Company | Detergent composition |
WO2011025615A2 (en) | 2009-08-13 | 2011-03-03 | The Procter & Gamble Company | Method of laundering fabrics at low temperature |
WO2011023716A1 (en) | 2009-08-26 | 2011-03-03 | Henkel Ag & Co. Kgaa | Improved washing performance using radical traps |
WO2011036263A1 (en) | 2009-09-25 | 2011-03-31 | Novozymes A/S | Subtilase variants |
WO2011036264A1 (en) | 2009-09-25 | 2011-03-31 | Novozymes A/S | Use of protease variants |
WO2011084412A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing thermobifida fusca lipase and methods of use thereof |
WO2011084417A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing geobacillus stearothermophilus lipase and methods of use thereof |
WO2011084599A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing bacillus subtilis lipase and methods of use thereof |
WO2011098531A1 (en) | 2010-02-10 | 2011-08-18 | Novozymes A/S | Variants and compositions comprising variants with high stability in presence of a chelating agent |
WO2011150157A2 (en) | 2010-05-28 | 2011-12-01 | Danisco Us Inc. | Detergent compositions containing streptomyces griseus lipase and methods of use thereof |
WO2012137147A1 (en) | 2011-04-08 | 2012-10-11 | Danisco Us, Inc. | Compositions |
WO2013001078A1 (en) | 2011-06-30 | 2013-01-03 | Novozymes A/S | Alpha-amylase variants |
WO2013001087A2 (en) | 2011-06-30 | 2013-01-03 | Novozymes A/S | Method for screening alpha-amylases |
WO2013113622A1 (en) | 2012-02-03 | 2013-08-08 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
Non-Patent Citations (41)
Title |
---|
"Powdered Detergents, Surfactant science series", vol. 71, MARCEL DEKKER, INC |
BARTON ET AL., NUCLEIC ACIDS RES., vol. 18, 1990, pages 7349 - 4966 |
BOWIE; SAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156 |
CALISSANO; MACINO, FUNGAL GENET. NEWSLETT., vol. 43, 1996, pages 15 - 16 |
CARTER ET AL., PROTEINS: STRUCTURE, FUNCTION, AND GENETICS, vol. 6, 1989, pages 240 - 248 |
COLLINS-RACIE ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 982 - 987 |
CONTRERAS ET AL., BIOTECHNOLOGY, vol. 9, 1991, pages 378 - 381 |
COOPER ET AL., EMBO J., vol. 12, 1993, pages 2575 - 2583 |
CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085 |
DAWSON ET AL., SCIENCE, vol. 266, 1994, pages 776 - 779 |
DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312 |
DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145 |
EATON ET AL., BIOCHEMISTRY, vol. 25, 1986, pages 505 - 512 |
FEINBERG, A. P.; VOGELSTEIN, B., ANAL. BIOCHEM., vol. 132, 1983, pages 6 - 13 |
FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107 |
HILTON ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 4699 - 4708 |
HODGDON; KALER, CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, vol. 12, 2007, pages 121 - 128 |
KREN ET AL., NAT. MED., vol. 4, 1998, pages 285 - 290 |
LOWMAN ET AL., BIOCHEM., vol. 30, 1991, pages 10832 - 10837 |
LOWMAN ET AL., BIOCHEMISTRY, vol. 30, 1991, pages 10832 - 10837 |
MARTIN ET AL., J. IND. MICROBIOL. BIOTECHNOL., vol. 3, 2003, pages 568 - 576 |
NEEDLEMAN, S.B.; WUNSCH, C.D., JOURNAL OF MOLECULAR BIOLOGY, vol. 48, 1970, pages 443 - 453 |
NER ET AL., DNA, vol. 7, 1988, pages 127 |
NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896 |
NILSSON ET AL., EMBO J., vol. 4, 1985, pages 1075 |
NILSSON ET AL., METHODS ENZYMOL., vol. 198, no. 3, 1991 |
PETER TOMME ET AL.: "Enzymatic Degradation of Insoluble Carbohydrates", 1996, ACS SYMPOSIUM SERIES, NO. 618, article "Cellulose-Binding Domains: Classification and Properties" |
RASMUSSEN-WILSON ET AL., APPL. ENVIRON. MICROBIOL., vol. 63, 1997, pages 3488 - 3493 |
REIDHAAR-OLSON; SAUER, SCIENCE, vol. 241, 1988, pages 53 - 57 |
SAMBROOK ET AL.: "Molecular Cloning, A Laboratory Manual, 2d edition,", 1989, COLD SPRING HARBOR |
SAMBROOK ET AL.: "Molecular cloning: A laboratory manual", 1989, COLD SPRING HARBOR LAB. |
SCHERER; DAVIS, PROC. NATL. ACAD. SCI. USA, vol. 76, 1979, pages 4949 - 4955 |
SIEZEN ET AL., PROTEIN ENGNG., vol. 4, 1991, pages 719 - 737 |
SIEZEN ET AL., PROTEIN SCIENCE, vol. 6, 1997, pages 501 - 523 |
SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904 |
STEVENS, DRUG DISCOVERY WORLD, vol. 4, 2003, pages 35 - 48 |
STORICI ET AL., NATURE BIOTECHNOL., vol. 19, 2001, pages 773 - 776 |
SVETINA ET AL., J. BIOTECHNOL., vol. 76, 2000, pages 245 - 251 |
TIAN ET AL., NATURE, vol. 432, 2004, pages 1050 - 1054 |
WARD ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 498 - 503 |
WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017060471A1 (en) | 2015-10-09 | 2017-04-13 | Novozymes A/S | Enzymatic or non-enzymatic biodiesel polishing process |
WO2020047215A1 (en) * | 2018-08-30 | 2020-03-05 | Danisco Us Inc | Enzyme-containing granules |
WO2023039270A3 (en) * | 2021-09-13 | 2023-04-20 | Danisco Us Inc. | Bioactive-containing granules |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10647947B2 (en) | Detergent composition | |
US11549104B2 (en) | Polypeptides having beta-glucanase activity, polynucleotides encoding same and uses thereof in cleaning and detergent compositions | |
AU2016323412B2 (en) | Detergent compositions comprising polypeptides having xanthan degrading activity | |
KR20200071135A (en) | Cleaning composition containing dispercin I | |
AU2014286135A1 (en) | Polypeptides with xanthan lyase activity having anti-redeposition effect and polynucleotides encoding same | |
KR20190045095A (en) | A detergent composition comprising xanthine lyase mutant I | |
EP3947619A1 (en) | Polypeptides having beta-glucanase activity, polynucleotides encoding same and uses thereof in cleaning and detergent compositions | |
EP4225905A2 (en) | Alpha-amylase variants | |
CN113302270A (en) | Low pH powder detergent compositions | |
CA3122942A1 (en) | Alpha-amylase variants and polynucleotides encoding same | |
EP3105321A1 (en) | Detergent composition, method and use of detergent composition | |
US20220186151A1 (en) | Stabilized glycoside hydrolase variants | |
WO2015049370A1 (en) | Detergent composition and use of detergent composition | |
WO2022089571A1 (en) | Detergent composition and cleaning method | |
EP4291646A2 (en) | Alpha-amylase variants | |
US20230313165A1 (en) | Variants of a family 44 xyloglucanase | |
EP3380609A1 (en) | Polypeptides having protease activity and polynucleotides encoding same | |
EP3861008A1 (en) | Polypeptides having alpha-mannan degrading activity and polynucleotides encoding same | |
EP2929020A1 (en) | Polypeptides having chlorophyllase activity and polynucleotides encoding same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14780508 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14780508 Country of ref document: EP Kind code of ref document: A1 |